A O
portion O
of O
Region O
II O
also O
resembles O
part O
of O
the O
human O
c B
- I
jun I
oncoprotein O
' O
s O
leucine O
zipper O
, O
which O
in O
turn O
, O
has O
been O
demonstrated O
to O
be O
the O
heterodimerization O
site O
between O
the O
jun B
and O
fos B
oncoproteins I
. O

All O
other O
normal O
and O
transformed O
lymphoid O
and O
nonlymphoid O
cell O
lines O
and O
normal O
tissues O
were O
negative O
for O
PANG B
expression O
except O
for O
the O
brain O
, O
wherein O
unique O
4 O
. O
0 O
- O
and O
6 O
. O
1 O
- O
kb O
transcripts O
were O
detected O
. O

This O
strategy O
was O
used O
to O
place O
both O
the O
Tn903 B
neo I
gene I
and O
the O
Rhodosporidium B
toruloides I
phenylalanine I
ammonia I
lyase I
( O
PAL B
) O
- O
encoding O
gene O
under O
the O
transcriptional O
control O
of O
pPGK B
: O
: O
REP2 B
. O

This O
strategy O
was O
used O
to O
place O
both O
the O
Tn903 B
neo I
gene I
and O
the O
Rhodosporidium B
toruloides I
phenylalanine I
ammonia I
lyase I
( O
PAL B
) O
- O
encoding O
gene O
under O
the O
transcriptional O
control O
of O
pPGK B
: O
: O
REP2 B
. O

This O
strategy O
was O
used O
to O
place O
both O
the O
Tn903 B
neo I
gene I
and O
the O
Rhodosporidium B
toruloides I
phenylalanine I
ammonia I
lyase I
( O
PAL B
) O
- O
encoding O
gene O
under O
the O
transcriptional O
control O
of O
pPGK B
: O
: O
REP2 B
. O

Phosphatidylinositol B
3 I
- I
kinase I
requirement O
in O
activation O
of O
the O
ras B
/ O
C B
- I
raf I
- I
1 I
/ O
MEK B
/ O
ERK B
and O
p70 B
( O
s6k B
) O
signaling O
cascade O
by O
the O
insulinomimetic O
agent O
vanadyl O
sulfate O
. O

Phosphatidylinositol B
3 I
- I
kinase I
requirement O
in O
activation O
of O
the O
ras B
/ O
C B
- I
raf I
- I
1 I
/ O
MEK B
/ O
ERK B
and O
p70 B
( O
s6k B
) O
signaling O
cascade O
by O
the O
insulinomimetic O
agent O
vanadyl O
sulfate O
. O

Phosphatidylinositol B
3 I
- I
kinase I
requirement O
in O
activation O
of O
the O
ras B
/ O
C B
- I
raf I
- I
1 I
/ O
MEK B
/ O
ERK B
and O
p70 B
( O
s6k B
) O
signaling O
cascade O
by O
the O
insulinomimetic O
agent O
vanadyl O
sulfate O
. O

Phosphatidylinositol B
3 I
- I
kinase I
requirement O
in O
activation O
of O
the O
ras B
/ O
C B
- I
raf I
- I
1 I
/ O
MEK B
/ O
ERK B
and O
p70 B
( O
s6k B
) O
signaling O
cascade O
by O
the O
insulinomimetic O
agent O
vanadyl O
sulfate O
. O

Phosphatidylinositol B
3 I
- I
kinase I
requirement O
in O
activation O
of O
the O
ras B
/ O
C B
- I
raf I
- I
1 I
/ O
MEK B
/ O
ERK B
and O
p70 B
( O
s6k B
) O
signaling O
cascade O
by O
the O
insulinomimetic O
agent O
vanadyl O
sulfate O
. O

In O
the O
same O
period O
we O
pointed O
out O
an O
increase O
of O
hematocrit O
( O
from O
29 O
% O
to O
35 O
% O
) O
and O
of O
the O
Hb B
( O
from O
9 O
. O
3 O
to O
11 O
. O
2 O
g O
/ O
dl O
) O
. O

Cotransfection O
of O
Ets B
- I
2 I
and O
p44 B
mitogen B
- I
activated I
protein I
( I
MAP I
) I
kinase I
expression O
vectors O
strongly O
potentiated O
HB B
- O
EGF B
promoter O
activation O
in O
response O
to O
deltaRaf B
- I
1 I
: O
ER B
. O

Cotransfection O
of O
Ets B
- I
2 I
and O
p44 B
mitogen B
- I
activated I
protein I
( I
MAP I
) I
kinase I
expression O
vectors O
strongly O
potentiated O
HB B
- O
EGF B
promoter O
activation O
in O
response O
to O
deltaRaf B
- I
1 I
: O
ER B
. O

Cotransfection O
of O
Ets B
- I
2 I
and O
p44 B
mitogen B
- I
activated I
protein I
( I
MAP I
) I
kinase I
expression O
vectors O
strongly O
potentiated O
HB B
- O
EGF B
promoter O
activation O
in O
response O
to O
deltaRaf B
- I
1 I
: O
ER B
. O

Cotransfection O
of O
Ets B
- I
2 I
and O
p44 B
mitogen B
- I
activated I
protein I
( I
MAP I
) I
kinase I
expression O
vectors O
strongly O
potentiated O
HB B
- O
EGF B
promoter O
activation O
in O
response O
to O
deltaRaf B
- I
1 I
: O
ER B
. O

Sequence O
analysis O
of O
the O
promoter O
region O
showed O
no O
TATA O
box O
but O
identified O
consensus O
binding O
motifs O
for O
Sp1 B
, O
CREB B
, O
and O
half O
sites O
of O
the O
estrogen B
receptor I
binding I
site I
. O

Sequence O
analysis O
of O
the O
promoter O
region O
showed O
no O
TATA O
box O
but O
identified O
consensus O
binding O
motifs O
for O
Sp1 B
, O
CREB B
, O
and O
half O
sites O
of O
the O
estrogen B
receptor I
binding I
site I
. O

Unique O
to O
this O
system O
, O
the O
activity O
of O
TraR B
is O
negatively O
modulated O
by O
an O
antiactivator O
called O
TraM B
. O

Unique O
to O
this O
system O
, O
the O
activity O
of O
TraR B
is O
negatively O
modulated O
by O
an O
antiactivator O
called O
TraM B
. O

E1A B
represses O
apolipoprotein B
AI I
enhancer I
activity O
in O
liver O
cells O
through O
a O
pRb B
- O
and O
CBP B
- O
independent O
pathway O
. O

E1A B
represses O
apolipoprotein B
AI I
enhancer I
activity O
in O
liver O
cells O
through O
a O
pRb B
- O
and O
CBP B
- O
independent O
pathway O
. O

E1A B
represses O
apolipoprotein B
AI I
enhancer I
activity O
in O
liver O
cells O
through O
a O
pRb B
- O
and O
CBP B
- O
independent O
pathway O
. O

Dominant O
negative O
Sos B
did O
not O
affect O
carbachol O
stimulation O
of O
HA B
- O
ERK2 B
but O
inhibited O
the O
stimulatory O
effect O
of O
EGF B
by O
60 O
% O
. O

Dominant O
negative O
Sos B
did O
not O
affect O
carbachol O
stimulation O
of O
HA B
- O
ERK2 B
but O
inhibited O
the O
stimulatory O
effect O
of O
EGF B
by O
60 O
% O
. O

Dominant O
negative O
Sos B
did O
not O
affect O
carbachol O
stimulation O
of O
HA B
- O
ERK2 B
but O
inhibited O
the O
stimulatory O
effect O
of O
EGF B
by O
60 O
% O
. O

Dominant O
negative O
Sos B
did O
not O
affect O
carbachol O
stimulation O
of O
HA B
- O
ERK2 B
but O
inhibited O
the O
stimulatory O
effect O
of O
EGF B
by O
60 O
% O
. O

Identification O
and O
characterization O
of O
two O
putative O
human B
arginine I
methyltransferases I
( O
HRMT1L1 B
and O
HRMT1L2 B
) O
. O

Identification O
and O
characterization O
of O
two O
putative O
human B
arginine I
methyltransferases I
( O
HRMT1L1 B
and O
HRMT1L2 B
) O
. O

Remarkably O
, O
U21 B
contains O
a O
long O
stretch O
( O
13 O
nt O
. O
) O
of O
complementarity O
to O
a O
highly O
conserved O
sequence O
in O
28S B
rRNA I
. O

Data O
from O
in O
vitro O
splicing O
assays O
, O
UV O
crosslinking O
and O
RNA O
- O
binding O
competition O
experiments O
indicates O
a O
strong O
correlation O
between O
the O
binding O
affinities O
of O
PSI B
for O
the O
SELEX O
sequences O
and O
their O
ability O
to O
modulate O
splicing O
of O
P B
element I
IVS3 B
in O
vitro O
. O

Data O
from O
in O
vitro O
splicing O
assays O
, O
UV O
crosslinking O
and O
RNA O
- O
binding O
competition O
experiments O
indicates O
a O
strong O
correlation O
between O
the O
binding O
affinities O
of O
PSI B
for O
the O
SELEX O
sequences O
and O
their O
ability O
to O
modulate O
splicing O
of O
P B
element I
IVS3 B
in O
vitro O
. O

Factors O
involved O
in O
specific O
transcription O
by O
mammalian O
RNA B
polymerase I
II I
: O
purification O
, O
genetic O
specificity O
, O
and O
TATA O
box O
- O
promoter O
interactions O
of O
TFIID B
. O

EsaR B
can O
repress O
its O
own O
expression O
but O
seems O
not O
to O
regulate O
the O
expression O
of O
esaI B
. O

EsaR B
can O
repress O
its O
own O
expression O
but O
seems O
not O
to O
regulate O
the O
expression O
of O
esaI B
. O

Neither O
ethanol O
nor O
estrogen O
has O
been O
shown O
to O
cause O
UROD B
- O
deficiency O
in O
animals O
. O

Also O
, O
transient O
overexpression O
of O
this O
protein O
in O
C2C12 O
cells O
reduced O
the O
transcription O
of O
a O
CAT B
- O
reporter O
regulated O
by O
an O
E12 B
/ O
MyoD B
driven O
enhancer O
. O

Also O
, O
transient O
overexpression O
of O
this O
protein O
in O
C2C12 O
cells O
reduced O
the O
transcription O
of O
a O
CAT B
- O
reporter O
regulated O
by O
an O
E12 B
/ O
MyoD B
driven O
enhancer O
. O

Also O
, O
transient O
overexpression O
of O
this O
protein O
in O
C2C12 O
cells O
reduced O
the O
transcription O
of O
a O
CAT B
- O
reporter O
regulated O
by O
an O
E12 B
/ O
MyoD B
driven O
enhancer O
. O

CONCLUSIONS O
: O
Using O
icodextrin O
- O
based O
instead O
of O
glucose O
- O
based O
PD O
fluids O
can O
largely O
reduce O
the O
formation O
of O
Amadori O
albumin B
and O
AGEs O
. O

As O
in O
Tb O
, O
U6 B
is O
a O
single O
- O
copy O
gene O
and O
two O
tRNA O
genes O
, O
tRNAGln B
and O
tRNAIle B
, O
are O
found O
upstream O
to O
the O
gene O
. O

As O
in O
Tb O
, O
U6 B
is O
a O
single O
- O
copy O
gene O
and O
two O
tRNA O
genes O
, O
tRNAGln B
and O
tRNAIle B
, O
are O
found O
upstream O
to O
the O
gene O
. O

As O
in O
Tb O
, O
U6 B
is O
a O
single O
- O
copy O
gene O
and O
two O
tRNA O
genes O
, O
tRNAGln B
and O
tRNAIle B
, O
are O
found O
upstream O
to O
the O
gene O
. O

A O
4 O
. O
8 O
- O
kilobase O
BamHI B
- O
HindIII B
fragment O
encoding O
the O
entire B
Neurospora I
crassa I
CuZn I
superoxide I
dismutase I
gene I
( O
herein O
designated O
sod B
- I
1 I
) O
was O
isolated O
from O
a O
genomic O
library O
using O
two O
60 O
- O
base O
deoxyoligonucleotide O
probes O
corresponding O
to O
the O
published O
N O
. O
crassa O
amino O
acid O
sequence O
. O

A O
4 O
. O
8 O
- O
kilobase O
BamHI B
- O
HindIII B
fragment O
encoding O
the O
entire B
Neurospora I
crassa I
CuZn I
superoxide I
dismutase I
gene I
( O
herein O
designated O
sod B
- I
1 I
) O
was O
isolated O
from O
a O
genomic O
library O
using O
two O
60 O
- O
base O
deoxyoligonucleotide O
probes O
corresponding O
to O
the O
published O
N O
. O
crassa O
amino O
acid O
sequence O
. O

We O
have O
previously O
shown O
that O
the O
adenoviral B
12S I
E1A I
protein I
modulates O
the O
phosphorylation O
status O
of O
p130 B
and O
p107 B
without O
apparent O
changes O
in O
the O
cell O
cycle O
dependent O
phosphorylation O
of O
the O
retinoblastoma B
protein I
. O

We O
have O
previously O
shown O
that O
the O
adenoviral B
12S I
E1A I
protein I
modulates O
the O
phosphorylation O
status O
of O
p130 B
and O
p107 B
without O
apparent O
changes O
in O
the O
cell O
cycle O
dependent O
phosphorylation O
of O
the O
retinoblastoma B
protein I
. O

In O
this O
paper O
we O
report O
that O
ligand O
binding O
induced O
tyrosine O
phosphorylation O
in O
BaF3 O
cells O
engineered O
to O
express O
the O
murine B
Mpl I
receptor I
( O
BaF3 O
/ O
mMpl B
) O
. O

Genome O
plasticity O
in O
the O
distal O
tail O
fiber O
locus O
of O
the O
T O
- O
even O
bacteriophage O
: O
recombination O
between O
conserved O
motifs O
swaps O
adhesin B
specificity O
. O

Inactivity O
of O
the O
human B
cytomegalovirus I
( I
HCMV I
) I
major I
immediate I
- I
early I
regulatory I
region I
( O
MIERR B
) O
, O
which O
is O
composed O
of O
promoter O
, O
enhancer O
, O
unique O
region O
, O
and O
modulator O
, O
is O
linked O
to O
lack O
of O
HCMV O
replication O
in O
latently O
infected O
cells O
and O
in O
other O
nonpermissive O
cell O
types O
, O
including O
human O
embryonal O
NTera2 O
carcinoma O
( O
NT2 O
) O
cells O
. O

The O
5 O
' O
flanking O
region O
contains O
potential O
binding O
sites O
for O
TATA B
- I
binding I
protein I
, O
Sp1 B
, O
nuclear B
factor I
1 I
( O
NF1 B
) O
, O
CAAT B
- I
box I
binding I
protein I
( O
C B
/ I
EBP I
) O
, O
hepatocyte B
nuclear I
factors I
1 I
and I
5 I
( O
HNF1 B
, O
HNF5 B
) O
and O
activator B
proteins I
1 I
and I
2 I
( O
AP1 B
, O
AP2 B
) O
. O

The O
5 O
' O
flanking O
region O
contains O
potential O
binding O
sites O
for O
TATA B
- I
binding I
protein I
, O
Sp1 B
, O
nuclear B
factor I
1 I
( O
NF1 B
) O
, O
CAAT B
- I
box I
binding I
protein I
( O
C B
/ I
EBP I
) O
, O
hepatocyte B
nuclear I
factors I
1 I
and I
5 I
( O
HNF1 B
, O
HNF5 B
) O
and O
activator B
proteins I
1 I
and I
2 I
( O
AP1 B
, O
AP2 B
) O
. O

The O
5 O
' O
flanking O
region O
contains O
potential O
binding O
sites O
for O
TATA B
- I
binding I
protein I
, O
Sp1 B
, O
nuclear B
factor I
1 I
( O
NF1 B
) O
, O
CAAT B
- I
box I
binding I
protein I
( O
C B
/ I
EBP I
) O
, O
hepatocyte B
nuclear I
factors I
1 I
and I
5 I
( O
HNF1 B
, O
HNF5 B
) O
and O
activator B
proteins I
1 I
and I
2 I
( O
AP1 B
, O
AP2 B
) O
. O

The O
5 O
' O
flanking O
region O
contains O
potential O
binding O
sites O
for O
TATA B
- I
binding I
protein I
, O
Sp1 B
, O
nuclear B
factor I
1 I
( O
NF1 B
) O
, O
CAAT B
- I
box I
binding I
protein I
( O
C B
/ I
EBP I
) O
, O
hepatocyte B
nuclear I
factors I
1 I
and I
5 I
( O
HNF1 B
, O
HNF5 B
) O
and O
activator B
proteins I
1 I
and I
2 I
( O
AP1 B
, O
AP2 B
) O
. O

The O
5 O
' O
flanking O
region O
contains O
potential O
binding O
sites O
for O
TATA B
- I
binding I
protein I
, O
Sp1 B
, O
nuclear B
factor I
1 I
( O
NF1 B
) O
, O
CAAT B
- I
box I
binding I
protein I
( O
C B
/ I
EBP I
) O
, O
hepatocyte B
nuclear I
factors I
1 I
and I
5 I
( O
HNF1 B
, O
HNF5 B
) O
and O
activator B
proteins I
1 I
and I
2 I
( O
AP1 B
, O
AP2 B
) O
. O

The O
5 O
' O
flanking O
region O
contains O
potential O
binding O
sites O
for O
TATA B
- I
binding I
protein I
, O
Sp1 B
, O
nuclear B
factor I
1 I
( O
NF1 B
) O
, O
CAAT B
- I
box I
binding I
protein I
( O
C B
/ I
EBP I
) O
, O
hepatocyte B
nuclear I
factors I
1 I
and I
5 I
( O
HNF1 B
, O
HNF5 B
) O
and O
activator B
proteins I
1 I
and I
2 I
( O
AP1 B
, O
AP2 B
) O
. O

In O
both O
cases O
, O
at O
the O
end O
of O
exposure O
the O
same O
level O
of O
blood B
carboxyhemoglobin I
( O
COHb B
) O
( O
about O
50 O
% O
) O
was O
reached O
. O

Weak O
promoter O
activity O
was O
observed O
for O
the O
promoter O
of O
the O
C1 B
and O
C2 B
ORFs O
( O
C1 B
- O
C2 B
gene O
) O
and O
for O
the O
promoter O
of O
the O
V1 B
ORF I
. O

Weak O
promoter O
activity O
was O
observed O
for O
the O
promoter O
of O
the O
C1 B
and O
C2 B
ORFs O
( O
C1 B
- O
C2 B
gene O
) O
and O
for O
the O
promoter O
of O
the O
V1 B
ORF I
. O

Weak O
promoter O
activity O
was O
observed O
for O
the O
promoter O
of O
the O
C1 B
and O
C2 B
ORFs O
( O
C1 B
- O
C2 B
gene O
) O
and O
for O
the O
promoter O
of O
the O
V1 B
ORF I
. O

Weak O
promoter O
activity O
was O
observed O
for O
the O
promoter O
of O
the O
C1 B
and O
C2 B
ORFs O
( O
C1 B
- O
C2 B
gene O
) O
and O
for O
the O
promoter O
of O
the O
V1 B
ORF I
. O

VDR B
/ O
RXR B
bound O
well O
to O
the O
VDREs O
and O
to O
DR4 O
and O
DR5 O
using O
the O
electrophoretic O
mobility O
shift O
assay O
. O

VDR B
/ O
RXR B
bound O
well O
to O
the O
VDREs O
and O
to O
DR4 O
and O
DR5 O
using O
the O
electrophoretic O
mobility O
shift O
assay O
. O

The O
amino O
acid O
sequence O
of O
matrilysin B
- I
2 I
also O
contains O
a O
threonine O
residue O
adjacent O
to O
the O
Zn O
- O
binding O
site O
that O
has O
been O
defined O
as O
a O
specific O
feature O
of O
matrilysin B
. O

Targeted O
disruption O
of O
the O
OGG1 B
gene I
in O
yeast O
revealed O
a O
second O
OG B
glycosylase I
/ I
lyase I
protein I
, O
tentatively O
named O
Ogg2 B
, O
which O
differs O
from O
Ogg1 B
in O
that O
it O
preferentially O
acts O
on O
OG O
: O
G O
. O

Targeted O
disruption O
of O
the O
OGG1 B
gene I
in O
yeast O
revealed O
a O
second O
OG B
glycosylase I
/ I
lyase I
protein I
, O
tentatively O
named O
Ogg2 B
, O
which O
differs O
from O
Ogg1 B
in O
that O
it O
preferentially O
acts O
on O
OG O
: O
G O
. O

The O
nucleotide O
sequence O
directly O
upstream O
of O
fimA B
contains O
two O
open O
reading O
frames O
, O
ORF5 O
and O
ORF1 O
, O
whose O
deduced O
protein O
products O
are O
homologous O
to O
members O
of O
a O
superfamily O
of O
ATP B
- I
binding I
cassette I
membrane I
transport I
proteins I
, O
including O
both O
prokaryotic O
and O
eukaryotic O
uptake O
and O
export O
systems O
. O

To O
this O
end O
, O
an O
expression O
cassette O
consisting O
of O
the O
gene O
for O
a O
green B
fluorescent I
protein I
( O
GFP B
) O
flanked O
at O
its O
3 O
' O
end O
by O
EAV O
- O
specific O
transcription O
- O
regulating O
sequences O
was O
constructed O
. O

These O
data O
are O
consistent O
with O
the O
idea O
that O
the O
neuron B
- I
specific I
SCG10 I
gene I
evolved O
by O
duplication O
and O
modification O
of O
the O
more O
broadly O
expressed O
stathmin B
/ O
Lap18 B
gene O
. O

These O
data O
are O
consistent O
with O
the O
idea O
that O
the O
neuron B
- I
specific I
SCG10 I
gene I
evolved O
by O
duplication O
and O
modification O
of O
the O
more O
broadly O
expressed O
stathmin B
/ O
Lap18 B
gene O
. O

As O
an O
oral O
, O
nontoxic O
compound O
with O
a O
mechanism O
of O
action O
distinct O
from O
that O
of O
ABL B
tyrosine I
kinase I
inhibition O
, O
FTI O
SCH66336 O
shows O
promise O
for O
the O
treatment O
of O
BCR B
/ O
ABL B
- O
induced O
leukemia O
. O

As O
an O
oral O
, O
nontoxic O
compound O
with O
a O
mechanism O
of O
action O
distinct O
from O
that O
of O
ABL B
tyrosine I
kinase I
inhibition O
, O
FTI O
SCH66336 O
shows O
promise O
for O
the O
treatment O
of O
BCR B
/ O
ABL B
- O
induced O
leukemia O
. O

Using O
sequence O
information O
from O
human B
BMAL1 I
( O
hBMAL1 B
) O
cDNAs O
previously O
reported O
by O
our O
laboratory O
, O
we O
have O
isolated O
and O
characterized O
cDNAs O
encoding O
three O
splice O
variants O
of O
the O
mouse B
BMAL1 I
( O
mBMAL1 B
) O
gene O
. O

Using O
sequence O
information O
from O
human B
BMAL1 I
( O
hBMAL1 B
) O
cDNAs O
previously O
reported O
by O
our O
laboratory O
, O
we O
have O
isolated O
and O
characterized O
cDNAs O
encoding O
three O
splice O
variants O
of O
the O
mouse B
BMAL1 I
( O
mBMAL1 B
) O
gene O
. O

These O
results O
suggest O
that O
UBP41 B
may O
play O
an O
important O
role O
in O
the O
recycling O
of O
ubiquitin B
by O
hydrolysis O
of O
branched B
poly I
- I
ubiquitin I
chains I
generated O
by O
the O
action O
of O
26 B
S I
proteasome I
on O
poly O
- O
ubiquitinated O
protein O
substrates O
, O
as O
well O
as O
in O
the O
production O
of O
free O
ubiquitin B
from O
linear B
poly I
- I
ubiquitin I
chains I
and O
of O
certain O
ribosomal O
proteins O
from O
ubiquitin B
fusion I
proteins I
. O

These O
results O
suggest O
that O
UBP41 B
may O
play O
an O
important O
role O
in O
the O
recycling O
of O
ubiquitin B
by O
hydrolysis O
of O
branched B
poly I
- I
ubiquitin I
chains I
generated O
by O
the O
action O
of O
26 B
S I
proteasome I
on O
poly O
- O
ubiquitinated O
protein O
substrates O
, O
as O
well O
as O
in O
the O
production O
of O
free O
ubiquitin B
from O
linear B
poly I
- I
ubiquitin I
chains I
and O
of O
certain O
ribosomal O
proteins O
from O
ubiquitin B
fusion I
proteins I
. O

These O
results O
suggest O
that O
UBP41 B
may O
play O
an O
important O
role O
in O
the O
recycling O
of O
ubiquitin B
by O
hydrolysis O
of O
branched B
poly I
- I
ubiquitin I
chains I
generated O
by O
the O
action O
of O
26 B
S I
proteasome I
on O
poly O
- O
ubiquitinated O
protein O
substrates O
, O
as O
well O
as O
in O
the O
production O
of O
free O
ubiquitin B
from O
linear B
poly I
- I
ubiquitin I
chains I
and O
of O
certain O
ribosomal O
proteins O
from O
ubiquitin B
fusion I
proteins I
. O

Both O
Z B
and O
R B
expression O
resulted O
in O
PML O
dispersion O
in O
EBV O
- O
positive O
cells O
. O

Both O
Z B
and O
R B
expression O
resulted O
in O
PML O
dispersion O
in O
EBV O
- O
positive O
cells O
. O

Based O
on O
peptide O
map O
similarities O
, O
partial O
amino O
- O
terminal O
sequence O
data O
, O
and O
common O
genetic O
origin O
, O
it O
is O
suggested O
that O
p60 B
and O
p62 B
have O
identical O
amino O
acid O
sequences O
carboxy O
- O
terminal O
to O
the O
p60 B
initiator O
methionine O
( O
residue O
21 O
of O
p62 B
) O
. O

Based O
on O
peptide O
map O
similarities O
, O
partial O
amino O
- O
terminal O
sequence O
data O
, O
and O
common O
genetic O
origin O
, O
it O
is O
suggested O
that O
p60 B
and O
p62 B
have O
identical O
amino O
acid O
sequences O
carboxy O
- O
terminal O
to O
the O
p60 B
initiator O
methionine O
( O
residue O
21 O
of O
p62 B
) O
. O

Based O
on O
peptide O
map O
similarities O
, O
partial O
amino O
- O
terminal O
sequence O
data O
, O
and O
common O
genetic O
origin O
, O
it O
is O
suggested O
that O
p60 B
and O
p62 B
have O
identical O
amino O
acid O
sequences O
carboxy O
- O
terminal O
to O
the O
p60 B
initiator O
methionine O
( O
residue O
21 O
of O
p62 B
) O
. O

Based O
on O
peptide O
map O
similarities O
, O
partial O
amino O
- O
terminal O
sequence O
data O
, O
and O
common O
genetic O
origin O
, O
it O
is O
suggested O
that O
p60 B
and O
p62 B
have O
identical O
amino O
acid O
sequences O
carboxy O
- O
terminal O
to O
the O
p60 B
initiator O
methionine O
( O
residue O
21 O
of O
p62 B
) O
. O

The O
atp B
1 I
and O
atp B
2 I
types O
of O
cDNA O
sequences O
were O
the O
most O
redundant O
among O
the O
28 O
different O
isoperoxidases B
identified O
among O
about O
200 O
peroxidase B
encoding I
ESTs I
. O

In O
patients O
with O
type O
IA O
maple O
syrup O
urine O
disease O
, O
the O
E1alpha B
subunit I
is O
affected O
, O
resulting O
in O
the O
loss O
of O
E1 B
and O
branched B
- I
chain I
ketoacid I
dehydrogenase I
catalytic O
activities O
. O

ME1a1 B
, O
a O
16 O
- O
base O
- O
pair O
nuclear O
factor O
binding O
site O
residing O
between O
the O
c B
- I
MYC I
P1 I
and I
P2 I
transcription I
initiation I
sites I
, O
is O
required O
for O
P2 O
activity O
. O

We O
have O
demonstrated O
that O
the O
activity O
of O
ILK B
is O
constitutively O
elevated O
in O
PTEN B
mutant I
cells O
. O

Members O
of O
the O
myocyte B
- I
specific I
enhancer I
- I
binding I
factor I
2 I
( O
MEF2 B
) O
family O
of O
transcription O
factors O
bind O
a O
conserved O
A O
/ O
T O
- O
rich O
sequence O
in O
the O
control O
regions O
of O
numerous O
muscle O
- O
specific O
genes O
. O

Two O
- O
dimensional O
gel O
electrophoresis O
of O
anti B
- I
p59fyn I
immunoprecipitates O
obtained O
from O
non O
- O
transformed O
resting O
human O
T O
lymphocytes O
resulted O
in O
the O
identification O
of O
an O
oligomeric O
protein O
complex O
which O
is O
constitutively O
formed O
between O
Fyn B
and O
several O
additional O
phosphoproteins O
( O
pp43 B
, O
pp72 B
, O
pp85 B
, O
the O
protein B
tyrosine I
kinase I
Pyk2 B
, O
as O
well O
as O
the O
two O
recently O
cloned O
adaptor O
proteins O
, O
SKAP55 B
and O
SLAP B
- I
130 I
) O
. O

Two O
- O
dimensional O
gel O
electrophoresis O
of O
anti B
- I
p59fyn I
immunoprecipitates O
obtained O
from O
non O
- O
transformed O
resting O
human O
T O
lymphocytes O
resulted O
in O
the O
identification O
of O
an O
oligomeric O
protein O
complex O
which O
is O
constitutively O
formed O
between O
Fyn B
and O
several O
additional O
phosphoproteins O
( O
pp43 B
, O
pp72 B
, O
pp85 B
, O
the O
protein B
tyrosine I
kinase I
Pyk2 B
, O
as O
well O
as O
the O
two O
recently O
cloned O
adaptor O
proteins O
, O
SKAP55 B
and O
SLAP B
- I
130 I
) O
. O

Two O
- O
dimensional O
gel O
electrophoresis O
of O
anti B
- I
p59fyn I
immunoprecipitates O
obtained O
from O
non O
- O
transformed O
resting O
human O
T O
lymphocytes O
resulted O
in O
the O
identification O
of O
an O
oligomeric O
protein O
complex O
which O
is O
constitutively O
formed O
between O
Fyn B
and O
several O
additional O
phosphoproteins O
( O
pp43 B
, O
pp72 B
, O
pp85 B
, O
the O
protein B
tyrosine I
kinase I
Pyk2 B
, O
as O
well O
as O
the O
two O
recently O
cloned O
adaptor O
proteins O
, O
SKAP55 B
and O
SLAP B
- I
130 I
) O
. O

Two O
- O
dimensional O
gel O
electrophoresis O
of O
anti B
- I
p59fyn I
immunoprecipitates O
obtained O
from O
non O
- O
transformed O
resting O
human O
T O
lymphocytes O
resulted O
in O
the O
identification O
of O
an O
oligomeric O
protein O
complex O
which O
is O
constitutively O
formed O
between O
Fyn B
and O
several O
additional O
phosphoproteins O
( O
pp43 B
, O
pp72 B
, O
pp85 B
, O
the O
protein B
tyrosine I
kinase I
Pyk2 B
, O
as O
well O
as O
the O
two O
recently O
cloned O
adaptor O
proteins O
, O
SKAP55 B
and O
SLAP B
- I
130 I
) O
. O

Two O
- O
dimensional O
gel O
electrophoresis O
of O
anti B
- I
p59fyn I
immunoprecipitates O
obtained O
from O
non O
- O
transformed O
resting O
human O
T O
lymphocytes O
resulted O
in O
the O
identification O
of O
an O
oligomeric O
protein O
complex O
which O
is O
constitutively O
formed O
between O
Fyn B
and O
several O
additional O
phosphoproteins O
( O
pp43 B
, O
pp72 B
, O
pp85 B
, O
the O
protein B
tyrosine I
kinase I
Pyk2 B
, O
as O
well O
as O
the O
two O
recently O
cloned O
adaptor O
proteins O
, O
SKAP55 B
and O
SLAP B
- I
130 I
) O
. O

Two O
- O
dimensional O
gel O
electrophoresis O
of O
anti B
- I
p59fyn I
immunoprecipitates O
obtained O
from O
non O
- O
transformed O
resting O
human O
T O
lymphocytes O
resulted O
in O
the O
identification O
of O
an O
oligomeric O
protein O
complex O
which O
is O
constitutively O
formed O
between O
Fyn B
and O
several O
additional O
phosphoproteins O
( O
pp43 B
, O
pp72 B
, O
pp85 B
, O
the O
protein B
tyrosine I
kinase I
Pyk2 B
, O
as O
well O
as O
the O
two O
recently O
cloned O
adaptor O
proteins O
, O
SKAP55 B
and O
SLAP B
- I
130 I
) O
. O

Although O
the O
OC B
promoter I
is O
activated O
in O
a O
C O
terminus O
dependent O
manner O
, O
the O
MDR B
, O
LTR O
and O
BSP B
promoters I
are O
repressed O
by O
three O
distinct O
mechanisms O
, O
either O
independent O
of O
or O
involving O
the O
AML B
C I
terminus I
, O
or O
requiring O
only O
the O
conserved O
C O
- O
terminal O
pentapeptide O
VWRPY O
. O

A O
region O
approximately O
100 O
bp O
upstream O
from O
the O
transcription O
start O
point O
of O
virB B
was O
identified O
as O
being O
necessary O
for O
full O
activation O
of O
this O
promoter O
by O
VirF B
. O

A O
region O
approximately O
100 O
bp O
upstream O
from O
the O
transcription O
start O
point O
of O
virB B
was O
identified O
as O
being O
necessary O
for O
full O
activation O
of O
this O
promoter O
by O
VirF B
. O

Expression O
of O
constitutively O
active O
MEK1 B
, O
the O
kinase O
that O
activates O
ERKs B
, O
or O
overexpression O
of O
ERK2 B
, O
but O
not O
JNK1 B
, O
inhibited O
Stat3 B
activation O
. O

Expression O
of O
constitutively O
active O
MEK1 B
, O
the O
kinase O
that O
activates O
ERKs B
, O
or O
overexpression O
of O
ERK2 B
, O
but O
not O
JNK1 B
, O
inhibited O
Stat3 B
activation O
. O

Expression O
of O
constitutively O
active O
MEK1 B
, O
the O
kinase O
that O
activates O
ERKs B
, O
or O
overexpression O
of O
ERK2 B
, O
but O
not O
JNK1 B
, O
inhibited O
Stat3 B
activation O
. O

Expression O
of O
constitutively O
active O
MEK1 B
, O
the O
kinase O
that O
activates O
ERKs B
, O
or O
overexpression O
of O
ERK2 B
, O
but O
not O
JNK1 B
, O
inhibited O
Stat3 B
activation O
. O

Expression O
of O
constitutively O
active O
MEK1 B
, O
the O
kinase O
that O
activates O
ERKs B
, O
or O
overexpression O
of O
ERK2 B
, O
but O
not O
JNK1 B
, O
inhibited O
Stat3 B
activation O
. O

Recent O
studies O
have O
revealed O
unconventional O
myosin B
V I
to O
be O
an O
important O
actin B
- O
based O
molecular O
motor O
involved O
in O
vesicular O
movement O
. O

EGFR B
levels O
were O
found O
to O
be O
elevated O
5 O
- O
, O
3 O
. O

It O
bound O
to O
vitamin B
D I
receptor I
( O
VDR B
) O
but O
not O
retinoic B
acid I
Xalpha I
receptor I
( O
RXRalpha B
) O
in O
the O
human O
T O
cell O
line O
MT2 O
cells O
. O

It O
bound O
to O
vitamin B
D I
receptor I
( O
VDR B
) O
but O
not O
retinoic B
acid I
Xalpha I
receptor I
( O
RXRalpha B
) O
in O
the O
human O
T O
cell O
line O
MT2 O
cells O
. O

Hrs B
has O
a O
FYVE O
double O
zinc O
finger O
domain O
, O
which O
specifically O
binds O
phosphatidylinositol O
( O
3 O
) O
- O
phosphate O
and O
is O
conserved O
in O
several O
proteins O
involved O
in O
vesicular O
traffic O
. O

IgM B
and O
IgG B
anti I
A I
and O
anti B
B I
antibody I
status O
of O
100 O
antenatal O
O O
group O
mothers O
( O
who O
had O
non O
O O
group O
husbands O
) O
were O
studied O
. O

EMSA O
with O
crude O
nuclear O
extracts O
demonstrated O
that O
stimulation O
with O
CD40L B
results O
in O
the O
induction O
of O
NF B
- I
kappaB I
complexes I
that O
bind O
to O
each O
of O
the O
three O
NF B
- I
kappaB I
sites I
and O
are O
composed O
mainly O
of O
p50 B
and O
RelB B
, O
but O
also O
include O
c B
- I
Rel I
and O
p65 B
. O

EMSA O
with O
crude O
nuclear O
extracts O
demonstrated O
that O
stimulation O
with O
CD40L B
results O
in O
the O
induction O
of O
NF B
- I
kappaB I
complexes I
that O
bind O
to O
each O
of O
the O
three O
NF B
- I
kappaB I
sites I
and O
are O
composed O
mainly O
of O
p50 B
and O
RelB B
, O
but O
also O
include O
c B
- I
Rel I
and O
p65 B
. O

EMSA O
with O
crude O
nuclear O
extracts O
demonstrated O
that O
stimulation O
with O
CD40L B
results O
in O
the O
induction O
of O
NF B
- I
kappaB I
complexes I
that O
bind O
to O
each O
of O
the O
three O
NF B
- I
kappaB I
sites I
and O
are O
composed O
mainly O
of O
p50 B
and O
RelB B
, O
but O
also O
include O
c B
- I
Rel I
and O
p65 B
. O

EMSA O
with O
crude O
nuclear O
extracts O
demonstrated O
that O
stimulation O
with O
CD40L B
results O
in O
the O
induction O
of O
NF B
- I
kappaB I
complexes I
that O
bind O
to O
each O
of O
the O
three O
NF B
- I
kappaB I
sites I
and O
are O
composed O
mainly O
of O
p50 B
and O
RelB B
, O
but O
also O
include O
c B
- I
Rel I
and O
p65 B
. O

Although O
metabolized O
by O
the O
cytochrome B
P I
- I
450 I
( O
CYP B
) O
system O
, O
venlafaxine O
inhibits O
CYP B
2D6 I
and I
3A4 I
to O
a O
far O
lesser O
extent O
than O
do O
the O
SSRIs O
. O

Collectively O
, O
the O
results O
suggest O
that O
ARF B
binding O
to O
Mdm2 B
induces O
a O
conformational O
change O
that O
facilitates O
nucleolar O
import O
of O
the O
ARF B
- O
Mdm2 B
complex O
and O
p53 B
- O
dependent O
cell O
cycle O
arrest O
. O

Collectively O
, O
the O
results O
suggest O
that O
ARF B
binding O
to O
Mdm2 B
induces O
a O
conformational O
change O
that O
facilitates O
nucleolar O
import O
of O
the O
ARF B
- O
Mdm2 B
complex O
and O
p53 B
- O
dependent O
cell O
cycle O
arrest O
. O

Collectively O
, O
the O
results O
suggest O
that O
ARF B
binding O
to O
Mdm2 B
induces O
a O
conformational O
change O
that O
facilitates O
nucleolar O
import O
of O
the O
ARF B
- O
Mdm2 B
complex O
and O
p53 B
- O
dependent O
cell O
cycle O
arrest O
. O

Collectively O
, O
the O
results O
suggest O
that O
ARF B
binding O
to O
Mdm2 B
induces O
a O
conformational O
change O
that O
facilitates O
nucleolar O
import O
of O
the O
ARF B
- O
Mdm2 B
complex O
and O
p53 B
- O
dependent O
cell O
cycle O
arrest O
. O

Collectively O
, O
the O
results O
suggest O
that O
ARF B
binding O
to O
Mdm2 B
induces O
a O
conformational O
change O
that O
facilitates O
nucleolar O
import O
of O
the O
ARF B
- O
Mdm2 B
complex O
and O
p53 B
- O
dependent O
cell O
cycle O
arrest O
. O

We O
mapped O
the O
DGCR6 B
gene I
to O
chromosome O
22q11 O
within O
a O
low O
copy O
repeat O
, O
termed O
sc11 O
. O
1a O
, O
and O
identified O
a O
second O
copy O
of O
the O
gene O
, O
DGCR6L B
, O
within O
the O
duplicate O
locus O
, O
termed O
sc11 O
. O
1b O
. O

The O
recruitment O
of O
constitutively O
phosphorylated O
p185 B
( O
neu B
) O
and O
the O
activated O
mitogenic O
pathway O
proteins O
to O
this O
membrane O
- O
microfilament O
interaction O
site O
provides O
a O
physical O
model O
for O
integrating O
the O
assembly O
of O
the O
mitogenic O
pathway O
with O
the O
transmission O
of O
growth O
factor O
signal O
to O
the O
cytoskeleton O
. O

The O
recruitment O
of O
constitutively O
phosphorylated O
p185 B
( O
neu B
) O
and O
the O
activated O
mitogenic O
pathway O
proteins O
to O
this O
membrane O
- O
microfilament O
interaction O
site O
provides O
a O
physical O
model O
for O
integrating O
the O
assembly O
of O
the O
mitogenic O
pathway O
with O
the O
transmission O
of O
growth O
factor O
signal O
to O
the O
cytoskeleton O
. O

Two O
mutants O
, O
each O
representative O
of O
a O
separate O
pet B
complementation O
group O
, O
have O
been O
analyzed O
. O

Molecular O
analysis O
of O
the O
pRA2 O
partitioning O
region O
: O
ParB B
autoregulates O
parAB B
transcription O
and O
forms O
a O
nucleoprotein O
complex O
with O
the O
plasmid O
partition O
site O
, O
parS B
. O

Molecular O
analysis O
of O
the O
pRA2 O
partitioning O
region O
: O
ParB B
autoregulates O
parAB B
transcription O
and O
forms O
a O
nucleoprotein O
complex O
with O
the O
plasmid O
partition O
site O
, O
parS B
. O

Molecular O
analysis O
of O
the O
pRA2 O
partitioning O
region O
: O
ParB B
autoregulates O
parAB B
transcription O
and O
forms O
a O
nucleoprotein O
complex O
with O
the O
plasmid O
partition O
site O
, O
parS B
. O

The O
levels O
of O
NPY B
- O
ir O
in O
the O
rat O
vas O
deferens O
were O
not O
affected O
by O
either O
surgical O
or O
pharmacological O
treatment O
. O

The O
diagnostic O
accuracy O
of O
serum O
PE B
- I
1 I
was O
0 O
. O
80 O
, O
and O
that O
of O
amylase B
0 O
. O
97 O
. O

These O
observations O
lead O
to O
the O
proposal O
that O
the O
RNAP B
II I
CTD I
might O
be O
an O
in O
vivo O
target O
for O
the O
activated O
p42mapk B
and O
p44mapk B
MAP I
kinases I
. O

We O
have O
separated O
a O
dermatan O
sulfate O
proteoglycan O
, O
epiphycan O
, O
from O
decorin B
and O
biglycan O
by O
using O
dissociative O
extraction O
of O
bovine O
fetal O
epiphyseal O
cartilage O
, O
followed O
by O
sequential O
ion O
- O
exchange O
, O
gel O
permeation O
, O
hydrophobic O
, O
and O
Zn2 O
+ O
chelate O
chromatographic O
steps O
. O

Glomerular O
mesangial O
cells O
expressed O
an O
abundant O
1 O
. O
1 O
kb O
mRNA O
transcript O
for O
Id1 B
, O
but O
in O
contrast O
to O
other O
cell O
types O
Id1 B
mRNA I
was O
expressed O
in O
both O
randomly O
cycling O
cells O
and O
in O
serum O
- O
deprived O
, O
quiescent O
cultures O
. O

The O
overall O
results O
of O
this O
paper O
are O
consistent O
with O
the O
conclusion O
that O
the O
carboxyl O
- O
terminal O
LBD O
is O
not O
sufficient O
for O
mediating O
PR B
dimerization O
and O
that O
multiple O
regions O
, O
including O
the O
hinge O
and O
amino O
- O
terminal O
sequences O
, O
contribute O
either O
directly O
or O
indirectly O
to O
homodimerization O
of O
PR B
. O

The O
overall O
results O
of O
this O
paper O
are O
consistent O
with O
the O
conclusion O
that O
the O
carboxyl O
- O
terminal O
LBD O
is O
not O
sufficient O
for O
mediating O
PR B
dimerization O
and O
that O
multiple O
regions O
, O
including O
the O
hinge O
and O
amino O
- O
terminal O
sequences O
, O
contribute O
either O
directly O
or O
indirectly O
to O
homodimerization O
of O
PR B
. O

The O
equilibrium O
dissociation O
binding O
constant O
for O
the O
interaction O
of O
TnrA B
with O
the O
nrgAB B
promoter I
fragment I
was O
7 O
. O
7 O
nM O
under O
the O
conditions O
used O
here O
. O

The O
activity O
of O
the O
minimal O
promoter O
was O
found O
to O
be O
controlled O
by O
a O
combination O
of O
the O
activities O
of O
the O
transcription O
factors O
Sp1 B
, O
Sp3 B
, O
and O
NF B
- I
Y I
. O

The O
activity O
of O
the O
minimal O
promoter O
was O
found O
to O
be O
controlled O
by O
a O
combination O
of O
the O
activities O
of O
the O
transcription O
factors O
Sp1 B
, O
Sp3 B
, O
and O
NF B
- I
Y I
. O

We O
evaluated O
the O
likelihood O
of O
tissues O
to O
be O
positive O
for O
carcinoembryonic B
antigen I
and O
the O
intensity O
of O
carcinoembryonic B
antigen I
staining O
in O
specimens O
of O
villous O
adenomas O
, O
mixed O
polypoid O
villous O
adenomas O
, O
polypoid O
adenomas O
, O
and O
diverticulitis O
using O
the O
peroxidase B
- O
antiperoxidase B
technique O
. O

We O
evaluated O
the O
likelihood O
of O
tissues O
to O
be O
positive O
for O
carcinoembryonic B
antigen I
and O
the O
intensity O
of O
carcinoembryonic B
antigen I
staining O
in O
specimens O
of O
villous O
adenomas O
, O
mixed O
polypoid O
villous O
adenomas O
, O
polypoid O
adenomas O
, O
and O
diverticulitis O
using O
the O
peroxidase B
- O
antiperoxidase B
technique O
. O

Comparison O
with O
the O
sequence O
databanks O
show O
that O
Tactile B
is O
a O
member O
of O
the O
immunoglobulin B
gene I
superfamily I
, O
with O
similarity O
to O
Drosophila B
amalgam I
, O
the O
melanoma B
Ag I
MUC I
- I
18 I
, O
members O
of O
the O
carcinoembryonic B
Ag I
family I
, O
the O
poliovirus B
receptor I
, O
and O
the O
neural B
cell I
adhesion I
molecule I
. O

Mutational O
analysis O
of O
essential O
IncP O
alpha O
plasmid O
transfer O
genes O
traF B
and O
traG B
and O
involvement O
of O
traF B
in O
phage O
sensitivity O
. O

Mutational O
analysis O
of O
essential O
IncP O
alpha O
plasmid O
transfer O
genes O
traF B
and O
traG B
and O
involvement O
of O
traF B
in O
phage O
sensitivity O
. O

Mutational O
analysis O
of O
essential O
IncP O
alpha O
plasmid O
transfer O
genes O
traF B
and O
traG B
and O
involvement O
of O
traF B
in O
phage O
sensitivity O
. O

This O
study O
was O
designed O
to O
compare O
the O
efficacy O
of O
efegatran O
plus O
streptokinase B
versus O
heparin O
plus O
accelerated O
tissue B
plasminogen I
activator I
( O
TPA B
) O
in O
coronary O
reperfusion O
in O
acute O
MI O
. O

This O
study O
was O
designed O
to O
compare O
the O
efficacy O
of O
efegatran O
plus O
streptokinase B
versus O
heparin O
plus O
accelerated O
tissue B
plasminogen I
activator I
( O
TPA B
) O
in O
coronary O
reperfusion O
in O
acute O
MI O
. O

Atcys1 B
, O
Athyp1 B
, O
AKin10 B
and O
the O
ORF O
are O
very O
close O
to O
each O
other O
and O
organized O
in O
the O
same O
polarity O
; O
hence O
, O
the O
intergenic O
regions O
probably O
contain O
, O
within O
less O
than O
0 O
. O
5 O
kb O
, O
all O
the O
regulatory O
elements O
necessary O
to O
govern O
initiation O
and O
termination O
of O
transcription O
. O

Atcys1 B
, O
Athyp1 B
, O
AKin10 B
and O
the O
ORF O
are O
very O
close O
to O
each O
other O
and O
organized O
in O
the O
same O
polarity O
; O
hence O
, O
the O
intergenic O
regions O
probably O
contain O
, O
within O
less O
than O
0 O
. O
5 O
kb O
, O
all O
the O
regulatory O
elements O
necessary O
to O
govern O
initiation O
and O
termination O
of O
transcription O
. O

Atcys1 B
, O
Athyp1 B
, O
AKin10 B
and O
the O
ORF O
are O
very O
close O
to O
each O
other O
and O
organized O
in O
the O
same O
polarity O
; O
hence O
, O
the O
intergenic O
regions O
probably O
contain O
, O
within O
less O
than O
0 O
. O
5 O
kb O
, O
all O
the O
regulatory O
elements O
necessary O
to O
govern O
initiation O
and O
termination O
of O
transcription O
. O

Southern O
blot O
analysis O
of O
endonuclease O
- O
digested O
genomic O
DNA O
from O
primary O
chick O
embryo O
fibroblasts O
( O
CEF O
) O
suggested O
that O
MEK2 B
is O
a O
single O
- O
copy O
gene O
in O
this O
vertebrate O
species O
. O

One O
complex O
most O
likely O
contained O
Sp1 B
, O
and O
another O
complex O
showed O
S O
- O
phase O
- O
specific O
binding O
, O
suggesting O
a O
direct O
role O
in O
the O
cell O
- O
cycle O
- O
dependent O
R1 B
gene I
expression O
. O

Taken O
together O
, O
these O
observations O
indicate O
that O
the O
C O
- O
terminal O
24 O
amino O
acids O
are O
sufficient O
for O
NodO B
secretion O
although O
the O
region O
adjacent O
to O
this O
domain O
appears O
to O
affect O
secretion O
efficiency O
. O

Pokeweed B
antiviral I
protein I
( O
PAP B
) O
from O
Phytolacca O
americana O
is O
a O
highly O
specific O
N B
- I
glycosidase I
removing O
adenine O
residues O
( O
A4324 O
in O
28S B
rRNA I
and O
A2660 O
in O
23S B
rRNA I
) O
from O
intact O
ribosomes O
of O
both O
eukaryotes O
and O
prokaryotes O
. O

Patients O
with O
an O
enzymatic O
activity O
below O
X O
- O
- O
1 O
manifested O
a O
decrease O
of O
the O
content O
of O
IgA B
, O
IgG B
, O
IgM B
, O
T O
and O
B O
lymphocytes O
, O
and O
of O
phagocytic O
activity O
of O
neutrophils O
as O
compared O
to O
patients O
exhibiting O
a O
high O
enzymatic O
activity O
. O

Patients O
with O
an O
enzymatic O
activity O
below O
X O
- O
- O
1 O
manifested O
a O
decrease O
of O
the O
content O
of O
IgA B
, O
IgG B
, O
IgM B
, O
T O
and O
B O
lymphocytes O
, O
and O
of O
phagocytic O
activity O
of O
neutrophils O
as O
compared O
to O
patients O
exhibiting O
a O
high O
enzymatic O
activity O
. O

Patients O
with O
an O
enzymatic O
activity O
below O
X O
- O
- O
1 O
manifested O
a O
decrease O
of O
the O
content O
of O
IgA B
, O
IgG B
, O
IgM B
, O
T O
and O
B O
lymphocytes O
, O
and O
of O
phagocytic O
activity O
of O
neutrophils O
as O
compared O
to O
patients O
exhibiting O
a O
high O
enzymatic O
activity O
. O

Pseudosubstrate O
( O
19 O
- O
36 O
) O
, O
derived O
from O
the O
C O
- O
terminus O
of O
Ca B
- I
dependent I
PKC I
isotypes I
, O
inhibited O
beta B
- I
PKC I
but O
not O
nPKC B
activity O
using O
either O
Histone B
IIIS I
or O
peptide O
( O
19 O
- O
31 O
) O
as O
substrate O
. O

By O
deletion O
analysis O
of O
the O
MLS1 B
control O
region O
, O
we O
identified O
two O
sites O
, O
UAS1 O
and O
UAS2 O
, O
as O
important O
for O
efficient O
derepression O
of O
the O
gene O
. O

Both O
carbachol O
( O
100 O
microM O
) O
and O
EGF B
( O
10 O
nM O
) O
induced O
Ras B
activation O
. O

Both O
carbachol O
( O
100 O
microM O
) O
and O
EGF B
( O
10 O
nM O
) O
induced O
Ras B
activation O
. O

Conversely O
, O
when O
VDR B
is O
overexpressed O
, O
vitamin O
D3 O
attenuates O
9 O
- O
cis O
RA O
induction O
from O
an O
RXR B
- O
responsive O
element O
. O

Conversely O
, O
when O
VDR B
is O
overexpressed O
, O
vitamin O
D3 O
attenuates O
9 O
- O
cis O
RA O
induction O
from O
an O
RXR B
- O
responsive O
element O
. O

In O
canrenoate O
- O
treated O
rats O
, O
ANP B
infusion O
caused O
greater O
increases O
in O
sodium O
excretion O
( O
FENA O
from O
3 O
. O
05 O
+ O
/ O
- O
0 O
. O
71 O
to O
7 O
. O
21 O
+ O
/ O
- O
0 O
. O
45 O
% O
; O
P O
< O
0 O
. O
05 O
; O
n O
= O
8 O
) O
than O
saline O
infusion O
( O
FENA O
from O
4 O
. O
16 O
+ O
/ O
- O
1 O
. O
11 O
to O
5 O
. O
47 O
+ O
/ O
- O
0 O
. O
66 O
% O
; O
n O
= O
6 O
) O
, O
despite O
the O
hypocapnia O
. O

Furthermore O
, O
we O
have O
identified O
a O
soluble O
form O
of O
ERp57 B
/ O
GRP58 B
by O
Western O
blotting O
and O
biosynthetic O
labeling O
. O

Furthermore O
, O
we O
have O
identified O
a O
soluble O
form O
of O
ERp57 B
/ O
GRP58 B
by O
Western O
blotting O
and O
biosynthetic O
labeling O
. O

The O
novel O
hematopoietic B
growth I
factor I
FLT3 I
ligand I
( O
FL B
) O
is O
the O
cognate O
ligand O
for O
the O
FLT3 B
, O
tyrosine B
kinase I
receptor I
( O
R B
) O
, O
also O
referred O
to O
as O
FLK B
- I
2 I
and O
STK B
- I
1 I
. O

The O
novel O
hematopoietic B
growth I
factor I
FLT3 I
ligand I
( O
FL B
) O
is O
the O
cognate O
ligand O
for O
the O
FLT3 B
, O
tyrosine B
kinase I
receptor I
( O
R B
) O
, O
also O
referred O
to O
as O
FLK B
- I
2 I
and O
STK B
- I
1 I
. O

The O
novel O
hematopoietic B
growth I
factor I
FLT3 I
ligand I
( O
FL B
) O
is O
the O
cognate O
ligand O
for O
the O
FLT3 B
, O
tyrosine B
kinase I
receptor I
( O
R B
) O
, O
also O
referred O
to O
as O
FLK B
- I
2 I
and O
STK B
- I
1 I
. O

It O
also O
suggests O
that O
there O
is O
another O
pathway O
which O
can O
activate O
SWI4 B
transcription O
in O
the O
absence O
of O
SWI6 B
. O

It O
also O
suggests O
that O
there O
is O
another O
pathway O
which O
can O
activate O
SWI4 B
transcription O
in O
the O
absence O
of O
SWI6 B
. O

Each O
of O
these O
genes O
contains O
a O
putative O
upstream O
ORF O
, O
while O
STA2 B
has O
two O
additional O
in O
- O
frame O
AUG O
codons O
5 O
' O
to O
the O
major O
cistron O
. O

Leukocyte O
cultures O
, O
prepared O
from O
blood O
drawn O
from O
these O
18 O
children O
at O
6 O
months O
of O
age O
, O
produced O
lower O
yields O
of O
IFN B
than O
those O
of O
the O
remaining O
53 O
children O
, O
when O
stimulated O
with O
adenovirus O
( O
P O
< O
0 O
. O
001 O
) O
, O
coronavirus O
( O
P O
< O
0 O
. O
001 O
) O
or O
rhinovirus O
( O
P O
= O
0 O
. O
002 O
) O
. O

In O
the O
absence O
of O
E1A243 B
, O
YY1 B
represses O
CRE O
- O
dependent O
transcription O
of O
c B
- I
fos I
by O
physically O
interacting O
with O
ATF B
/ O
CREB B
proteins O
bound O
to O
the O
- O
67 O
CRE O
. O

In O
the O
absence O
of O
E1A243 B
, O
YY1 B
represses O
CRE O
- O
dependent O
transcription O
of O
c B
- I
fos I
by O
physically O
interacting O
with O
ATF B
/ O
CREB B
proteins O
bound O
to O
the O
- O
67 O
CRE O
. O

In O
the O
absence O
of O
E1A243 B
, O
YY1 B
represses O
CRE O
- O
dependent O
transcription O
of O
c B
- I
fos I
by O
physically O
interacting O
with O
ATF B
/ O
CREB B
proteins O
bound O
to O
the O
- O
67 O
CRE O
. O

In O
the O
absence O
of O
E1A243 B
, O
YY1 B
represses O
CRE O
- O
dependent O
transcription O
of O
c B
- I
fos I
by O
physically O
interacting O
with O
ATF B
/ O
CREB B
proteins O
bound O
to O
the O
- O
67 O
CRE O
. O

This O
establishes O
Rad3 B
/ O
Mec1 B
as O
the O
only O
conserved O
protein O
which O
is O
required O
for O
all O
the O
DNA O
structure O
checkpoints O
in O
both O
yeast O
model O
systems O
. O

This O
establishes O
Rad3 B
/ O
Mec1 B
as O
the O
only O
conserved O
protein O
which O
is O
required O
for O
all O
the O
DNA O
structure O
checkpoints O
in O
both O
yeast O
model O
systems O
. O

Hailey O
- O
Hailey O
disease O
is O
caused O
by O
mutations O
in O
ATP2C1 B
encoding O
a O
novel O
Ca O
( O
2 O
+ O
) O
pump O
. O

Moreover O
, O
the O
same O
mutations O
alter O
the O
structure O
of O
junB B
5 O
' O
flanking O
DNA O
within O
chromatin O
. O

Serial O
followup O
strength O
data O
for O
2 O
patients O
were O
compared O
to O
change O
in O
creatinine B
kinase I
( O
CK B
) O
levels O
. O

Recently O
, O
a O
mutation O
in O
the O
amino O
- O
terminus O
of O
IB1 B
was O
associated O
with O
diabetes O
. O

To O
determine O
the O
signal B
recognition I
particle I
( O
SRP B
) O
- O
SRP B
receptor I
( O
Srb B
) O
system O
in O
Bacillus O
subtilis O
( O
Bs O
) O
, O
we O
cloned O
the O
Bs B
srb I
gene I
, O
which O
encodes O
a O
homologue O
of O
the O
mammalian B
SRP I
receptor I
alpha I
- I
subunit I
[ O
Oguro O
et O
al O
. O
, O
DNA O
Res O
. O

To O
determine O
the O
signal B
recognition I
particle I
( O
SRP B
) O
- O
SRP B
receptor I
( O
Srb B
) O
system O
in O
Bacillus O
subtilis O
( O
Bs O
) O
, O
we O
cloned O
the O
Bs B
srb I
gene I
, O
which O
encodes O
a O
homologue O
of O
the O
mammalian B
SRP I
receptor I
alpha I
- I
subunit I
[ O
Oguro O
et O
al O
. O
, O
DNA O
Res O
. O

Its O
hydropathy O
profile O
predicts O
seven O
transmembrane O
spans O
and O
a O
hydrophilic O
amino O
terminus O
of O
approximately O
100 O
residues O
, O
and O
it O
suggests O
the O
presence O
of O
an O
amphiphilic O
alpha O
- O
helix O
( O
L O
- O
61 O
to O
F O
- O
97 O
) O
in O
close O
proximity O
to O
the O
first O
strongly O
hydrophobic O
segment O
of O
ProW B
. O

We O
have O
previously O
demonstrated O
that O
expression O
of O
the O
gene O
for O
the O
reproductive O
neuropeptide O
, O
GnRH B
, O
is O
repressed O
by O
the O
glutamate O
/ O
NO O
/ O
cyclic O
GMP O
( O
cGMP O
) O
signal O
transduction O
pathway O
through O
cGMP B
- I
dependent I
protein I
kinase I
in O
the O
hypothalamic O
GnRH B
- O
secreting O
neuronal O
cell O
line O
GT1 O
- O
7 O
. O

We O
have O
previously O
demonstrated O
that O
expression O
of O
the O
gene O
for O
the O
reproductive O
neuropeptide O
, O
GnRH B
, O
is O
repressed O
by O
the O
glutamate O
/ O
NO O
/ O
cyclic O
GMP O
( O
cGMP O
) O
signal O
transduction O
pathway O
through O
cGMP B
- I
dependent I
protein I
kinase I
in O
the O
hypothalamic O
GnRH B
- O
secreting O
neuronal O
cell O
line O
GT1 O
- O
7 O
. O

Moreover O
, O
the O
ability O
to O
selectivity O
arrest O
elongation O
by O
polIII B
at O
defined O
positions O
within O
the O
tRNA O
gene O
transcription O
unit O
has O
permitted O
the O
identification O
of O
discrete O
functional O
properties O
of O
paused O
mammalian B
polIII I
ternary I
complexes I
. O

Molecular O
cloning O
and O
characterization O
of O
a O
new O
member O
of O
the O
rat B
placental I
prolactin I
( O
PRL B
) O
family O
, O
PRL B
- O
like O
protein B
H I
. O

Molecular O
cloning O
and O
characterization O
of O
a O
new O
member O
of O
the O
rat B
placental I
prolactin I
( O
PRL B
) O
family O
, O
PRL B
- O
like O
protein B
H I
. O

The O
variations O
were O
caused O
by O
opposite O
shifts O
in O
TSH B
frequency O
distribution O
in O
mothers O
and O
neonates O
. O

Cells O
containing O
alpha O
subunits O
that O
lacked O
a O
distal O
domain O
( O
term O
- O
3 O
) O
or O
had O
the O
alternatively O
spliced O
alpha O
- O
2 O
distal O
domain O
showed O
markedly O
decreased O
ability O
to O
support O
tyrosine O
phosphorylation O
of O
Jak B
- I
2 I
and O
its O
substrates O
or O
to O
up O
- O
regulate O
CD86 B
. O

Finally O
, O
the O
mechanism O
of O
ASK1 B
activation O
involves O
, O
in O
part O
, O
homo O
- O
oligomerization O
. O

Also O
, O
the O
human B
glycoprotein I
alpha I
- I
subunit I
promoter I
was O
induced O
10 O
- O
fold O
by O
FSK B
in O
GH4 O
rat O
pituitary O
cells O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

The O
differential O
investigation O
of O
lipoproteins O
, O
however O
, O
showed O
that O
the O
high B
- I
density I
lipoprotein I
( O
HDL B
) O
fractions O
are O
absolutely O
or O
relatively O
decreased O
with O
respect O
to O
low B
- I
density I
lipoproteins I
( O
LDL B
) O
in O
cerebral O
infarcts O
and O
in O
transient O
ischaemic O
attacks O
. O

The O
differential O
investigation O
of O
lipoproteins O
, O
however O
, O
showed O
that O
the O
high B
- I
density I
lipoprotein I
( O
HDL B
) O
fractions O
are O
absolutely O
or O
relatively O
decreased O
with O
respect O
to O
low B
- I
density I
lipoproteins I
( O
LDL B
) O
in O
cerebral O
infarcts O
and O
in O
transient O
ischaemic O
attacks O
. O

Recruitment O
of O
an O
RNA B
polymerase I
II I
complex I
is O
mediated O
by O
the O
constitutive O
activation O
domain O
in O
CREB B
, O
independently O
of O
CREB B
phosphorylation O
. O

Recruitment O
of O
an O
RNA B
polymerase I
II I
complex I
is O
mediated O
by O
the O
constitutive O
activation O
domain O
in O
CREB B
, O
independently O
of O
CREB B
phosphorylation O
. O

These O
RZR B
subtypes O
represent O
members O
of O
a O
new O
family O
of O
orphan B
nuclear I
receptors I
that O
most O
likely O
regulate O
specific O
gene O
expression O
. O

Primary O
adrenal O
hypersensitivity O
to O
ACTH B
drive O
in O
obesity O
has O
also O
been O
suggested O
. O

Downregulation O
of O
FUS B
expression O
in O
BCR B
/ O
ABL B
- O
expressing O
32Dcl3 O
cells O
was O
associated O
with O
suppression O
of O
growth O
factor O
- O
independent O
colony O
formation O
, O
restoration O
of O
G B
- I
CSF I
- O
induced O
granulocytic O
differentiation O
and O
reduced O
tumorigenic O
potential O
in O
vivo O
. O

Downregulation O
of O
FUS B
expression O
in O
BCR B
/ O
ABL B
- O
expressing O
32Dcl3 O
cells O
was O
associated O
with O
suppression O
of O
growth O
factor O
- O
independent O
colony O
formation O
, O
restoration O
of O
G B
- I
CSF I
- O
induced O
granulocytic O
differentiation O
and O
reduced O
tumorigenic O
potential O
in O
vivo O
. O

Downregulation O
of O
FUS B
expression O
in O
BCR B
/ O
ABL B
- O
expressing O
32Dcl3 O
cells O
was O
associated O
with O
suppression O
of O
growth O
factor O
- O
independent O
colony O
formation O
, O
restoration O
of O
G B
- I
CSF I
- O
induced O
granulocytic O
differentiation O
and O
reduced O
tumorigenic O
potential O
in O
vivo O
. O

We O
have O
overexpressed O
, O
purified O
, O
characterized O
, O
and O
crystallized O
the O
BTB B
/ O
POZ O
domain O
from O
PLZF B
( O
PLZF B
- O
BTB B
/ O
POZ O
) O
. O

We O
have O
overexpressed O
, O
purified O
, O
characterized O
, O
and O
crystallized O
the O
BTB B
/ O
POZ O
domain O
from O
PLZF B
( O
PLZF B
- O
BTB B
/ O
POZ O
) O
. O

We O
have O
overexpressed O
, O
purified O
, O
characterized O
, O
and O
crystallized O
the O
BTB B
/ O
POZ O
domain O
from O
PLZF B
( O
PLZF B
- O
BTB B
/ O
POZ O
) O
. O

We O
have O
overexpressed O
, O
purified O
, O
characterized O
, O
and O
crystallized O
the O
BTB B
/ O
POZ O
domain O
from O
PLZF B
( O
PLZF B
- O
BTB B
/ O
POZ O
) O
. O

Molecular O
cloning O
and O
sequencing O
of O
a O
cDNA O
encoding O
SR B
beta I
revealed O
that O
SR B
beta I
is O
a O
transmembrane O
protein O
and O
, O
like O
SR B
alpha I
and O
SRP54 B
, O
is O
a O
member O
of O
the O
GTPase B
superfamily I
. O

Study O
of O
antinuclear O
autoantibodies O
by O
immunofluorescence O
technic O
in O
collagen B
diseases O

Interestingly O
, O
continuation O
of O
the O
interferon B
therapy O
in O
the O
presence O
of O
a O
mild O
- O
to O
- O
moderate O
exacerbation O
of O
sarcoidosis O
may O
be O
safe O
in O
a O
minority O
of O
patients O
with O
noncritical O
organ O
involvement O
. O

Three O
of O
the O
short O
ORFs O
in O
the O
central O
region O
of O
BIV O
have O
been O
identified O
by O
location O
and O
structural O
similarity O
to O
the O
nonstructural O
/ O
regulatory O
genes O
( O
vif B
, O
tat B
, O
and O
rev B
) O
of O
other O
lentiviruses O
; O
we O
also O
discovered O
two O
unique O
ORFs O
, O
termed O
W O
and O
Y O
, O
which O
may O
serve O
as O
exons O
for O
novel O
genes O
. O

Three O
of O
the O
short O
ORFs O
in O
the O
central O
region O
of O
BIV O
have O
been O
identified O
by O
location O
and O
structural O
similarity O
to O
the O
nonstructural O
/ O
regulatory O
genes O
( O
vif B
, O
tat B
, O
and O
rev B
) O
of O
other O
lentiviruses O
; O
we O
also O
discovered O
two O
unique O
ORFs O
, O
termed O
W O
and O
Y O
, O
which O
may O
serve O
as O
exons O
for O
novel O
genes O
. O

Three O
of O
the O
short O
ORFs O
in O
the O
central O
region O
of O
BIV O
have O
been O
identified O
by O
location O
and O
structural O
similarity O
to O
the O
nonstructural O
/ O
regulatory O
genes O
( O
vif B
, O
tat B
, O
and O
rev B
) O
of O
other O
lentiviruses O
; O
we O
also O
discovered O
two O
unique O
ORFs O
, O
termed O
W O
and O
Y O
, O
which O
may O
serve O
as O
exons O
for O
novel O
genes O
. O

( O
2 O
) O
Erythroid O
32D O
Epo1 B
cells O
showed O
a O
lower O
level O
of O
bulk O
PKC B
catalytic O
activity O
, O
lacked O
the O
expression O
of O
epsilon B
and I
eta I
PKC I
isoforms I
, O
and O
showed O
a O
weak O
or O
absent O
upregulation O
of O
the O
remaining O
isoforms O
, O
except O
betaI B
, O
upon O
readdition O
of O
Epo B
to O
growth O
factor O
- O
starved O
cells O
. O

( O
2 O
) O
Erythroid O
32D O
Epo1 B
cells O
showed O
a O
lower O
level O
of O
bulk O
PKC B
catalytic O
activity O
, O
lacked O
the O
expression O
of O
epsilon B
and I
eta I
PKC I
isoforms I
, O
and O
showed O
a O
weak O
or O
absent O
upregulation O
of O
the O
remaining O
isoforms O
, O
except O
betaI B
, O
upon O
readdition O
of O
Epo B
to O
growth O
factor O
- O
starved O
cells O
. O

( O
2 O
) O
Erythroid O
32D O
Epo1 B
cells O
showed O
a O
lower O
level O
of O
bulk O
PKC B
catalytic O
activity O
, O
lacked O
the O
expression O
of O
epsilon B
and I
eta I
PKC I
isoforms I
, O
and O
showed O
a O
weak O
or O
absent O
upregulation O
of O
the O
remaining O
isoforms O
, O
except O
betaI B
, O
upon O
readdition O
of O
Epo B
to O
growth O
factor O
- O
starved O
cells O
. O

( O
2 O
) O
Erythroid O
32D O
Epo1 B
cells O
showed O
a O
lower O
level O
of O
bulk O
PKC B
catalytic O
activity O
, O
lacked O
the O
expression O
of O
epsilon B
and I
eta I
PKC I
isoforms I
, O
and O
showed O
a O
weak O
or O
absent O
upregulation O
of O
the O
remaining O
isoforms O
, O
except O
betaI B
, O
upon O
readdition O
of O
Epo B
to O
growth O
factor O
- O
starved O
cells O
. O

Removal O
of O
the O
GST B
domain I
from O
GST B
- O
Tax B
by O
thrombin B
restores O
Tax B
' O
s O
ability O
to O
assemble O
a O
ternary O
Tax B
- O
CREB B
- O
21 O
- O
bp O
- O
repeat O
complex O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Removal O
of O
the O
GST B
domain I
from O
GST B
- O
Tax B
by O
thrombin B
restores O
Tax B
' O
s O
ability O
to O
assemble O
a O
ternary O
Tax B
- O
CREB B
- O
21 O
- O
bp O
- O
repeat O
complex O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Removal O
of O
the O
GST B
domain I
from O
GST B
- O
Tax B
by O
thrombin B
restores O
Tax B
' O
s O
ability O
to O
assemble O
a O
ternary O
Tax B
- O
CREB B
- O
21 O
- O
bp O
- O
repeat O
complex O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Removal O
of O
the O
GST B
domain I
from O
GST B
- O
Tax B
by O
thrombin B
restores O
Tax B
' O
s O
ability O
to O
assemble O
a O
ternary O
Tax B
- O
CREB B
- O
21 O
- O
bp O
- O
repeat O
complex O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Removal O
of O
the O
GST B
domain I
from O
GST B
- O
Tax B
by O
thrombin B
restores O
Tax B
' O
s O
ability O
to O
assemble O
a O
ternary O
Tax B
- O
CREB B
- O
21 O
- O
bp O
- O
repeat O
complex O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Removal O
of O
the O
GST B
domain I
from O
GST B
- O
Tax B
by O
thrombin B
restores O
Tax B
' O
s O
ability O
to O
assemble O
a O
ternary O
Tax B
- O
CREB B
- O
21 O
- O
bp O
- O
repeat O
complex O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Previous O
work O
has O
shown O
that O
spleen B
necrosis I
virus I
( I
SNV I
) I
long I
terminal I
repeats I
( O
LTRs O
) O
are O
associated O
with O
Rex B
/ O
Rex B
- O
responsive O
element O
- O
independent O
expression O
of O
bovine O
leukemia O
virus O
RNA O
and O
supports O
the O
hypothesis O
that O
SNV O
RNA O
contains O
a O
cis O
- O
acting O
element O
that O
interacts O
with O
cellular B
Rex I
- I
like I
proteins I
. O

Previous O
work O
has O
shown O
that O
spleen B
necrosis I
virus I
( I
SNV I
) I
long I
terminal I
repeats I
( O
LTRs O
) O
are O
associated O
with O
Rex B
/ O
Rex B
- O
responsive O
element O
- O
independent O
expression O
of O
bovine O
leukemia O
virus O
RNA O
and O
supports O
the O
hypothesis O
that O
SNV O
RNA O
contains O
a O
cis O
- O
acting O
element O
that O
interacts O
with O
cellular B
Rex I
- I
like I
proteins I
. O

RANTES B
( O
regulated B
upon I
activation I
, I
normally I
T I
- I
cell I
expressed I
and I
presumably I
secreted I
) O
is O
a O
CC O
chemokine O
which O
recruits O
and O
activates O
monocytes O
, O
lymphocytes O
, O
and O
eosinophils O
, O
all O
cell O
types O
present O
in O
the O
lung O
inflammatory O
infiltrate O
induced O
by O
RSV O
infection O
. O

The O
major O
promoter O
responds O
strongly O
to O
virus O
- O
encoded O
trans O
activators O
EIA B
and O
EIV B
and O
contains O
four O
elements O
: O
a O
TAGA O
motif O
analogous O
to O
the O
TATA O
box O
, O
two O
EIIF B
sites I
present O
in O
an O
inverted O
orientation O
, O
and O
an O
ATF B
/ O
CREB B
site O
. O

The O
major O
promoter O
responds O
strongly O
to O
virus O
- O
encoded O
trans O
activators O
EIA B
and O
EIV B
and O
contains O
four O
elements O
: O
a O
TAGA O
motif O
analogous O
to O
the O
TATA O
box O
, O
two O
EIIF B
sites I
present O
in O
an O
inverted O
orientation O
, O
and O
an O
ATF B
/ O
CREB B
site O
. O

The O
major O
promoter O
responds O
strongly O
to O
virus O
- O
encoded O
trans O
activators O
EIA B
and O
EIV B
and O
contains O
four O
elements O
: O
a O
TAGA O
motif O
analogous O
to O
the O
TATA O
box O
, O
two O
EIIF B
sites I
present O
in O
an O
inverted O
orientation O
, O
and O
an O
ATF B
/ O
CREB B
site O
. O

The O
major O
promoter O
responds O
strongly O
to O
virus O
- O
encoded O
trans O
activators O
EIA B
and O
EIV B
and O
contains O
four O
elements O
: O
a O
TAGA O
motif O
analogous O
to O
the O
TATA O
box O
, O
two O
EIIF B
sites I
present O
in O
an O
inverted O
orientation O
, O
and O
an O
ATF B
/ O
CREB B
site O
. O

However O
, O
reoperation O
for O
bulky O
cervical O
disease O
( O
group O
3 O
) O
rarely O
results O
in O
normal O
calcitonin B
levels O
and O
is O
associated O
with O
a O
high O
incidence O
of O
permanent O
hypoparathyroidism O
. O

To O
confirm O
the O
GapIII B
protein I
activity O
, O
constructs O
containing O
different O
GapIII B
- O
GRD B
domains O
were O
transformed O
into O
iral B
mutant O
yeast O
to O
determine O
their O
relative O
ability O
to O
replace O
IRA1 B
functionally O
. O

To O
confirm O
the O
GapIII B
protein I
activity O
, O
constructs O
containing O
different O
GapIII B
- O
GRD B
domains O
were O
transformed O
into O
iral B
mutant O
yeast O
to O
determine O
their O
relative O
ability O
to O
replace O
IRA1 B
functionally O
. O

To O
confirm O
the O
GapIII B
protein I
activity O
, O
constructs O
containing O
different O
GapIII B
- O
GRD B
domains O
were O
transformed O
into O
iral B
mutant O
yeast O
to O
determine O
their O
relative O
ability O
to O
replace O
IRA1 B
functionally O
. O

To O
confirm O
the O
GapIII B
protein I
activity O
, O
constructs O
containing O
different O
GapIII B
- O
GRD B
domains O
were O
transformed O
into O
iral B
mutant O
yeast O
to O
determine O
their O
relative O
ability O
to O
replace O
IRA1 B
functionally O
. O

These O
cell O
lines O
, O
selected O
for O
the O
ability O
to O
support O
the O
replication O
of O
a O
temperature O
- O
sensitive O
VP5 B
mutant I
, O
were O
used O
to O
isolate O
VP5 B
and O
VP23 B
null O
mutants O
. O

These O
cell O
lines O
, O
selected O
for O
the O
ability O
to O
support O
the O
replication O
of O
a O
temperature O
- O
sensitive O
VP5 B
mutant I
, O
were O
used O
to O
isolate O
VP5 B
and O
VP23 B
null O
mutants O
. O

In O
293 O
cells O
, O
expression O
of O
the O
NF B
- I
kappa I
B I
inhibitor O
, O
I B
kappa I
B I
- I
alpha I
, O
reduced O
the O
stimulatory O
activity O
of O
LMP B
. O

The O
studied O
protein O
fragments O
consist O
of O
residues O
Arg183 O
- O
His267 O
of O
the O
human B
ER I
and O
residues O
Lys438 O
- O
Gln520 O
of O
the O
rat O
GR B
. O

The O
revertant O
TATA O
boxes O
accelerated O
the O
kinetics O
of O
HIV O
replication O
when O
present O
in O
the O
context O
of O
an O
LTR O
containing O
a O
Sp1 B
mutation O
( O
deletion O
or O
site O
specific O
) O
; O
no O
effect O
was O
observed O
on O
the O
infectivity O
of O
wild O
- O
type O
HIV O
. O

In O
11 O
patients O
with O
Horton O
' O
s O
headache O
morphological O
investigations O
( O
differential O
white O
blood O
cell O
count O
) O
, O
cytoenzymatic O
determinations O
( O
alkaline B
and I
acid I
phosphatase I
, O
non B
- I
specific I
esterase I
) O
and O
cytoimmunological O
tests O
( O
IgM B
and O
IgG B
binding O
) O
were O
carried O
out O
on O
capillary O
blood O
neutrophils O
obtained O
from O
the O
area O
of O
pain O
, O
non O
- O
painful O
area O
of O
the O
skin O
on O
the O
head O
on O
the O
contralateral O
side O
, O
and O
from O
the O
finger O
. O

In O
11 O
patients O
with O
Horton O
' O
s O
headache O
morphological O
investigations O
( O
differential O
white O
blood O
cell O
count O
) O
, O
cytoenzymatic O
determinations O
( O
alkaline B
and I
acid I
phosphatase I
, O
non B
- I
specific I
esterase I
) O
and O
cytoimmunological O
tests O
( O
IgM B
and O
IgG B
binding O
) O
were O
carried O
out O
on O
capillary O
blood O
neutrophils O
obtained O
from O
the O
area O
of O
pain O
, O
non O
- O
painful O
area O
of O
the O
skin O
on O
the O
head O
on O
the O
contralateral O
side O
, O
and O
from O
the O
finger O
. O

In O
co O
- O
transfection O
studies O
, O
an O
AP B
- I
2 I
but O
not O
an O
Egr B
- I
1 I
expression O
vector O
activated O
VPF B
/ O
VEGF B
transcription O
, O
thus O
indicating O
that O
AP B
- I
2 I
protein I
is O
functionally O
important O
in O
TGF B
alpha I
- O
induced O
VPF B
/ O
VEGF B
gene O
expression O
. O

In O
co O
- O
transfection O
studies O
, O
an O
AP B
- I
2 I
but O
not O
an O
Egr B
- I
1 I
expression O
vector O
activated O
VPF B
/ O
VEGF B
transcription O
, O
thus O
indicating O
that O
AP B
- I
2 I
protein I
is O
functionally O
important O
in O
TGF B
alpha I
- O
induced O
VPF B
/ O
VEGF B
gene O
expression O
. O

In O
co O
- O
transfection O
studies O
, O
an O
AP B
- I
2 I
but O
not O
an O
Egr B
- I
1 I
expression O
vector O
activated O
VPF B
/ O
VEGF B
transcription O
, O
thus O
indicating O
that O
AP B
- I
2 I
protein I
is O
functionally O
important O
in O
TGF B
alpha I
- O
induced O
VPF B
/ O
VEGF B
gene O
expression O
. O

In O
co O
- O
transfection O
studies O
, O
an O
AP B
- I
2 I
but O
not O
an O
Egr B
- I
1 I
expression O
vector O
activated O
VPF B
/ O
VEGF B
transcription O
, O
thus O
indicating O
that O
AP B
- I
2 I
protein I
is O
functionally O
important O
in O
TGF B
alpha I
- O
induced O
VPF B
/ O
VEGF B
gene O
expression O
. O

Thus O
, O
YMIP B
is O
a O
functional O
homolog O
of O
RMIP B
and O
represents O
a O
new O
component O
of O
the O
yeast O
mitochondrial O
import O
machinery O
. O

Thus O
, O
YMIP B
is O
a O
functional O
homolog O
of O
RMIP B
and O
represents O
a O
new O
component O
of O
the O
yeast O
mitochondrial O
import O
machinery O
. O

Reverse B
transcriptase I
and O
protease O
activities O
of O
avian O
leukosis O
virus O
Gag B
- O
Pol B
fusion O
proteins O
expressed O
in O
insect O
cells O
. O

Reverse B
transcriptase I
and O
protease O
activities O
of O
avian O
leukosis O
virus O
Gag B
- O
Pol B
fusion O
proteins O
expressed O
in O
insect O
cells O
. O

The O
codon O
usage O
is O
particularly O
marked O
for O
the O
gag B
, O
pol B
, O
and O
env B
genes I
. O

The O
codon O
usage O
is O
particularly O
marked O
for O
the O
gag B
, O
pol B
, O
and O
env B
genes I
. O

These O
data O
define O
a O
conserved O
pathway O
wherein O
sequential O
histone B
modifications O
establish O
a O
" O
histone B
code O
" O
essential O
for O
the O
epigenetic O
inheritance O
of O
heterochromatin O
assembly O
. O

These O
data O
define O
a O
conserved O
pathway O
wherein O
sequential O
histone B
modifications O
establish O
a O
" O
histone B
code O
" O
essential O
for O
the O
epigenetic O
inheritance O
of O
heterochromatin O
assembly O
. O

Expression O
of O
a O
dominant B
- I
negative I
ras I
gene I
also O
blocks O
TIS10 B
/ O
PGS2 B
induction O
by O
v B
- I
src I
. O

Expression O
of O
a O
dominant B
- I
negative I
ras I
gene I
also O
blocks O
TIS10 B
/ O
PGS2 B
induction O
by O
v B
- I
src I
. O

No O
significant O
differences O
existed O
between O
the O
two O
age O
groups O
in O
baseline O
characteristics O
, O
including O
treatment O
protocol O
, O
performance O
status O
, O
and O
serum B
lactate I
dehydrogenase I
( O
LDH B
) O
level O
. O

No O
difference O
in O
telomere O
length O
was O
seen O
in O
mutants O
affected O
in O
the O
regulation O
of O
Cdc2 B
, O
whereas O
some O
of O
the O
DNA O
repair O
mutants O
examined O
had O
slightly O
longer O
telomeres O
than O
did O
the O
wild O
type O
. O

The O
gene O
structure O
of O
Elk1 B
spans O
15 O
. O
2 O
kb O
and O
consists O
of O
seven O
exons O
and O
six O
introns O
. O

Northern O
blot O
analysis O
of O
total O
cellular O
RNA O
indicated O
that O
xylP B
encodes O
a O
1 O
. O
3 O
- O
kb O
transcript O
which O
is O
induced O
by O
xylan O
. O

Twenty O
eligible O
patients O
with O
cirrhosis O
were O
randomized O
into O
two O
groups O
: O
10 O
patients O
treated O
with O
6 O
million O
units O
of O
natural O
IFN B
- I
beta I
twice O
a O
week O
for O
36 O
months O
and O
10 O
patients O
without O
IFN B
therapy O
. O

The O
results O
indicate O
that O
hrpRS B
and O
hrpL B
are O
part O
of O
a O
regulatory O
cascade O
in O
which O
HrpR B
and O
HrpS B
activate O
expression O
of O
hrpL B
and O
HrpL B
, O
a O
putative O
sigma B
factor I
, O
induces O
expression O
of O
HrpL B
- I
responsive I
genes I
. O

The O
results O
indicate O
that O
hrpRS B
and O
hrpL B
are O
part O
of O
a O
regulatory O
cascade O
in O
which O
HrpR B
and O
HrpS B
activate O
expression O
of O
hrpL B
and O
HrpL B
, O
a O
putative O
sigma B
factor I
, O
induces O
expression O
of O
HrpL B
- I
responsive I
genes I
. O

The O
results O
indicate O
that O
hrpRS B
and O
hrpL B
are O
part O
of O
a O
regulatory O
cascade O
in O
which O
HrpR B
and O
HrpS B
activate O
expression O
of O
hrpL B
and O
HrpL B
, O
a O
putative O
sigma B
factor I
, O
induces O
expression O
of O
HrpL B
- I
responsive I
genes I
. O

The O
results O
indicate O
that O
hrpRS B
and O
hrpL B
are O
part O
of O
a O
regulatory O
cascade O
in O
which O
HrpR B
and O
HrpS B
activate O
expression O
of O
hrpL B
and O
HrpL B
, O
a O
putative O
sigma B
factor I
, O
induces O
expression O
of O
HrpL B
- I
responsive I
genes I
. O

The O
results O
indicate O
that O
hrpRS B
and O
hrpL B
are O
part O
of O
a O
regulatory O
cascade O
in O
which O
HrpR B
and O
HrpS B
activate O
expression O
of O
hrpL B
and O
HrpL B
, O
a O
putative O
sigma B
factor I
, O
induces O
expression O
of O
HrpL B
- I
responsive I
genes I
. O

The O
results O
indicate O
that O
hrpRS B
and O
hrpL B
are O
part O
of O
a O
regulatory O
cascade O
in O
which O
HrpR B
and O
HrpS B
activate O
expression O
of O
hrpL B
and O
HrpL B
, O
a O
putative O
sigma B
factor I
, O
induces O
expression O
of O
HrpL B
- I
responsive I
genes I
. O

A O
possible O
role O
for O
the O
mixed O
function O
oxidase B
enzyme O
system O
in O
the O
requirement O
for O
selenium O
in O
the O
rat O
. O

The O
general O
transcription B
factor I
IIA I
( O
TFIIA B
) O
interacts O
with O
the O
TATA B
binding I
protein I
( O
TBP B
) O
and O
promoter O
DNA O
to O
mediate O
transcription O
activation O
in O
vitro O
. O

The O
general O
transcription B
factor I
IIA I
( O
TFIIA B
) O
interacts O
with O
the O
TATA B
binding I
protein I
( O
TBP B
) O
and O
promoter O
DNA O
to O
mediate O
transcription O
activation O
in O
vitro O
. O

CD4 B
lymphocyte O
and O
viral O
load O
levels O
suggested O
an O
optimal O
response O
to O
ARV O
therapy O
at O
the O
time O
LD O
developed O
. O

Homozygous O
null O
embryos O
also O
displayed O
abnormalities O
in O
heart O
development O
, O
consistent O
with O
the O
conclusion O
that O
Tek B
is O
necessary O
for O
endocardial O
/ O
myocardial O
interactions O
during O
development O
. O

Isolation O
of O
cDNAs B
encoding I
gibbon I
and I
monkey I
platelet I
and I
T I
cell I
activation I
antigen I
1 I
( O
PTA1 B
) O
. O

Since O
the O
regulation O
of O
SWI4 B
is O
required O
for O
normal O
cell O
cycle O
progression O
, O
we O
have O
characterized O
cis O
- O
and O
trans O
- O
acting O
regulators O
of O
SWI4 B
transcription O
. O

Since O
the O
regulation O
of O
SWI4 B
is O
required O
for O
normal O
cell O
cycle O
progression O
, O
we O
have O
characterized O
cis O
- O
and O
trans O
- O
acting O
regulators O
of O
SWI4 B
transcription O
. O

Analysis O
of O
lacZ B
transcriptional I
fusions I
shows O
that O
the O
KdgR B
- I
binding I
sites I
negatively O
affect O
the O
expression O
of O
rsmB B
. O

As O
expected O
, O
the O
insulin B
effect O
to O
increase O
ras B
GTP I
formation O
and O
MAP B
kinase I
activity O
was O
negligible O
in O
A O
/ O
K1018 O
cells O
but O
normal O
, O
or O
supernormal O
, O
in O
Y O
/ O
F2 O
cells O
. O

I O
report O
here O
that O
induction O
of O
HSP82 B
is O
regulated O
by O
the O
early O
meiotic O
IME1 B
- O
IME2 B
transcriptional O
cascade O
. O

I O
report O
here O
that O
induction O
of O
HSP82 B
is O
regulated O
by O
the O
early O
meiotic O
IME1 B
- O
IME2 B
transcriptional O
cascade O
. O

I O
report O
here O
that O
induction O
of O
HSP82 B
is O
regulated O
by O
the O
early O
meiotic O
IME1 B
- O
IME2 B
transcriptional O
cascade O
. O

This O
report O
substantiates O
that O
at O
least O
two O
of O
the O
18 O
kDa O
hsps B
in O
maize O
are O
products O
of O
different O
but O
related O
genes O
. O

Oligonucleotide O
competitors O
were O
used O
to O
evaluate O
the O
accessibility O
of O
the O
TATA O
- O
binding O
site O
in O
TIF B
- I
IB I
, O
TFIID B
, O
and O
TFIIIB B
. O

Oligonucleotide O
competitors O
were O
used O
to O
evaluate O
the O
accessibility O
of O
the O
TATA O
- O
binding O
site O
in O
TIF B
- I
IB I
, O
TFIID B
, O
and O
TFIIIB B
. O

Insertion O
of O
short O
oligonucleotides O
encoding O
the O
basic O
amino O
acid O
motifs O
726 O
- O
GRKRKSP O
- O
732 O
from O
IE175 B
and O
500 O
- O
VRPRKRR O
- O
506 O
from O
IE110 B
into O
deleted O
cytoplasmic O
forms O
of O
the O
two O
proteins O
restored O
the O
karyophilic O
phenotype O
and O
confirmed O
that O
these O
motifs O
are O
both O
necessary O
and O
sufficient O
for O
proper O
nuclear O
localization O
. O

Insertion O
of O
short O
oligonucleotides O
encoding O
the O
basic O
amino O
acid O
motifs O
726 O
- O
GRKRKSP O
- O
732 O
from O
IE175 B
and O
500 O
- O
VRPRKRR O
- O
506 O
from O
IE110 B
into O
deleted O
cytoplasmic O
forms O
of O
the O
two O
proteins O
restored O
the O
karyophilic O
phenotype O
and O
confirmed O
that O
these O
motifs O
are O
both O
necessary O
and O
sufficient O
for O
proper O
nuclear O
localization O
. O

Addition O
of O
phalloidin O
- O
stabilized O
F B
- I
actin I
nuclei O
and O
phalloidin O
restored O
L266D O
actin B
' O
s O
ability O
to O
polymerize O
at O
4 O
degrees O
C O
. O

The O
protein O
product O
of O
orfD B
, O
which O
is O
probably O
a O
new O
tra B
gene I
( O
named O
traX B
) O
, O
contains O
65 O
% O
hydrophobic O
amino O
acids O
, O
especially O
rich O
in O
alanine O
and O
leucine O
. O

The O
protein O
product O
of O
orfD B
, O
which O
is O
probably O
a O
new O
tra B
gene I
( O
named O
traX B
) O
, O
contains O
65 O
% O
hydrophobic O
amino O
acids O
, O
especially O
rich O
in O
alanine O
and O
leucine O
. O

Six O
distinct O
Ets B
mRNAs I
were O
identified O
: O
Ets2 B
, O
Fli1 B
, O
GABPalpha B
, O
SAP1 B
, O
Elk1 B
, O
and O
PE1 B
. O

Six O
distinct O
Ets B
mRNAs I
were O
identified O
: O
Ets2 B
, O
Fli1 B
, O
GABPalpha B
, O
SAP1 B
, O
Elk1 B
, O
and O
PE1 B
. O

Six O
distinct O
Ets B
mRNAs I
were O
identified O
: O
Ets2 B
, O
Fli1 B
, O
GABPalpha B
, O
SAP1 B
, O
Elk1 B
, O
and O
PE1 B
. O

Six O
distinct O
Ets B
mRNAs I
were O
identified O
: O
Ets2 B
, O
Fli1 B
, O
GABPalpha B
, O
SAP1 B
, O
Elk1 B
, O
and O
PE1 B
. O

Six O
distinct O
Ets B
mRNAs I
were O
identified O
: O
Ets2 B
, O
Fli1 B
, O
GABPalpha B
, O
SAP1 B
, O
Elk1 B
, O
and O
PE1 B
. O

Six O
distinct O
Ets B
mRNAs I
were O
identified O
: O
Ets2 B
, O
Fli1 B
, O
GABPalpha B
, O
SAP1 B
, O
Elk1 B
, O
and O
PE1 B
. O

These O
two O
repeat O
motifs O
are O
organized O
in O
an O
extremely O
well O
- O
ordered O
pattern O
in O
each O
domain O
, O
which O
suggests O
that O
SbHRGP3 B
belongs O
to O
a O
new O
group O
of O
proteins O
having O
the O
repeat O
motifs O
of O
two O
distinct O
groups O
of O
dicot B
extensins I
. O

Both O
NUP98 B
- O
HOXA9 B
chimeras O
transformed O
NIH O
3T3 O
fibroblasts O
, O
and O
this O
transformation O
required O
the O
HOXA9 B
domains I
for O
DNA O
binding O
and O
PBX B
interaction O
. O

Both O
NUP98 B
- O
HOXA9 B
chimeras O
transformed O
NIH O
3T3 O
fibroblasts O
, O
and O
this O
transformation O
required O
the O
HOXA9 B
domains I
for O
DNA O
binding O
and O
PBX B
interaction O
. O

Both O
NUP98 B
- O
HOXA9 B
chimeras O
transformed O
NIH O
3T3 O
fibroblasts O
, O
and O
this O
transformation O
required O
the O
HOXA9 B
domains I
for O
DNA O
binding O
and O
PBX B
interaction O
. O

However O
, O
cotransfection O
studies O
indicate O
that O
RVR B
does O
not O
activate O
transcription O
when O
this O
hormone O
response O
element O
is O
linked O
to O
a O
reporter O
gene O
but O
rather O
acts O
as O
a O
potent O
competitive O
repressor O
of O
ROR B
alpha I
function O
. O

We O
have O
characterized O
a O
panel O
of O
6 O
monoclonal O
antibodies O
raised O
against O
human B
platelet I
talin I
by O
Western O
blotting O
, O
immune O
precipitation O
, O
and O
immunofluorescence O
, O
and O
shown O
that O
antibodies B
TA205 I
and O
TD77 B
disrupt O
actin B
stress O
fibers O
and O
focal O
adhesions O
, O
and O
inhibit O
cell O
motility O
when O
microinjected O
into O
human O
fibroblasts O
. O

We O
have O
characterized O
a O
panel O
of O
6 O
monoclonal O
antibodies O
raised O
against O
human B
platelet I
talin I
by O
Western O
blotting O
, O
immune O
precipitation O
, O
and O
immunofluorescence O
, O
and O
shown O
that O
antibodies B
TA205 I
and O
TD77 B
disrupt O
actin B
stress O
fibers O
and O
focal O
adhesions O
, O
and O
inhibit O
cell O
motility O
when O
microinjected O
into O
human O
fibroblasts O
. O

We O
have O
now O
identified O
, O
after O
21 O
serial O
undiluted O
passages O
of O
MHV O
, O
a O
small B
DI I
RNA I
, O
DIssF B
, O
which O
is O
efficiently O
packaged O
into O
virions O
. O

In O
these O
constructs O
, O
GUS B
expression O
was O
driven O
by O
promoter O
regions O
derived O
from O
the O
Arabidopsis B
alcohol I
dehydrogenase I
( O
Adh1 B
) O
, O
maize B
ubiquitin I
( O
Ubi1 B
) O
, O
rice B
actin I
( O
Act1 B
) O
and O
CaMV B
35S I
genes I
. O

In O
these O
constructs O
, O
GUS B
expression O
was O
driven O
by O
promoter O
regions O
derived O
from O
the O
Arabidopsis B
alcohol I
dehydrogenase I
( O
Adh1 B
) O
, O
maize B
ubiquitin I
( O
Ubi1 B
) O
, O
rice B
actin I
( O
Act1 B
) O
and O
CaMV B
35S I
genes I
. O

In O
these O
constructs O
, O
GUS B
expression O
was O
driven O
by O
promoter O
regions O
derived O
from O
the O
Arabidopsis B
alcohol I
dehydrogenase I
( O
Adh1 B
) O
, O
maize B
ubiquitin I
( O
Ubi1 B
) O
, O
rice B
actin I
( O
Act1 B
) O
and O
CaMV B
35S I
genes I
. O

In O
these O
constructs O
, O
GUS B
expression O
was O
driven O
by O
promoter O
regions O
derived O
from O
the O
Arabidopsis B
alcohol I
dehydrogenase I
( O
Adh1 B
) O
, O
maize B
ubiquitin I
( O
Ubi1 B
) O
, O
rice B
actin I
( O
Act1 B
) O
and O
CaMV B
35S I
genes I
. O

Both O
Rep78 B
and O
Rep68 B
cut O
the O
terminal O
AAV O
sequence O
at O
the O
same O
site O
( O
nucleotide O
124 O
) O
. O

Both O
Rep78 B
and O
Rep68 B
cut O
the O
terminal O
AAV O
sequence O
at O
the O
same O
site O
( O
nucleotide O
124 O
) O
. O

In O
this O
regard O
, O
it O
differs O
from O
a O
recently O
reported O
BFA O
- O
sensitive O
ARF B
- O
GEP B
that O
contains O
a O
Sec7 B
domain I
. O

In O
this O
regard O
, O
it O
differs O
from O
a O
recently O
reported O
BFA O
- O
sensitive O
ARF B
- O
GEP B
that O
contains O
a O
Sec7 B
domain I
. O

Circulating O
platelets O
may O
be O
activated O
by O
exposed O
triple O
- O
helical O
collagen B
in O
atherosclerotic O
lesions O
in O
Mg O
- O
deficient O
ruminants O
. O

Cytokine O
- O
induced O
NF B
- I
kappa I
B I
DNA O
binding O
activity O
, O
RelA B
nuclear O
translocation O
, O
I B
kappa I
B I
alpha I
degradation O
, O
I B
kappa I
B I
serine O
32 O
phosphorylation O
, O
and O
I B
kappa I
B I
kinase I
( O
IKK B
) O
activity O
were O
blocked O
by O
curcumin O
treatment O
. O

Cytokine O
- O
induced O
NF B
- I
kappa I
B I
DNA O
binding O
activity O
, O
RelA B
nuclear O
translocation O
, O
I B
kappa I
B I
alpha I
degradation O
, O
I B
kappa I
B I
serine O
32 O
phosphorylation O
, O
and O
I B
kappa I
B I
kinase I
( O
IKK B
) O
activity O
were O
blocked O
by O
curcumin O
treatment O
. O

Actins B
show O
two O
different O
forms O
of O
N O
- O
terminal O
processing O
dependent O
on O
their O
N O
- O
terminal O
sequence O
. O

However O
, O
alterations O
in O
electrostatic O
and O
hydrophobic O
interactions O
created O
by O
the O
three O
amino O
acid O
substitutions O
prevent O
the O
conformational O
change O
in O
the O
enzyme O
usually O
produced O
by O
calmodulin B
binding O
. O

We O
found O
that O
T3 O
( O
10 O
( O
- O
8 O
) O
M O
) O
selectively O
stimulates O
transcription O
from O
rGH B
- O
TRE O
- O
and O
TREpal O
- O
, O
but O
not O
ME O
- O
TRE O
- O
and O
F2 O
- O
TRE O
- O
, O
containing O
templates O
in O
which O
these O
TREs O
are O
linked O
in O
front O
of O
the O
rGH B
minimal I
promoter I
containing O
only O
the O
TATA B
box I
binding I
protein I
, O
but O
not O
any O
other O
proximal O
binding O
protein O
, O
sequence O
. O

All O
ribosomal B
protein I
( O
rp B
) O
gene O
promoters O
from O
Saccharomyces O
cerevisiae O
studied O
so O
far O
contain O
either O
( O
usually O
two O
) O
binding O
sites O
for O
the O
global O
gene O
regulator O
Rap1p B
or O
one O
binding O
site O
for O
another O
global O
factor O
, O
Abf1p B
. O

All O
ribosomal B
protein I
( O
rp B
) O
gene O
promoters O
from O
Saccharomyces O
cerevisiae O
studied O
so O
far O
contain O
either O
( O
usually O
two O
) O
binding O
sites O
for O
the O
global O
gene O
regulator O
Rap1p B
or O
one O
binding O
site O
for O
another O
global O
factor O
, O
Abf1p B
. O

All O
ribosomal B
protein I
( O
rp B
) O
gene O
promoters O
from O
Saccharomyces O
cerevisiae O
studied O
so O
far O
contain O
either O
( O
usually O
two O
) O
binding O
sites O
for O
the O
global O
gene O
regulator O
Rap1p B
or O
one O
binding O
site O
for O
another O
global O
factor O
, O
Abf1p B
. O

All O
three O
NR B
isoforms O
are O
expressed O
in O
cv O
. O

While O
determination O
of O
the O
protein O
content O
of O
the O
formulae O
gave O
no O
valid O
information O
, O
RAST O
/ O
EAST O
inhibition O
was O
highest O
for O
cow O
' O
s O
milk O
, O
followed O
by O
the O
partially O
hydrolysed O
whey O
formula O
, O
partially O
hydrolysed O
whey O
/ O
casein B
formula O
, O
soy B
/ I
pork I
collagen I
formula O
, O
and O
the O
amino O
acid O
formula O
. O

To O
determine O
which O
sequences O
in O
the O
rat B
P450c17 I
promoter I
may O
be O
responsible O
for O
basal O
and O
cAMP O
- O
stimulated O
gene O
transcription O
, O
deletion O
constructs O
containing O
between O
- O
1 O
, O
560 O
and O
- O
53 O
base O
pairs O
of O
5 O
' O
- O
flanking O
DNA O
from O
the O
rat B
P450c17 I
gene I
were O
ligated O
to O
plasmids O
expressing O
the O
reporter O
gene O
luciferase B
and O
transfected O
into O
two O
mouse O
cell O
lines O
, O
adrenal O
Y O
- O
1 O
cells O
, O
and O
testicular O
Leydig O
MA O
- O
10 O
cells O
. O

This O
region O
contains O
a O
motif O
with O
partial O
identity O
with O
the O
binding O
site O
for O
the O
ubiquitous O
transcription O
factor O
upstream B
stimulatory I
factor I
( O
USF B
) O
, O
which O
binds O
to O
the O
human B
insulin I
promoter I
. O

The O
RAS B
- O
cyclic B
AMP I
- I
dependent I
protein I
kinase I
cAPK B
pathway O
prevents O
the O
UAS O
activity O
of O
IREu B
in O
the O
presence O
of O
glucose O
as O
the O
sole O
carbon O
source O
, O
while O
the O
transcriptional O
activators O
Msn2p B
and O
Msn4p B
promote O
the O
UAS O
activity O
of O
this O
repeat O
in O
the O
presence O
of O
acetate O
. O

The O
RAS B
- O
cyclic B
AMP I
- I
dependent I
protein I
kinase I
cAPK B
pathway O
prevents O
the O
UAS O
activity O
of O
IREu B
in O
the O
presence O
of O
glucose O
as O
the O
sole O
carbon O
source O
, O
while O
the O
transcriptional O
activators O
Msn2p B
and O
Msn4p B
promote O
the O
UAS O
activity O
of O
this O
repeat O
in O
the O
presence O
of O
acetate O
. O

The O
RAS B
- O
cyclic B
AMP I
- I
dependent I
protein I
kinase I
cAPK B
pathway O
prevents O
the O
UAS O
activity O
of O
IREu B
in O
the O
presence O
of O
glucose O
as O
the O
sole O
carbon O
source O
, O
while O
the O
transcriptional O
activators O
Msn2p B
and O
Msn4p B
promote O
the O
UAS O
activity O
of O
this O
repeat O
in O
the O
presence O
of O
acetate O
. O

The O
RAS B
- O
cyclic B
AMP I
- I
dependent I
protein I
kinase I
cAPK B
pathway O
prevents O
the O
UAS O
activity O
of O
IREu B
in O
the O
presence O
of O
glucose O
as O
the O
sole O
carbon O
source O
, O
while O
the O
transcriptional O
activators O
Msn2p B
and O
Msn4p B
promote O
the O
UAS O
activity O
of O
this O
repeat O
in O
the O
presence O
of O
acetate O
. O

The O
RAS B
- O
cyclic B
AMP I
- I
dependent I
protein I
kinase I
cAPK B
pathway O
prevents O
the O
UAS O
activity O
of O
IREu B
in O
the O
presence O
of O
glucose O
as O
the O
sole O
carbon O
source O
, O
while O
the O
transcriptional O
activators O
Msn2p B
and O
Msn4p B
promote O
the O
UAS O
activity O
of O
this O
repeat O
in O
the O
presence O
of O
acetate O
. O

RT O
- O
PCR O
and O
in O
situ O
hybridization O
analyses O
of O
a O
time O
course O
of O
juvenile O
testis O
development O
indicate O
that O
Spo11 B
expression O
begins O
in O
early O
meiotic O
Prophase O
I O
, O
prior O
to O
the O
pachytene O
stage O
, O
with O
increasing O
accumulation O
of O
mRNA O
through O
the O
pachytene O
stage O
. O

As O
assessed O
by O
a O
genetic O
assay O
that O
measures O
AAI O
- O
dependent O
DNA O
binding O
, O
TraM B
inhibited O
TraR B
function O
before O
and O
after O
the O
transcription O
factor O
had O
bound O
to O
its O
DNA O
recognition O
site O
. O

As O
assessed O
by O
a O
genetic O
assay O
that O
measures O
AAI O
- O
dependent O
DNA O
binding O
, O
TraM B
inhibited O
TraR B
function O
before O
and O
after O
the O
transcription O
factor O
had O
bound O
to O
its O
DNA O
recognition O
site O
. O

Phorbol O
esters O
stimulated O
phosphorylation O
of O
CSK B
35H I
proteins I
, O
thus O
emphasizing O
that O
sequences O
isolated O
according O
to O
PKC B
binding O
activity O
in O
vitro O
are O
also O
PKC B
substrates O
in O
vivo O
. O

Phorbol O
esters O
stimulated O
phosphorylation O
of O
CSK B
35H I
proteins I
, O
thus O
emphasizing O
that O
sequences O
isolated O
according O
to O
PKC B
binding O
activity O
in O
vitro O
are O
also O
PKC B
substrates O
in O
vivo O
. O

Structure O
and O
regulation O
of O
the O
gene O
encoding O
the O
neuron O
- O
specific O
protein B
kinase I
C I
substrate O
neurogranin B
( O
RC3 B
protein I
) O
. O

The O
promoter O
region O
showed O
no O
consensus O
TATA O
box O
but O
it O
contains O
CCAAT O
and O
CreA B
boxes O
known O
to O
be O
involved O
in O
both O
stress O
and O
carbon O
- O
catabolite O
regulation O
of O
fungal O
promoters O
. O

We O
also O
provide O
evidence O
that O
gar2 B
is O
phosphorylated O
in O
vitro O
by O
a O
p13 B
( O
suc1 B
) O
- O
Sepharose O
- O
bound O
kinase O
from O
Schizosaccharomyces O
pombe O
extracts O
that O
displays O
cell O
cycle O
- O
regulated O
activity O
similar O
to O
that O
of O
the O
p34 B
( O
cdc2 B
( O
kinase O
. O

We O
also O
provide O
evidence O
that O
gar2 B
is O
phosphorylated O
in O
vitro O
by O
a O
p13 B
( O
suc1 B
) O
- O
Sepharose O
- O
bound O
kinase O
from O
Schizosaccharomyces O
pombe O
extracts O
that O
displays O
cell O
cycle O
- O
regulated O
activity O
similar O
to O
that O
of O
the O
p34 B
( O
cdc2 B
( O
kinase O
. O

We O
also O
provide O
evidence O
that O
gar2 B
is O
phosphorylated O
in O
vitro O
by O
a O
p13 B
( O
suc1 B
) O
- O
Sepharose O
- O
bound O
kinase O
from O
Schizosaccharomyces O
pombe O
extracts O
that O
displays O
cell O
cycle O
- O
regulated O
activity O
similar O
to O
that O
of O
the O
p34 B
( O
cdc2 B
( O
kinase O
. O

We O
also O
provide O
evidence O
that O
gar2 B
is O
phosphorylated O
in O
vitro O
by O
a O
p13 B
( O
suc1 B
) O
- O
Sepharose O
- O
bound O
kinase O
from O
Schizosaccharomyces O
pombe O
extracts O
that O
displays O
cell O
cycle O
- O
regulated O
activity O
similar O
to O
that O
of O
the O
p34 B
( O
cdc2 B
( O
kinase O
. O

We O
also O
provide O
evidence O
that O
gar2 B
is O
phosphorylated O
in O
vitro O
by O
a O
p13 B
( O
suc1 B
) O
- O
Sepharose O
- O
bound O
kinase O
from O
Schizosaccharomyces O
pombe O
extracts O
that O
displays O
cell O
cycle O
- O
regulated O
activity O
similar O
to O
that O
of O
the O
p34 B
( O
cdc2 B
( O
kinase O
. O

TPBF B
has O
two O
potential O
coiled O
- O
coil O
regions O
, O
a O
basic O
region O
, O
a O
proline O
- O
rich O
region O
, O
a O
histidine O
- O
rich O
N O
terminus O
, O
and O
a O
nuclear O
targeting O
sequence O
. O

However O
, O
a O
10 O
- O
- O
15 O
% O
lengthening O
of O
the O
partial O
thromboplastin B
time O
is O
evident O
after O
24 O
hours O
of O
storage O
. O

Members O
of O
the O
meis1 B
and O
pbx B
homeodomain I
protein I
families I
cooperatively O
bind O
a O
cAMP O
- O
responsive O
sequence O
( O
CRS1 O
) O
from O
bovine B
CYP17 I
. O

Approximately O
20 O
% O
of O
ALCLs O
that O
express O
ALK B
do O
not O
contain O
the O
t O
( O
2 O
; O
5 O
) O
, O
suggesting O
that O
other O
genetic O
abnormalities O
can O
result O
in O
aberrant O
ALK B
expression O
. O

Approximately O
20 O
% O
of O
ALCLs O
that O
express O
ALK B
do O
not O
contain O
the O
t O
( O
2 O
; O
5 O
) O
, O
suggesting O
that O
other O
genetic O
abnormalities O
can O
result O
in O
aberrant O
ALK B
expression O
. O

The O
fatigue O
exercise O
showed O
relatively O
high O
blood O
lactate O
concentration O
[ O
12 O
. O
5 O
( O
SD O
2 O
. O
6 O
) O
mmol O
x O
l O
( O
- O
1 O
) O
] O
and O
an O
increase O
of O
serum B
creatine I
kinase I
( O
CK B
) O
activity O
delayed O
by O
2 O
days O
[ O
540 O
( O
SD O
407 O
) O
U O
x O
l O
( O
- O
1 O
) O
] O
. O

We O
have O
performed O
toeprinting O
analyses O
on O
repA B
mRNA I
of O
plasmid O
R1 O
, O
both O
free O
and O
in O
duplex O
with O
the O
antisense O
RNA O
, O
CopA B
. O

Each O
recombinant O
product O
was O
a O
fusion O
protein O
with O
a O
B O
domain O
of O
Staphylococcal B
protein I
A I
( O
SPA B
) O
. O

An O
FP B
mutant I
, O
AcFP875 B
- I
2 I
, O
had O
a O
1 O
. O
6 O
- O
kbp O
insertion O
of O
S O
. O
frugiperda O
DNA O
near O
the O
5 O
' O
end O
of O
these O
transcripts O
which O
by O
S1 B
analysis O
were O
shown O
to O
initiate O
within O
the O
host O
cell O
sequence O
. O

These O
data O
suggest O
that O
other O
Ras B
effectors I
can O
collaborate O
with O
PI B
3 I
- I
kinase I
and O
with O
each O
other O
to O
activate O
Pak B
. O

MSSPs B
are O
believed O
to O
regulate O
DNA O
replication O
, O
transcription O
, O
apopotosis O
and O
cell O
cycle O
progression O
by O
interacting O
with O
the O
C B
- I
MYC I
protein I
. O

We O
have O
shown O
previously O
that O
in O
contrast O
to O
other O
extracellular O
matrix O
molecules O
pepsin B
- O
solubilized O
collagen B
VI I
( O
CVI B
) O
can O
stimulate O
DNA O
synthesis O
of O
various O
mesenchymal O
cell O
types O
, O
apparently O
independent O
of O
integrin B
- O
mediated O
signal O
transduction O
. O

We O
have O
shown O
previously O
that O
in O
contrast O
to O
other O
extracellular O
matrix O
molecules O
pepsin B
- O
solubilized O
collagen B
VI I
( O
CVI B
) O
can O
stimulate O
DNA O
synthesis O
of O
various O
mesenchymal O
cell O
types O
, O
apparently O
independent O
of O
integrin B
- O
mediated O
signal O
transduction O
. O

We O
have O
shown O
previously O
that O
in O
contrast O
to O
other O
extracellular O
matrix O
molecules O
pepsin B
- O
solubilized O
collagen B
VI I
( O
CVI B
) O
can O
stimulate O
DNA O
synthesis O
of O
various O
mesenchymal O
cell O
types O
, O
apparently O
independent O
of O
integrin B
- O
mediated O
signal O
transduction O
. O

Proteins O
known O
to O
bind O
the O
PEPCK B
CRE O
include O
the O
CRE B
- I
binding I
protein I
( O
CREB B
) O
and O
members O
of O
the O
CCAAT B
/ I
enhancer I
- I
binding I
protein I
( O
C B
/ I
EBP I
) O
family O
. O

Proteins O
known O
to O
bind O
the O
PEPCK B
CRE O
include O
the O
CRE B
- I
binding I
protein I
( O
CREB B
) O
and O
members O
of O
the O
CCAAT B
/ I
enhancer I
- I
binding I
protein I
( O
C B
/ I
EBP I
) O
family O
. O

Although O
IL B
- I
2 I
and O
IFN B
- I
alpha I
activated O
STAT1 B
alpha I
and O
STAT5 B
, O
IL B
- I
2 I
predominantly O
activated O
STAT5 B
, O
while O
IFN B
- I
alpha I
predominantly O
activated O
STAT1 B
alpha I
. O

Although O
IL B
- I
2 I
and O
IFN B
- I
alpha I
activated O
STAT1 B
alpha I
and O
STAT5 B
, O
IL B
- I
2 I
predominantly O
activated O
STAT5 B
, O
while O
IFN B
- I
alpha I
predominantly O
activated O
STAT1 B
alpha I
. O

We O
demonstrate O
that O
Ddc1p B
interacts O
physically O
in O
vivo O
with O
Mec3p B
, O
and O
this O
interaction O
requires O
Rad17p B
. O

We O
demonstrate O
that O
Ddc1p B
interacts O
physically O
in O
vivo O
with O
Mec3p B
, O
and O
this O
interaction O
requires O
Rad17p B
. O

We O
demonstrate O
that O
Ddc1p B
interacts O
physically O
in O
vivo O
with O
Mec3p B
, O
and O
this O
interaction O
requires O
Rad17p B
. O

These O
results O
suggest O
that O
G B
beta I
gamma I
- O
stimulated O
Shc B
phosphorylation O
represents O
an O
early O
step O
in O
the O
pathway O
leading O
to O
p21ras B
activation O
, O
similar O
to O
the O
mechanism O
utilized O
by O
growth B
factor I
tyrosine I
kinase I
receptors I
. O

These O
results O
suggest O
that O
G B
beta I
gamma I
- O
stimulated O
Shc B
phosphorylation O
represents O
an O
early O
step O
in O
the O
pathway O
leading O
to O
p21ras B
activation O
, O
similar O
to O
the O
mechanism O
utilized O
by O
growth B
factor I
tyrosine I
kinase I
receptors I
. O

To O
understand O
the O
function O
of O
receptor B
- I
linked I
tyrosine I
phosphatases I
in O
neural O
development O
, O
we O
sought O
to O
identify O
LAR B
isoforms I
preferentially O
expressed O
in O
the O
nervous O
system O
and O
cellular O
processes O
regulating O
LAR B
alternative O
splicing O
. O

Sp1 B
can O
activate O
transcription O
through O
immunoglobulin B
kappa I
- I
chain I
enhancer I
or O
P B
- I
selectin I
promoter I
NF B
- I
kappaB I
sites I
. O

p50 B
homodimers I
replace O
Sp1 B
from O
the O
P B
- I
selectin I
promoter I
by O
binding O
site O
competition O
and O
thereby O
either O
inhibit O
basal O
Sp1 B
- O
driven O
expression O
or O
, O
in O
concert O
with O
Bcl B
- I
3 I
, O
stimulate O
expression O
. O

p50 B
homodimers I
replace O
Sp1 B
from O
the O
P B
- I
selectin I
promoter I
by O
binding O
site O
competition O
and O
thereby O
either O
inhibit O
basal O
Sp1 B
- O
driven O
expression O
or O
, O
in O
concert O
with O
Bcl B
- I
3 I
, O
stimulate O
expression O
. O

The O
delta B
srb10 I
mutation I
also O
influenced O
on O
the O
transcript O
levels O
of O
meiosis O
- O
inducing O
genes O
called O
IME1 B
and O
IME2 B
: O
the O
mutation O
elevated O
the O
transcript O
level O
of O
IME1 B
but O
reduced O
that O
of O
IME2 B
, O
resulting O
in O
partial O
defects O
in O
premeiotic O
DNA O
synthesis O
and O
meiosis O
. O

The O
delta B
srb10 I
mutation I
also O
influenced O
on O
the O
transcript O
levels O
of O
meiosis O
- O
inducing O
genes O
called O
IME1 B
and O
IME2 B
: O
the O
mutation O
elevated O
the O
transcript O
level O
of O
IME1 B
but O
reduced O
that O
of O
IME2 B
, O
resulting O
in O
partial O
defects O
in O
premeiotic O
DNA O
synthesis O
and O
meiosis O
. O

The O
delta B
srb10 I
mutation I
also O
influenced O
on O
the O
transcript O
levels O
of O
meiosis O
- O
inducing O
genes O
called O
IME1 B
and O
IME2 B
: O
the O
mutation O
elevated O
the O
transcript O
level O
of O
IME1 B
but O
reduced O
that O
of O
IME2 B
, O
resulting O
in O
partial O
defects O
in O
premeiotic O
DNA O
synthesis O
and O
meiosis O
. O

The O
delta B
srb10 I
mutation I
also O
influenced O
on O
the O
transcript O
levels O
of O
meiosis O
- O
inducing O
genes O
called O
IME1 B
and O
IME2 B
: O
the O
mutation O
elevated O
the O
transcript O
level O
of O
IME1 B
but O
reduced O
that O
of O
IME2 B
, O
resulting O
in O
partial O
defects O
in O
premeiotic O
DNA O
synthesis O
and O
meiosis O
. O

The O
gene O
product O
of O
cotS B
was O
confirmed O
to O
be O
identical O
to O
Cot40 B
- I
2 I
by O
SDS O
- O
PAGE O
and O
immunoblotting O
from O
Escherichia O
coli O
transformed O
with O
a O
plasmid O
containing O
the O
cotS B
region I
. O

Apart O
from O
iron O
regulation O
, O
sodA B
expression O
was O
affected O
by O
changes O
in O
DNA O
topology O
induced O
by O
coumermycin O
A O
but O
not O
by O
the O
global O
virulence O
regulatory O
Bvg B
system I
. O

c B
- I
Fos I
transcriptional O
activity O
stimulated O
by O
H B
- I
Ras I
- I
activated I
protein I
kinase I
distinct O
from O
JNK B
and O
ERK B
. O

c B
- I
Fos I
transcriptional O
activity O
stimulated O
by O
H B
- I
Ras I
- I
activated I
protein I
kinase I
distinct O
from O
JNK B
and O
ERK B
. O

Quantitative O
evaluation O
of O
the O
steady O
state O
kinetics O
of O
MEK B
inhibition O
by O
these O
compounds O
reveals O
that O
U0126 O
has O
approximately O
100 O
- O
fold O
higher O
affinity O
for O
deltaN3 B
- I
S218E I
/ I
S222D I
MEK I
than O
does O
PD098059 O
. O

The O
DNA O
sequences O
predict O
proteins O
for O
SRP54sc B
and O
SRP54sp B
that O
are O
47 O
% O
and O
52 O
% O
identical O
to O
SRP54mam B
, O
respectively O
. O

The O
DNA O
sequences O
predict O
proteins O
for O
SRP54sc B
and O
SRP54sp B
that O
are O
47 O
% O
and O
52 O
% O
identical O
to O
SRP54mam B
, O
respectively O
. O

The O
DNA O
sequences O
predict O
proteins O
for O
SRP54sc B
and O
SRP54sp B
that O
are O
47 O
% O
and O
52 O
% O
identical O
to O
SRP54mam B
, O
respectively O
. O

The O
predicted O
amino O
acid O
sequence O
of O
m B
- I
Staf I
is O
highly O
homologous O
to O
that O
of O
Staf B
, O
another O
selenocysteine B
tRNA I
gene I
transcription I
activating I
factor I
of O
Xenopus O
laevis O
. O

The O
sequence O
similarity O
has O
suggested O
that O
SCG10 B
and O
stathmin B
have O
been O
derived O
from O
structurally O
and O
evolutionarily O
related O
genes O
. O

The O
sequence O
similarity O
has O
suggested O
that O
SCG10 B
and O
stathmin B
have O
been O
derived O
from O
structurally O
and O
evolutionarily O
related O
genes O
. O

The O
cwg2 B
- I
1 I
mutation I
was O
identified O
as O
a O
guanine O
to O
adenine O
substitution O
at O
nucleotide O
604 O
of O
the O
coding O
region O
, O
originating O
the O
change O
A202T O
in O
the O
cwg2p B
. O

These O
results O
provide O
evidence O
of O
a O
bypass O
of O
p53 B
- O
induced O
Waf1 B
/ O
Cip1 B
- O
mediated O
cell O
cycle O
regulatory O
pathways O
by O
a O
member O
of O
the O
myb B
oncogene I
family I
. O

These O
results O
provide O
evidence O
of O
a O
bypass O
of O
p53 B
- O
induced O
Waf1 B
/ O
Cip1 B
- O
mediated O
cell O
cycle O
regulatory O
pathways O
by O
a O
member O
of O
the O
myb B
oncogene I
family I
. O

These O
results O
provide O
evidence O
of O
a O
bypass O
of O
p53 B
- O
induced O
Waf1 B
/ O
Cip1 B
- O
mediated O
cell O
cycle O
regulatory O
pathways O
by O
a O
member O
of O
the O
myb B
oncogene I
family I
. O

Extracellular B
- I
regulated I
kinase I
( O
ERK B
) O
activation O
and O
molecular O
coupling O
of O
the O
adaptor O
proteins O
p130 B
Crk B
- I
associated I
substrate I
( O
CAS B
) O
and O
c B
- I
CrkII I
( O
Crk B
) O
represent O
two O
distinct O
pathways O
that O
induce O
cell O
invasion O
and O
protect O
cells O
from O
apoptosis O
in O
a O
three O
- O
dimensional O
collagen B
matrix O
. O

Extracellular B
- I
regulated I
kinase I
( O
ERK B
) O
activation O
and O
molecular O
coupling O
of O
the O
adaptor O
proteins O
p130 B
Crk B
- I
associated I
substrate I
( O
CAS B
) O
and O
c B
- I
CrkII I
( O
Crk B
) O
represent O
two O
distinct O
pathways O
that O
induce O
cell O
invasion O
and O
protect O
cells O
from O
apoptosis O
in O
a O
three O
- O
dimensional O
collagen B
matrix O
. O

Extracellular B
- I
regulated I
kinase I
( O
ERK B
) O
activation O
and O
molecular O
coupling O
of O
the O
adaptor O
proteins O
p130 B
Crk B
- I
associated I
substrate I
( O
CAS B
) O
and O
c B
- I
CrkII I
( O
Crk B
) O
represent O
two O
distinct O
pathways O
that O
induce O
cell O
invasion O
and O
protect O
cells O
from O
apoptosis O
in O
a O
three O
- O
dimensional O
collagen B
matrix O
. O

Extracellular B
- I
regulated I
kinase I
( O
ERK B
) O
activation O
and O
molecular O
coupling O
of O
the O
adaptor O
proteins O
p130 B
Crk B
- I
associated I
substrate I
( O
CAS B
) O
and O
c B
- I
CrkII I
( O
Crk B
) O
represent O
two O
distinct O
pathways O
that O
induce O
cell O
invasion O
and O
protect O
cells O
from O
apoptosis O
in O
a O
three O
- O
dimensional O
collagen B
matrix O
. O

Extracellular B
- I
regulated I
kinase I
( O
ERK B
) O
activation O
and O
molecular O
coupling O
of O
the O
adaptor O
proteins O
p130 B
Crk B
- I
associated I
substrate I
( O
CAS B
) O
and O
c B
- I
CrkII I
( O
Crk B
) O
represent O
two O
distinct O
pathways O
that O
induce O
cell O
invasion O
and O
protect O
cells O
from O
apoptosis O
in O
a O
three O
- O
dimensional O
collagen B
matrix O
. O

NF B
- I
kappa I
B I
p65 B
, O
p50 B
, O
and O
Rel B
functionally O
synergize O
with O
C B
/ I
EBP I
alpha I
, O
C B
/ I
EBP I
beta I
, O
and O
C B
/ I
EBP I
delta I
. O

NF B
- I
kappa I
B I
p65 B
, O
p50 B
, O
and O
Rel B
functionally O
synergize O
with O
C B
/ I
EBP I
alpha I
, O
C B
/ I
EBP I
beta I
, O
and O
C B
/ I
EBP I
delta I
. O

NF B
- I
kappa I
B I
p65 B
, O
p50 B
, O
and O
Rel B
functionally O
synergize O
with O
C B
/ I
EBP I
alpha I
, O
C B
/ I
EBP I
beta I
, O
and O
C B
/ I
EBP I
delta I
. O

A O
motif O
( O
TGATGTCA O
) O
which O
matches O
a O
CREB B
site I
and O
is O
similar O
to O
an O
AP B
- I
1 I
site I
is O
embedded O
within O
ER2 B
. O

Thus O
, O
dpp B
and O
omb B
promote O
both O
dorsal O
leg O
cell O
fate O
as O
well O
as O
transdetermination O
- O
competent O
leg O
disc O
cells O
. O

Thus O
, O
dpp B
and O
omb B
promote O
both O
dorsal O
leg O
cell O
fate O
as O
well O
as O
transdetermination O
- O
competent O
leg O
disc O
cells O
. O

Y15170 B
( O
Surf B
- I
2 I
, O
Surf B
- I
4 I
) O
, O
Y15171 B
( O
Surf B
- I
3 I
, O
Surf B
- I
1 I
, O
Surf B
- I
6 I
) O
, O
and O
Y15172 B
( O
Surf B
- I
5 I
. O
) O
] O

Y15170 B
( O
Surf B
- I
2 I
, O
Surf B
- I
4 I
) O
, O
Y15171 B
( O
Surf B
- I
3 I
, O
Surf B
- I
1 I
, O
Surf B
- I
6 I
) O
, O
and O
Y15172 B
( O
Surf B
- I
5 I
. O
) O
] O

Y15170 B
( O
Surf B
- I
2 I
, O
Surf B
- I
4 I
) O
, O
Y15171 B
( O
Surf B
- I
3 I
, O
Surf B
- I
1 I
, O
Surf B
- I
6 I
) O
, O
and O
Y15172 B
( O
Surf B
- I
5 I
. O
) O
] O

The O
- O
64 O
/ O
- O
37 O
region O
interacted O
with O
purified O
Sp1 B
and O
an O
unidentified O
protein O
( O
s O
) O
, O
proximal B
regulatory I
factor I
( I
s I
) I
I I
( O
PRF B
- I
I I
) O
. O

In O
one O
acromegalic O
patient O
visual O
improvement O
was O
obtained O
while O
the O
abnormal O
GH B
secretion O
remained O
unaltered O
. O

Using O
anchored O
PCR O
, O
a O
VL B
element I
rearranged O
to O
CL2 B
was O
isolated O
. O

Sequence O
analysis O
suggests O
that O
TtrA B
contains O
a O
molybdopterin O
guanine O
dinucleotide O
cofactor O
and O
a O
[ O
4Fe O
- O
4S O
] O
cluster O
, O
that O
TtrB B
binds O
four O
[ O
4Fe O
- O
4S O
] O
clusters O
, O
and O
that O
TtrC B
is O
an O
integral O
membrane O
protein O
containing O
a O
quinol O
oxidation O
site O
. O

Sequence O
analysis O
suggests O
that O
TtrA B
contains O
a O
molybdopterin O
guanine O
dinucleotide O
cofactor O
and O
a O
[ O
4Fe O
- O
4S O
] O
cluster O
, O
that O
TtrB B
binds O
four O
[ O
4Fe O
- O
4S O
] O
clusters O
, O
and O
that O
TtrC B
is O
an O
integral O
membrane O
protein O
containing O
a O
quinol O
oxidation O
site O
. O

Sequence O
analysis O
suggests O
that O
TtrA B
contains O
a O
molybdopterin O
guanine O
dinucleotide O
cofactor O
and O
a O
[ O
4Fe O
- O
4S O
] O
cluster O
, O
that O
TtrB B
binds O
four O
[ O
4Fe O
- O
4S O
] O
clusters O
, O
and O
that O
TtrC B
is O
an O
integral O
membrane O
protein O
containing O
a O
quinol O
oxidation O
site O
. O

Exposure O
of O
peripheral O
blood O
T O
cells O
from O
young O
subjects O
to O
PHA B
or O
cross O
- O
linked O
anti B
- I
CD3 I
monoclonal I
antibodies I
stimulated O
rapid O
increases O
in O
MAPK B
and O
MEK B
enzymatic O
activity O
. O

Exposure O
of O
peripheral O
blood O
T O
cells O
from O
young O
subjects O
to O
PHA B
or O
cross O
- O
linked O
anti B
- I
CD3 I
monoclonal I
antibodies I
stimulated O
rapid O
increases O
in O
MAPK B
and O
MEK B
enzymatic O
activity O
. O

Exposure O
of O
peripheral O
blood O
T O
cells O
from O
young O
subjects O
to O
PHA B
or O
cross O
- O
linked O
anti B
- I
CD3 I
monoclonal I
antibodies I
stimulated O
rapid O
increases O
in O
MAPK B
and O
MEK B
enzymatic O
activity O
. O

Marked O
thrombocytopenia O
, O
depletion O
of O
serum B
fibrinogen I
and O
prolonged O
prothrombin B
and O
activated O
partial O
thromboplastin B
time O
, O
were O
recorded O
at O
5 O
to O
10 O
and O
30 O
to O
40 O
minutes O
after O
intravenous O
envenomation O
. O

Marked O
thrombocytopenia O
, O
depletion O
of O
serum B
fibrinogen I
and O
prolonged O
prothrombin B
and O
activated O
partial O
thromboplastin B
time O
, O
were O
recorded O
at O
5 O
to O
10 O
and O
30 O
to O
40 O
minutes O
after O
intravenous O
envenomation O
. O

It O
is O
now O
estimated O
that O
inactivation O
mutants O
of O
PTEN B
exist O
in O
60 O
% O
of O
all O
forms O
of O
solid O
tumors O
. O

Southern O
blot O
analysis O
using O
probes O
from O
the O
3 O
' O
portions O
of O
the O
genomic O
and O
B B
. I
napus I
MA I
and O
MB B
cDNA I
clones O
showed O
that O
MA B
type I
myrosinases B
are O
encoded O
by O
approximately O
4 O
genes O
, O
while O
MB B
type I
myrosinases B
are O
encoded O
by O
more O
than O
10 O
genes O
in O
B O
. O
napus O
. O

Southern O
blot O
analysis O
using O
probes O
from O
the O
3 O
' O
portions O
of O
the O
genomic O
and O
B B
. I
napus I
MA I
and O
MB B
cDNA I
clones O
showed O
that O
MA B
type I
myrosinases B
are O
encoded O
by O
approximately O
4 O
genes O
, O
while O
MB B
type I
myrosinases B
are O
encoded O
by O
more O
than O
10 O
genes O
in O
B O
. O
napus O
. O

A O
Dictyostelium O
transformant O
overexpressing O
DdPTPa B
does O
not O
develop O
normally O
. O

The O
XS2 B
gene I
down O
- O
regulates O
but O
does O
not O
abolish O
expression O
of O
LU B
genes I
and O
does O
not O
affect O
expression O
of O
CD44 B
. O

Null O
alleles O
of O
SAS4 B
and O
SAS5 B
bypassed O
the O
role O
of O
the O
Abf1p B
binding I
site I
of O
the O
HMR B
- I
E I
silencer I
but O
not O
the O
role O
of O
the O
ACS B
or O
Rap1p B
binding I
site I
. O

Null O
alleles O
of O
SAS4 B
and O
SAS5 B
bypassed O
the O
role O
of O
the O
Abf1p B
binding I
site I
of O
the O
HMR B
- I
E I
silencer I
but O
not O
the O
role O
of O
the O
ACS B
or O
Rap1p B
binding I
site I
. O

Null O
alleles O
of O
SAS4 B
and O
SAS5 B
bypassed O
the O
role O
of O
the O
Abf1p B
binding I
site I
of O
the O
HMR B
- I
E I
silencer I
but O
not O
the O
role O
of O
the O
ACS B
or O
Rap1p B
binding I
site I
. O

Surprisingly O
, O
the O
RXR B
- O
specific O
ligand O
9 O
- O
cis O
- O
retinoic O
acid O
induced O
binding O
of O
SRC B
- I
1 I
to O
the O
RXR B
component I
of O
the O
TRE O
- O
bound O
heterodimer O
. O

As O
expected O
, O
homologous B
loxP I
sequences I
efficiently O
underwent O
Cre B
- O
mediated O
recombination O
. O

Control O
of O
fatty O
liver O
syndrome O
in O
a O
Jersey O
herd O
by O
a O
change O
of O
diet O
and O
the O
use O
of O
recombinant O
bovine O
somatotrophin B
. O

Precipitation O
using O
GST B
fusion I
proteins I
containing O
Fyn B
SH2 B
, O
SH3 B
, O
and O
SH2 B
/ O
SH3 B
domains O
revealed O
that O
PI B
3 I
- I
kinase I
bound O
principally O
to O
the O
SH3 B
domain I
of O
Fyn B
. O

Precipitation O
using O
GST B
fusion I
proteins I
containing O
Fyn B
SH2 B
, O
SH3 B
, O
and O
SH2 B
/ O
SH3 B
domains O
revealed O
that O
PI B
3 I
- I
kinase I
bound O
principally O
to O
the O
SH3 B
domain I
of O
Fyn B
. O

Precipitation O
using O
GST B
fusion I
proteins I
containing O
Fyn B
SH2 B
, O
SH3 B
, O
and O
SH2 B
/ O
SH3 B
domains O
revealed O
that O
PI B
3 I
- I
kinase I
bound O
principally O
to O
the O
SH3 B
domain I
of O
Fyn B
. O

Precipitation O
using O
GST B
fusion I
proteins I
containing O
Fyn B
SH2 B
, O
SH3 B
, O
and O
SH2 B
/ O
SH3 B
domains O
revealed O
that O
PI B
3 I
- I
kinase I
bound O
principally O
to O
the O
SH3 B
domain I
of O
Fyn B
. O

Precipitation O
using O
GST B
fusion I
proteins I
containing O
Fyn B
SH2 B
, O
SH3 B
, O
and O
SH2 B
/ O
SH3 B
domains O
revealed O
that O
PI B
3 I
- I
kinase I
bound O
principally O
to O
the O
SH3 B
domain I
of O
Fyn B
. O

Precipitation O
using O
GST B
fusion I
proteins I
containing O
Fyn B
SH2 B
, O
SH3 B
, O
and O
SH2 B
/ O
SH3 B
domains O
revealed O
that O
PI B
3 I
- I
kinase I
bound O
principally O
to O
the O
SH3 B
domain I
of O
Fyn B
. O

Unlike O
the O
mammalian O
proteins O
, O
XFGF3 B
is O
efficiently O
secreted O
as O
a O
Mr O
31 O
, O
000 O
glycoprotein O
, O
gp31 B
, O
which O
undergoes O
proteolytic O
cleavage O
to O
produce O
an O
NH2 O
- O
terminally O
truncated O
product O
, O
gp27 B
. O

Unlike O
the O
mammalian O
proteins O
, O
XFGF3 B
is O
efficiently O
secreted O
as O
a O
Mr O
31 O
, O
000 O
glycoprotein O
, O
gp31 B
, O
which O
undergoes O
proteolytic O
cleavage O
to O
produce O
an O
NH2 O
- O
terminally O
truncated O
product O
, O
gp27 B
. O

Unlike O
the O
mammalian O
proteins O
, O
XFGF3 B
is O
efficiently O
secreted O
as O
a O
Mr O
31 O
, O
000 O
glycoprotein O
, O
gp31 B
, O
which O
undergoes O
proteolytic O
cleavage O
to O
produce O
an O
NH2 O
- O
terminally O
truncated O
product O
, O
gp27 B
. O

Tristetraprolin B
( O
TTP B
) O
is O
the O
prototype O
of O
a O
group O
of O
potential O
transcription O
factors O
that O
contain O
two O
or O
more O
unusual O
CCCH O
zinc O
fingers O
. O

Tristetraprolin B
( O
TTP B
) O
is O
the O
prototype O
of O
a O
group O
of O
potential O
transcription O
factors O
that O
contain O
two O
or O
more O
unusual O
CCCH O
zinc O
fingers O
. O

Mss4 B
also O
acts O
as O
a O
relatively O
inefficient O
guanine B
nucleotide I
exchange I
factor I
( O
GEF B
) O
. O

Mss4 B
also O
acts O
as O
a O
relatively O
inefficient O
guanine B
nucleotide I
exchange I
factor I
( O
GEF B
) O
. O

From O
this O
library O
, O
LEU2 B
and O
HIS3 B
cDNAs O
were O
recovered O
at O
a O
frequency O
of O
about O
1 O
in O
10 O
( O
4 O
) O
and O
in O
12 O
out O
of O
13 O
cases O
these O
were O
expressed O
in O
a O
galactose O
- O
dependent O
manner O
. O

From O
this O
library O
, O
LEU2 B
and O
HIS3 B
cDNAs O
were O
recovered O
at O
a O
frequency O
of O
about O
1 O
in O
10 O
( O
4 O
) O
and O
in O
12 O
out O
of O
13 O
cases O
these O
were O
expressed O
in O
a O
galactose O
- O
dependent O
manner O
. O

Here O
, O
we O
identify O
Rsc3 B
and O
Rsc30 B
as O
novel O
components O
of O
the O
essential O
yeast B
remodeler I
RSC I
complex I
. O

Here O
, O
we O
identify O
Rsc3 B
and O
Rsc30 B
as O
novel O
components O
of O
the O
essential O
yeast B
remodeler I
RSC I
complex I
. O

Electromobility O
shift O
and O
cotransfection O
assays O
demonstrated O
that O
HNF1alpha B
, O
but O
not O
HNF4 B
, O
bound O
to O
its O
cognate O
site O
and O
transactivated O
G6Pase B
gene I
expression O
. O

Electromobility O
shift O
and O
cotransfection O
assays O
demonstrated O
that O
HNF1alpha B
, O
but O
not O
HNF4 B
, O
bound O
to O
its O
cognate O
site O
and O
transactivated O
G6Pase B
gene I
expression O
. O

Comparison O
with O
the O
bHLH B
/ O
PAS B
family O
genes O
revealed O
that O
the O
intron O
/ O
exon O
splice O
pattern O
of O
mBMAL1 B
most O
closely O
matches O
that O
of O
the O
mAhr B
, O
which O
suggests O
that O
BMAL1 B
and O
Ahr B
belong O
to O
the O
same O
subclass O
and O
may O
be O
derived O
from O
a O
common O
primordial O
gene O
. O

Comparison O
with O
the O
bHLH B
/ O
PAS B
family O
genes O
revealed O
that O
the O
intron O
/ O
exon O
splice O
pattern O
of O
mBMAL1 B
most O
closely O
matches O
that O
of O
the O
mAhr B
, O
which O
suggests O
that O
BMAL1 B
and O
Ahr B
belong O
to O
the O
same O
subclass O
and O
may O
be O
derived O
from O
a O
common O
primordial O
gene O
. O

Comparison O
with O
the O
bHLH B
/ O
PAS B
family O
genes O
revealed O
that O
the O
intron O
/ O
exon O
splice O
pattern O
of O
mBMAL1 B
most O
closely O
matches O
that O
of O
the O
mAhr B
, O
which O
suggests O
that O
BMAL1 B
and O
Ahr B
belong O
to O
the O
same O
subclass O
and O
may O
be O
derived O
from O
a O
common O
primordial O
gene O
. O

Comparison O
with O
the O
bHLH B
/ O
PAS B
family O
genes O
revealed O
that O
the O
intron O
/ O
exon O
splice O
pattern O
of O
mBMAL1 B
most O
closely O
matches O
that O
of O
the O
mAhr B
, O
which O
suggests O
that O
BMAL1 B
and O
Ahr B
belong O
to O
the O
same O
subclass O
and O
may O
be O
derived O
from O
a O
common O
primordial O
gene O
. O

Comparison O
with O
the O
bHLH B
/ O
PAS B
family O
genes O
revealed O
that O
the O
intron O
/ O
exon O
splice O
pattern O
of O
mBMAL1 B
most O
closely O
matches O
that O
of O
the O
mAhr B
, O
which O
suggests O
that O
BMAL1 B
and O
Ahr B
belong O
to O
the O
same O
subclass O
and O
may O
be O
derived O
from O
a O
common O
primordial O
gene O
. O

Comparison O
with O
the O
bHLH B
/ O
PAS B
family O
genes O
revealed O
that O
the O
intron O
/ O
exon O
splice O
pattern O
of O
mBMAL1 B
most O
closely O
matches O
that O
of O
the O
mAhr B
, O
which O
suggests O
that O
BMAL1 B
and O
Ahr B
belong O
to O
the O
same O
subclass O
and O
may O
be O
derived O
from O
a O
common O
primordial O
gene O
. O

These O
results O
indicate O
that O
the O
total O
number O
of O
subunit O
c O
in O
F0 B
should O
be O
a O
multiple O
of O
2 O
and O
3 O
. O

The O
continuing O
development O
of O
ligands O
that O
function O
as O
selective O
estrogens O
or O
antiestrogens O
for O
ERalpha B
or O
ERbeta B
should O
allow O
optimized O
tissue O
selectivity O
of O
these O
agents O
for O
menopausal O
hormone O
replacement O
therapy O
and O
the O
treatment O
and O
prevention O
of O
breast O
cancer O
. O

The O
continuing O
development O
of O
ligands O
that O
function O
as O
selective O
estrogens O
or O
antiestrogens O
for O
ERalpha B
or O
ERbeta B
should O
allow O
optimized O
tissue O
selectivity O
of O
these O
agents O
for O
menopausal O
hormone O
replacement O
therapy O
and O
the O
treatment O
and O
prevention O
of O
breast O
cancer O
. O

Possibly O
, O
the O
scr1 B
- I
1 I
mutation I
does O
not O
affect O
signal O
recognition O
or O
translational O
arrest O
but O
instead O
results O
in O
maintenance O
of O
translational O
arrest O
of O
AEP B
synthesis O
. O

In O
contrast O
to O
the O
wild O
- O
type O
protein O
, O
expression O
of O
p45 B
NF B
- I
E2 I
lacking O
this O
activation O
domain O
in O
an O
NF B
- I
E2 I
null O
cell O
line O
fails O
to O
support O
enhancer O
- O
dependent O
transcription O
in O
transient O
assays O
. O

Levels O
of O
the O
MEK B
inhibitor O
PD98059 O
that O
block O
EGF B
- O
induced O
mitogenesis O
and O
MAP B
kinase I
phosphorylation O
also O
abrogate O
EGF B
- O
induced O
focal O
adhesion O
disassembly O
and O
cell O
motility O
. O

Levels O
of O
the O
MEK B
inhibitor O
PD98059 O
that O
block O
EGF B
- O
induced O
mitogenesis O
and O
MAP B
kinase I
phosphorylation O
also O
abrogate O
EGF B
- O
induced O
focal O
adhesion O
disassembly O
and O
cell O
motility O
. O

Levels O
of O
the O
MEK B
inhibitor O
PD98059 O
that O
block O
EGF B
- O
induced O
mitogenesis O
and O
MAP B
kinase I
phosphorylation O
also O
abrogate O
EGF B
- O
induced O
focal O
adhesion O
disassembly O
and O
cell O
motility O
. O

Finally O
, O
there O
are O
a O
growing O
number O
of O
arguments O
favouring O
the O
use O
of O
ACE B
inhibitors O
very O
early O
in O
patients O
with O
diabetes O
mellitus O
. O

Deleting O
SNF1 B
repressed O
meiosis O
at O
the O
same O
three O
steps O
that O
were O
inhibited O
by O
glucose O
, O
suggesting O
that O
glucose O
blocks O
meiosis O
by O
inhibiting O
Snf1 B
. O

Deleting O
SNF1 B
repressed O
meiosis O
at O
the O
same O
three O
steps O
that O
were O
inhibited O
by O
glucose O
, O
suggesting O
that O
glucose O
blocks O
meiosis O
by O
inhibiting O
Snf1 B
. O

Entry O
of O
yeast O
cells O
into O
the O
mitotic O
cell O
cycle O
( O
Start O
) O
involves O
a O
form O
of O
the O
CDC28 B
kinase I
that O
associates O
with O
G1 O
- O
specific O
cyclins B
encoded O
by O
CLN1 B
and O
CLN2 B
( O
ref O
. O

Entry O
of O
yeast O
cells O
into O
the O
mitotic O
cell O
cycle O
( O
Start O
) O
involves O
a O
form O
of O
the O
CDC28 B
kinase I
that O
associates O
with O
G1 O
- O
specific O
cyclins B
encoded O
by O
CLN1 B
and O
CLN2 B
( O
ref O
. O

Entry O
of O
yeast O
cells O
into O
the O
mitotic O
cell O
cycle O
( O
Start O
) O
involves O
a O
form O
of O
the O
CDC28 B
kinase I
that O
associates O
with O
G1 O
- O
specific O
cyclins B
encoded O
by O
CLN1 B
and O
CLN2 B
( O
ref O
. O

In O
order O
to O
study O
the O
influence O
of O
iron O
overload O
on O
the O
polymorphonuclear O
leucocyte O
( O
PMN O
) O
metabolism O
of O
patients O
on O
chronic O
hemodialysis O
, O
generation O
of O
superoxide O
anion O
( O
O2 O
- O
) O
by O
PMN O
in O
whole O
blood O
was O
compared O
in O
two O
groups O
of O
hemodialyzed O
patients O
: O
group O
A O
consisted O
of O
twenty O
- O
one O
individuals O
with O
serum O
ferritin B
levels O
above O
1000 O
ng O
/ O
ml O
and O
group O
B O
of O
nineteen O
individuals O
with O
serum O
ferritin B
levels O
below O
1000 O
ng O
/ O
ml O
. O

In O
order O
to O
study O
the O
influence O
of O
iron O
overload O
on O
the O
polymorphonuclear O
leucocyte O
( O
PMN O
) O
metabolism O
of O
patients O
on O
chronic O
hemodialysis O
, O
generation O
of O
superoxide O
anion O
( O
O2 O
- O
) O
by O
PMN O
in O
whole O
blood O
was O
compared O
in O
two O
groups O
of O
hemodialyzed O
patients O
: O
group O
A O
consisted O
of O
twenty O
- O
one O
individuals O
with O
serum O
ferritin B
levels O
above O
1000 O
ng O
/ O
ml O
and O
group O
B O
of O
nineteen O
individuals O
with O
serum O
ferritin B
levels O
below O
1000 O
ng O
/ O
ml O
. O

These O
results O
suggest O
that O
VP1 B
was O
efficiently O
transported O
to O
the O
nucleus O
and O
localized O
in O
the O
discrete O
subnuclear O
regions O
, O
possibly O
with O
VP2 B
and O
VP3 B
. O

These O
results O
suggest O
that O
VP1 B
was O
efficiently O
transported O
to O
the O
nucleus O
and O
localized O
in O
the O
discrete O
subnuclear O
regions O
, O
possibly O
with O
VP2 B
and O
VP3 B
. O

These O
results O
suggest O
that O
VP1 B
was O
efficiently O
transported O
to O
the O
nucleus O
and O
localized O
in O
the O
discrete O
subnuclear O
regions O
, O
possibly O
with O
VP2 B
and O
VP3 B
. O

Zebrafish O
cyclops B
( O
cyc B
) O
encodes O
a O
Transforming B
Growth I
Factor I
beta I
( O
TGFbeta B
) O
signaling O
factor O
closely O
related O
to O
mouse O
Nodal B
. O

Zebrafish O
cyclops B
( O
cyc B
) O
encodes O
a O
Transforming B
Growth I
Factor I
beta I
( O
TGFbeta B
) O
signaling O
factor O
closely O
related O
to O
mouse O
Nodal B
. O

Zebrafish O
cyclops B
( O
cyc B
) O
encodes O
a O
Transforming B
Growth I
Factor I
beta I
( O
TGFbeta B
) O
signaling O
factor O
closely O
related O
to O
mouse O
Nodal B
. O

Zebrafish O
cyclops B
( O
cyc B
) O
encodes O
a O
Transforming B
Growth I
Factor I
beta I
( O
TGFbeta B
) O
signaling O
factor O
closely O
related O
to O
mouse O
Nodal B
. O

Combined O
expression O
of O
c B
- I
Jun I
and O
p65 B
induced O
vigorous O
transcription O
of O
IL B
- I
2 I
promoter O
- O
and O
CD28RE B
- I
driven I
reporter I
constructs I
in O
both O
LFA B
- I
3 I
- O
and O
B7 B
- I
1 I
- O
costimulated O
Jurkat O
cells O
. O

Unlike O
ARF B
, O
the O
ARP B
immunoreactivity O
was O
detected O
in O
plasma O
membranes O
but O
not O
in O
cytosol O
of O
fractionated O
3T3 O
- O
L1 O
cells O
. O

Unlike O
ARF B
, O
the O
ARP B
immunoreactivity O
was O
detected O
in O
plasma O
membranes O
but O
not O
in O
cytosol O
of O
fractionated O
3T3 O
- O
L1 O
cells O
. O

USF B
synthesized O
in O
an O
in O
vitro O
transcription O
and O
translation O
system O
also O
binds O
to O
the O
ADH B
promoter I
as O
well O
as O
to O
the O
MLP O
. O

The O
tyrosine B
hydroxylase I
gene I
( O
TH B
) O
contains O
a O
single O
copy O
of O
a O
consensus O
CRE O
at O
- O
45 O
to O
- O
38 O
base O
pair O
( O
bp O
) O
upstream O
of O
the O
transcription O
initiation O
site O
. O

Restriction O
analysis O
and O
Southern O
hybridization O
revealed O
the O
presence O
of O
Tn5422 B
in O
all O
the O
plasmid O
- O
mediated O
cadmium O
- O
resistant O
L O
. O
monocytogenes O
strains O
tested O
but O
not O
in O
strains O
encoding O
cadmium O
resistance O
on O
the O
chromosome O
. O

The O
dnaQ B
- O
lacZ B
and O
the O
rnh B
- O
lacZ B
fused O
genes O
were O
constructed O
and O
hybrid O
proteins O
with O
beta B
- I
galactosidase I
activity O
were O
produced O
. O

The O
dnaQ B
- O
lacZ B
and O
the O
rnh B
- O
lacZ B
fused O
genes O
were O
constructed O
and O
hybrid O
proteins O
with O
beta B
- I
galactosidase I
activity O
were O
produced O
. O

The O
dnaQ B
- O
lacZ B
and O
the O
rnh B
- O
lacZ B
fused O
genes O
were O
constructed O
and O
hybrid O
proteins O
with O
beta B
- I
galactosidase I
activity O
were O
produced O
. O

The O
dnaQ B
- O
lacZ B
and O
the O
rnh B
- O
lacZ B
fused O
genes O
were O
constructed O
and O
hybrid O
proteins O
with O
beta B
- I
galactosidase I
activity O
were O
produced O
. O

Moreover O
, O
this O
enhancement O
of O
transcriptional O
activation O
by O
COUP B
- I
TFI I
requires O
specifically O
the O
AF O
- O
1 O
transactivation O
function O
of O
ER B
and O
can O
be O
observed O
in O
the O
presence O
of O
E2 O
or O
4 O
- O
hydroxytamoxifen O
but O
not O
ICI O
164384 O
. O

The O
novel O
approach O
to O
insulin B
administration O
known O
as O
chronic O
intermittent O
intravenous O
insulin B
therapy O
( O
CIIIT O
) O
delivers O
insulin B
in O
a O
pulsatile O
fashion O
and O
achieves O
physiological O
insulin B
concentration O
in O
the O
portal O
vein O
. O

The O
novel O
approach O
to O
insulin B
administration O
known O
as O
chronic O
intermittent O
intravenous O
insulin B
therapy O
( O
CIIIT O
) O
delivers O
insulin B
in O
a O
pulsatile O
fashion O
and O
achieves O
physiological O
insulin B
concentration O
in O
the O
portal O
vein O
. O

The O
novel O
approach O
to O
insulin B
administration O
known O
as O
chronic O
intermittent O
intravenous O
insulin B
therapy O
( O
CIIIT O
) O
delivers O
insulin B
in O
a O
pulsatile O
fashion O
and O
achieves O
physiological O
insulin B
concentration O
in O
the O
portal O
vein O
. O

The O
novel O
approach O
to O
insulin B
administration O
known O
as O
chronic O
intermittent O
intravenous O
insulin B
therapy O
( O
CIIIT O
) O
delivers O
insulin B
in O
a O
pulsatile O
fashion O
and O
achieves O
physiological O
insulin B
concentration O
in O
the O
portal O
vein O
. O

Endocrine O
cells O
were O
studied O
by O
means O
of O
Grimelius O
' O
silver O
staining O
and O
immunostaining O
for O
chromogranin B
, O
a O
general O
marker O
of O
endocrine O
cells O
. O

In O
hemodialyzed O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
) O
leptin B
levels O
were O
significantly O
higher O
when O
compared O
to O
CAPD O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
, O
respectively O
) O
. O

In O
hemodialyzed O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
) O
leptin B
levels O
were O
significantly O
higher O
when O
compared O
to O
CAPD O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
, O
respectively O
) O
. O

In O
hemodialyzed O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
) O
leptin B
levels O
were O
significantly O
higher O
when O
compared O
to O
CAPD O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
, O
respectively O
) O
. O

In O
hemodialyzed O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
) O
leptin B
levels O
were O
significantly O
higher O
when O
compared O
to O
CAPD O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
, O
respectively O
) O
. O

In O
hemodialyzed O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
) O
leptin B
levels O
were O
significantly O
higher O
when O
compared O
to O
CAPD O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
, O
respectively O
) O
. O

Aryl B
hydrocarbon I
receptor I
nuclear I
translocator I
( O
ARNT B
) O
is O
a O
component O
of O
the O
transcription O
factors O
, O
aryl B
hydrocarbon I
receptor I
( O
AhR B
) O
and O
hypoxia B
- I
inducible I
factor I
1 I
, O
which O
transactivate O
their O
target O
genes O
, O
such O
as O
CYP1A1 B
and O
erythropoietin B
, O
in O
response O
to O
xenobiotic O
aromatic O
hydrocarbons O
and O
to O
low O
O2 O
concentration O
, O
respectively O
. O

Aryl B
hydrocarbon I
receptor I
nuclear I
translocator I
( O
ARNT B
) O
is O
a O
component O
of O
the O
transcription O
factors O
, O
aryl B
hydrocarbon I
receptor I
( O
AhR B
) O
and O
hypoxia B
- I
inducible I
factor I
1 I
, O
which O
transactivate O
their O
target O
genes O
, O
such O
as O
CYP1A1 B
and O
erythropoietin B
, O
in O
response O
to O
xenobiotic O
aromatic O
hydrocarbons O
and O
to O
low O
O2 O
concentration O
, O
respectively O
. O

Aryl B
hydrocarbon I
receptor I
nuclear I
translocator I
( O
ARNT B
) O
is O
a O
component O
of O
the O
transcription O
factors O
, O
aryl B
hydrocarbon I
receptor I
( O
AhR B
) O
and O
hypoxia B
- I
inducible I
factor I
1 I
, O
which O
transactivate O
their O
target O
genes O
, O
such O
as O
CYP1A1 B
and O
erythropoietin B
, O
in O
response O
to O
xenobiotic O
aromatic O
hydrocarbons O
and O
to O
low O
O2 O
concentration O
, O
respectively O
. O

Aryl B
hydrocarbon I
receptor I
nuclear I
translocator I
( O
ARNT B
) O
is O
a O
component O
of O
the O
transcription O
factors O
, O
aryl B
hydrocarbon I
receptor I
( O
AhR B
) O
and O
hypoxia B
- I
inducible I
factor I
1 I
, O
which O
transactivate O
their O
target O
genes O
, O
such O
as O
CYP1A1 B
and O
erythropoietin B
, O
in O
response O
to O
xenobiotic O
aromatic O
hydrocarbons O
and O
to O
low O
O2 O
concentration O
, O
respectively O
. O

Characterization O
of O
the O
microtubule O
binding O
domain O
of O
microtubule B
actin I
crosslinking I
factor I
( O
MACF B
) O
: O
identification O
of O
a O
novel O
group O
of O
microtubule B
associated I
proteins I
. O

Polysome O
and O
40S B
ribosome I
fractions O
were O
severely O
decreased O
in O
the O
krr1 B
mutant I
and O
Kri1p B
- O
depleted O
cells O
. O

Analysis O
of O
a O
set O
of O
deletion O
constructs O
in O
transient O
transfection O
assays O
measuring O
heterologous O
reporter O
gene O
( O
luciferase B
) O
activity O
demonstrated O
that O
the O
182 O
- O
bp O
5 O
' O
- O
flanking O
region O
provides O
full O
promoter O
activity O
in O
IL B
- I
2 I
- O
stimulated O
L2 O
cells O
. O

Systematic O
functional O
analysis O
of O
V1a B
/ I
V2 I
hybrid I
receptors I
showed O
that O
the O
second O
intracellular O
loop O
of O
the O
V1a B
receptor I
is O
required O
and O
sufficient O
for O
efficient O
coupling O
to O
Gq B
/ I
11 I
, O
whereas O
the O
third O
intracellular O
loop O
of O
the O
V2 B
receptor I
is O
required O
and O
sufficient O
for O
coupling O
to O
Gs B
. O

To O
determine O
whether O
P35 B
could O
activate O
the O
39k O
promoter O
in O
the O
absence O
of O
IE1 B
, O
the O
p35 B
open O
reading O
frame O
was O
cloned O
under O
the O
control O
of O
the O
ie1 B
promoter I
. O

To O
determine O
whether O
P35 B
could O
activate O
the O
39k O
promoter O
in O
the O
absence O
of O
IE1 B
, O
the O
p35 B
open O
reading O
frame O
was O
cloned O
under O
the O
control O
of O
the O
ie1 B
promoter I
. O

To O
determine O
whether O
P35 B
could O
activate O
the O
39k O
promoter O
in O
the O
absence O
of O
IE1 B
, O
the O
p35 B
open O
reading O
frame O
was O
cloned O
under O
the O
control O
of O
the O
ie1 B
promoter I
. O

Mutation O
analysis O
demonstrates O
that O
the O
motif O
TCCCCT O
is O
critical O
for O
PyRo1 B
interaction O
. O

The O
hypertension O
with O
elevated O
PRA O
, O
however O
, O
was O
resistant O
to O
the O
angiotensin B
II I
( O
AII B
) O
analog O
[ O
Sar1 O
, O
Ile8 O
] O
ALL O
. O

These O
data O
show O
that O
PTH B
and O
cAMP O
can O
repress O
collagen B
promoter I
activity O
in O
calvariae O
from O
transgenic O
mice O
, O
suggesting O
that O
the O
alpha B
1 I
( I
I I
) I
collagen I
promoter I
may O
contain O
cis O
elements O
down O
- O
stream O
of O
- O
2 O
. O
3 O
kilobases O
that O
mediate O
PTH B
and O
cAMP O
repression O
of O
collagen B
gene I
expression O
in O
bone O
. O

These O
data O
show O
that O
PTH B
and O
cAMP O
can O
repress O
collagen B
promoter I
activity O
in O
calvariae O
from O
transgenic O
mice O
, O
suggesting O
that O
the O
alpha B
1 I
( I
I I
) I
collagen I
promoter I
may O
contain O
cis O
elements O
down O
- O
stream O
of O
- O
2 O
. O
3 O
kilobases O
that O
mediate O
PTH B
and O
cAMP O
repression O
of O
collagen B
gene I
expression O
in O
bone O
. O

Reconstitution O
of O
complexes O
containing O
p62 B
and O
the O
src B
family I
kinase I
p59fyn B
in O
HeLa O
cells O
demonstrated O
that O
complex O
formation O
resulted O
in O
tyrosine O
phosphorylation O
of O
p62 B
and O
was O
mediated O
by O
both O
the O
SH3 B
and O
SH2 B
domains I
of O
p59fyn B
. O

Reconstitution O
of O
complexes O
containing O
p62 B
and O
the O
src B
family I
kinase I
p59fyn B
in O
HeLa O
cells O
demonstrated O
that O
complex O
formation O
resulted O
in O
tyrosine O
phosphorylation O
of O
p62 B
and O
was O
mediated O
by O
both O
the O
SH3 B
and O
SH2 B
domains I
of O
p59fyn B
. O

Reconstitution O
of O
complexes O
containing O
p62 B
and O
the O
src B
family I
kinase I
p59fyn B
in O
HeLa O
cells O
demonstrated O
that O
complex O
formation O
resulted O
in O
tyrosine O
phosphorylation O
of O
p62 B
and O
was O
mediated O
by O
both O
the O
SH3 B
and O
SH2 B
domains I
of O
p59fyn B
. O

Reconstitution O
of O
complexes O
containing O
p62 B
and O
the O
src B
family I
kinase I
p59fyn B
in O
HeLa O
cells O
demonstrated O
that O
complex O
formation O
resulted O
in O
tyrosine O
phosphorylation O
of O
p62 B
and O
was O
mediated O
by O
both O
the O
SH3 B
and O
SH2 B
domains I
of O
p59fyn B
. O

Reconstitution O
of O
complexes O
containing O
p62 B
and O
the O
src B
family I
kinase I
p59fyn B
in O
HeLa O
cells O
demonstrated O
that O
complex O
formation O
resulted O
in O
tyrosine O
phosphorylation O
of O
p62 B
and O
was O
mediated O
by O
both O
the O
SH3 B
and O
SH2 B
domains I
of O
p59fyn B
. O

In O
this O
study O
, O
we O
investigated O
the O
signal O
transduction O
pathways O
that O
are O
involved O
in O
OM B
- O
induced O
LDLR B
transcription O
. O

In O
this O
study O
, O
we O
investigated O
the O
signal O
transduction O
pathways O
that O
are O
involved O
in O
OM B
- O
induced O
LDLR B
transcription O
. O

Whole O
- O
mount O
in O
situ O
hybridization O
to O
early O
mouse O
embryos O
of O
9 O
. O
5 O
- O
10 O
. O
5 O
days O
indicated O
a O
complex O
pattern O
of O
Arp1 B
expression O
spatially O
overlapping O
with O
the O
expression O
of O
All1 B
. O

Whole O
- O
mount O
in O
situ O
hybridization O
to O
early O
mouse O
embryos O
of O
9 O
. O
5 O
- O
10 O
. O
5 O
days O
indicated O
a O
complex O
pattern O
of O
Arp1 B
expression O
spatially O
overlapping O
with O
the O
expression O
of O
All1 B
. O

Analysis O
of O
the O
gag B
and O
rev B
proteins I
in O
the O
transfected O
cells O
demonstrated O
that O
these O
proteins O
were O
not O
detectable O
in O
cells O
transfected O
with O
the O
tat B
mutants I
but O
could O
be O
readily O
detected O
when O
the O
mutations O
were O
complemented O
in O
trans O
with O
a O
tat B
expression O
vector O
. O

Analysis O
of O
the O
gag B
and O
rev B
proteins I
in O
the O
transfected O
cells O
demonstrated O
that O
these O
proteins O
were O
not O
detectable O
in O
cells O
transfected O
with O
the O
tat B
mutants I
but O
could O
be O
readily O
detected O
when O
the O
mutations O
were O
complemented O
in O
trans O
with O
a O
tat B
expression O
vector O
. O

The O
ability O
to O
maintain O
expression O
of O
FAS1 B
in O
nmt1 B
- O
451Dino2 B
Delta O
cells O
suggests O
the O
existence O
of O
another O
transcription O
factor O
, O
or O
factors O
, O
whose O
expression O
/ O
activity O
is O
inversely O
related O
to O
overall O
levels O
of O
cellular O
protein O
N O
- O
myristoy O
- O
lation O
. O

The O
ability O
to O
maintain O
expression O
of O
FAS1 B
in O
nmt1 B
- O
451Dino2 B
Delta O
cells O
suggests O
the O
existence O
of O
another O
transcription O
factor O
, O
or O
factors O
, O
whose O
expression O
/ O
activity O
is O
inversely O
related O
to O
overall O
levels O
of O
cellular O
protein O
N O
- O
myristoy O
- O
lation O
. O

The O
ability O
to O
maintain O
expression O
of O
FAS1 B
in O
nmt1 B
- O
451Dino2 B
Delta O
cells O
suggests O
the O
existence O
of O
another O
transcription O
factor O
, O
or O
factors O
, O
whose O
expression O
/ O
activity O
is O
inversely O
related O
to O
overall O
levels O
of O
cellular O
protein O
N O
- O
myristoy O
- O
lation O
. O

Small B
GTPases I
of O
the O
Ypt B
/ O
Rab B
family O
are O
involved O
in O
the O
regulation O
of O
vesicular O
transport O
. O

Small B
GTPases I
of O
the O
Ypt B
/ O
Rab B
family O
are O
involved O
in O
the O
regulation O
of O
vesicular O
transport O
. O

Dopamine B
beta I
- I
hydroxylase I
( O
DBH B
) O
catalyzes O
the O
conversion O
of O
dopamine O
to O
noradrenaline O
and O
is O
selectively O
expressed O
in O
noradrenergic O
and O
adrenergic O
neurons O
and O
neuroendocrine O
cells O
. O

This O
result O
indicates O
that O
separate O
complexes O
exist O
containing O
ankyrin B
and O
fodrin B
with O
either O
uvomorulin B
or O
Na B
+ I
, I
K I
+ I
- I
ATPase I
. O

This O
result O
indicates O
that O
separate O
complexes O
exist O
containing O
ankyrin B
and O
fodrin B
with O
either O
uvomorulin B
or O
Na B
+ I
, I
K I
+ I
- I
ATPase I
. O

This O
result O
indicates O
that O
separate O
complexes O
exist O
containing O
ankyrin B
and O
fodrin B
with O
either O
uvomorulin B
or O
Na B
+ I
, I
K I
+ I
- I
ATPase I
. O

These O
results O
indicate O
that O
baculovirus O
- O
expressed O
TR B
mediates O
transcriptional O
activation O
and O
repression O
in O
a O
promoter O
- O
specific O
manner O
in O
vitro O
. O

Certain O
spt10 B
spontaneous O
alleles O
are O
good O
suppressors O
but O
have O
a O
normal O
growth O
rate O
, O
suggesting O
that O
the O
SPT10 B
protein I
may O
have O
two O
distinct O
functions O
. O

Pitx2 B
rescues O
the O
GABAergic O
differentiation O
defect O
and O
partially O
rescues O
the O
axon O
guidance O
and O
behavioral O
phenotypes O
of O
unc B
- I
30 I
mutants I
, O
indicating O
a O
high O
degree O
of O
functional O
conservation O
between O
these O
evolutionarily O
related O
genes O
. O

Stimulation O
of O
[ O
3H O
] O
PA O
production O
upon O
CD3 B
cross O
- O
linking O
was O
77 O
% O
lower O
in O
permeabilized O
CD45 B
- I
cells O
than O
in O
CD45 B
+ I
cells O
, O
consistent O
with O
the O
reduced O
activity O
of O
p59fyn B
in O
CD45 B
- I
cells O
. O

Stimulation O
of O
[ O
3H O
] O
PA O
production O
upon O
CD3 B
cross O
- O
linking O
was O
77 O
% O
lower O
in O
permeabilized O
CD45 B
- I
cells O
than O
in O
CD45 B
+ I
cells O
, O
consistent O
with O
the O
reduced O
activity O
of O
p59fyn B
in O
CD45 B
- I
cells O
. O

One O
- O
third O
of O
the O
men O
with O
azoospermia O
and O
with O
sperm O
density O
of O
less O
than O
10 O
million O
had O
marked O
FSH B
elevation O
and O
our O
experience O
confirms O
the O
work O
of O
others O
that O
this O
indicates O
a O
poor O
prognosis O
. O

The O
PSD2 B
gene I
was O
heterologously O
expressed O
by O
infection O
of O
Sf O
- O
9 O
insect O
cells O
with O
recombinant O
baculovirus O
, O
resulting O
in O
a O
10 O
- O
fold O
increase O
in O
PSD B
activity O
. O

Co O
- O
transfection O
of O
a O
tat B
expressing O
plasmid O
with O
these O
viruses O
containing O
the O
tat B
ORF I
mutations O
resulted O
in O
higher O
levels O
of O
virus O
production O
demonstrating O
that O
the O
effects O
of O
both O
mutants O
are O
tat B
specific O
. O

Co O
- O
transfection O
of O
a O
tat B
expressing O
plasmid O
with O
these O
viruses O
containing O
the O
tat B
ORF I
mutations O
resulted O
in O
higher O
levels O
of O
virus O
production O
demonstrating O
that O
the O
effects O
of O
both O
mutants O
are O
tat B
specific O
. O

This O
construct O
, O
termed O
pDeltaCREC B
/ O
EBP B
, O
binds O
C B
/ I
EBPalpha I
and I
beta I
but O
not O
CREB B
, O
yet O
it O
confers O
a O
nearly O
complete O
glucocorticoid O
response O
when O
transiently O
transfected O
into O
H4IIE O
rat O
hepatoma O
cells O
. O

This O
construct O
, O
termed O
pDeltaCREC B
/ O
EBP B
, O
binds O
C B
/ I
EBPalpha I
and I
beta I
but O
not O
CREB B
, O
yet O
it O
confers O
a O
nearly O
complete O
glucocorticoid O
response O
when O
transiently O
transfected O
into O
H4IIE O
rat O
hepatoma O
cells O
. O

This O
construct O
, O
termed O
pDeltaCREC B
/ O
EBP B
, O
binds O
C B
/ I
EBPalpha I
and I
beta I
but O
not O
CREB B
, O
yet O
it O
confers O
a O
nearly O
complete O
glucocorticoid O
response O
when O
transiently O
transfected O
into O
H4IIE O
rat O
hepatoma O
cells O
. O

In O
the O
cell O
- O
free O
import O
assay O
, O
beta B
- I
catenin I
rapidly O
migrates O
into O
the O
nucleus O
without O
the O
exogenous O
addition O
of O
cytosol O
, O
Ran B
, O
or O
ATP O
/ O
GTP O
. O

Phosphorylation O
of O
myosin B
- I
binding I
subunit I
( O
MBS B
) O
of O
myosin B
phosphatase I
by O
Rho B
- I
kinase I
in O
vivo O
. O

Since O
RCC1p B
acts O
as O
GNRP B
for O
Ran B
, O
a O
small B
nuclear I
GTPase I
of O
the O
ras B
superfamily I
, O
we O
have O
identified O
two O
homologs O
of O
Ran B
in O
S O
. O
cerevisiae O
( O
CNR1 B
and O
CNR2 B
) O
. O

Since O
RCC1p B
acts O
as O
GNRP B
for O
Ran B
, O
a O
small B
nuclear I
GTPase I
of O
the O
ras B
superfamily I
, O
we O
have O
identified O
two O
homologs O
of O
Ran B
in O
S O
. O
cerevisiae O
( O
CNR1 B
and O
CNR2 B
) O
. O

Since O
RCC1p B
acts O
as O
GNRP B
for O
Ran B
, O
a O
small B
nuclear I
GTPase I
of O
the O
ras B
superfamily I
, O
we O
have O
identified O
two O
homologs O
of O
Ran B
in O
S O
. O
cerevisiae O
( O
CNR1 B
and O
CNR2 B
) O
. O

Since O
RCC1p B
acts O
as O
GNRP B
for O
Ran B
, O
a O
small B
nuclear I
GTPase I
of O
the O
ras B
superfamily I
, O
we O
have O
identified O
two O
homologs O
of O
Ran B
in O
S O
. O
cerevisiae O
( O
CNR1 B
and O
CNR2 B
) O
. O

Since O
RCC1p B
acts O
as O
GNRP B
for O
Ran B
, O
a O
small B
nuclear I
GTPase I
of O
the O
ras B
superfamily I
, O
we O
have O
identified O
two O
homologs O
of O
Ran B
in O
S O
. O
cerevisiae O
( O
CNR1 B
and O
CNR2 B
) O
. O

Since O
RCC1p B
acts O
as O
GNRP B
for O
Ran B
, O
a O
small B
nuclear I
GTPase I
of O
the O
ras B
superfamily I
, O
we O
have O
identified O
two O
homologs O
of O
Ran B
in O
S O
. O
cerevisiae O
( O
CNR1 B
and O
CNR2 B
) O
. O

Although O
previous O
data O
have O
suggested O
that O
Rev B
uses O
the O
same O
export O
pathway O
as O
uracil O
- O
rich O
small O
nuclear O
RNAs O
and O
5S B
ribosomal I
RNA I
, O
the O
CTE O
seems O
to O
interact O
with O
evolutionarily O
conserved O
factors O
that O
are O
essential O
for O
cellular O
mRNA O
export O
. O

The O
E1 B
replication I
protein I
of O
bovine O
papillomavirus O
type O
1 O
contains O
an O
extended O
nuclear O
localization O
signal O
that O
includes O
a O
p34cdc2 B
phosphorylation O
site O
. O

In O
contrast O
, O
the O
lumenal O
domains O
of O
Sec12p B
, O
Stl1p B
and O
Stl2p B
are O
very O
different O
in O
size O
and O
do O
not O
show O
any O
appreciable O
homology O
. O

In O
contrast O
, O
the O
lumenal O
domains O
of O
Sec12p B
, O
Stl1p B
and O
Stl2p B
are O
very O
different O
in O
size O
and O
do O
not O
show O
any O
appreciable O
homology O
. O

In O
contrast O
, O
the O
lumenal O
domains O
of O
Sec12p B
, O
Stl1p B
and O
Stl2p B
are O
very O
different O
in O
size O
and O
do O
not O
show O
any O
appreciable O
homology O
. O

Like O
Epo B
, O
HNF B
- I
4 I
is O
expressed O
in O
kidney O
, O
liver O
, O
and O
Hep3B O
cells O
but O
not O
in O
HeLa O
cells O
. O

The O
promoter O
of O
the O
rat B
PGS I
- I
2 I
gene I
contains O
a O
CAAT B
enhancer I
- I
binding I
protein I
consensus I
site I
( I
CAAT I
box I
) I
which O
can O
confer O
hormone O
inducibility O
to O
a O
PGS B
- I
2 I
. O
CAT B
reporter O
gene O
, O
as O
well O
as O
a O
putative O
E O
- O
box O
region O
. O

The O
effect O
of O
six O
arginine O
mutations O
of O
oxidative O
phosphorylation O
and O
AAC B
expression O
. O

The O
5 O
' O
ends O
of O
F3R B
late O
transcripts O
were O
located O
to O
an O
A O
within O
the O
sequence O
5 O
' O
- O
TAAAG O
, O
41 O
nt O
downstream O
from O
the O
early O
promoter O
and O
17 O
nt O
upstream O
from O
the O
initiation O
codon O
. O

The O
following O
evidence O
indicates O
that O
the O
69 O
- O
kD O
protein O
is O
a O
common O
, O
rather O
than O
a O
U1 B
- O
specific O
, O
protein O
, O
possibly O
associating O
with O
the O
snRNP O
core O
particles O
by O
protein O
- O
protein O
interaction O
. O

They O
suggest O
that O
decreased O
steady O
- O
state O
levels O
of O
IME1 B
and O
IME2 B
mRNA I
were O
not O
merely O
the O
result O
of O
non O
- O
specific O
adverse O
affects O
on O
nucleic O
acid O
metabolism O
caused O
by O
the O
yvh1 B
disruption O
. O

They O
suggest O
that O
decreased O
steady O
- O
state O
levels O
of O
IME1 B
and O
IME2 B
mRNA I
were O
not O
merely O
the O
result O
of O
non O
- O
specific O
adverse O
affects O
on O
nucleic O
acid O
metabolism O
caused O
by O
the O
yvh1 B
disruption O
. O

We O
remain O
convinced O
that O
antilymphocyte B
globulin I
( O
ALG B
) O
is O
a O
potent O
immunosuppressive O
agent O
in O
humans O
. O

When O
transiently O
transfected O
into O
K562 O
cells O
, O
this O
Lg B
genomic O
clone O
is O
actively O
transcribed O
, O
suggesting O
that O
, O
although O
it O
possesses O
the O
characteristics O
of O
a O
processed O
pseudogene O
, O
it O
is O
likely O
to O
correspond O
to O
the O
gene O
encoding O
this O
new O
ferritin B
subunit I
. O

Serum O
lipids O
and O
lipoproteins O
of O
29 O
insulin B
dependent O
diabetic O
children O
have O
been O
determined O
and O
related O
to O
the O
metabolic O
status O
of O
the O
patients O
. O

Thus O
, O
TRAF2 B
initiates O
SAPK B
and O
p38 B
activation O
by O
binding O
two O
proximal O
protein O
kinases O
: O
GCK B
and O
RIP B
. O

Thus O
, O
TRAF2 B
initiates O
SAPK B
and O
p38 B
activation O
by O
binding O
two O
proximal O
protein O
kinases O
: O
GCK B
and O
RIP B
. O

Thus O
, O
TRAF2 B
initiates O
SAPK B
and O
p38 B
activation O
by O
binding O
two O
proximal O
protein O
kinases O
: O
GCK B
and O
RIP B
. O

Thus O
, O
TRAF2 B
initiates O
SAPK B
and O
p38 B
activation O
by O
binding O
two O
proximal O
protein O
kinases O
: O
GCK B
and O
RIP B
. O

Thus O
, O
TRAF2 B
initiates O
SAPK B
and O
p38 B
activation O
by O
binding O
two O
proximal O
protein O
kinases O
: O
GCK B
and O
RIP B
. O

The O
Cili B
- I
2 I
sequences I
possess O
similarity O
to O
the O
RNaseH B
domain I
of O
Lian B
- O
Aa1 B
, O
a O
mosquito B
non I
- I
LTR I
retrotransposon I
. O

The O
Cili B
- I
2 I
sequences I
possess O
similarity O
to O
the O
RNaseH B
domain I
of O
Lian B
- O
Aa1 B
, O
a O
mosquito B
non I
- I
LTR I
retrotransposon I
. O

Conserved O
and O
distinct O
roles O
of O
kreisler B
in O
regulation O
of O
the O
paralogous O
Hoxa3 B
and O
Hoxb3 B
genes I
. O

Conserved O
and O
distinct O
roles O
of O
kreisler B
in O
regulation O
of O
the O
paralogous O
Hoxa3 B
and O
Hoxb3 B
genes I
. O

Among O
these O
360 O
ZFPs B
, O
a O
novel O
ZFP B
cDNA I
named O
HFHZ B
( O
human B
fetal I
heart I
ZFP I
) O
with O
sequence O
homology O
to O
a O
Kruppel B
- I
associated I
box I
( O
KRAB B
) O
was O
identified O
. O

Among O
these O
360 O
ZFPs B
, O
a O
novel O
ZFP B
cDNA I
named O
HFHZ B
( O
human B
fetal I
heart I
ZFP I
) O
with O
sequence O
homology O
to O
a O
Kruppel B
- I
associated I
box I
( O
KRAB B
) O
was O
identified O
. O

Among O
these O
360 O
ZFPs B
, O
a O
novel O
ZFP B
cDNA I
named O
HFHZ B
( O
human B
fetal I
heart I
ZFP I
) O
with O
sequence O
homology O
to O
a O
Kruppel B
- I
associated I
box I
( O
KRAB B
) O
was O
identified O
. O

Therefore O
, O
PC B
- I
PLC I
is O
a O
component O
of O
a O
signal O
transduction O
pathway O
leading O
to O
transcription O
of O
c B
- I
fos I
and O
junB B
that O
collaborates O
with O
c B
- I
myc I
and O
is O
independent O
of O
PKC B
- I
delta I
and O
Ras B
activation O
. O

Therefore O
, O
PC B
- I
PLC I
is O
a O
component O
of O
a O
signal O
transduction O
pathway O
leading O
to O
transcription O
of O
c B
- I
fos I
and O
junB B
that O
collaborates O
with O
c B
- I
myc I
and O
is O
independent O
of O
PKC B
- I
delta I
and O
Ras B
activation O
. O

Mutations O
in O
the O
VPS45 B
gene I
, O
a O
SEC1 B
homologue O
, O
result O
in O
vacuolar O
protein O
sorting O
defects O
and O
accumulation O
of O
membrane O
vesicles O
. O

Taken O
together O
, O
these O
results O
suggest O
that O
silymarin O
may O
exert O
a O
strong O
anticarcinogenic O
effect O
against O
PCA O
and O
that O
this O
effect O
is O
likely O
to O
involve O
impairment O
of O
erbB1 B
- O
SHC B
- O
mediated O
signaling O
pathway O
, O
induction O
of O
CDKIs B
, O
and O
a O
resultant O
G1 O
arrest O
. O

Taken O
together O
, O
these O
results O
suggest O
that O
silymarin O
may O
exert O
a O
strong O
anticarcinogenic O
effect O
against O
PCA O
and O
that O
this O
effect O
is O
likely O
to O
involve O
impairment O
of O
erbB1 B
- O
SHC B
- O
mediated O
signaling O
pathway O
, O
induction O
of O
CDKIs B
, O
and O
a O
resultant O
G1 O
arrest O
. O

Taken O
together O
, O
these O
results O
suggest O
that O
silymarin O
may O
exert O
a O
strong O
anticarcinogenic O
effect O
against O
PCA O
and O
that O
this O
effect O
is O
likely O
to O
involve O
impairment O
of O
erbB1 B
- O
SHC B
- O
mediated O
signaling O
pathway O
, O
induction O
of O
CDKIs B
, O
and O
a O
resultant O
G1 O
arrest O
. O

PAO O
blocks O
turnover O
of O
the O
phosphoryl O
group O
of O
pp15 B
, O
causing O
its O
accumulation O
, O
and O
thereby O
appears O
to O
interrupt O
signal O
transmission O
from O
the O
receptor O
to O
the O
glucose O
- O
transport O
system O
. O

Mutagenesis O
of O
IM1 B
enhances O
the O
ability O
of O
c B
- I
Fos I
to O
activate O
an O
AP1 B
bearing I
promoter I
. O

By O
using O
the O
full O
- O
length O
cytoplasmic O
domain O
and O
mutants O
with O
progressive O
carboxy O
- O
terminal O
deletions O
, O
internal O
deletions O
, O
or O
point O
mutations O
, O
we O
identified O
the O
first O
150 O
amino O
acid O
residues O
of O
LIFR B
as O
the O
minimal O
region O
necessary O
for O
signaling O
. O

Evidence O
for O
a O
novel O
MAPKKK B
- O
independent O
pathway O
controlling O
the O
stress O
activated O
Sty1 B
/ O
Spc1 B
MAP O
kinase O
in O
fission O
yeast O
. O

Evidence O
for O
a O
novel O
MAPKKK B
- O
independent O
pathway O
controlling O
the O
stress O
activated O
Sty1 B
/ O
Spc1 B
MAP O
kinase O
in O
fission O
yeast O
. O

Evidence O
for O
a O
novel O
MAPKKK B
- O
independent O
pathway O
controlling O
the O
stress O
activated O
Sty1 B
/ O
Spc1 B
MAP O
kinase O
in O
fission O
yeast O
. O

The O
activity O
of O
Rac1 B
leads O
to O
STAT3 B
translocation O
to O
the O
nucleus O
coincident O
with O
STAT3 B
- O
dependent O
gene O
expression O
. O

The O
activity O
of O
Rac1 B
leads O
to O
STAT3 B
translocation O
to O
the O
nucleus O
coincident O
with O
STAT3 B
- O
dependent O
gene O
expression O
. O

The O
activity O
of O
Rac1 B
leads O
to O
STAT3 B
translocation O
to O
the O
nucleus O
coincident O
with O
STAT3 B
- O
dependent O
gene O
expression O
. O

The O
GEF B
and O
GAP B
activities O
for O
Ypt1p B
localize O
to O
particulate O
cellular O
fractions O
. O

The O
GEF B
and O
GAP B
activities O
for O
Ypt1p B
localize O
to O
particulate O
cellular O
fractions O
. O

The O
GEF B
and O
GAP B
activities O
for O
Ypt1p B
localize O
to O
particulate O
cellular O
fractions O
. O

Upon O
tyrosine O
phosphorylation O
at O
the O
ITIMs O
, O
these O
molecules O
recruit O
SH2 B
domain O
- O
containing O
phosphatases O
such O
as O
SH2 B
- O
containing O
tyrosine B
phosphatase I
- I
1 I
and O
negatively O
regulate O
cell O
activity O
. O

Upon O
tyrosine O
phosphorylation O
at O
the O
ITIMs O
, O
these O
molecules O
recruit O
SH2 B
domain O
- O
containing O
phosphatases O
such O
as O
SH2 B
- O
containing O
tyrosine B
phosphatase I
- I
1 I
and O
negatively O
regulate O
cell O
activity O
. O

The O
promoter O
for O
HMG B
- I
CoA I
synthase I
contains O
two O
binding O
sites O
for O
the O
sterol B
regulatory I
element I
- I
binding I
proteins I
( O
SREBPs B
) O
. O

Here O
we O
provide O
the O
first O
evidence O
for O
the O
involvement O
of O
GCN1 B
- O
GCN2 B
interaction O
in O
activation O
of O
GCN2 B
per O
se O
. O

Here O
we O
provide O
the O
first O
evidence O
for O
the O
involvement O
of O
GCN1 B
- O
GCN2 B
interaction O
in O
activation O
of O
GCN2 B
per O
se O
. O

Here O
we O
provide O
the O
first O
evidence O
for O
the O
involvement O
of O
GCN1 B
- O
GCN2 B
interaction O
in O
activation O
of O
GCN2 B
per O
se O
. O

The O
results O
raise O
the O
possibility O
that O
pH O
induced O
post O
- O
translational O
modifications O
of O
DdRPA B
are O
involved O
in O
events O
that O
halt O
cell O
proliferation O
and O
induce O
differentiation O
in O
Dictyostelium O
. O

This O
transcriptional O
regulation O
occurs O
through O
modulation O
of O
the O
forkhead B
transcription I
factor I
FKHR B
- I
L1 I
, O
and O
IL B
- I
3 I
inhibited O
FKHR B
- I
L1 I
activity O
in O
a O
PI3K B
- O
dependent O
manner O
. O

TIP30 B
has O
an O
intrinsic O
kinase O
activity O
required O
for O
up O
- O
regulation O
of O
a O
subset O
of O
apoptotic O
genes O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

Binding O
activity O
in O
rat O
liver O
nuclear O
extracts O
includes O
these O
orphan O
receptors O
as O
judged O
from O
electromobility O
supershift O
experiments O
and O
from O
results O
obtained O
with O
expressed O
receptors O
, O
although O
the O
element O
in O
CYP2C11 B
did O
not O
bind O
HNF B
- I
4 I
. O

Isolation O
and O
characterization O
of O
the O
rat O
chromosomal O
gene O
for O
a O
polypeptide O
( O
pS1 B
) O
antigenically O
related O
to O
statin B
. O

Isolation O
and O
characterization O
of O
the O
rat O
chromosomal O
gene O
for O
a O
polypeptide O
( O
pS1 B
) O
antigenically O
related O
to O
statin B
. O

These O
data O
reveal O
a O
complex O
network O
of O
interactions O
between O
GTPases B
in O
the O
ARF B
family I
and O
their O
effectors O
and O
reveal O
a O
potential O
for O
cross O
- O
talk O
not O
demonstrated O
previously O
. O

The O
interferon B
- O
induced O
RNA B
- I
dependent I
protein I
kinase I
( O
PKR B
) O
is O
considered O
to O
play O
an O
important O
role O
in O
the O
cellular O
defense O
against O
viral O
infection O
and O
, O
in O
addition O
, O
has O
been O
suggested O
to O
be O
a O
tumor O
suppressor O
gene O
because O
of O
its O
growth O
- O
suppressive O
properties O
. O

The O
interferon B
- O
induced O
RNA B
- I
dependent I
protein I
kinase I
( O
PKR B
) O
is O
considered O
to O
play O
an O
important O
role O
in O
the O
cellular O
defense O
against O
viral O
infection O
and O
, O
in O
addition O
, O
has O
been O
suggested O
to O
be O
a O
tumor O
suppressor O
gene O
because O
of O
its O
growth O
- O
suppressive O
properties O
. O

Immunoreactive O
AR B
content O
in O
transfected O
COS O
- O
1 O
cells O
was O
not O
influenced O
by O
exposure O
to O
8 O
- O
Br O
- O
cAMP O
. O

Substrates O
for O
p210 B
( O
bcr B
- O
abl B
) O
are O
likely O
to O
be O
involved O
in O
the O
pathogenesis O
of O
CML O
. O

Substrates O
for O
p210 B
( O
bcr B
- O
abl B
) O
are O
likely O
to O
be O
involved O
in O
the O
pathogenesis O
of O
CML O
. O

Substrates O
for O
p210 B
( O
bcr B
- O
abl B
) O
are O
likely O
to O
be O
involved O
in O
the O
pathogenesis O
of O
CML O
. O

We O
now O
demonstrate O
that O
CCAAT B
/ I
enhancer I
- I
binding I
protein I
( I
C I
/ I
EBP I
) I
delta I
is O
a O
major O
component O
of O
a O
PGE2 O
- O
stimulated O
DNA O
- O
protein O
complex O
involving O
HS3D B
and O
find O
that O
C B
/ I
EBPdelta I
transactivates O
IGF B
- I
I I
promoter I
1 I
through O
this O
site O
. O

PABP B
is O
a O
modular O
protein O
, O
with O
four O
N O
- O
terminal O
RNA O
- O
binding O
domains O
and O
an O
extensive O
C O
terminus O
. O

Transactivation O
of O
oIFNtau B
enhancer O
- O
reporter O
constructs O
was O
primarily O
regulated O
by O
three O
regions O
containing O
AP B
- I
1 I
site I
, O
GATA B
like I
sequence I
and O
site O
( O
s O
) O
unidentified O
. O

Single O
amino O
acid O
substitutions O
at O
the O
acyl O
- O
CoA O
- O
binding O
domain O
interrupt O
14 O
[ O
C O
] O
palmitoyl O
- O
CoA O
binding O
of O
ACBP2 B
, O
an O
Arabidopsis O
acyl B
- I
CoA I
- I
binding I
protein I
with O
ankyrin B
repeats O
. O

Single O
amino O
acid O
substitutions O
at O
the O
acyl O
- O
CoA O
- O
binding O
domain O
interrupt O
14 O
[ O
C O
] O
palmitoyl O
- O
CoA O
binding O
of O
ACBP2 B
, O
an O
Arabidopsis O
acyl B
- I
CoA I
- I
binding I
protein I
with O
ankyrin B
repeats O
. O

This O
sequenced O
region O
of O
the O
V O
beta O
locus O
contains O
an O
average O
number O
of O
repetitive O
DNA O
elements O
( O
21 O
Alu B
, O
three O
L1 B
, O
three O
MER O
, O
and O
three O
retrovirus O
- O
related O
elements O
. O

This O
sequenced O
region O
of O
the O
V O
beta O
locus O
contains O
an O
average O
number O
of O
repetitive O
DNA O
elements O
( O
21 O
Alu B
, O
three O
L1 B
, O
three O
MER O
, O
and O
three O
retrovirus O
- O
related O
elements O
. O

Defects O
of O
fibrillin B
( O
FBN1 B
) O
, O
a O
glycoprotein O
component O
of O
the O
extracellular O
microfibril O
, O
cause O
Marfan O
syndrome O
. O

Defects O
of O
fibrillin B
( O
FBN1 B
) O
, O
a O
glycoprotein O
component O
of O
the O
extracellular O
microfibril O
, O
cause O
Marfan O
syndrome O
. O

Three O
mutants O
( O
pms1 B
, O
pms2 B
and O
pms3 B
) O
isolated O
earlier O
from O
MW104 O
- O
1B O
were O
shown O
to O
correct O
in O
vitro O
constructed O
plasmids O
with O
defined O
DNA O
mismatches O
( O
G O
/ O
T O
, O
A O
/ O
C O
, O
G O
/ O
G O
, O
etc O
. O
) O
poorly O
( O
Kramer O
et O
al O
. O
, O
1989a O
) O
. O

Three O
mutants O
( O
pms1 B
, O
pms2 B
and O
pms3 B
) O
isolated O
earlier O
from O
MW104 O
- O
1B O
were O
shown O
to O
correct O
in O
vitro O
constructed O
plasmids O
with O
defined O
DNA O
mismatches O
( O
G O
/ O
T O
, O
A O
/ O
C O
, O
G O
/ O
G O
, O
etc O
. O
) O
poorly O
( O
Kramer O
et O
al O
. O
, O
1989a O
) O
. O

Three O
mutants O
( O
pms1 B
, O
pms2 B
and O
pms3 B
) O
isolated O
earlier O
from O
MW104 O
- O
1B O
were O
shown O
to O
correct O
in O
vitro O
constructed O
plasmids O
with O
defined O
DNA O
mismatches O
( O
G O
/ O
T O
, O
A O
/ O
C O
, O
G O
/ O
G O
, O
etc O
. O
) O
poorly O
( O
Kramer O
et O
al O
. O
, O
1989a O
) O
. O

Platelet O
counts O
and O
function O
as O
well O
as O
fibrinogen B
and O
von B
Willebrand I
factor I
( O
vWF B
) O
levels O
were O
determined O
in O
each O
sample O
. O

Platelet O
counts O
and O
function O
as O
well O
as O
fibrinogen B
and O
von B
Willebrand I
factor I
( O
vWF B
) O
levels O
were O
determined O
in O
each O
sample O
. O

Because O
results O
of O
recent O
randomized O
trials O
indicate O
minimal O
efficacy O
of O
continuing O
MAC O
prophylaxis O
in O
patients O
who O
respond O
to O
potent O
combination O
antiretroviral O
therapy O
, O
the O
observed O
high O
incidence O
of O
macrolide O
- O
resistant O
bacterial O
colonization O
of O
the O
respiratory O
tract O
in O
this O
trial O
supports O
the O
discontinuation O
of O
macrolide O
prophylaxis O
in O
all O
AIDS O
patients O
whose O
CD4 B
counts O
have O
risen O
above O
100 O
cells O
/ O
microL O
. O

The O
first O
identification O
of O
the O
active O
37LRP B
/ O
p40 B
gene O
presented O
in O
this O
study O
is O
a O
critical O
step O
toward O
the O
isolation O
of O
the O
corresponding O
human O
gene O
and O
the O
understanding O
of O
the O
molecular O
mechanisms O
involved O
in O
the O
up O
- O
regulation O
of O
its O
expression O
during O
tumor O
invasion O
and O
metastasis O
. O

The O
first O
identification O
of O
the O
active O
37LRP B
/ O
p40 B
gene O
presented O
in O
this O
study O
is O
a O
critical O
step O
toward O
the O
isolation O
of O
the O
corresponding O
human O
gene O
and O
the O
understanding O
of O
the O
molecular O
mechanisms O
involved O
in O
the O
up O
- O
regulation O
of O
its O
expression O
during O
tumor O
invasion O
and O
metastasis O
. O

Inclusion O
in O
this O
family O
of O
proteins O
suggests O
that O
FliQ B
and O
FliR B
may O
participate O
in O
an O
export O
pathway O
required O
for O
flagellum O
assembly O
. O

Inclusion O
in O
this O
family O
of O
proteins O
suggests O
that O
FliQ B
and O
FliR B
may O
participate O
in O
an O
export O
pathway O
required O
for O
flagellum O
assembly O
. O

In O
our O
studies O
, O
we O
utilized O
HIV O
- O
1 O
HXB2 B
and O
HIV O
- O
1 O
Z2Z6 B
core I
enhancers I
because O
the O
Z2Z6 B
strain O
has O
a O
single O
point O
mutation O
flanking O
the O
right O
ETS B
- I
binding I
site I
. O

In O
our O
studies O
, O
we O
utilized O
HIV O
- O
1 O
HXB2 B
and O
HIV O
- O
1 O
Z2Z6 B
core I
enhancers I
because O
the O
Z2Z6 B
strain O
has O
a O
single O
point O
mutation O
flanking O
the O
right O
ETS B
- I
binding I
site I
. O

We O
also O
found O
that O
environmental O
conditions O
for O
meiosis O
finely O
regulate O
the O
transcript O
levels O
of O
KIN28 B
and O
CCL1 B
, O
such O
that O
nitrogen O
starvation O
first O
elevates O
them O
but O
subsequent O
alkalization O
of O
medium O
decreases O
them O
. O

We O
also O
found O
that O
environmental O
conditions O
for O
meiosis O
finely O
regulate O
the O
transcript O
levels O
of O
KIN28 B
and O
CCL1 B
, O
such O
that O
nitrogen O
starvation O
first O
elevates O
them O
but O
subsequent O
alkalization O
of O
medium O
decreases O
them O
. O

Platelet B
- I
derived I
growth I
factor I
- O
dependent O
activation O
of O
phosphatidylinositol B
3 I
- I
kinase I
is O
regulated O
by O
receptor O
binding O
of O
SH2 B
- I
domain I
- I
containing I
proteins I
which O
influence O
Ras B
activity O
. O

Relatively O
large O
DNA O
rearrangements O
spanning O
the O
region O
with O
tandem O
direct O
repeats O
encoding O
the O
carboxy O
- O
terminal O
histone B
H1 I
- I
like I
structure O
of O
AlgP B
were O
detected O
in O
several O
strains O
upon O
conversion O
from O
the O
mucoid O
to O
the O
nonmucoid O
phenotype O
. O

A O
2 O
kb O
transcript O
was O
isolated O
from O
brain O
that O
encodes O
a O
approximately O
57 O
kDa O
protein O
; O
the O
predicted O
protein O
contains O
the O
known O
N B
- I
terminal I
Ets I
domain I
of O
PE1 B
and O
a O
novel O
C O
- O
terminal O
domain O
with O
signficant O
homology O
to O
murine B
ERF I
. O

The O
high B
density I
lipoprotein I
( I
HDL I
) I
receptor I
mediates O
the O
uptake O
of O
cholesterol O
and O
cholesteryl O
esters O
, O
substrates O
for O
steroidogenesis O
, O
from O
an O
HDL B
particle O
in O
the O
adrenal O
gland O
and O
gonads O
. O

The O
mechanism O
involves O
Gbetagamma B
subunit O
- O
mediated O
increases O
in O
tyrosine O
phosphorylation O
of O
the O
Shc B
adapter I
protein I
, O
Shc B
* O
Grb2 B
complex O
formation O
, O
and O
recruitment O
of O
Ras B
guanine I
nucleotide I
exchange I
factor I
activity O
. O

The O
mechanism O
involves O
Gbetagamma B
subunit O
- O
mediated O
increases O
in O
tyrosine O
phosphorylation O
of O
the O
Shc B
adapter I
protein I
, O
Shc B
* O
Grb2 B
complex O
formation O
, O
and O
recruitment O
of O
Ras B
guanine I
nucleotide I
exchange I
factor I
activity O
. O

The O
mechanism O
involves O
Gbetagamma B
subunit O
- O
mediated O
increases O
in O
tyrosine O
phosphorylation O
of O
the O
Shc B
adapter I
protein I
, O
Shc B
* O
Grb2 B
complex O
formation O
, O
and O
recruitment O
of O
Ras B
guanine I
nucleotide I
exchange I
factor I
activity O
. O

In O
contrast O
, O
gel O
mobility O
shift O
experiments O
have O
failed O
to O
reveal O
that O
HAP2 B
or O
HAP3 B
binds O
to O
domain O
1 O
or O
that O
hap3 B
mutations O
affect O
the O
complexes O
bound O
to O
it O
. O

In O
contrast O
, O
gel O
mobility O
shift O
experiments O
have O
failed O
to O
reveal O
that O
HAP2 B
or O
HAP3 B
binds O
to O
domain O
1 O
or O
that O
hap3 B
mutations O
affect O
the O
complexes O
bound O
to O
it O
. O

In O
contrast O
, O
gel O
mobility O
shift O
experiments O
have O
failed O
to O
reveal O
that O
HAP2 B
or O
HAP3 B
binds O
to O
domain O
1 O
or O
that O
hap3 B
mutations O
affect O
the O
complexes O
bound O
to O
it O
. O

Here O
we O
report O
the O
purification O
of O
this O
larger O
form O
as O
an O
approximately O
320 O
- O
kDa O
particle O
that O
contains O
mRNP3 B
+ I
4 I
and O
nine O
additional O
polypeptides O
, O
including O
mRNA O
- O
binding O
polypeptides O
of O
34 O
and O
36 O
kDa O
and O
a O
doublet O
of O
110 O
/ O
105 O
kDa O
that O
proved O
to O
be O
nucleolin B
. O

Once O
the O
proliferation O
of O
fibroblasts O
and O
collagen B
synthesis O
had O
led O
to O
an O
increase O
of O
mechanical O
strength O
, O
no O
negative O
effect O
on O
wound O
healing O
could O
be O
detected O
applying O
the O
same O
chemotherapeutic O
agents O
. O

In O
co O
- O
transfection O
studies O
, O
the O
expression O
of O
c B
- I
Jun I
plus O
c B
- I
Fos I
enhanced O
the O
transactivation O
of O
oIFNtau B
- O
CAT B
but O
the O
expression O
of O
GATA B
- I
1 I
, O
GATA B
- I
2 I
or O
GATA B
- I
3 I
did O
not O
. O

In O
co O
- O
transfection O
studies O
, O
the O
expression O
of O
c B
- I
Jun I
plus O
c B
- I
Fos I
enhanced O
the O
transactivation O
of O
oIFNtau B
- O
CAT B
but O
the O
expression O
of O
GATA B
- I
1 I
, O
GATA B
- I
2 I
or O
GATA B
- I
3 I
did O
not O
. O

Another O
stem O
- O
loop O
called O
structure O
III O
near O
the O
3 O
' O
- O
end O
of O
repY B
sequesters O
both O
the O
5 O
' O
- O
rCGCC O
- O
3 O
' O
sequence O
and O
the O
repZ B
ribosome I
- I
binding I
site I
. O

Finally O
, O
some O
point O
mutations O
in O
the O
Gag B
- O
Pol B
PR O
domain O
inhibited O
activation O
of O
RT B
in O
trans O
by O
a O
wild O
- O
type O
PR B
, O
suggesting O
that O
the O
correct O
conformation O
of O
the O
PR B
domain O
in O
Gag B
- O
Pol B
is O
prerequisite O
for O
activation O
of O
RT B
. O

Finally O
, O
some O
point O
mutations O
in O
the O
Gag B
- O
Pol B
PR O
domain O
inhibited O
activation O
of O
RT B
in O
trans O
by O
a O
wild O
- O
type O
PR B
, O
suggesting O
that O
the O
correct O
conformation O
of O
the O
PR B
domain O
in O
Gag B
- O
Pol B
is O
prerequisite O
for O
activation O
of O
RT B
. O

Finally O
, O
some O
point O
mutations O
in O
the O
Gag B
- O
Pol B
PR O
domain O
inhibited O
activation O
of O
RT B
in O
trans O
by O
a O
wild O
- O
type O
PR B
, O
suggesting O
that O
the O
correct O
conformation O
of O
the O
PR B
domain O
in O
Gag B
- O
Pol B
is O
prerequisite O
for O
activation O
of O
RT B
. O

Finally O
, O
some O
point O
mutations O
in O
the O
Gag B
- O
Pol B
PR O
domain O
inhibited O
activation O
of O
RT B
in O
trans O
by O
a O
wild O
- O
type O
PR B
, O
suggesting O
that O
the O
correct O
conformation O
of O
the O
PR B
domain O
in O
Gag B
- O
Pol B
is O
prerequisite O
for O
activation O
of O
RT B
. O

Finally O
, O
some O
point O
mutations O
in O
the O
Gag B
- O
Pol B
PR O
domain O
inhibited O
activation O
of O
RT B
in O
trans O
by O
a O
wild O
- O
type O
PR B
, O
suggesting O
that O
the O
correct O
conformation O
of O
the O
PR B
domain O
in O
Gag B
- O
Pol B
is O
prerequisite O
for O
activation O
of O
RT B
. O

Finally O
, O
some O
point O
mutations O
in O
the O
Gag B
- O
Pol B
PR O
domain O
inhibited O
activation O
of O
RT B
in O
trans O
by O
a O
wild O
- O
type O
PR B
, O
suggesting O
that O
the O
correct O
conformation O
of O
the O
PR B
domain O
in O
Gag B
- O
Pol B
is O
prerequisite O
for O
activation O
of O
RT B
. O

Finally O
, O
some O
point O
mutations O
in O
the O
Gag B
- O
Pol B
PR O
domain O
inhibited O
activation O
of O
RT B
in O
trans O
by O
a O
wild O
- O
type O
PR B
, O
suggesting O
that O
the O
correct O
conformation O
of O
the O
PR B
domain O
in O
Gag B
- O
Pol B
is O
prerequisite O
for O
activation O
of O
RT B
. O

Finally O
, O
some O
point O
mutations O
in O
the O
Gag B
- O
Pol B
PR O
domain O
inhibited O
activation O
of O
RT B
in O
trans O
by O
a O
wild O
- O
type O
PR B
, O
suggesting O
that O
the O
correct O
conformation O
of O
the O
PR B
domain O
in O
Gag B
- O
Pol B
is O
prerequisite O
for O
activation O
of O
RT B
. O

Electrophoretic O
mobility O
shift O
assays O
revealed O
that O
Sp1 B
binds O
to O
two O
different O
regions O
in O
the O
proximal O
promoter O
, O
a O
typical O
Sp1 B
site I
located O
at O
( O
- O
38 O
; O
- O
33 O
) O
and O
a O
G O
/ O
C O
- O
rich O
region O
between O
( O
- O
67 O
; O
- O
62 O
) O
. O

BiP670 B
retains O
basal O
and O
Ca2 O
+ O
ionophore O
A23187 O
- O
inducible O
activities O
. O

Antimicrobial O
Susceptibility O
of O
Klebsiella O
pneumoniae O
Producing O
Extended B
- I
Spectrum I
beta I
- I
lactamase I
( O
ESBL B
) O
Isolated O
in O
Hospitals O
in O
Brazil O
. O

The O
LTR O
- O
binding O
activities O
of O
VBP B
, O
a1 B
/ I
EBP I
, O
and O
B B
- I
cell I
nuclear I
extract I
protein I
were O
compared O
and O
mapped O
by O
gel O
shift O
, O
DNase B
I I
footprinting O
, O
and O
methylation O
interference O
assays O
. O

These O
results O
indicate O
that O
ATF B
- I
2 I
plays O
a O
central O
role O
in O
TGF B
- I
beta I
signaling O
by O
acting O
as O
a O
common O
nuclear O
target O
of O
both O
Smad B
and O
TAK1 B
pathways O
. O

These O
results O
indicate O
that O
ATF B
- I
2 I
plays O
a O
central O
role O
in O
TGF B
- I
beta I
signaling O
by O
acting O
as O
a O
common O
nuclear O
target O
of O
both O
Smad B
and O
TAK1 B
pathways O
. O

Similarly O
, O
in O
mammalian O
cells O
PBP74 B
is O
synthesized O
as O
a O
pre O
- O
protein O
that O
requires O
membrane O
potential O
- O
dependent O
import O
into O
mitochondria O
for O
its O
maturation O
. O

This O
model O
is O
supported O
by O
experiments O
showing O
that O
Cdr2 B
associates O
with O
the O
N B
- I
terminal I
regulatory I
domain I
of I
Wee1 I
in O
cell O
lysates O
and O
phosphorylates O
Wee1 B
in O
vitro O
. O

This O
model O
is O
supported O
by O
experiments O
showing O
that O
Cdr2 B
associates O
with O
the O
N B
- I
terminal I
regulatory I
domain I
of I
Wee1 I
in O
cell O
lysates O
and O
phosphorylates O
Wee1 B
in O
vitro O
. O

Consistent O
with O
previous O
reports O
, O
addition O
of O
a O
myristoylation O
signal O
to O
mSos1 B
( O
MyrSos1 B
) O
rendered O
it O
transforming O
for O
NIH O
3T3 O
cells O
and O
deletion O
of O
the O
mSos B
C I
terminus I
( O
MyrSos1 B
- I
deltaC I
) O
did O
not O
interfere O
with O
this O
activity O
. O

Consistent O
with O
previous O
reports O
, O
addition O
of O
a O
myristoylation O
signal O
to O
mSos1 B
( O
MyrSos1 B
) O
rendered O
it O
transforming O
for O
NIH O
3T3 O
cells O
and O
deletion O
of O
the O
mSos B
C I
terminus I
( O
MyrSos1 B
- I
deltaC I
) O
did O
not O
interfere O
with O
this O
activity O
. O

The O
U14 B
genes I
of O
mouse O
as O
well O
as O
rat O
, O
hamster O
, O
human O
, O
Xenopus O
and O
trout O
are O
encoded O
within O
introns O
of O
the O
constitutively O
expressed O
70 B
- I
kDa I
- I
cognate I
- I
heat I
- I
shock I
protein I
gene I
( O
hsc70 B
) O
. O

Expression O
of O
human B
RACK1 I
efficiently O
relieves O
E1A B
- O
mediated O
growth O
inhibition O
in O
HF7c O
and O
protects O
human O
tumor O
cells O
from O
E1A B
- O
induced O
apoptosis O
. O

Expression O
of O
human B
RACK1 I
efficiently O
relieves O
E1A B
- O
mediated O
growth O
inhibition O
in O
HF7c O
and O
protects O
human O
tumor O
cells O
from O
E1A B
- O
induced O
apoptosis O
. O

The O
mutations O
did O
not O
affect O
the O
repression O
of O
CPA1 B
by O
arginine O
. O

Taken O
together O
, O
these O
observations O
indicate O
that O
inhibition O
of O
p27 B
( O
KIP1 B
) O
transcription O
through O
PI3K B
- O
induced O
FKHR B
- I
L1 I
phosphorylation O
provides O
a O
novel O
mechanism O
of O
regulating O
cytokine O
- O
mediated O
survival O
and O
proliferation O
. O

Taken O
together O
, O
these O
observations O
indicate O
that O
inhibition O
of O
p27 B
( O
KIP1 B
) O
transcription O
through O
PI3K B
- O
induced O
FKHR B
- I
L1 I
phosphorylation O
provides O
a O
novel O
mechanism O
of O
regulating O
cytokine O
- O
mediated O
survival O
and O
proliferation O
. O

Taken O
together O
, O
these O
observations O
indicate O
that O
inhibition O
of O
p27 B
( O
KIP1 B
) O
transcription O
through O
PI3K B
- O
induced O
FKHR B
- I
L1 I
phosphorylation O
provides O
a O
novel O
mechanism O
of O
regulating O
cytokine O
- O
mediated O
survival O
and O
proliferation O
. O

We O
observed O
abundant O
levels O
of O
Rev B
- O
erbA B
alpha I
mRNA O
in O
dividing O
C2C12 O
myoblasts O
, O
which O
were O
suppressed O
when O
the O
cells O
differentiated O
into O
postmitotic O
multinucleated O
myotubes O
. O

The O
gene O
is O
contained O
within O
a O
1 O
. O
8 O
- O
kilobase O
AccI B
- O
EcoRI B
restriction O
fragment O
mapping O
at O
map O
coordinates O
0 O
. O
136 O
to O
0 O
. O
148 O
in O
the O
UL O
region O
of O
the O
EHV O
- O
1 O
genome O
and O
is O
transcribed O
from O
right O
to O
left O
. O

The O
gene O
is O
contained O
within O
a O
1 O
. O
8 O
- O
kilobase O
AccI B
- O
EcoRI B
restriction O
fragment O
mapping O
at O
map O
coordinates O
0 O
. O
136 O
to O
0 O
. O
148 O
in O
the O
UL O
region O
of O
the O
EHV O
- O
1 O
genome O
and O
is O
transcribed O
from O
right O
to O
left O
. O

A O
chimeric O
VP16 B
- O
Tat B
construct O
containing O
the O
leucine O
mutations O
showed O
no O
increased O
AP B
- I
1 I
responsiveness O
in O
comparison O
with O
that O
of O
the O
VP16 B
activation I
domain I
alone O
. O

A O
chimeric O
VP16 B
- O
Tat B
construct O
containing O
the O
leucine O
mutations O
showed O
no O
increased O
AP B
- I
1 I
responsiveness O
in O
comparison O
with O
that O
of O
the O
VP16 B
activation I
domain I
alone O
. O

CONCLUSIONS O
: O
This O
randomized O
study O
shows O
that O
Vivostat O
fibrin B
sealant O
is O
effective O
in O
preventing O
air O
leakage O
after O
small O
lung O
resections O
in O
pigs O
, O
even O
at O
high O
inspiratory O
pressures O
. O

Splice O
variations O
in O
genes O
coding O
for O
the O
transmembrane B
FGF I
receptor I
( O
FGFR B
) O
result O
in O
isoforms O
that O
vary O
in O
the O
ectodomain O
, O
intracellular O
juxtamembrane O
domain O
, O
and O
the O
intracellular O
kinase O
domain O
. O

A O
short O
sequence O
surrounding O
the O
major O
JNK B
phosphorylation O
site O
of O
c B
- I
Jun I
is O
conserved O
in O
c B
- I
Fos I
and O
is O
part O
of O
its O
activation O
domain O
, O
suggesting O
that O
c B
- I
Fos I
may O
be O
similarly O
regulated O
. O

In O
HCMV O
( O
Towne O
) O
- O
infected O
HF O
cells O
at O
24 O
to O
48 O
h O
, O
IE2 B
also O
accumulated O
in O
newly O
formed O
viral O
DNA O
replication O
compartments O
containing O
the O
polymerase B
processivity I
factor I
( O
UL44 B
) O
, O
the O
single B
- I
stranded I
DNA I
binding I
protein I
( O
SSB B
; O
UL57 B
) O
, O
the O
UL112 B
- I
113 I
accessory I
protein I
, O
and O
newly O
incorporated O
bromodeoxyuridine O
( O
BrdU O
) O
. O

In O
HCMV O
( O
Towne O
) O
- O
infected O
HF O
cells O
at O
24 O
to O
48 O
h O
, O
IE2 B
also O
accumulated O
in O
newly O
formed O
viral O
DNA O
replication O
compartments O
containing O
the O
polymerase B
processivity I
factor I
( O
UL44 B
) O
, O
the O
single B
- I
stranded I
DNA I
binding I
protein I
( O
SSB B
; O
UL57 B
) O
, O
the O
UL112 B
- I
113 I
accessory I
protein I
, O
and O
newly O
incorporated O
bromodeoxyuridine O
( O
BrdU O
) O
. O

In O
HCMV O
( O
Towne O
) O
- O
infected O
HF O
cells O
at O
24 O
to O
48 O
h O
, O
IE2 B
also O
accumulated O
in O
newly O
formed O
viral O
DNA O
replication O
compartments O
containing O
the O
polymerase B
processivity I
factor I
( O
UL44 B
) O
, O
the O
single B
- I
stranded I
DNA I
binding I
protein I
( O
SSB B
; O
UL57 B
) O
, O
the O
UL112 B
- I
113 I
accessory I
protein I
, O
and O
newly O
incorporated O
bromodeoxyuridine O
( O
BrdU O
) O
. O

In O
HCMV O
( O
Towne O
) O
- O
infected O
HF O
cells O
at O
24 O
to O
48 O
h O
, O
IE2 B
also O
accumulated O
in O
newly O
formed O
viral O
DNA O
replication O
compartments O
containing O
the O
polymerase B
processivity I
factor I
( O
UL44 B
) O
, O
the O
single B
- I
stranded I
DNA I
binding I
protein I
( O
SSB B
; O
UL57 B
) O
, O
the O
UL112 B
- I
113 I
accessory I
protein I
, O
and O
newly O
incorporated O
bromodeoxyuridine O
( O
BrdU O
) O
. O

Moreover O
, O
Lck B
was O
reversibly O
co O
- O
immunoprecipitated O
with O
p95Vav B
, O
and O
the O
stoichiometry O
of O
binding O
increased O
in O
anti B
- I
CD3 I
- O
treated O
Jurkat O
cells O
. O

Moreover O
, O
Lck B
was O
reversibly O
co O
- O
immunoprecipitated O
with O
p95Vav B
, O
and O
the O
stoichiometry O
of O
binding O
increased O
in O
anti B
- I
CD3 I
- O
treated O
Jurkat O
cells O
. O

The O
binding O
of O
PH B
domains I
to O
Gbetagamma B
was O
inhibited O
by O
preincubation O
of O
Gbetagamma B
with O
the O
GDP O
- O
bound O
but O
not O
the O
GTP O
- O
bound O
form O
of O
Gialpha B
. O

The O
binding O
of O
PH B
domains I
to O
Gbetagamma B
was O
inhibited O
by O
preincubation O
of O
Gbetagamma B
with O
the O
GDP O
- O
bound O
but O
not O
the O
GTP O
- O
bound O
form O
of O
Gialpha B
. O

The O
binding O
of O
PH B
domains I
to O
Gbetagamma B
was O
inhibited O
by O
preincubation O
of O
Gbetagamma B
with O
the O
GDP O
- O
bound O
but O
not O
the O
GTP O
- O
bound O
form O
of O
Gialpha B
. O

A O
mutation O
in O
the O
C O
domain O
of O
Rb B
, O
L901Q O
, O
has O
been O
identified O
that O
completely O
abolishes O
cdk4 B
/ O
D1 B
phosphorylation O
of O
the O
isolated O
C O
domain O
. O

A O
mutation O
in O
the O
C O
domain O
of O
Rb B
, O
L901Q O
, O
has O
been O
identified O
that O
completely O
abolishes O
cdk4 B
/ O
D1 B
phosphorylation O
of O
the O
isolated O
C O
domain O
. O

A O
mutation O
in O
the O
C O
domain O
of O
Rb B
, O
L901Q O
, O
has O
been O
identified O
that O
completely O
abolishes O
cdk4 B
/ O
D1 B
phosphorylation O
of O
the O
isolated O
C O
domain O
. O

The O
highly O
amyloidogenic O
42 O
- O
residue O
form O
of O
Abeta B
( O
Abeta42 B
) O
is O
the O
first O
species O
to O
be O
deposited O
in O
both O
sporadic O
and O
familial O
AD O
. O

The O
highly O
amyloidogenic O
42 O
- O
residue O
form O
of O
Abeta B
( O
Abeta42 B
) O
is O
the O
first O
species O
to O
be O
deposited O
in O
both O
sporadic O
and O
familial O
AD O
. O

This O
short O
communication O
compares O
a O
novel O
fluorimetric O
microplate O
enzyme O
immunoassay O
( O
FEIA O
) O
with O
a O
commercial O
time O
- O
resolved O
fluoroimmunoassay O
for O
the O
determination O
of O
thyrotropin B
in O
dried O
blood O
spots O
. O

Double O
mutant O
analysis O
suggests O
that O
Rad54p B
and O
Mus81p B
act O
in O
one O
pathway O
for O
the O
repair O
of O
, O
or O
tolerance O
to O
, O
UV O
- O
induced O
DNA O
damage O
. O

Double O
mutant O
analysis O
suggests O
that O
Rad54p B
and O
Mus81p B
act O
in O
one O
pathway O
for O
the O
repair O
of O
, O
or O
tolerance O
to O
, O
UV O
- O
induced O
DNA O
damage O
. O

The O
similar O
phenotypes O
of O
bur6 B
and O
bur3 B
( O
mot1 B
) O
mutations O
suggest O
that O
Bur6p B
and O
Mot1p B
have O
related O
, O
but O
not O
identical O
, O
functions O
in O
modulating O
the O
activity O
of O
the O
general O
transcription O
machinery O
in O
vivo O
. O

The O
similar O
phenotypes O
of O
bur6 B
and O
bur3 B
( O
mot1 B
) O
mutations O
suggest O
that O
Bur6p B
and O
Mot1p B
have O
related O
, O
but O
not O
identical O
, O
functions O
in O
modulating O
the O
activity O
of O
the O
general O
transcription O
machinery O
in O
vivo O
. O

The O
similar O
phenotypes O
of O
bur6 B
and O
bur3 B
( O
mot1 B
) O
mutations O
suggest O
that O
Bur6p B
and O
Mot1p B
have O
related O
, O
but O
not O
identical O
, O
functions O
in O
modulating O
the O
activity O
of O
the O
general O
transcription O
machinery O
in O
vivo O
. O

The O
similar O
phenotypes O
of O
bur6 B
and O
bur3 B
( O
mot1 B
) O
mutations O
suggest O
that O
Bur6p B
and O
Mot1p B
have O
related O
, O
but O
not O
identical O
, O
functions O
in O
modulating O
the O
activity O
of O
the O
general O
transcription O
machinery O
in O
vivo O
. O

The O
similar O
phenotypes O
of O
bur6 B
and O
bur3 B
( O
mot1 B
) O
mutations O
suggest O
that O
Bur6p B
and O
Mot1p B
have O
related O
, O
but O
not O
identical O
, O
functions O
in O
modulating O
the O
activity O
of O
the O
general O
transcription O
machinery O
in O
vivo O
. O

Sp1 B
binds O
two O
sites O
in O
the O
CD11c B
promoter I
in O
vivo O
specifically O
in O
myeloid O
cells O
and O
cooperates O
with O
AP1 B
to O
activate O
transcription O
. O

Sp1 B
binds O
two O
sites O
in O
the O
CD11c B
promoter I
in O
vivo O
specifically O
in O
myeloid O
cells O
and O
cooperates O
with O
AP1 B
to O
activate O
transcription O
. O

Small B
Maf I
proteins I
heterodimerize O
with O
Fos B
and O
may O
act O
as O
competitive O
repressors O
of O
the O
NF B
- I
E2 I
transcription I
factor I
. O

The O
isolated O
POT1 B
clones O
hybridized O
to O
a O
1 O
. O
4 O
kb O
RNA O
species O
, O
which O
was O
induced O
approximately O
30 O
- O
fold O
when O
oleate O
was O
the O
carbon O
source O
. O

Uses O
of O
orthoclone O
OKT3 B
for O
prophylaxis O
of O
rejection O
and O
induction O
in O
initial O
nonfunction O
in O
kidney O
transplantation O
. O

Genomic O
DNA O
hybridization O
suggests O
that O
SpSHR2 B
is O
a O
single O
- O
copy O
gene O
in O
the O
S O
. O
purpuratus O
genome O
. O

We O
concluded O
that O
activation O
of O
c B
- I
fosER I
mediated O
transcriptional O
inhibition O
of O
p21 B
( O
Cip1 B
/ O
WAF1 B
) O
through O
a O
previously O
uncharacterized O
AP B
- I
1 I
site I
, O
revealing O
an O
important O
role O
for O
c B
- I
fos I
in O
negative O
control O
of O
cell O
cycle O
regulatory O
genes O
. O

We O
concluded O
that O
activation O
of O
c B
- I
fosER I
mediated O
transcriptional O
inhibition O
of O
p21 B
( O
Cip1 B
/ O
WAF1 B
) O
through O
a O
previously O
uncharacterized O
AP B
- I
1 I
site I
, O
revealing O
an O
important O
role O
for O
c B
- I
fos I
in O
negative O
control O
of O
cell O
cycle O
regulatory O
genes O
. O

We O
concluded O
that O
activation O
of O
c B
- I
fosER I
mediated O
transcriptional O
inhibition O
of O
p21 B
( O
Cip1 B
/ O
WAF1 B
) O
through O
a O
previously O
uncharacterized O
AP B
- I
1 I
site I
, O
revealing O
an O
important O
role O
for O
c B
- I
fos I
in O
negative O
control O
of O
cell O
cycle O
regulatory O
genes O
. O

An O
inactive O
analog O
of O
wortmannin O
, O
WM12 O
, O
did O
not O
affect O
TCR B
/ O
CD3 B
- O
induced O
Erk2 B
activation O
, O
and O
wortmannin O
had O
no O
effect O
on O
the O
activity O
of O
Erk2 B
when O
added O
directly O
to O
the O
in O
vitro O
assays O
. O

An O
inactive O
analog O
of O
wortmannin O
, O
WM12 O
, O
did O
not O
affect O
TCR B
/ O
CD3 B
- O
induced O
Erk2 B
activation O
, O
and O
wortmannin O
had O
no O
effect O
on O
the O
activity O
of O
Erk2 B
when O
added O
directly O
to O
the O
in O
vitro O
assays O
. O

An O
inactive O
analog O
of O
wortmannin O
, O
WM12 O
, O
did O
not O
affect O
TCR B
/ O
CD3 B
- O
induced O
Erk2 B
activation O
, O
and O
wortmannin O
had O
no O
effect O
on O
the O
activity O
of O
Erk2 B
when O
added O
directly O
to O
the O
in O
vitro O
assays O
. O

An O
inactive O
analog O
of O
wortmannin O
, O
WM12 O
, O
did O
not O
affect O
TCR B
/ O
CD3 B
- O
induced O
Erk2 B
activation O
, O
and O
wortmannin O
had O
no O
effect O
on O
the O
activity O
of O
Erk2 B
when O
added O
directly O
to O
the O
in O
vitro O
assays O
. O

Western O
blotting O
( O
immunoblotting O
) O
with O
an O
antiserum O
to O
a O
partial O
SOD B
expressed O
in O
Escherichia O
coli O
revealed O
two O
proteins O
with O
estimated O
molecular O
masses O
of O
19 O
and O
29 O
kDa O
. O

Plasmids O
were O
constructed O
with O
the O
mouse O
promoter O
region O
linked O
to O
the O
reporter B
gene I
chloramphenicol I
acetyltransferase I
( O
CAT B
) O
, O
and O
transiently O
and O
stably O
transfected O
in O
the O
INS O
- O
1 O
cells O
. O

TRAF2 B
is O
known O
to O
associate O
with O
TRADD B
, O
and O
expression O
of O
a O
dominant O
- O
negative O
N O
- O
terminal O
deletion O
TRAF2 B
mutant I
was O
found O
to O
partially O
inhibit O
LMP1 B
- O
induced O
JNK B
activation O
in O
293 O
cells O
. O

TRAF2 B
is O
known O
to O
associate O
with O
TRADD B
, O
and O
expression O
of O
a O
dominant O
- O
negative O
N O
- O
terminal O
deletion O
TRAF2 B
mutant I
was O
found O
to O
partially O
inhibit O
LMP1 B
- O
induced O
JNK B
activation O
in O
293 O
cells O
. O

TRAF2 B
is O
known O
to O
associate O
with O
TRADD B
, O
and O
expression O
of O
a O
dominant O
- O
negative O
N O
- O
terminal O
deletion O
TRAF2 B
mutant I
was O
found O
to O
partially O
inhibit O
LMP1 B
- O
induced O
JNK B
activation O
in O
293 O
cells O
. O

TRAF2 B
is O
known O
to O
associate O
with O
TRADD B
, O
and O
expression O
of O
a O
dominant O
- O
negative O
N O
- O
terminal O
deletion O
TRAF2 B
mutant I
was O
found O
to O
partially O
inhibit O
LMP1 B
- O
induced O
JNK B
activation O
in O
293 O
cells O
. O

A O
contiguous O
and O
sequentially O
occupied O
secondary O
Fur B
- I
binding I
site I
in O
entC B
was O
protected O
at O
higher O
Fur B
concentrations O
, O
extending O
the O
protected O
region O
to O
+ O
49 O
, O
and O
sequestering O
the O
putative O
Shine O
- O
Dalgarno O
sequence O
. O

A O
contiguous O
and O
sequentially O
occupied O
secondary O
Fur B
- I
binding I
site I
in O
entC B
was O
protected O
at O
higher O
Fur B
concentrations O
, O
extending O
the O
protected O
region O
to O
+ O
49 O
, O
and O
sequestering O
the O
putative O
Shine O
- O
Dalgarno O
sequence O
. O

The O
evidence O
in O
support O
of O
this O
was O
derived O
from O
the O
fact O
that O
the O
affinity O
or O
interaction O
between O
the O
two O
subunits O
was O
impaired O
as O
indicated O
by O
the O
first O
order O
rate O
constant O
of O
hCG B
alpha I
1 I
beta I
( O
km O
= O
4 O
. O
1 O
x O
10 O
( O
- O
2 O
) O
min O
- O
1 O
) O
at O
pH O
3 O
. O
0 O
at O
23 O
degrees O
C O
which O
is O
one O
order O
of O
magnitude O
greater O
relative O
to O
rehCG B
( O
kw O
= O
4 O
. O
6 O
x O
10 O
( O
- O
3 O
) O
min O
- O
1 O
) O
. O

Epstein B
- I
Barr I
virus I
- I
encoded I
latent I
membrane I
protein I
1 I
activates O
the O
JNK B
pathway O
through O
its O
extreme O
C O
terminus O
via O
a O
mechanism O
involving O
TRADD B
and O
TRAF2 B
. O

Epstein B
- I
Barr I
virus I
- I
encoded I
latent I
membrane I
protein I
1 I
activates O
the O
JNK B
pathway O
through O
its O
extreme O
C O
terminus O
via O
a O
mechanism O
involving O
TRADD B
and O
TRAF2 B
. O

Epstein B
- I
Barr I
virus I
- I
encoded I
latent I
membrane I
protein I
1 I
activates O
the O
JNK B
pathway O
through O
its O
extreme O
C O
terminus O
via O
a O
mechanism O
involving O
TRADD B
and O
TRAF2 B
. O

The O
git1 B
, O
git3 B
, O
git5 B
, O
git7 B
, O
git8 B
and O
git10 B
genes I
act O
upstream O
of O
adenylate B
cyclase I
, O
presumably O
encoding O
an O
adenylate B
cyclase I
activation O
pathway O
. O

The O
git1 B
, O
git3 B
, O
git5 B
, O
git7 B
, O
git8 B
and O
git10 B
genes I
act O
upstream O
of O
adenylate B
cyclase I
, O
presumably O
encoding O
an O
adenylate B
cyclase I
activation O
pathway O
. O

The O
git1 B
, O
git3 B
, O
git5 B
, O
git7 B
, O
git8 B
and O
git10 B
genes I
act O
upstream O
of O
adenylate B
cyclase I
, O
presumably O
encoding O
an O
adenylate B
cyclase I
activation O
pathway O
. O

The O
git1 B
, O
git3 B
, O
git5 B
, O
git7 B
, O
git8 B
and O
git10 B
genes I
act O
upstream O
of O
adenylate B
cyclase I
, O
presumably O
encoding O
an O
adenylate B
cyclase I
activation O
pathway O
. O

The O
git1 B
, O
git3 B
, O
git5 B
, O
git7 B
, O
git8 B
and O
git10 B
genes I
act O
upstream O
of O
adenylate B
cyclase I
, O
presumably O
encoding O
an O
adenylate B
cyclase I
activation O
pathway O
. O

In O
a O
heterologous O
transcriptional O
system O
in O
which O
the O
upstream O
regions O
of O
oIFNtau B
were O
inserted O
in O
front O
of O
simian B
virus I
40 I
( I
SV40 I
) I
promoter I
, O
the O
regions O
between O
bases O
- O
654 O
and O
- O
555 O
were O
determined O
as O
being O
the O
enhancer O
region O
required O
for O
oIFNtau B
- O
SV40 O
- O
CAT B
transactivation O
. O

In O
a O
heterologous O
transcriptional O
system O
in O
which O
the O
upstream O
regions O
of O
oIFNtau B
were O
inserted O
in O
front O
of O
simian B
virus I
40 I
( I
SV40 I
) I
promoter I
, O
the O
regions O
between O
bases O
- O
654 O
and O
- O
555 O
were O
determined O
as O
being O
the O
enhancer O
region O
required O
for O
oIFNtau B
- O
SV40 O
- O
CAT B
transactivation O
. O

In O
a O
heterologous O
transcriptional O
system O
in O
which O
the O
upstream O
regions O
of O
oIFNtau B
were O
inserted O
in O
front O
of O
simian B
virus I
40 I
( I
SV40 I
) I
promoter I
, O
the O
regions O
between O
bases O
- O
654 O
and O
- O
555 O
were O
determined O
as O
being O
the O
enhancer O
region O
required O
for O
oIFNtau B
- O
SV40 O
- O
CAT B
transactivation O
. O

In O
an O
attempt O
to O
understand O
Wee1 B
regulation O
during O
cell O
cycle O
, O
yeast O
two O
- O
hybrid O
screening O
was O
used O
to O
identify O
Wee1 B
- I
binding I
protein I
( I
s I
) I
. O

Mutations O
in O
the O
nuclear B
gene I
CBP1 I
of I
Saccharomyces I
cerevisiae I
result O
in O
degradation O
of O
mitochondrially B
encoded I
cytochrome I
b I
( O
cob B
) O
RNA O
; O
thus O
, O
the O
cells O
are O
unable O
to O
respire O
. O

Plasma B
secretin I
, O
pancreozymin B
, O
and O
somatostatin B
- I
like I
hormone I
in O
chronic O
renal O
failure O
patients O
. O

Minor O
differences O
were O
noted O
with O
latamoxef O
producing O
mild O
persistant O
elevation O
of O
prothrombin B
time O
( O
0 O
. O
7 O
second O
) O
associated O
with O
depression O
of O
factor B
II I
and O
factor B
VII I
. O

Consistent O
with O
these O
findings O
, O
relatively O
weak O
transcriptional O
silencing O
by O
the O
native O
VDR B
was O
observed O
using O
the O
osteopontin B
VDRE O
. O

Consistent O
with O
these O
findings O
, O
relatively O
weak O
transcriptional O
silencing O
by O
the O
native O
VDR B
was O
observed O
using O
the O
osteopontin B
VDRE O
. O

The O
U17 B
/ O
U16 B
and O
the O
U16 B
+ I
gene I
products I
transactivated O
the O
HIV B
LTR I
. O

The O
U17 B
/ O
U16 B
and O
the O
U16 B
+ I
gene I
products I
transactivated O
the O
HIV B
LTR I
. O

Implication O
of O
PAF B
and O
acetylhydrolase B
( O
PAF B
- I
AH I
) O
activity O
in O
periodontal O
disease O
. O

Implication O
of O
PAF B
and O
acetylhydrolase B
( O
PAF B
- I
AH I
) O
activity O
in O
periodontal O
disease O
. O

We O
describe O
a O
novel O
cytoplasmic B
tyrosine I
kinase I
, O
termed O
BPK B
( O
B B
cell I
progenitor I
kinase I
) O
, O
which O
is O
expressed O
in O
all O
stages O
of O
the O
B O
lineage O
and O
in O
myeloid O
cells O
. O

RNase B
protection O
analysis O
of O
two O
rRNA O
fragments O
whose O
genes O
are O
adjacent O
provided O
evidence O
for O
a O
polycistronic O
transcript O
containing O
sequences O
from O
both O
, O
as O
well O
as O
separate O
small O
RNAs O
. O

PATIENTS O
AND O
METHODS O
: O
We O
report O
our O
experience O
with O
seven O
children O
with O
active O
small O
bowel O
Crohn O
' O
s O
disease O
given O
a O
casein B
- O
based O
, O
polymeric O
feed O
rich O
in O
TGF B
- I
beta I
2 I
( O
Specific O
Polymeric O
Diet O
; O
Nestle O
- O
Clintec O
; O
Vevey O
, O
Switzerland O
) O
as O
complete O
nutrition O
for O
8 O
weeks O
. O

Consistent O
effects O
on O
pVHL B
function O
were O
observed O
for O
all O
mutations O
within O
each O
subclass O
. O

Pokeweed B
mitogen I
( O
PWM B
) O
or O
anti B
- I
CD3 I
significantly O
increases O
c B
- I
jun I
messenger I
RNA I
( I
mRNA I
) I
levels O
in O
T O
cells O
. O

Apart O
from O
two O
proline O
- O
rich O
regions O
( O
amino O
acids O
1 O
- O
117 O
and O
239 O
- O
270 O
) O
, O
p230 B
contains O
a O
very O
high O
frequency O
of O
heptad O
repeats O
, O
characteristic O
of O
alpha O
- O
helices O
that O
form O
dimeric O
coiled O
- O
coil O
structures O
. O

p230 B
also O
includes O
the O
sequence O
ESLALEELEL O
( O
amino O
acids O
538 O
- O
546 O
) O
, O
a O
motif O
found O
in O
the O
granin B
family I
of O
acidic O
proteins O
present O
in O
secretory O
granules O
of O
neuroendocrine O
cells O
. O

The O
cis O
- O
acting O
elements O
that O
control O
promoter O
activity O
include O
binding O
sites O
for O
transcription O
factors O
Sp1 B
and O
alphaCbf B
, O
a O
60 B
- I
kDa I
CCAAT I
box I
- I
binding I
protein I
. O

The O
cis O
- O
acting O
elements O
that O
control O
promoter O
activity O
include O
binding O
sites O
for O
transcription O
factors O
Sp1 B
and O
alphaCbf B
, O
a O
60 B
- I
kDa I
CCAAT I
box I
- I
binding I
protein I
. O

Human O
T O
- O
cell O
leukemia O
virus O
type O
I O
( O
HTLV O
- O
I O
) O
encodes O
a O
40 O
- O
kDa O
nuclear O
protein O
, O
Tax B
, O
which O
stimulates O
transcription O
from O
three O
21 O
- O
base O
pair O
( O
bp O
) O
repeats O
in O
its O
U3 O
region O
. O

Our O
results O
suggest O
that O
WASP B
activates O
transcription O
following O
TCR B
stimulation O
in O
a O
manner O
that O
is O
independent O
of O
its O
role O
in O
Arp2 B
/ I
3 I
- O
directed O
actin B
polymerization O
. O

Our O
results O
suggest O
that O
WASP B
activates O
transcription O
following O
TCR B
stimulation O
in O
a O
manner O
that O
is O
independent O
of O
its O
role O
in O
Arp2 B
/ I
3 I
- O
directed O
actin B
polymerization O
. O

Our O
results O
suggest O
that O
WASP B
activates O
transcription O
following O
TCR B
stimulation O
in O
a O
manner O
that O
is O
independent O
of O
its O
role O
in O
Arp2 B
/ I
3 I
- O
directed O
actin B
polymerization O
. O

Furthermore O
, O
stable O
expression O
of O
a O
constitutively O
active O
form O
of O
chicken O
Notch1 B
or O
Notch2 B
in O
a O
B O
cell O
line O
results O
in O
a O
down O
- O
regulation O
of O
surface O
IgM B
expression O
, O
which O
is O
accompanied O
by O
the O
reduction O
of O
IgH B
gene I
transcripts I
. O

Furthermore O
, O
stable O
expression O
of O
a O
constitutively O
active O
form O
of O
chicken O
Notch1 B
or O
Notch2 B
in O
a O
B O
cell O
line O
results O
in O
a O
down O
- O
regulation O
of O
surface O
IgM B
expression O
, O
which O
is O
accompanied O
by O
the O
reduction O
of O
IgH B
gene I
transcripts I
. O

Furthermore O
, O
stable O
expression O
of O
a O
constitutively O
active O
form O
of O
chicken O
Notch1 B
or O
Notch2 B
in O
a O
B O
cell O
line O
results O
in O
a O
down O
- O
regulation O
of O
surface O
IgM B
expression O
, O
which O
is O
accompanied O
by O
the O
reduction O
of O
IgH B
gene I
transcripts I
. O

Intracellular O
localization O
studies O
using O
the O
mDAP B
- I
3 I
/ O
EGFP B
fusion O
protein O
, O
cell O
fractionation O
and O
protease O
protection O
experiments O
localized O
mDAP B
- I
3 I
to O
the O
mitochondrial O
matrix O
. O

Unexpectedly O
, O
all O
ENK B
- I
specific I
motifs I
formed O
specific O
and O
highly O
abundant O
protein O
- O
DNA O
complexes O
when O
nuclear O
extracts O
from O
the O
human O
tumor O
cell O
line O
( O
HeLa O
) O
, O
which O
does O
not O
express O
ENK B
, O
were O
used O
. O

We O
have O
attempted O
to O
clone O
two O
recessive O
extragenic O
suppressors O
of O
such O
ts O
mutants O
( O
sdp1 B
for O
mutation B
pol3 I
- I
14 I
and O
sdp5 B
- I
1 I
for O
mutation B
pol3 I
- I
11 I
) O
by O
transforming O
thermoresistant O
haploid O
strains O
pol3 B
- I
14 I
sdp1 I
and O
pol3 B
- I
11 I
sdp5 I
- I
1 I
with O
wild O
- O
type O
genomic O
libraries O
in O
singlecopy O
or O
multicopy O
vectors O
. O

RESULTS O
: O
Using O
information O
in O
the O
dbEST O
database O
of O
expressed O
sequence O
tags O
, O
we O
isolated O
an O
Arabidopsis O
thaliana O
gene O
( O
GCR1 B
) O
that O
encodes O
a O
protein O
with O
seven O
predicted O
membrane O
- O
spanning O
domains O
and O
other O
features O
characteristic O
of O
7TM B
receptors I
. O

Consistent O
with O
ErbB B
- I
2 I
being O
a O
shared O
receptor O
subunit O
, O
its O
tyrosine O
phosphorylation O
was O
increased O
by O
both O
heterologous O
ligands O
and O
it O
mediated O
a O
trans O
- O
inhibitory O
effect O
of O
NDF B
on O
EGF B
binding O
. O

Consistent O
with O
ErbB B
- I
2 I
being O
a O
shared O
receptor O
subunit O
, O
its O
tyrosine O
phosphorylation O
was O
increased O
by O
both O
heterologous O
ligands O
and O
it O
mediated O
a O
trans O
- O
inhibitory O
effect O
of O
NDF B
on O
EGF B
binding O
. O

The O
p97 B
- O
depleted O
nuclei O
remained O
largely O
competent O
for O
nuclear O
protein O
import O
. O

We O
here O
demonstrate O
that O
a O
temperature O
- O
sensitive O
fission O
yeast O
mutant O
which O
has O
a O
mutation O
in O
a O
homologous O
gene O
, O
and O
two O
of O
three O
additional O
( O
mtr1 B
/ O
prp20 B
/ O
srm1 B
) O
mutants O
accumulate O
nuclear O
poly O
( O
A O
) O
+ O
RNA O
at O
37 O
degrees O
C O
. O

We O
here O
demonstrate O
that O
a O
temperature O
- O
sensitive O
fission O
yeast O
mutant O
which O
has O
a O
mutation O
in O
a O
homologous O
gene O
, O
and O
two O
of O
three O
additional O
( O
mtr1 B
/ O
prp20 B
/ O
srm1 B
) O
mutants O
accumulate O
nuclear O
poly O
( O
A O
) O
+ O
RNA O
at O
37 O
degrees O
C O
. O

We O
here O
demonstrate O
that O
a O
temperature O
- O
sensitive O
fission O
yeast O
mutant O
which O
has O
a O
mutation O
in O
a O
homologous O
gene O
, O
and O
two O
of O
three O
additional O
( O
mtr1 B
/ O
prp20 B
/ O
srm1 B
) O
mutants O
accumulate O
nuclear O
poly O
( O
A O
) O
+ O
RNA O
at O
37 O
degrees O
C O
. O

The O
Rlm1 B
protein I
, O
a O
member O
of O
the O
MADS B
box I
family I
of O
transcription O
factors O
, O
functions O
downstream O
of O
Mpk1 B
in O
the O
pathway O
. O

RESULTS O
: O
Surprisingly O
, O
PAF B
blockade O
increased O
mortality O
after O
trauma O
( O
5 O
of O
11 O
WEB O
- O
2086 O
animals O
versus O
1 O
of O
9 O
vehicle O
animals O
; O
p O
= O
0 O
. O
15 O
) O
and O
depressed O
cardiac O
index O
and O
O2 O
delivery O
at O
72 O
hours O
( O
p O
< O
0 O
. O
05 O
) O
. O

The O
N O
- O
terminal O
small O
segment O
of O
yeast B
TAF145 I
( O
yTAF145 B
) O
binds O
to O
TBP B
and O
thereby O
inhibits O
TBP B
function O
. O

The O
N O
- O
terminal O
small O
segment O
of O
yeast B
TAF145 I
( O
yTAF145 B
) O
binds O
to O
TBP B
and O
thereby O
inhibits O
TBP B
function O
. O

The O
N O
- O
terminal O
small O
segment O
of O
yeast B
TAF145 I
( O
yTAF145 B
) O
binds O
to O
TBP B
and O
thereby O
inhibits O
TBP B
function O
. O

Southern O
analysis O
on O
genomic O
DNA O
isolated O
from O
tissues O
and O
cell O
lines O
from O
several O
mouse O
strains O
using O
mCD22 B
cDNA I
demonstrated O
that O
the O
Cd22 B
locus I
encoding O
mCD22 B
is O
a O
single O
copy O
gene O
of O
< O
or O
= O
30 O
kb O
. O

TNF B
Treatment O
of O
cell O
activated O
the O
p38 B
MAP I
kinase I
pathway O
, O
as O
revealed O
by O
increased O
phosphorylation O
of O
p38 B
MAP I
kinase I
itself O
, O
activation O
of O
the O
substrate O
protein O
MAPKAP B
kinase I
- I
2 I
, O
and O
culminating O
in O
the O
phosphorylation O
of O
the O
heat B
shock I
protein I
27 I
( O
hsp27 B
) O
. O

TNF B
Treatment O
of O
cell O
activated O
the O
p38 B
MAP I
kinase I
pathway O
, O
as O
revealed O
by O
increased O
phosphorylation O
of O
p38 B
MAP I
kinase I
itself O
, O
activation O
of O
the O
substrate O
protein O
MAPKAP B
kinase I
- I
2 I
, O
and O
culminating O
in O
the O
phosphorylation O
of O
the O
heat B
shock I
protein I
27 I
( O
hsp27 B
) O
. O

The O
deduced O
amino O
acid O
sequence O
of O
the O
gene O
has O
significant O
homology O
to O
the O
interferon B
regulatory I
factors I
( O
IRFs B
) O
. O

NF B
- I
kappa I
B I
/ O
Rel B
transcription O
factors O
participate O
in O
the O
activation O
of O
numerous O
genes O
involved O
in O
immune O
regulation O
/ O
inflammation O
including O
cytokines O
, O
cell O
surface O
receptors O
, O
adhesion O
molecules O
, O
and O
acute O
phase O
proteins O
. O

Manganese O
ions O
were O
found O
to O
be O
essential O
for O
autophosphorylation O
of O
BGLF4 B
, O
and O
magnesium O
can O
stimulate O
the O
activity O
. O

Tyrosine O
phosphorylation O
of O
cellular O
proteins O
is O
the O
earliest O
identifiable O
event O
following O
T B
- I
cell I
antigen I
receptor I
( O
TCR B
) O
stimulation O
and O
is O
essential O
for O
activating O
downstream O
signaling O
machinery O
. O

The O
interaction O
between O
DDB B
and O
E2F1 B
can O
also O
be O
detected O
by O
coimmunoprecipitation O
experiments O
. O

The O
interaction O
between O
DDB B
and O
E2F1 B
can O
also O
be O
detected O
by O
coimmunoprecipitation O
experiments O
. O

Multiple O
SWI6 B
- O
dependent O
cis O
- O
acting O
elements O
control O
SWI4 B
transcription O
through O
the O
cell O
cycle O
. O

Multiple O
SWI6 B
- O
dependent O
cis O
- O
acting O
elements O
control O
SWI4 B
transcription O
through O
the O
cell O
cycle O
. O

To O
determine O
whether O
vanadate O
could O
inhibit O
PEPCK B
gene I
transcription O
, O
a O
series O
of O
chimeric O
genes O
containing O
several O
deletions O
in O
the O
P B
- I
enolypyruvate I
carboxykinase I
promoter I
between O
- O
550 O
and O
- O
68 O
was O
linked O
to O
the O
structural O
genes O
for O
either O
amino B
- I
3 I
- I
glycosyl I
phosphotransferase I
( O
neo B
) O
or O
chloramphenicol B
acetyltransferase I
and O
introduced O
into O
hepatoma O
cells O
using O
three O
methods O
: O
( O
a O
) O
infection O
with O
a O
Moloney O
murine O
leukemia O
virus O
- O
based O
retrovirus O
, O
( O
b O

) O
transfection O
and O
stable O
selection O
for O
neo B
expression O
, O
or O
( O
c O
) O
transient O
expression O
of O
chloroamphenicol B
acetyltransferase I
. O

The O
expression O
of O
alpha B
- I
amylase I
can O
be O
transactivated O
by O
the O
transcription O
factor O
GAMyb B
, O
which O
is O
itself O
induced O
by O
GA O
. O

Furthermore O
, O
transfection O
of O
cells O
with O
the O
spacer O
- O
RING O
domain O
alone O
suppressed O
the O
antiapoptotic O
function O
of O
the O
N O
- O
terminal O
BIR B
domain O
of O
c B
- I
IAP1 I
and O
induced O
apoptosis O
. O

Comparable O
amounts O
of O
alpha B
5 I
beta I
1 I
integrin I
were O
isolated O
from O
these O
cells O
by O
chromatography O
of O
detergent O
extracts O
on O
a O
fibronectin B
cell O
- O
binding O
fragment O
affinity O
column O
and O
elution O
with O
EDTA O
. O

These O
data O
show O
that O
the O
alpha O
- O
helix O
domain O
of O
p57 B
( O
Kip2 B
) O
, O
which O
is O
conserved O
in O
the O
Cip B
/ O
Kip B
proteins O
, O
is O
implicated O
in O
protein O
- O
protein O
interaction O
and O
confers O
a O
specific O
regulatory O
mechanism O
, O
outside O
of O
their O
Cdk B
- O
inhibitory O
activity O
, O
by O
which O
the O
p57 B
( O
Kip2 B
) O
family O
members O
positively O
act O
on O
myogenic O
differentiation O
. O

These O
data O
show O
that O
the O
alpha O
- O
helix O
domain O
of O
p57 B
( O
Kip2 B
) O
, O
which O
is O
conserved O
in O
the O
Cip B
/ O
Kip B
proteins O
, O
is O
implicated O
in O
protein O
- O
protein O
interaction O
and O
confers O
a O
specific O
regulatory O
mechanism O
, O
outside O
of O
their O
Cdk B
- O
inhibitory O
activity O
, O
by O
which O
the O
p57 B
( O
Kip2 B
) O
family O
members O
positively O
act O
on O
myogenic O
differentiation O
. O

These O
data O
show O
that O
the O
alpha O
- O
helix O
domain O
of O
p57 B
( O
Kip2 B
) O
, O
which O
is O
conserved O
in O
the O
Cip B
/ O
Kip B
proteins O
, O
is O
implicated O
in O
protein O
- O
protein O
interaction O
and O
confers O
a O
specific O
regulatory O
mechanism O
, O
outside O
of O
their O
Cdk B
- O
inhibitory O
activity O
, O
by O
which O
the O
p57 B
( O
Kip2 B
) O
family O
members O
positively O
act O
on O
myogenic O
differentiation O
. O

These O
data O
show O
that O
the O
alpha O
- O
helix O
domain O
of O
p57 B
( O
Kip2 B
) O
, O
which O
is O
conserved O
in O
the O
Cip B
/ O
Kip B
proteins O
, O
is O
implicated O
in O
protein O
- O
protein O
interaction O
and O
confers O
a O
specific O
regulatory O
mechanism O
, O
outside O
of O
their O
Cdk B
- O
inhibitory O
activity O
, O
by O
which O
the O
p57 B
( O
Kip2 B
) O
family O
members O
positively O
act O
on O
myogenic O
differentiation O
. O

These O
data O
show O
that O
the O
alpha O
- O
helix O
domain O
of O
p57 B
( O
Kip2 B
) O
, O
which O
is O
conserved O
in O
the O
Cip B
/ O
Kip B
proteins O
, O
is O
implicated O
in O
protein O
- O
protein O
interaction O
and O
confers O
a O
specific O
regulatory O
mechanism O
, O
outside O
of O
their O
Cdk B
- O
inhibitory O
activity O
, O
by O
which O
the O
p57 B
( O
Kip2 B
) O
family O
members O
positively O
act O
on O
myogenic O
differentiation O
. O

These O
data O
show O
that O
the O
alpha O
- O
helix O
domain O
of O
p57 B
( O
Kip2 B
) O
, O
which O
is O
conserved O
in O
the O
Cip B
/ O
Kip B
proteins O
, O
is O
implicated O
in O
protein O
- O
protein O
interaction O
and O
confers O
a O
specific O
regulatory O
mechanism O
, O
outside O
of O
their O
Cdk B
- O
inhibitory O
activity O
, O
by O
which O
the O
p57 B
( O
Kip2 B
) O
family O
members O
positively O
act O
on O
myogenic O
differentiation O
. O

These O
data O
show O
that O
the O
alpha O
- O
helix O
domain O
of O
p57 B
( O
Kip2 B
) O
, O
which O
is O
conserved O
in O
the O
Cip B
/ O
Kip B
proteins O
, O
is O
implicated O
in O
protein O
- O
protein O
interaction O
and O
confers O
a O
specific O
regulatory O
mechanism O
, O
outside O
of O
their O
Cdk B
- O
inhibitory O
activity O
, O
by O
which O
the O
p57 B
( O
Kip2 B
) O
family O
members O
positively O
act O
on O
myogenic O
differentiation O
. O

The O
pyrR B
and O
pyrP B
genes I
encoded O
polypeptides O
with O
calculated O
molecular O
masses O
of O
19 O
. O
9 O
and O
45 O
. O
2 O
kDa O
, O
respectively O
. O

Instead O
, O
they O
contained O
dendritic O
cells O
that O
express O
melanogenic O
marker O
proteins O
such O
as O
tyrosinase B
and O
tyrosinase B
- I
related I
protein I
1 I
. O

Higher O
fasting O
serum O
gastrin B
concentration O
( O
102 O
. O
0 O
+ O
/ O
- O
21 O
. O
1 O
vs O
63 O
. O
3 O
+ O
/ O
- O
8 O
. O
3 O
ng O
. O
l O
- O
1 O
) O
, O
and O
greater O
postprandial O
gastrin B
release O
( O
AUC0 O
- O
120 O
: O
16690 O
+ O
/ O
- O
2648 O
vs O
10654 O
+ O
/ O
- O
1283 O
ng O
. O
l O
- O
1 O
min O
) O
were O
observed O
after O
VTP O
- O
HM O
than O
after O
VTP O
- O
Cas O
. O

Higher O
fasting O
serum O
gastrin B
concentration O
( O
102 O
. O
0 O
+ O
/ O
- O
21 O
. O
1 O
vs O
63 O
. O
3 O
+ O
/ O
- O
8 O
. O
3 O
ng O
. O
l O
- O
1 O
) O
, O
and O
greater O
postprandial O
gastrin B
release O
( O
AUC0 O
- O
120 O
: O
16690 O
+ O
/ O
- O
2648 O
vs O
10654 O
+ O
/ O
- O
1283 O
ng O
. O
l O
- O
1 O
min O
) O
were O
observed O
after O
VTP O
- O
HM O
than O
after O
VTP O
- O
Cas O
. O

Mutations O
within O
conserved O
region O
2 O
( O
CR2 O
) O
of O
E1A B
that O
inhibit O
the O
binding O
of O
E1A B
to O
the O
retinoblastoma B
gene I
product I
( O
pRb B
) O
further O
enhanced O
the O
stimulation O
of O
transcription O
from O
the O
PEPCK B
promoter I
by O
2 O
3 O
- O
fold O
compared O
with O
wild B
type I
E1A I
. O

Mutations O
within O
conserved O
region O
2 O
( O
CR2 O
) O
of O
E1A B
that O
inhibit O
the O
binding O
of O
E1A B
to O
the O
retinoblastoma B
gene I
product I
( O
pRb B
) O
further O
enhanced O
the O
stimulation O
of O
transcription O
from O
the O
PEPCK B
promoter I
by O
2 O
3 O
- O
fold O
compared O
with O
wild B
type I
E1A I
. O

Mutations O
within O
conserved O
region O
2 O
( O
CR2 O
) O
of O
E1A B
that O
inhibit O
the O
binding O
of O
E1A B
to O
the O
retinoblastoma B
gene I
product I
( O
pRb B
) O
further O
enhanced O
the O
stimulation O
of O
transcription O
from O
the O
PEPCK B
promoter I
by O
2 O
3 O
- O
fold O
compared O
with O
wild B
type I
E1A I
. O

Mapping O
of O
intracellular O
localization O
domains O
and O
evidence O
for O
colocalization O
interactions O
between O
the O
IE110 B
and O
IE175 B
nuclear O
transactivator O
proteins O
of O
herpes O
simplex O
virus O
. O

Mapping O
of O
intracellular O
localization O
domains O
and O
evidence O
for O
colocalization O
interactions O
between O
the O
IE110 B
and O
IE175 B
nuclear O
transactivator O
proteins O
of O
herpes O
simplex O
virus O
. O

Vimentin B
positivity O
was O
noted O
in O
the O
undifferentiated O
and O
fibroblastic O
components O
. O

Both O
immunophilins B
may O
have O
important O
roles O
in O
receptor O
assembly O
and O
may O
represent O
a O
new O
category O
of O
ligand O
- O
and O
calcium O
- O
dependent O
modulators O
of O
protein O
function O
. O

Increased O
erythropoietin B
synthesis O
in O
patients O
with O
COLD O
or O
left O
heart O
failure O
is O
related O
to O
alterations O
in O
renal O
haemodynamics O
. O

These O
results O
suggest O
that O
Cdc42p B
is O
in O
fact O
required O
for O
pheromone O
response O
and O
that O
interaction O
with O
the O
PAK B
Ste20p B
is O
critical O
for O
that O
role O
. O

These O
results O
suggest O
that O
Cdc42p B
is O
in O
fact O
required O
for O
pheromone O
response O
and O
that O
interaction O
with O
the O
PAK B
Ste20p B
is O
critical O
for O
that O
role O
. O

These O
results O
suggest O
that O
Cdc42p B
is O
in O
fact O
required O
for O
pheromone O
response O
and O
that O
interaction O
with O
the O
PAK B
Ste20p B
is O
critical O
for O
that O
role O
. O

Specific O
IgE B
levels O
decreased O
slightly O
, O
but O
always O
remained O
within O
the O
pathological O
range O
. O

Transfection O
analyses O
indicated O
that O
the O
expression O
of O
Tbxas1 B
is O
controlled O
by O
a O
short O
( O
70 O
- O
bp O
) O
positive O
regulatory O
sequence O
and O
several O
upstream O
repressive O
elements O
. O

Effect O
of O
castration O
on O
pituitary B
and I
serum I
LH I
and O
FSH B
in O
testosterone O
- O
sterilized O
rats O
. O

Substantial O
evidence O
supports O
a O
critical O
role O
for O
the O
activation O
of O
the O
Raf B
- I
1 I
/ O
MEK B
/ O
mitogen B
- I
activated I
protein I
kinase I
pathway O
in O
oncogenic O
Ras B
- O
mediated O
transformation O
. O

Substantial O
evidence O
supports O
a O
critical O
role O
for O
the O
activation O
of O
the O
Raf B
- I
1 I
/ O
MEK B
/ O
mitogen B
- I
activated I
protein I
kinase I
pathway O
in O
oncogenic O
Ras B
- O
mediated O
transformation O
. O

Several O
mutations O
disrupted O
the O
endonuclease O
and O
helicase B
activities O
; O
however O
, O
only O
one O
amino B
- I
terminal I
- I
charge I
cluster I
mutant I
protein I
( O
D40A O
- O
D42A O
- O
D44A O
) O
completely O
lost O
AAV O
hairpin O
DNA O
binding O
activity O
. O

The O
84 B
. I
1C I
mAb I
recognizes O
a O
site O
on O
IgE B
which O
is O
identical O
or O
very O
close O
to O
the O
Fc B
epsilon I
R I
binding I
site I
, O
and O
95 O
. O
3 O
recognizes O
a O
site O
on O
IgE B
which O
is O
related O
, O
but O
not O
identical O
to O
the O
Fc B
epsilon I
R I
binding I
site I
. O

The O
84 B
. I
1C I
mAb I
recognizes O
a O
site O
on O
IgE B
which O
is O
identical O
or O
very O
close O
to O
the O
Fc B
epsilon I
R I
binding I
site I
, O
and O
95 O
. O
3 O
recognizes O
a O
site O
on O
IgE B
which O
is O
related O
, O
but O
not O
identical O
to O
the O
Fc B
epsilon I
R I
binding I
site I
. O

Abrogation O
of O
p53 B
function O
by O
E6 B
resulted O
in O
an O
increase O
in O
the O
spontaneous O
mutation O
frequencies O
at O
the O
heterozygous O
thymidine B
kinase I
( O
TK B
) O
locus O
but O
not O
at O
the O
hemizygous O
hypoxanthine B
phosphoribosyl I
transferase I
( O
HPRT B
) O
locus O
. O

Abrogation O
of O
p53 B
function O
by O
E6 B
resulted O
in O
an O
increase O
in O
the O
spontaneous O
mutation O
frequencies O
at O
the O
heterozygous O
thymidine B
kinase I
( O
TK B
) O
locus O
but O
not O
at O
the O
hemizygous O
hypoxanthine B
phosphoribosyl I
transferase I
( O
HPRT B
) O
locus O
. O

Abrogation O
of O
p53 B
function O
by O
E6 B
resulted O
in O
an O
increase O
in O
the O
spontaneous O
mutation O
frequencies O
at O
the O
heterozygous O
thymidine B
kinase I
( O
TK B
) O
locus O
but O
not O
at O
the O
hemizygous O
hypoxanthine B
phosphoribosyl I
transferase I
( O
HPRT B
) O
locus O
. O

Abrogation O
of O
p53 B
function O
by O
E6 B
resulted O
in O
an O
increase O
in O
the O
spontaneous O
mutation O
frequencies O
at O
the O
heterozygous O
thymidine B
kinase I
( O
TK B
) O
locus O
but O
not O
at O
the O
hemizygous O
hypoxanthine B
phosphoribosyl I
transferase I
( O
HPRT B
) O
locus O
. O

In O
contrast O
to O
the O
selective O
expression O
of O
the O
receptor O
, O
FL B
expression O
was O
detected O
in O
90 O
- O
100 O
% O
of O
the O
various O
cell O
types O
of O
leukemia O
cell O
lines O
from O
all O
hematopoietic O
cell O
lineages O
. O

A O
second O
important O
molecule O
in O
TCR B
signal O
transduction O
is O
the O
guanine B
nucleotide I
binding I
protein I
, O
p21ras B
, O
which O
is O
coupled O
to O
the O
TCR B
by O
a O
protein B
tyrosine I
kinase I
dependent O
mechanism O
. O

A O
second O
important O
molecule O
in O
TCR B
signal O
transduction O
is O
the O
guanine B
nucleotide I
binding I
protein I
, O
p21ras B
, O
which O
is O
coupled O
to O
the O
TCR B
by O
a O
protein B
tyrosine I
kinase I
dependent O
mechanism O
. O

A O
second O
important O
molecule O
in O
TCR B
signal O
transduction O
is O
the O
guanine B
nucleotide I
binding I
protein I
, O
p21ras B
, O
which O
is O
coupled O
to O
the O
TCR B
by O
a O
protein B
tyrosine I
kinase I
dependent O
mechanism O
. O

Statins B
: O
lower O
lipids O
and O
better O
bones O
? O

We O
propose O
a O
model O
in O
which O
Sro7 B
function O
is O
involved O
in O
the O
targeting O
of O
the O
myosin B
proteins I
to O
their O
intrinsic O
pathways O
. O

A O
large O
deletion O
in O
the O
CTD B
- I
binding I
motif I
blocks O
down O
- O
regulation O
but O
does O
not O
affect O
the O
essential O
function O
of O
Nrd1 B
. O

The O
MET4 B
gene O
was O
cloned O
, O
and O
its O
sequence O
reveals O
that O
it O
encodes O
a O
protein O
related O
to O
the O
family O
of O
the O
bZIP B
transcriptional I
activators I
. O

Immunofluorescence O
studies O
in O
C2C12 O
myotubes O
show O
that O
Smad2 B
and O
MEF2A B
co O
- O
localise O
in O
the O
nucleus O
of O
multinuclear O
myotubes O
during O
differentiation O
. O

Immunofluorescence O
studies O
in O
C2C12 O
myotubes O
show O
that O
Smad2 B
and O
MEF2A B
co O
- O
localise O
in O
the O
nucleus O
of O
multinuclear O
myotubes O
during O
differentiation O
. O

Tumor B
necrosis I
factor I
signaling O
to O
stress B
- I
activated I
protein I
kinase I
( O
SAPK B
) O
/ O
Jun B
NH2 I
- I
terminal I
kinase I
( O
JNK B
) O
and O
p38 B
. O

Tumor B
necrosis I
factor I
signaling O
to O
stress B
- I
activated I
protein I
kinase I
( O
SAPK B
) O
/ O
Jun B
NH2 I
- I
terminal I
kinase I
( O
JNK B
) O
and O
p38 B
. O

Tumor B
necrosis I
factor I
signaling O
to O
stress B
- I
activated I
protein I
kinase I
( O
SAPK B
) O
/ O
Jun B
NH2 I
- I
terminal I
kinase I
( O
JNK B
) O
and O
p38 B
. O

Gel O
filtration O
and O
co O
- O
immunoprecipitation O
analyses O
reveal O
that O
Mad2p B
tightly O
associates O
with O
another O
spindle O
checkpoint O
component O
, O
Mad1p B
. O

Gel O
filtration O
and O
co O
- O
immunoprecipitation O
analyses O
reveal O
that O
Mad2p B
tightly O
associates O
with O
another O
spindle O
checkpoint O
component O
, O
Mad1p B
. O

This O
region O
of O
hsp90 B
mediates O
ATP O
- O
independent O
chaperone O
activity O
, O
overlaps O
the O
hsp90 B
dimerization I
domain I
, O
and O
includes O
structural O
elements O
important O
for O
steroid B
receptor I
interaction O
. O

A O
particularly O
striking O
HpaII B
tiny O
fragment O
island O
, O
extending O
over O
nearly O
2 O
, O
000 O
base O
pairs O
, O
surrounds O
the O
USF2 B
translation I
initiation I
site I
. O

Comparisons O
with O
other O
known O
germins B
and O
germin B
- I
like I
proteins I
indicate O
that O
these O
Arabidopsis O
GLP B
subfamilies O
are O
unique O
from O
wheat O
germin B
. O

Comparisons O
with O
other O
known O
germins B
and O
germin B
- I
like I
proteins I
indicate O
that O
these O
Arabidopsis O
GLP B
subfamilies O
are O
unique O
from O
wheat O
germin B
. O

Comparisons O
with O
other O
known O
germins B
and O
germin B
- I
like I
proteins I
indicate O
that O
these O
Arabidopsis O
GLP B
subfamilies O
are O
unique O
from O
wheat O
germin B
. O

Sequence O
comparisons O
strongly O
suggest O
that O
the O
S27a B
and O
the O
ubiquitin B
coding O
sequences O
found O
in O
the O
genome O
of O
CP O
Rit O
were O
both O
derived O
from O
a O
bovine O
mRNA O
encoding O
a O
hybrid O
protein O
with O
the O
structure O
NH2 O
- O
ubiquitin B
- O
S27a B
- O
COOH O
. O

Sequence O
comparisons O
strongly O
suggest O
that O
the O
S27a B
and O
the O
ubiquitin B
coding O
sequences O
found O
in O
the O
genome O
of O
CP O
Rit O
were O
both O
derived O
from O
a O
bovine O
mRNA O
encoding O
a O
hybrid O
protein O
with O
the O
structure O
NH2 O
- O
ubiquitin B
- O
S27a B
- O
COOH O
. O

Sequence O
comparisons O
strongly O
suggest O
that O
the O
S27a B
and O
the O
ubiquitin B
coding O
sequences O
found O
in O
the O
genome O
of O
CP O
Rit O
were O
both O
derived O
from O
a O
bovine O
mRNA O
encoding O
a O
hybrid O
protein O
with O
the O
structure O
NH2 O
- O
ubiquitin B
- O
S27a B
- O
COOH O
. O

Sequence O
comparisons O
strongly O
suggest O
that O
the O
S27a B
and O
the O
ubiquitin B
coding O
sequences O
found O
in O
the O
genome O
of O
CP O
Rit O
were O
both O
derived O
from O
a O
bovine O
mRNA O
encoding O
a O
hybrid O
protein O
with O
the O
structure O
NH2 O
- O
ubiquitin B
- O
S27a B
- O
COOH O
. O

Oncogenic O
signalling O
by O
E2F1 B
has O
recently O
been O
linked O
to O
stabilization O
and O
activation O
of O
the O
tumour O
suppressor O
p53 B
( O
refs O
1 O
, O
3 O
, O
4 O
) O
. O

Oncogenic O
signalling O
by O
E2F1 B
has O
recently O
been O
linked O
to O
stabilization O
and O
activation O
of O
the O
tumour O
suppressor O
p53 B
( O
refs O
1 O
, O
3 O
, O
4 O
) O
. O

TBP B
can O
be O
phosphorylated O
in O
vitro O
by O
extracts O
of O
U937 O
cells O
or O
by O
bacterially O
expressed O
activated O
ERK2 B
; O
the O
phosphorylation O
sites O
were O
mapped O
to O
ERK B
kinase I
consensus I
sites I
in O
the O
TBP B
amino I
- I
terminal I
domain I
. O

TBP B
can O
be O
phosphorylated O
in O
vitro O
by O
extracts O
of O
U937 O
cells O
or O
by O
bacterially O
expressed O
activated O
ERK2 B
; O
the O
phosphorylation O
sites O
were O
mapped O
to O
ERK B
kinase I
consensus I
sites I
in O
the O
TBP B
amino I
- I
terminal I
domain I
. O

Although O
RAD17 B
, O
RAD24 B
and O
MEC3 B
are O
not O
required O
for O
cell O
cycle O
arrest O
when O
S O
phase O
is O
inhibited O
by O
hydroxyurea O
( O
HU O
) O
, O
they O
do O
contribute O
to O
the O
viability O
of O
yeast O
cells O
grown O
in O
the O
presence O
of O
HU O
, O
possibly O
because O
they O
are O
required O
for O
the O
repair O
of O
HU O
- O
induced O
DNA O
damage O
. O

Although O
RAD17 B
, O
RAD24 B
and O
MEC3 B
are O
not O
required O
for O
cell O
cycle O
arrest O
when O
S O
phase O
is O
inhibited O
by O
hydroxyurea O
( O
HU O
) O
, O
they O
do O
contribute O
to O
the O
viability O
of O
yeast O
cells O
grown O
in O
the O
presence O
of O
HU O
, O
possibly O
because O
they O
are O
required O
for O
the O
repair O
of O
HU O
- O
induced O
DNA O
damage O
. O

Although O
RAD17 B
, O
RAD24 B
and O
MEC3 B
are O
not O
required O
for O
cell O
cycle O
arrest O
when O
S O
phase O
is O
inhibited O
by O
hydroxyurea O
( O
HU O
) O
, O
they O
do O
contribute O
to O
the O
viability O
of O
yeast O
cells O
grown O
in O
the O
presence O
of O
HU O
, O
possibly O
because O
they O
are O
required O
for O
the O
repair O
of O
HU O
- O
induced O
DNA O
damage O
. O

We O
have O
found O
that O
the O
expression O
of O
GTPase B
- O
deficient O
mutants O
of O
alpha B
12 I
( O
alpha B
12Q229L I
) O
or O
alpha B
13 I
( O
alpha B
13Q226L I
) O
leads O
to O
robust O
activation O
of O
the O
Jun B
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
. O

We O
have O
found O
that O
the O
expression O
of O
GTPase B
- O
deficient O
mutants O
of O
alpha B
12 I
( O
alpha B
12Q229L I
) O
or O
alpha B
13 I
( O
alpha B
13Q226L I
) O
leads O
to O
robust O
activation O
of O
the O
Jun B
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
. O

We O
have O
found O
that O
the O
expression O
of O
GTPase B
- O
deficient O
mutants O
of O
alpha B
12 I
( O
alpha B
12Q229L I
) O
or O
alpha B
13 I
( O
alpha B
13Q226L I
) O
leads O
to O
robust O
activation O
of O
the O
Jun B
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
. O

In O
support O
of O
this O
interpretation O
we O
demonstrate O
that O
MQ9b B
binds O
strongly O
5 O
of O
17 O
motif O
- O
positive O
, O
pathogen O
- O
derived O
synthetic O
peptides O
. O

In O
electrophoretic O
mobility O
shift O
assays O
, O
the O
PERE B
formed O
three O
major O
complexes O
( O
P1 O
, O
P2 O
and O
P3 O
) O
with O
proteins O
in O
nuclear O
extracts O
from O
HeLa O
or O
293 O
cells O
. O

The O
present O
data O
also O
indicate O
that O
patients O
with O
TGBM O
nephropathy O
often O
have O
concomitant O
IgA B
nephropathy O
and O
mesangial O
proliferative O
glomerulonephritis O
. O

We O
previously O
showed O
that O
this O
proteolysis O
1 O
) O
can O
be O
acutely O
promoted O
by O
the O
phorbol O
ester O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
, O
2 O
) O
requires O
a O
metalloprotease B
activity O
, O
3 O
) O
generates O
both O
shed O
GHBP B
and O
a O
membrane B
- I
associated I
GHR I
transmembrane I
/ I
cytoplasmic I
domain I
remnant O
, O
and O
4 O
) O
results O
in O
down O
- O
regulation O
of O
GHR B
abundance O
and O
GH B
signaling O
. O

We O
previously O
showed O
that O
this O
proteolysis O
1 O
) O
can O
be O
acutely O
promoted O
by O
the O
phorbol O
ester O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
, O
2 O
) O
requires O
a O
metalloprotease B
activity O
, O
3 O
) O
generates O
both O
shed O
GHBP B
and O
a O
membrane B
- I
associated I
GHR I
transmembrane I
/ I
cytoplasmic I
domain I
remnant O
, O
and O
4 O
) O
results O
in O
down O
- O
regulation O
of O
GHR B
abundance O
and O
GH B
signaling O
. O

We O
previously O
showed O
that O
this O
proteolysis O
1 O
) O
can O
be O
acutely O
promoted O
by O
the O
phorbol O
ester O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
, O
2 O
) O
requires O
a O
metalloprotease B
activity O
, O
3 O
) O
generates O
both O
shed O
GHBP B
and O
a O
membrane B
- I
associated I
GHR I
transmembrane I
/ I
cytoplasmic I
domain I
remnant O
, O
and O
4 O
) O
results O
in O
down O
- O
regulation O
of O
GHR B
abundance O
and O
GH B
signaling O
. O

We O
previously O
showed O
that O
this O
proteolysis O
1 O
) O
can O
be O
acutely O
promoted O
by O
the O
phorbol O
ester O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
, O
2 O
) O
requires O
a O
metalloprotease B
activity O
, O
3 O
) O
generates O
both O
shed O
GHBP B
and O
a O
membrane B
- I
associated I
GHR I
transmembrane I
/ I
cytoplasmic I
domain I
remnant O
, O
and O
4 O
) O
results O
in O
down O
- O
regulation O
of O
GHR B
abundance O
and O
GH B
signaling O
. O

However O
, O
by O
an O
NS35 B
- I
specific I
RNA I
capture O
assay O
, O
the O
multimers O
were O
shown O
to O
possess O
the O
RNA O
- O
binding O
activity O
previously O
demonstrated O
for O
NS35 B
. O

Sp1 B
and O
two O
Sp3 B
isoforms I
were O
detected O
as O
the O
primary O
cellular O
constituents O
of O
DNA O
- O
protein O
complexes O
formed O
with O
the O
NF B
- I
kappaB I
- I
proximal I
site I
. O

The O
first O
open O
reading O
frame O
of O
the O
blueberry O
scorch O
carlavirus O
( O
BBScV O
) O
genome O
encodes O
a O
putative O
replication O
- O
associated O
protein O
of O
223 O
kDa O
( O
p223 B
) O
. O

IgG B
and O
IgM B
antibody O
activity O
was O
determined O
by O
adding O
a O
1 O
: O
100 O
dilution O
of O
serum O
to O
plates O
coated O
with O
A60 B
antigen I
. O

IgG B
and O
IgM B
antibody O
activity O
was O
determined O
by O
adding O
a O
1 O
: O
100 O
dilution O
of O
serum O
to O
plates O
coated O
with O
A60 B
antigen I
. O

We O
demonstrate O
here O
that O
the O
- O
DEDDDL O
sequence O
stabilizes O
GDP O
binding O
to O
Ran B
, O
and O
that O
the O
domain O
is O
required O
for O
high O
affinity O
interaction O
with O
a O
Ran B
- I
binding I
protein I
, O
HTF9A B
/ O
RanBP1 B
. O

We O
demonstrate O
here O
that O
the O
- O
DEDDDL O
sequence O
stabilizes O
GDP O
binding O
to O
Ran B
, O
and O
that O
the O
domain O
is O
required O
for O
high O
affinity O
interaction O
with O
a O
Ran B
- I
binding I
protein I
, O
HTF9A B
/ O
RanBP1 B
. O

We O
demonstrate O
here O
that O
the O
- O
DEDDDL O
sequence O
stabilizes O
GDP O
binding O
to O
Ran B
, O
and O
that O
the O
domain O
is O
required O
for O
high O
affinity O
interaction O
with O
a O
Ran B
- I
binding I
protein I
, O
HTF9A B
/ O
RanBP1 B
. O

The O
major O
transcription O
factors O
controlling O
arginine O
metabolism O
in O
Escherichia O
coli O
and O
Bacillus O
subtilis O
, O
ArgR B
and O
AhrC B
, O
respectively O
, O
are O
homologous O
multimeric O
proteins O
that O
form O
l O
- O
arginine O
- O
dependent O
DNA O
- O
binding O
complexes O
capable O
of O
repressing O
transcription O
of O
the O
biosynthetic O
genes O
( O
both O
) O
, O
activating O
transcription O
of O
catabolic O
genes O
( O
AhrC B
only O
) O
or O
facilitating O
plasmid O
dimer O
resolution O
( O
both O
) O
. O

The O
major O
transcription O
factors O
controlling O
arginine O
metabolism O
in O
Escherichia O
coli O
and O
Bacillus O
subtilis O
, O
ArgR B
and O
AhrC B
, O
respectively O
, O
are O
homologous O
multimeric O
proteins O
that O
form O
l O
- O
arginine O
- O
dependent O
DNA O
- O
binding O
complexes O
capable O
of O
repressing O
transcription O
of O
the O
biosynthetic O
genes O
( O
both O
) O
, O
activating O
transcription O
of O
catabolic O
genes O
( O
AhrC B
only O
) O
or O
facilitating O
plasmid O
dimer O
resolution O
( O
both O
) O
. O

The O
major O
transcription O
factors O
controlling O
arginine O
metabolism O
in O
Escherichia O
coli O
and O
Bacillus O
subtilis O
, O
ArgR B
and O
AhrC B
, O
respectively O
, O
are O
homologous O
multimeric O
proteins O
that O
form O
l O
- O
arginine O
- O
dependent O
DNA O
- O
binding O
complexes O
capable O
of O
repressing O
transcription O
of O
the O
biosynthetic O
genes O
( O
both O
) O
, O
activating O
transcription O
of O
catabolic O
genes O
( O
AhrC B
only O
) O
or O
facilitating O
plasmid O
dimer O
resolution O
( O
both O
) O
. O

Based O
on O
the O
current O
literature O
, O
the O
mechanisms O
involved O
in O
the O
toxicity O
of O
OA B
indicate O
three O
major O
effects O
: O
( O
1 O
) O
inhibition O
of O
mitochondrial O
respiration O
correlated O
with O
a O
depletion O
of O
ATP O
; O
( O
2 O
) O
inhibition O
of O
tRNA B
- I
synthetase I
accompanied O
by O
a O
reduced O
protein O
synthesis O
; O
and O
( O
3 O
) O
enhanced O
lipid O
peroxidation O
. O

E2F1 B
- O
mediated O
transcriptional O
inhibition O
of O
the O
plasminogen B
activator I
inhibitor I
type I
1 I
gene I
. O

We O
also O
show O
that O
p65 B
binds O
to O
these O
targets O
with O
almost O
equal O
affinity O
and O
that O
different O
residues O
have O
variable O
roles O
in O
binding O
different O
kappaB B
targets I
. O

A O
poor O
correlation O
was O
also O
observed O
between O
PbB O
and O
ALAD B
activity O
of O
the O
stearate O
workers O
. O

Binding O
of O
meAda B
is O
necessary O
to O
activate O
transcription O
of O
the O
adaptive O
response O
genes O
; O
accordingly O
, O
in O
vitro O
transcription O
of O
aidB B
is O
dependent O
on O
the O
presence O
of O
meAda B
. O

Binding O
of O
meAda B
is O
necessary O
to O
activate O
transcription O
of O
the O
adaptive O
response O
genes O
; O
accordingly O
, O
in O
vitro O
transcription O
of O
aidB B
is O
dependent O
on O
the O
presence O
of O
meAda B
. O

Binding O
of O
meAda B
is O
necessary O
to O
activate O
transcription O
of O
the O
adaptive O
response O
genes O
; O
accordingly O
, O
in O
vitro O
transcription O
of O
aidB B
is O
dependent O
on O
the O
presence O
of O
meAda B
. O

These O
findings O
suggest O
a O
functional O
cross O
- O
talk O
between O
RB B
protein I
and O
p21ras B
, O
which O
balances O
the O
cell O
phenotype O
between O
normal O
and O
transformed O
states O
. O

GH B
failed O
to O
stimulate O
phosphorylation O
or O
activation O
of O
Jun B
N I
- I
terminal I
kinase I
under O
the O
conditions O
used O
. O

The O
ERH B
expression O
profile O
is O
similar O
, O
to O
that O
of O
An3 B
, O
which O
localizes O
to O
the O
animal O
hemisphere O
of O
oocytes O
and O
is O
abundantly O
expressed O
in O
the O
embryo O
. O

The O
ERH B
expression O
profile O
is O
similar O
, O
to O
that O
of O
An3 B
, O
which O
localizes O
to O
the O
animal O
hemisphere O
of O
oocytes O
and O
is O
abundantly O
expressed O
in O
the O
embryo O
. O

It O
is O
, O
however O
, O
extremely O
homologous O
to O
a O
third O
' O
non O
- O
classical O
' O
gene O
, O
HLA B
- I
5 I
. I
4 I
, O
and O
to O
the O
chimpanzee O
gene O
, O
Ch28 B
. O

The O
p130 B
and O
p62 B
tyrosine O
- O
phosphorylated O
proteins O
that O
complexed O
v B
- I
Src I
SH2 B
in O
vitro O
also O
associated O
with O
v B
- I
Src I
in O
v B
- I
src I
- O
transformed O
Rat O
- O
2 O
cells O
; O
this O
in O
vivo O
binding O
was O
dependent O
on O
the O
v B
- I
Src I
SH2 B
domain O
. O

The O
p130 B
and O
p62 B
tyrosine O
- O
phosphorylated O
proteins O
that O
complexed O
v B
- I
Src I
SH2 B
in O
vitro O
also O
associated O
with O
v B
- I
Src I
in O
v B
- I
src I
- O
transformed O
Rat O
- O
2 O
cells O
; O
this O
in O
vivo O
binding O
was O
dependent O
on O
the O
v B
- I
Src I
SH2 B
domain O
. O

The O
p130 B
and O
p62 B
tyrosine O
- O
phosphorylated O
proteins O
that O
complexed O
v B
- I
Src I
SH2 B
in O
vitro O
also O
associated O
with O
v B
- I
Src I
in O
v B
- I
src I
- O
transformed O
Rat O
- O
2 O
cells O
; O
this O
in O
vivo O
binding O
was O
dependent O
on O
the O
v B
- I
Src I
SH2 B
domain O
. O

The O
p130 B
and O
p62 B
tyrosine O
- O
phosphorylated O
proteins O
that O
complexed O
v B
- I
Src I
SH2 B
in O
vitro O
also O
associated O
with O
v B
- I
Src I
in O
v B
- I
src I
- O
transformed O
Rat O
- O
2 O
cells O
; O
this O
in O
vivo O
binding O
was O
dependent O
on O
the O
v B
- I
Src I
SH2 B
domain O
. O

Previously O
, O
we O
showed O
that O
the O
APRE O
is O
a O
cytokine O
[ O
tumor B
necrosis I
factor I
- I
alpha I
( O
TNFalpha B
) O
] O
- O
inducible O
enhancer O
by O
binding O
the O
heterodimeric B
nuclear I
factor I
- I
kappaB I
( O
NF B
- I
kappaB I
) O
complex O
Rel B
A I
x O
NF B
- I
kappaB1 I
. O

Of O
the O
remaining O
seven O
, O
five O
reacted O
either O
with O
immediate O
and O
strong O
symptoms O
or O
had O
spontaneously O
reduced O
gluten B
intake O
, O
or O
had O
an O
acquired O
IgA B
deficiency O
. O

Of O
the O
remaining O
seven O
, O
five O
reacted O
either O
with O
immediate O
and O
strong O
symptoms O
or O
had O
spontaneously O
reduced O
gluten B
intake O
, O
or O
had O
an O
acquired O
IgA B
deficiency O
. O

The O
possible O
roles O
of O
HRMT1L1 B
and O
HRMT1L2 B
in O
human O
disease O
are O
currently O
unknown O
. O

The O
possible O
roles O
of O
HRMT1L1 B
and O
HRMT1L2 B
in O
human O
disease O
are O
currently O
unknown O
. O

As O
no O
complete O
PPARgamma B
antagonists O
have O
been O
described O
hitherto O
, O
we O
have O
constructed O
a O
dominant O
- O
negative O
mutant O
receptor O
to O
inhibit O
wild O
- O
type O
PPARgamma B
action O
. O

As O
no O
complete O
PPARgamma B
antagonists O
have O
been O
described O
hitherto O
, O
we O
have O
constructed O
a O
dominant O
- O
negative O
mutant O
receptor O
to O
inhibit O
wild O
- O
type O
PPARgamma B
action O
. O

Finally O
, O
we O
present O
evidence O
that O
fimbrin B
is O
a O
third O
distinct O
plastin B
isoform I
which O
is O
specifically O
expressed O
at O
high O
levels O
in O
the O
small O
intestine O
. O

Leukemia B
- I
inhibitory I
factor I
( O
LIF B
) O
is O
a O
neuropoietin B
able O
to O
regulate O
the O
differentiation O
and O
the O
survival O
of O
many O
cell O
types O
, O
which O
include O
some O
neuronal O
populations O
. O

Leukemia B
- I
inhibitory I
factor I
( O
LIF B
) O
is O
a O
neuropoietin B
able O
to O
regulate O
the O
differentiation O
and O
the O
survival O
of O
many O
cell O
types O
, O
which O
include O
some O
neuronal O
populations O
. O

Using O
a O
conditional O
- O
lethal O
mutant O
allele O
of O
SUP45 B
( O
sup45 B
- I
2 I
) O
and O
a O
combination O
of O
in O
vivo O
and O
in O
vitro O
approaches O
, O
we O
demonstrate O
that O
the O
product O
of O
the O
SUP45 B
gene I
( O
Sup45p B
or O
eRF1 B
) O
is O
a O
factor O
required O
for O
translation O
termination O
in O
yeast O
. O

Using O
a O
conditional O
- O
lethal O
mutant O
allele O
of O
SUP45 B
( O
sup45 B
- I
2 I
) O
and O
a O
combination O
of O
in O
vivo O
and O
in O
vitro O
approaches O
, O
we O
demonstrate O
that O
the O
product O
of O
the O
SUP45 B
gene I
( O
Sup45p B
or O
eRF1 B
) O
is O
a O
factor O
required O
for O
translation O
termination O
in O
yeast O
. O

Using O
a O
conditional O
- O
lethal O
mutant O
allele O
of O
SUP45 B
( O
sup45 B
- I
2 I
) O
and O
a O
combination O
of O
in O
vivo O
and O
in O
vitro O
approaches O
, O
we O
demonstrate O
that O
the O
product O
of O
the O
SUP45 B
gene I
( O
Sup45p B
or O
eRF1 B
) O
is O
a O
factor O
required O
for O
translation O
termination O
in O
yeast O
. O

Expression O
of O
lacZ B
from O
the O
promoter O
of O
the O
Escherichia B
coli I
spc I
operon I
cloned O
into O
vectors O
carrying O
the O
W205 O
trp B
- O
lac B
fusion O
. O

Expression O
of O
lacZ B
from O
the O
promoter O
of O
the O
Escherichia B
coli I
spc I
operon I
cloned O
into O
vectors O
carrying O
the O
W205 O
trp B
- O
lac B
fusion O
. O

Expression O
of O
lacZ B
from O
the O
promoter O
of O
the O
Escherichia B
coli I
spc I
operon I
cloned O
into O
vectors O
carrying O
the O
W205 O
trp B
- O
lac B
fusion O
. O

We O
have O
now O
tested O
all O
known O
mammalian B
Groucho I
family I
members I
for O
their O
ability O
to O
interact O
specifically O
with O
individual O
Tcf B
/ O
Lef B
family O
members O
. O

We O
have O
now O
tested O
all O
known O
mammalian B
Groucho I
family I
members I
for O
their O
ability O
to O
interact O
specifically O
with O
individual O
Tcf B
/ O
Lef B
family O
members O
. O

A O
cDNA O
clone O
corresponding O
to O
the O
putative O
GA B
20 I
- O
oxidase B
genomic O
sequence O
was O
constructed O
with O
the O
reverse O
transcription O
- O
PCR O
method O
, O
and O
the O
identity O
of O
the O
cDNA O
clone O
was O
confirmed O
by O
analyzing O
the O
capability O
of O
the O
fusion O
protein O
expressed O
in O
Escherichia O
coli O
to O
convert O
GA53 B
to O
GA44 B
and O
GA19 B
to O
GA20 B
. O

A O
cDNA O
clone O
corresponding O
to O
the O
putative O
GA B
20 I
- O
oxidase B
genomic O
sequence O
was O
constructed O
with O
the O
reverse O
transcription O
- O
PCR O
method O
, O
and O
the O
identity O
of O
the O
cDNA O
clone O
was O
confirmed O
by O
analyzing O
the O
capability O
of O
the O
fusion O
protein O
expressed O
in O
Escherichia O
coli O
to O
convert O
GA53 B
to O
GA44 B
and O
GA19 B
to O
GA20 B
. O

A O
cDNA O
clone O
corresponding O
to O
the O
putative O
GA B
20 I
- O
oxidase B
genomic O
sequence O
was O
constructed O
with O
the O
reverse O
transcription O
- O
PCR O
method O
, O
and O
the O
identity O
of O
the O
cDNA O
clone O
was O
confirmed O
by O
analyzing O
the O
capability O
of O
the O
fusion O
protein O
expressed O
in O
Escherichia O
coli O
to O
convert O
GA53 B
to O
GA44 B
and O
GA19 B
to O
GA20 B
. O

A O
cDNA O
clone O
corresponding O
to O
the O
putative O
GA B
20 I
- O
oxidase B
genomic O
sequence O
was O
constructed O
with O
the O
reverse O
transcription O
- O
PCR O
method O
, O
and O
the O
identity O
of O
the O
cDNA O
clone O
was O
confirmed O
by O
analyzing O
the O
capability O
of O
the O
fusion O
protein O
expressed O
in O
Escherichia O
coli O
to O
convert O
GA53 B
to O
GA44 B
and O
GA19 B
to O
GA20 B
. O

A O
cDNA O
clone O
corresponding O
to O
the O
putative O
GA B
20 I
- O
oxidase B
genomic O
sequence O
was O
constructed O
with O
the O
reverse O
transcription O
- O
PCR O
method O
, O
and O
the O
identity O
of O
the O
cDNA O
clone O
was O
confirmed O
by O
analyzing O
the O
capability O
of O
the O
fusion O
protein O
expressed O
in O
Escherichia O
coli O
to O
convert O
GA53 B
to O
GA44 B
and O
GA19 B
to O
GA20 B
. O

We O
also O
isolated O
two O
alternatively O
spliced O
forms O
of O
human B
CD6 I
cDNA I
lacking O
sequences O
encoding O
membrane O
- O
proximal O
regions O
of O
the O
cytoplasmic O
domain O
which O
maintain O
the O
same O
reading O
frame O
as O
CD6 B
- O
PB1 B
. O

We O
also O
isolated O
two O
alternatively O
spliced O
forms O
of O
human B
CD6 I
cDNA I
lacking O
sequences O
encoding O
membrane O
- O
proximal O
regions O
of O
the O
cytoplasmic O
domain O
which O
maintain O
the O
same O
reading O
frame O
as O
CD6 B
- O
PB1 B
. O

These O
results O
further O
support O
an O
important O
role O
for O
CBF2 B
in O
mediating O
EBNA2 B
transactivation O
; O
they O
identify O
the O
hnRNP B
protein I
AUF1 I
as O
a O
major O
component O
of O
CBF2 B
and O
are O
also O
the O
first O
evidence O
of O
a O
cis O
- O
acting O
sequence O
other O
than O
a O
CBF1 B
binding I
element I
that O
is O
able O
to O
confer O
responsiveness O
to O
EBNA2 B
. O

These O
results O
further O
support O
an O
important O
role O
for O
CBF2 B
in O
mediating O
EBNA2 B
transactivation O
; O
they O
identify O
the O
hnRNP B
protein I
AUF1 I
as O
a O
major O
component O
of O
CBF2 B
and O
are O
also O
the O
first O
evidence O
of O
a O
cis O
- O
acting O
sequence O
other O
than O
a O
CBF1 B
binding I
element I
that O
is O
able O
to O
confer O
responsiveness O
to O
EBNA2 B
. O

These O
results O
further O
support O
an O
important O
role O
for O
CBF2 B
in O
mediating O
EBNA2 B
transactivation O
; O
they O
identify O
the O
hnRNP B
protein I
AUF1 I
as O
a O
major O
component O
of O
CBF2 B
and O
are O
also O
the O
first O
evidence O
of O
a O
cis O
- O
acting O
sequence O
other O
than O
a O
CBF1 B
binding I
element I
that O
is O
able O
to O
confer O
responsiveness O
to O
EBNA2 B
. O

These O
results O
further O
support O
an O
important O
role O
for O
CBF2 B
in O
mediating O
EBNA2 B
transactivation O
; O
they O
identify O
the O
hnRNP B
protein I
AUF1 I
as O
a O
major O
component O
of O
CBF2 B
and O
are O
also O
the O
first O
evidence O
of O
a O
cis O
- O
acting O
sequence O
other O
than O
a O
CBF1 B
binding I
element I
that O
is O
able O
to O
confer O
responsiveness O
to O
EBNA2 B
. O

To O
understand O
whether O
Shc B
localization O
in O
membrane O
rafts O
is O
sufficient O
to O
regulate O
Shc B
function O
, O
we O
constructed O
a O
Shc B
chimera I
containing O
the O
Ras B
membrane I
localization I
motif I
at O
the O
C O
- O
terminus O
. O

To O
understand O
whether O
Shc B
localization O
in O
membrane O
rafts O
is O
sufficient O
to O
regulate O
Shc B
function O
, O
we O
constructed O
a O
Shc B
chimera I
containing O
the O
Ras B
membrane I
localization I
motif I
at O
the O
C O
- O
terminus O
. O

These O
observations O
provide O
strong O
support O
for O
the O
idea O
that O
expression O
of O
mutant O
tRNA O
can O
confer O
a O
mutator O
phenotype O
, O
including O
the O
UVM O
- O
constitutive O
phenotype O
observed O
in O
mutA B
and O
mutC B
cells O
. O

These O
observations O
provide O
strong O
support O
for O
the O
idea O
that O
expression O
of O
mutant O
tRNA O
can O
confer O
a O
mutator O
phenotype O
, O
including O
the O
UVM O
- O
constitutive O
phenotype O
observed O
in O
mutA B
and O
mutC B
cells O
. O

The O
serum O
erythropoietin B
( O
EPO B
) O
concentrations O
of O
15 O
male O
triathletes O
( O
26 O
. O
3 O
U O
. O
ml O
- O
1 O
) O
were O
significantly O
lower O
than O
those O
of O
45 O
male O
distance O
runners O
( O
31 O
. O
6 O
U O
. O
ml O
- O
1 O
; O
P O
less O
than O
0 O
. O
05 O
) O
. O

The O
serum O
erythropoietin B
( O
EPO B
) O
concentrations O
of O
15 O
male O
triathletes O
( O
26 O
. O
3 O
U O
. O
ml O
- O
1 O
) O
were O
significantly O
lower O
than O
those O
of O
45 O
male O
distance O
runners O
( O
31 O
. O
6 O
U O
. O
ml O
- O
1 O
; O
P O
less O
than O
0 O
. O
05 O
) O
. O

At O
the O
C O
- O
terminus O
of O
the O
protein O
is O
a O
domain O
that O
contains O
sequences O
very O
similar O
to O
those O
found O
in O
the O
breakpoint O
cluster O
region O
gene O
product O
, O
n B
- I
chimerin I
, O
and O
rho B
GAP I
, O
all O
of O
which O
have O
been O
shown O
to O
possess O
intrinsic O
GAP B
activity O
on O
small B
GTPases I
. O

Both O
of O
these O
dogs O
had O
low O
serum O
IgG B
( O
3 O
. O
5 O
to O
7 O
. O
2 O
mg O
/ O
ml O
) O
and O
the O
second O
littermate O
also O
had O
reduced O
serum O
IgA B
( O
< O
0 O
. O
1 O
to O
0 O
. O
15 O
mg O
/ O
ml O
) O
. O

Both O
of O
these O
dogs O
had O
low O
serum O
IgG B
( O
3 O
. O
5 O
to O
7 O
. O
2 O
mg O
/ O
ml O
) O
and O
the O
second O
littermate O
also O
had O
reduced O
serum O
IgA B
( O
< O
0 O
. O
1 O
to O
0 O
. O
15 O
mg O
/ O
ml O
) O
. O

Slap B
negatively O
regulates O
Src B
mitogenic O
function O
but O
does O
not O
revert O
Src B
- O
induced O
cell O
morphology O
changes O
. O

Slap B
negatively O
regulates O
Src B
mitogenic O
function O
but O
does O
not O
revert O
Src B
- O
induced O
cell O
morphology O
changes O
. O

Slap B
negatively O
regulates O
Src B
mitogenic O
function O
but O
does O
not O
revert O
Src B
- O
induced O
cell O
morphology O
changes O
. O

RT O
- O
PCR O
analysis O
showed O
that O
PLP B
- I
H I
as O
well O
as O
PLP B
- I
C I
and O
PLP B
- I
D I
are O
expressed O
in O
all O
rat O
strains O
examined O
, O
confirming O
that O
PLP B
diversity O
is O
not O
due O
to O
strain O
differences O
. O

Previous O
work O
showed O
that O
repA B
( O
initiator O
protein O
) O
expression O
requires O
tap B
( O
leader O
peptide O
) O
translation O
. O

Previous O
work O
showed O
that O
repA B
( O
initiator O
protein O
) O
expression O
requires O
tap B
( O
leader O
peptide O
) O
translation O
. O

In O
Rat O
1a O
cells O
, O
m1R B
stimulation O
of O
phospholipase B
C I
beta I
and O
the O
marked O
rise O
in O
intracellular O
calcium O
stimulated O
cyclic O
AMP O
( O
cAMP O
) O
synthesis O
, O
resulting O
in O
the O
activation O
of O
protein B
kinase I
A I
. O

Because O
the O
mutant O
defective O
in O
DNA O
binding O
also O
fails O
to O
stimulate O
Abf1 B
ARS1 O
DNA O
- O
binding O
activity O
, O
our O
results O
suggest O
that O
Cdc6 B
DNA O
- O
binding O
activity O
may O
play O
a O
pivotal O
role O
in O
the O
initiation O
of O
DNA O
replication O
. O

Because O
the O
mutant O
defective O
in O
DNA O
binding O
also O
fails O
to O
stimulate O
Abf1 B
ARS1 O
DNA O
- O
binding O
activity O
, O
our O
results O
suggest O
that O
Cdc6 B
DNA O
- O
binding O
activity O
may O
play O
a O
pivotal O
role O
in O
the O
initiation O
of O
DNA O
replication O
. O

The O
statistical O
analysis O
of O
data O
of O
TRH B
test O
on O
a O
sample O
of O
57 O
healthy O
volunteers O
has O
permitted O
an O
evaluation O
of O
the O
upper O
limits O
of O
the O
normal O
thyrotropin B
response O
; O
the O
secretory O
area O
( O
As O
) O
was O
shown O
to O
be O
more O
discriminating O
. O

The O
statistical O
analysis O
of O
data O
of O
TRH B
test O
on O
a O
sample O
of O
57 O
healthy O
volunteers O
has O
permitted O
an O
evaluation O
of O
the O
upper O
limits O
of O
the O
normal O
thyrotropin B
response O
; O
the O
secretory O
area O
( O
As O
) O
was O
shown O
to O
be O
more O
discriminating O
. O

This O
conformer O
features O
a O
Type O
I O
beta O
- O
turn O
and O
has O
extensive O
hydrophobic O
contacts O
with O
the O
FKBP12 B
binding O
surface O
. O

Consistent O
with O
the O
hepatic O
and O
epidermal O
expression O
of O
histidase B
, O
this O
finding O
suggests O
that O
histidase B
transcription O
may O
be O
regulated O
by O
these O
factors O
. O

Consistent O
with O
the O
hepatic O
and O
epidermal O
expression O
of O
histidase B
, O
this O
finding O
suggests O
that O
histidase B
transcription O
may O
be O
regulated O
by O
these O
factors O
. O

In O
Saccharomyces O
cerevisiae O
, O
eIF6 B
is O
encoded O
by O
a O
single O
- O
copy O
essential O
gene O
. O

Results O
of O
the O
official O
inspection O
of O
the O
commercial O
anti O
- O
inflammatory O
enzyme O
preparations O
containing O
chymotrypsin B
and O
trypsin B
by O
means O
of O
modified O
NF O
13 O
methods O

Results O
of O
the O
official O
inspection O
of O
the O
commercial O
anti O
- O
inflammatory O
enzyme O
preparations O
containing O
chymotrypsin B
and O
trypsin B
by O
means O
of O
modified O
NF O
13 O
methods O

Regulation O
of O
irgA B
by O
iron O
in O
V O
. O
cholerae O
occurs O
at O
the O
transcriptional O
level O
, O
and O
there O
is O
an O
interrupted O
dyad O
symmetric O
sequence O
in O
the O
vicinity O
of O
the O
promoter O
that O
is O
homologous O
to O
Fur B
binding I
sites I
of O
E O
. O
coli O
. O

We O
recently O
characterized O
a O
single O
yeast B
hnRNP I
methyltransferase I
( O
HMT1 B
) O
. O

We O
recently O
characterized O
a O
single O
yeast B
hnRNP I
methyltransferase I
( O
HMT1 B
) O
. O

LY290181 O
appears O
to O
inhibit O
uPA B
promoter I
activation O
by O
blocking O
phorbol O
ester O
- O
stimulated O
binding O
of O
nuclear O
proteins O
to O
the O
uPA B
PEA3 B
/ O
12 O
- O
0 O
- O
tetradecanoylphorbol O
13 O
- O
acetate O
responsive O
element O
( O
TRE O
) O
. O

LY290181 O
appears O
to O
inhibit O
uPA B
promoter I
activation O
by O
blocking O
phorbol O
ester O
- O
stimulated O
binding O
of O
nuclear O
proteins O
to O
the O
uPA B
PEA3 B
/ O
12 O
- O
0 O
- O
tetradecanoylphorbol O
13 O
- O
acetate O
responsive O
element O
( O
TRE O
) O
. O

The O
divergence O
in O
primary O
structure O
between O
the O
sheep O
CRF1 B
and O
the O
other O
mammalian B
CRF1s I
is O
primarily O
localized O
to O
the O
extracellular O
amino O
terminal O
domain O
of O
the O
receptor O
( O
18 O
of O
22 O
divergent O
residues O
, O
ovine O
vs O
human B
CRF1 I
) O
. O

We O
then O
demonstrated O
that O
1 O
) O
GAL4 B
- O
REV B
- O
erbA B
alpha I
chimeras O
that O
contain O
the O
' O
AB O
' O
region O
and O
lack O
the O
' O
E O
' O
region O
activated O
transcription O
of O
GAL4 B
response I
elements I
in O
the O
presence O
of O
8 O
- O
Br O
- O
cAMP O
and O
2 O
) O
the O
ligand O
- O
binding O
domain O
( O
LBD O
) O
contains O
an O
active O
transcriptional O
silencer O
. O

We O
then O
demonstrated O
that O
1 O
) O
GAL4 B
- O
REV B
- O
erbA B
alpha I
chimeras O
that O
contain O
the O
' O
AB O
' O
region O
and O
lack O
the O
' O
E O
' O
region O
activated O
transcription O
of O
GAL4 B
response I
elements I
in O
the O
presence O
of O
8 O
- O
Br O
- O
cAMP O
and O
2 O
) O
the O
ligand O
- O
binding O
domain O
( O
LBD O
) O
contains O
an O
active O
transcriptional O
silencer O
. O

We O
also O
show O
that O
activation O
of O
protein B
kinase I
A I
( O
PKA B
) O
signaling O
is O
sufficient O
to O
down O
- O
regulate O
caveolin B
- I
1 I
protein I
expression O
and O
promoter O
activity O
. O

Genomic O
locus O
of O
chCTCF B
contains O
a O
GC O
- O
rich O
untranslated O
exon O
separated O
from O
seven O
coding O
exons O
by O
a O
long O
intron O
. O

Heat O
- O
labile O
- O
like O
enterotoxin O
( O
LT B
) O
was O
produced O
by O
26 O
of O
42 O
stool O
isolates O
( O
62 O
% O
) O
, O
while O
only O
1 O
of O
the O
42 O
isolates O
( O
2 O
% O
) O
produced O
enterotoxinlike O
activity O
in O
suckling O
mice O
; O
65 O
% O
of O
the O
cytotoxin O
- O
producing O
strains O
also O
produced O
an O
LT B
- I
like I
material O
. O

In O
the O
present O
study O
, O
we O
show O
that O
SRm160 B
/ I
300 I
is O
required O
for O
a O
purine O
- O
rich O
ESE B
to O
promote O
the O
splicing O
of O
a O
pre O
- O
mRNA O
derived O
from O
the O
Drosophila B
doublesex I
gene I
. O

Further O
evidence O
for O
a O
clustered O
organization O
of O
FAX B
- O
ZFP B
transcription O
units O
is O
provided O
by O
Southern O
blot O
analysis O
of O
large O
genomic O
restriction O
fragments O
separated O
by O
transverse O
field O
gel O
electrophoresis O
, O
and O
by O
in O
situ O
hybridization O
on O
intact O
chromosomes O
. O

Further O
evidence O
for O
a O
clustered O
organization O
of O
FAX B
- O
ZFP B
transcription O
units O
is O
provided O
by O
Southern O
blot O
analysis O
of O
large O
genomic O
restriction O
fragments O
separated O
by O
transverse O
field O
gel O
electrophoresis O
, O
and O
by O
in O
situ O
hybridization O
on O
intact O
chromosomes O
. O

In O
adherent O
macrophages O
, O
absence O
of O
CD45 B
led O
to O
the O
hyperphosphorylation O
and O
hyperactivation O
of O
p56 B
/ I
59 I
( O
hck B
) O
and O
p53 B
/ I
56 I
( O
lyn B
) O
, O
but O
not O
of O
p58 B
( O
c B
- I
fgr I
) O
. O

In O
adherent O
macrophages O
, O
absence O
of O
CD45 B
led O
to O
the O
hyperphosphorylation O
and O
hyperactivation O
of O
p56 B
/ I
59 I
( O
hck B
) O
and O
p53 B
/ I
56 I
( O
lyn B
) O
, O
but O
not O
of O
p58 B
( O
c B
- I
fgr I
) O
. O

In O
adherent O
macrophages O
, O
absence O
of O
CD45 B
led O
to O
the O
hyperphosphorylation O
and O
hyperactivation O
of O
p56 B
/ I
59 I
( O
hck B
) O
and O
p53 B
/ I
56 I
( O
lyn B
) O
, O
but O
not O
of O
p58 B
( O
c B
- I
fgr I
) O
. O

In O
adherent O
macrophages O
, O
absence O
of O
CD45 B
led O
to O
the O
hyperphosphorylation O
and O
hyperactivation O
of O
p56 B
/ I
59 I
( O
hck B
) O
and O
p53 B
/ I
56 I
( O
lyn B
) O
, O
but O
not O
of O
p58 B
( O
c B
- I
fgr I
) O
. O

The O
structural O
study O
of O
peptides O
belonging O
to O
the O
terminal O
domains O
of O
histone B
H1 I
can O
be O
considered O
as O
a O
step O
toward O
the O
understanding O
of O
the O
function O
of O
H1 B
in O
chromatin O
. O

In O
our O
previous O
studies O
, O
transcriptional O
activation O
was O
shown O
to O
correlate O
with O
IEP86 B
binding O
to O
both O
the O
TATA B
- I
box I
binding I
protein I
( O
TBP B
) O
and O
the O
transcription O
factor O
bound O
upstream O
. O

In O
our O
previous O
studies O
, O
transcriptional O
activation O
was O
shown O
to O
correlate O
with O
IEP86 B
binding O
to O
both O
the O
TATA B
- I
box I
binding I
protein I
( O
TBP B
) O
and O
the O
transcription O
factor O
bound O
upstream O
. O

Peroxisome B
proliferator I
- I
activated I
receptors I
( O
PPARs B
) O
and O
retinoid B
X I
receptors I
( O
RXRs B
) O
are O
nuclear B
hormone I
receptors I
that O
are O
activated O
by O
fatty O
acids O
and O
9 O
- O
cis O
- O
retinoic O
acid O
, O
respectively O
. O

Peroxisome B
proliferator I
- I
activated I
receptors I
( O
PPARs B
) O
and O
retinoid B
X I
receptors I
( O
RXRs B
) O
are O
nuclear B
hormone I
receptors I
that O
are O
activated O
by O
fatty O
acids O
and O
9 O
- O
cis O
- O
retinoic O
acid O
, O
respectively O
. O

Using O
mutagenesis O
, O
we O
have O
identified O
two O
mutations O
of O
the O
second O
actin B
- I
binding I
domain I
that O
can O
also O
suppress O
the O
act1 B
mutations O
of O
interest O
. O

A O
point O
mutation O
in O
Galphao B
and O
Galphai1 B
blocks O
interaction O
with O
regulator O
of O
G B
protein I
signaling O
proteins O
. O

A O
point O
mutation O
in O
Galphao B
and O
Galphai1 B
blocks O
interaction O
with O
regulator O
of O
G B
protein I
signaling O
proteins O
. O

Activation O
of O
PKA B
by O
8 O
- O
bromo O
- O
cyclic O
AMP O
or O
forskolin O
, O
and O
inhibition O
of O
PKC B
by O
calphostin O
C O
, O
resulted O
in O
a O
significant O
decrease O
in O
3TP B
activity O
as O
well O
as O
in O
vitro O
ERK B
kinase I
activity O
in O
CRAC O
. O

Activation O
of O
PKA B
by O
8 O
- O
bromo O
- O
cyclic O
AMP O
or O
forskolin O
, O
and O
inhibition O
of O
PKC B
by O
calphostin O
C O
, O
resulted O
in O
a O
significant O
decrease O
in O
3TP B
activity O
as O
well O
as O
in O
vitro O
ERK B
kinase I
activity O
in O
CRAC O
. O

Activation O
of O
PKA B
by O
8 O
- O
bromo O
- O
cyclic O
AMP O
or O
forskolin O
, O
and O
inhibition O
of O
PKC B
by O
calphostin O
C O
, O
resulted O
in O
a O
significant O
decrease O
in O
3TP B
activity O
as O
well O
as O
in O
vitro O
ERK B
kinase I
activity O
in O
CRAC O
. O

Radiation O
- O
induced O
changes O
in O
the O
area O
of O
alveoli O
and O
septa O
as O
well O
as O
collagen B
content O
were O
seen O
11 O
weeks O
after O
irradiation O
. O

Our O
results O
suggest O
that O
the O
C O
- O
terminal O
region O
of O
Crk B
contains O
negative O
regulatory O
elements O
important O
for O
both O
Abl B
and O
FAK B
dependent O
signal O
pathways O
, O
and O
offers O
a O
paradigm O
for O
an O
autoinhibitory O
region O
in O
the O
SH3 B
linker O
/ O
C O
- O
terminal O
SH3 B
domain O
. O

Our O
results O
suggest O
that O
the O
C O
- O
terminal O
region O
of O
Crk B
contains O
negative O
regulatory O
elements O
important O
for O
both O
Abl B
and O
FAK B
dependent O
signal O
pathways O
, O
and O
offers O
a O
paradigm O
for O
an O
autoinhibitory O
region O
in O
the O
SH3 B
linker O
/ O
C O
- O
terminal O
SH3 B
domain O
. O

Our O
results O
suggest O
that O
the O
C O
- O
terminal O
region O
of O
Crk B
contains O
negative O
regulatory O
elements O
important O
for O
both O
Abl B
and O
FAK B
dependent O
signal O
pathways O
, O
and O
offers O
a O
paradigm O
for O
an O
autoinhibitory O
region O
in O
the O
SH3 B
linker O
/ O
C O
- O
terminal O
SH3 B
domain O
. O

Our O
results O
suggest O
that O
the O
C O
- O
terminal O
region O
of O
Crk B
contains O
negative O
regulatory O
elements O
important O
for O
both O
Abl B
and O
FAK B
dependent O
signal O
pathways O
, O
and O
offers O
a O
paradigm O
for O
an O
autoinhibitory O
region O
in O
the O
SH3 B
linker O
/ O
C O
- O
terminal O
SH3 B
domain O
. O

Our O
results O
suggest O
that O
the O
C O
- O
terminal O
region O
of O
Crk B
contains O
negative O
regulatory O
elements O
important O
for O
both O
Abl B
and O
FAK B
dependent O
signal O
pathways O
, O
and O
offers O
a O
paradigm O
for O
an O
autoinhibitory O
region O
in O
the O
SH3 B
linker O
/ O
C O
- O
terminal O
SH3 B
domain O
. O

The O
sequence O
and O
isolated O
cDNAs O
will O
provide O
useful O
reagents O
for O
studying O
the O
expression O
of O
Brca1 B
in O
the O
mouse O
, O
and O
for O
testing O
the O
importance O
of O
the O
evolutionarily O
conserved O
domains O
. O

RVR B
' O
loss O
of O
function O
' O
studies O
by O
constitutive O
over O
- O
expression O
of O
a O
dominant O
negative O
RVR B
delta I
E I
resulted O
in O
increased O
levels O
of O
p21Cip1 B
/ O
Waf1 B
and O
myogenin B
mRNAs I
after O
serum O
withdrawal O
. O

RVR B
' O
loss O
of O
function O
' O
studies O
by O
constitutive O
over O
- O
expression O
of O
a O
dominant O
negative O
RVR B
delta I
E I
resulted O
in O
increased O
levels O
of O
p21Cip1 B
/ O
Waf1 B
and O
myogenin B
mRNAs I
after O
serum O
withdrawal O
. O

RVR B
' O
loss O
of O
function O
' O
studies O
by O
constitutive O
over O
- O
expression O
of O
a O
dominant O
negative O
RVR B
delta I
E I
resulted O
in O
increased O
levels O
of O
p21Cip1 B
/ O
Waf1 B
and O
myogenin B
mRNAs I
after O
serum O
withdrawal O
. O

This O
soluble O
form O
of O
the O
HGFr B
( O
sHGFr B
) O
bound O
HGF B
with O
an O
affinity O
similar O
to O
that O
of O
the O
authentic O
, O
membrane O
- O
associated O
receptor O
. O

This O
soluble O
form O
of O
the O
HGFr B
( O
sHGFr B
) O
bound O
HGF B
with O
an O
affinity O
similar O
to O
that O
of O
the O
authentic O
, O
membrane O
- O
associated O
receptor O
. O

This O
soluble O
form O
of O
the O
HGFr B
( O
sHGFr B
) O
bound O
HGF B
with O
an O
affinity O
similar O
to O
that O
of O
the O
authentic O
, O
membrane O
- O
associated O
receptor O
. O

Splicing O
of O
the O
K B
- I
SAM I
alternative O
exon O
of O
the O
fibroblast B
growth I
factor I
receptor I
2 I
gene I
is O
heavily O
dependent O
on O
the O
U O
- O
rich O
sequence O
IAS1 B
lying O
immediately O
downstream O
from O
its O
5 O
' O
splice O
site O
. O

Patients O
with O
detectable O
serum O
TNF B
levels O
had O
significantly O
lower O
serum O
T3 O
concentrations O
compared O
to O
those O
with O
undetectable O
levels O
[ O
1 O
. O
072 O
+ O
/ O
- O
0 O
. O
588 O
vs O
. O

Finally O
, O
antibody O
binding O
to O
site O
IIIa O
on O
the O
hCG B
- I
ectodomain I
complex I
was O
also O
hindered O
by O
an O
anti O
- O
peptide O
mAb O
directed O
against O
a O
peptide O
encoded O
by O
the O
eighth O
exon O
( O
pE O
x O
8 O
) O
of O
the O
LHR B
. O

RegA B
is O
a O
positive O
yet O
nonessential O
regulator O
of O
tol B
- O
oprL B
expression O
. O

RegA B
is O
a O
positive O
yet O
nonessential O
regulator O
of O
tol B
- O
oprL B
expression O
. O

RegA B
is O
a O
positive O
yet O
nonessential O
regulator O
of O
tol B
- O
oprL B
expression O
. O

Collectively O
, O
this O
study O
emphasizes O
a O
critical O
role O
of O
Phox2a B
as O
well O
as O
its O
functional O
synergism O
with O
other O
transcription O
factors O
( O
e O
. O
g O
. O
, O
CREB B
, O
AP2 B
, O
and O
Sp1 B
) O
in O
transcriptional O
activation O
of O
the O
DBH B
gene I
. O

Collectively O
, O
this O
study O
emphasizes O
a O
critical O
role O
of O
Phox2a B
as O
well O
as O
its O
functional O
synergism O
with O
other O
transcription O
factors O
( O
e O
. O
g O
. O
, O
CREB B
, O
AP2 B
, O
and O
Sp1 B
) O
in O
transcriptional O
activation O
of O
the O
DBH B
gene I
. O

Collectively O
, O
this O
study O
emphasizes O
a O
critical O
role O
of O
Phox2a B
as O
well O
as O
its O
functional O
synergism O
with O
other O
transcription O
factors O
( O
e O
. O
g O
. O
, O
CREB B
, O
AP2 B
, O
and O
Sp1 B
) O
in O
transcriptional O
activation O
of O
the O
DBH B
gene I
. O

Collectively O
, O
this O
study O
emphasizes O
a O
critical O
role O
of O
Phox2a B
as O
well O
as O
its O
functional O
synergism O
with O
other O
transcription O
factors O
( O
e O
. O
g O
. O
, O
CREB B
, O
AP2 B
, O
and O
Sp1 B
) O
in O
transcriptional O
activation O
of O
the O
DBH B
gene I
. O

Our O
data O
demonstrate O
directly O
that O
Rpm1r B
is O
transcribed O
with O
its O
substrates O
, O
tRNA B
met I
f I
and O
tRNAPro B
, O
from O
a O
promoter O
located O
upstream O
of O
the O
tRNA B
met I
f I
gene I
and O
suggest O
that O
a O
portion O
also O
originates O
from O
a O
second O
promoter O
, O
located O
between O
the O
tRNA B
met I
f I
gene I
and O
RPM1 B
. O

Our O
data O
demonstrate O
directly O
that O
Rpm1r B
is O
transcribed O
with O
its O
substrates O
, O
tRNA B
met I
f I
and O
tRNAPro B
, O
from O
a O
promoter O
located O
upstream O
of O
the O
tRNA B
met I
f I
gene I
and O
suggest O
that O
a O
portion O
also O
originates O
from O
a O
second O
promoter O
, O
located O
between O
the O
tRNA B
met I
f I
gene I
and O
RPM1 B
. O

Our O
data O
demonstrate O
directly O
that O
Rpm1r B
is O
transcribed O
with O
its O
substrates O
, O
tRNA B
met I
f I
and O
tRNAPro B
, O
from O
a O
promoter O
located O
upstream O
of O
the O
tRNA B
met I
f I
gene I
and O
suggest O
that O
a O
portion O
also O
originates O
from O
a O
second O
promoter O
, O
located O
between O
the O
tRNA B
met I
f I
gene I
and O
RPM1 B
. O

Blood O
from O
dams O
was O
collected O
prior O
to O
inoculation O
and O
at O
time O
of O
necropsy O
for O
measurement O
of O
IgM B
and O
IgG B
antibodies I
to O
M O
. O
pulmonis O
. O

Consistent O
with O
this O
model O
, O
a O
synthetic O
construct O
containing O
three O
tandem O
copies O
of O
the O
native O
LDL B
receptor I
SREBP B
site O
linked O
to O
a O
single O
Sp1 B
site I
was O
also O
significantly O
activated O
in O
a O
buttonhead B
- O
independent O
fashion O
. O

Consistent O
with O
this O
model O
, O
a O
synthetic O
construct O
containing O
three O
tandem O
copies O
of O
the O
native O
LDL B
receptor I
SREBP B
site O
linked O
to O
a O
single O
Sp1 B
site I
was O
also O
significantly O
activated O
in O
a O
buttonhead B
- O
independent O
fashion O
. O

Alternatively O
, O
PC12 O
- O
E2 O
cells O
were O
submitted O
to O
treatment O
with O
antibodies O
to O
the O
fibroblast B
growth I
factor I
( I
FGF I
) I
receptor I
, O
inhibitors O
of O
the O
nonreceptor B
tyrosine I
kinase I
p59 B
( O
fyn B
) O
, O
PLC B
, O
PKC B
and O
MEK B
and O
an O
activator O
of O
PKC B
, O
phorbol O
- O
12 O
- O
myristate O
- O
13 O
- O
acetate O
( O
PMA O
) O
. O

Alternatively O
, O
PC12 O
- O
E2 O
cells O
were O
submitted O
to O
treatment O
with O
antibodies O
to O
the O
fibroblast B
growth I
factor I
( I
FGF I
) I
receptor I
, O
inhibitors O
of O
the O
nonreceptor B
tyrosine I
kinase I
p59 B
( O
fyn B
) O
, O
PLC B
, O
PKC B
and O
MEK B
and O
an O
activator O
of O
PKC B
, O
phorbol O
- O
12 O
- O
myristate O
- O
13 O
- O
acetate O
( O
PMA O
) O
. O

Alternatively O
, O
PC12 O
- O
E2 O
cells O
were O
submitted O
to O
treatment O
with O
antibodies O
to O
the O
fibroblast B
growth I
factor I
( I
FGF I
) I
receptor I
, O
inhibitors O
of O
the O
nonreceptor B
tyrosine I
kinase I
p59 B
( O
fyn B
) O
, O
PLC B
, O
PKC B
and O
MEK B
and O
an O
activator O
of O
PKC B
, O
phorbol O
- O
12 O
- O
myristate O
- O
13 O
- O
acetate O
( O
PMA O
) O
. O

Alternatively O
, O
PC12 O
- O
E2 O
cells O
were O
submitted O
to O
treatment O
with O
antibodies O
to O
the O
fibroblast B
growth I
factor I
( I
FGF I
) I
receptor I
, O
inhibitors O
of O
the O
nonreceptor B
tyrosine I
kinase I
p59 B
( O
fyn B
) O
, O
PLC B
, O
PKC B
and O
MEK B
and O
an O
activator O
of O
PKC B
, O
phorbol O
- O
12 O
- O
myristate O
- O
13 O
- O
acetate O
( O
PMA O
) O
. O

Alternatively O
, O
PC12 O
- O
E2 O
cells O
were O
submitted O
to O
treatment O
with O
antibodies O
to O
the O
fibroblast B
growth I
factor I
( I
FGF I
) I
receptor I
, O
inhibitors O
of O
the O
nonreceptor B
tyrosine I
kinase I
p59 B
( O
fyn B
) O
, O
PLC B
, O
PKC B
and O
MEK B
and O
an O
activator O
of O
PKC B
, O
phorbol O
- O
12 O
- O
myristate O
- O
13 O
- O
acetate O
( O
PMA O
) O
. O

Alternatively O
, O
PC12 O
- O
E2 O
cells O
were O
submitted O
to O
treatment O
with O
antibodies O
to O
the O
fibroblast B
growth I
factor I
( I
FGF I
) I
receptor I
, O
inhibitors O
of O
the O
nonreceptor B
tyrosine I
kinase I
p59 B
( O
fyn B
) O
, O
PLC B
, O
PKC B
and O
MEK B
and O
an O
activator O
of O
PKC B
, O
phorbol O
- O
12 O
- O
myristate O
- O
13 O
- O
acetate O
( O
PMA O
) O
. O

Cyclin B
- I
dependent I
kinase I
- I
2 I
( O
Cdk2 B
) O
forms O
an O
inactive O
complex O
with O
cyclin B
D1 I
since O
Cdk2 B
associated O
with O
cyclin B
D1 I
is O
not O
phosphorylated O
by O
Cdk7 B
- O
cyclin B
- I
H I
. O

Cyclin B
- I
dependent I
kinase I
- I
2 I
( O
Cdk2 B
) O
forms O
an O
inactive O
complex O
with O
cyclin B
D1 I
since O
Cdk2 B
associated O
with O
cyclin B
D1 I
is O
not O
phosphorylated O
by O
Cdk7 B
- O
cyclin B
- I
H I
. O

Cyclin B
- I
dependent I
kinase I
- I
2 I
( O
Cdk2 B
) O
forms O
an O
inactive O
complex O
with O
cyclin B
D1 I
since O
Cdk2 B
associated O
with O
cyclin B
D1 I
is O
not O
phosphorylated O
by O
Cdk7 B
- O
cyclin B
- I
H I
. O

Expression O
of O
the O
second O
gene O
( O
XT3 B
) O
was O
found O
to O
be O
conserved O
in O
human O
kidney O
, O
and O
partial O
sequence O
was O
obtained O
from O
a O
human O
cDNA O
library O
. O

A O
human O
cytoplasmic O
signaling O
protein O
has O
been O
cloned O
that O
possesses O
the O
same O
structural O
arrangement O
of O
SH3 B
- O
SH2 B
- O
SH3 B
domains O
as O
Grb2 B
. O

A O
human O
cytoplasmic O
signaling O
protein O
has O
been O
cloned O
that O
possesses O
the O
same O
structural O
arrangement O
of O
SH3 B
- O
SH2 B
- O
SH3 B
domains O
as O
Grb2 B
. O

A O
human O
cytoplasmic O
signaling O
protein O
has O
been O
cloned O
that O
possesses O
the O
same O
structural O
arrangement O
of O
SH3 B
- O
SH2 B
- O
SH3 B
domains O
as O
Grb2 B
. O

A O
human O
cytoplasmic O
signaling O
protein O
has O
been O
cloned O
that O
possesses O
the O
same O
structural O
arrangement O
of O
SH3 B
- O
SH2 B
- O
SH3 B
domains O
as O
Grb2 B
. O

The O
epidermal B
growth I
factor I
( I
EGF I
) I
receptor I
, O
which O
exhibits O
intrinsic O
protein B
tyrosine I
kinase I
activity O
, O
undergoes O
a O
rapid O
, O
intramolecular O
self O
- O
phosphorylation O
reaction O
following O
EGF B
activation O
. O

However O
, O
tyrA B
can O
be O
expressed O
efficiently O
from O
an O
internal O
promoter O
which O
appears O
to O
lie O
within O
the O
3 O
' O
portion O
of O
aroF B
. O

However O
, O
tyrA B
can O
be O
expressed O
efficiently O
from O
an O
internal O
promoter O
which O
appears O
to O
lie O
within O
the O
3 O
' O
portion O
of O
aroF B
. O

OKA O
and O
calyculin O
A O
do O
not O
decrease O
OCFRE B
DNA O
- O
protein O
interactions O
, O
suggesting O
that O
important O
protein O
- O
protein O
interactions O
are O
phosphatase O
regulated O
. O

SCID O
V B
( O
D B
) O
J B
recombination O
can O
be O
partly O
rescued O
in O
T O
- O
lymphocytes O
by O
either O
DNA O
- O
damaging O
agents O
( O
gamma O
- O
irradiation O
and O
bieomycin O
) O
or O
a O
null O
mutation O
of O
the O
p53 B
gene I
, O
possibly O
because O
of O
transiently O
elevated O
DNA O
repair O
activity O
in O
response O
to O
DNA O
damage O
or O
to O
delayed O
apoptosis O
in O
the O
absence O
of O
p53 B
. O

SCID O
V B
( O
D B
) O
J B
recombination O
can O
be O
partly O
rescued O
in O
T O
- O
lymphocytes O
by O
either O
DNA O
- O
damaging O
agents O
( O
gamma O
- O
irradiation O
and O
bieomycin O
) O
or O
a O
null O
mutation O
of O
the O
p53 B
gene I
, O
possibly O
because O
of O
transiently O
elevated O
DNA O
repair O
activity O
in O
response O
to O
DNA O
damage O
or O
to O
delayed O
apoptosis O
in O
the O
absence O
of O
p53 B
. O

SCID O
V B
( O
D B
) O
J B
recombination O
can O
be O
partly O
rescued O
in O
T O
- O
lymphocytes O
by O
either O
DNA O
- O
damaging O
agents O
( O
gamma O
- O
irradiation O
and O
bieomycin O
) O
or O
a O
null O
mutation O
of O
the O
p53 B
gene I
, O
possibly O
because O
of O
transiently O
elevated O
DNA O
repair O
activity O
in O
response O
to O
DNA O
damage O
or O
to O
delayed O
apoptosis O
in O
the O
absence O
of O
p53 B
. O

SCID O
V B
( O
D B
) O
J B
recombination O
can O
be O
partly O
rescued O
in O
T O
- O
lymphocytes O
by O
either O
DNA O
- O
damaging O
agents O
( O
gamma O
- O
irradiation O
and O
bieomycin O
) O
or O
a O
null O
mutation O
of O
the O
p53 B
gene I
, O
possibly O
because O
of O
transiently O
elevated O
DNA O
repair O
activity O
in O
response O
to O
DNA O
damage O
or O
to O
delayed O
apoptosis O
in O
the O
absence O
of O
p53 B
. O

These O
cells O
fail O
to O
generate O
the O
signals O
to O
phosphorylate O
CREB B
and O
produce O
significantly O
less O
of O
the O
cytokine O
Interleukin B
- I
2 I
( O
IL B
- I
2 I
) O
in O
response O
to O
agents O
that O
either O
increase O
intracellular O
Ca2 O
+ O
and O
/ O
or O
activate O
protein B
kinase I
C I
. O

Treating O
renal O
anaemia O
with O
recombinant O
human O
erythropoietin B
. O

The O
activated O
glucocorticoid B
receptor I
forms O
a O
complex O
with O
Stat5 B
and O
enhances O
Stat5 B
- O
mediated O
transcriptional O
induction O
. O

The O
activated O
glucocorticoid B
receptor I
forms O
a O
complex O
with O
Stat5 B
and O
enhances O
Stat5 B
- O
mediated O
transcriptional O
induction O
. O

We O
conclude O
that O
RPMS B
acts O
as O
a O
negative O
regulator O
of O
EBNA2 B
and O
Notch B
activity O
through O
its O
interactions O
with O
the O
CBF1 B
- I
associated I
corepressor I
complex I
. O

We O
conclude O
that O
RPMS B
acts O
as O
a O
negative O
regulator O
of O
EBNA2 B
and O
Notch B
activity O
through O
its O
interactions O
with O
the O
CBF1 B
- I
associated I
corepressor I
complex I
. O

We O
conclude O
that O
RPMS B
acts O
as O
a O
negative O
regulator O
of O
EBNA2 B
and O
Notch B
activity O
through O
its O
interactions O
with O
the O
CBF1 B
- I
associated I
corepressor I
complex I
. O

The O
human B
ABCG1 I
gene I
encodes O
a O
member O
of O
the O
ATP B
- I
binding I
cassette I
( O
ABC B
) O
superfamily O
of O
transporter B
proteins I
and O
is O
highly O
induced O
when O
macrophages O
are O
incubated O
with O
oxysterols O
. O

Here O
we O
describe O
an O
in O
vitro O
assay O
where O
the O
NS3 B
- I
4A I
polyprotein I
, O
NS3 B
, O
the O
serine B
proteinase I
domain I
( I
the I
N I
- I
terminal I
181 I
residues I
of I
NS3 I
) I
, O
and O
the O
NS4A B
cofactor I
were O
produced O
by O
cell O
- O
free O
translation O
and O
tested O
for O
trans O
- O
processing O
of O
radiolabeled O
substrates O
. O

The O
genomic O
and O
transcriptional O
complexity O
of O
the O
Crry B
and O
Crry B
- O
ps B
genes O
. O

The O
genomic O
and O
transcriptional O
complexity O
of O
the O
Crry B
and O
Crry B
- O
ps B
genes O
. O

The O
genomic O
and O
transcriptional O
complexity O
of O
the O
Crry B
and O
Crry B
- O
ps B
genes O
. O

These O
results O
indicate O
that O
the O
PCNA B
gene I
is O
a O
likely O
target O
gene O
of O
E2F B
. O

SBF B
binds O
to O
the O
promoter O
prior O
to O
the O
activation O
of O
transcription O
in O
late O
G1 O
, O
suggesting O
that O
Cln B
/ O
Cdc28 B
kinase O
regulates O
the O
ability O
of O
previously O
bound O
SBF B
to O
activate O
transcription O
. O

SBF B
binds O
to O
the O
promoter O
prior O
to O
the O
activation O
of O
transcription O
in O
late O
G1 O
, O
suggesting O
that O
Cln B
/ O
Cdc28 B
kinase O
regulates O
the O
ability O
of O
previously O
bound O
SBF B
to O
activate O
transcription O
. O

SBF B
binds O
to O
the O
promoter O
prior O
to O
the O
activation O
of O
transcription O
in O
late O
G1 O
, O
suggesting O
that O
Cln B
/ O
Cdc28 B
kinase O
regulates O
the O
ability O
of O
previously O
bound O
SBF B
to O
activate O
transcription O
. O

SBF B
binds O
to O
the O
promoter O
prior O
to O
the O
activation O
of O
transcription O
in O
late O
G1 O
, O
suggesting O
that O
Cln B
/ O
Cdc28 B
kinase O
regulates O
the O
ability O
of O
previously O
bound O
SBF B
to O
activate O
transcription O
. O

Altogether O
these O
results O
suggest O
that O
, O
in O
KG1a O
cells O
, O
TNFalpha B
can O
stimulate O
in O
parallel O
PC B
- I
PLC I
and O
PLD B
, O
whose O
lipid O
products O
activate O
in O
turn O
mitogen B
- I
activated I
protein I
kinase I
( O
MAP B
kinase I
) O
and O
NF B
- I
kappaB I
signalling O
respectively O
. O

Altogether O
these O
results O
suggest O
that O
, O
in O
KG1a O
cells O
, O
TNFalpha B
can O
stimulate O
in O
parallel O
PC B
- I
PLC I
and O
PLD B
, O
whose O
lipid O
products O
activate O
in O
turn O
mitogen B
- I
activated I
protein I
kinase I
( O
MAP B
kinase I
) O
and O
NF B
- I
kappaB I
signalling O
respectively O
. O

Interspecific O
backcross O
analysis O
using O
progeny O
derived O
from O
matings O
of O
( O
C57BL O
/ O
6J O
x O
Mus O
spretus O
) O
F1 O
x O
C57BL O
/ O
6J O
mice O
indicates O
that O
the O
thrombospondin B
gene I
is O
tightly O
linked O
to O
the O
Fshb B
, O
Actcl B
, O
Ltk B
, O
and O
B2M B
loci I
on O
murine O
chromosome O
2 O
. O

Interspecific O
backcross O
analysis O
using O
progeny O
derived O
from O
matings O
of O
( O
C57BL O
/ O
6J O
x O
Mus O
spretus O
) O
F1 O
x O
C57BL O
/ O
6J O
mice O
indicates O
that O
the O
thrombospondin B
gene I
is O
tightly O
linked O
to O
the O
Fshb B
, O
Actcl B
, O
Ltk B
, O
and O
B2M B
loci I
on O
murine O
chromosome O
2 O
. O

Interspecific O
backcross O
analysis O
using O
progeny O
derived O
from O
matings O
of O
( O
C57BL O
/ O
6J O
x O
Mus O
spretus O
) O
F1 O
x O
C57BL O
/ O
6J O
mice O
indicates O
that O
the O
thrombospondin B
gene I
is O
tightly O
linked O
to O
the O
Fshb B
, O
Actcl B
, O
Ltk B
, O
and O
B2M B
loci I
on O
murine O
chromosome O
2 O
. O

Surprisingly O
, O
Northern O
( O
RNA O
) O
blot O
analysis O
and O
reverse B
transcriptase I
- O
PCRs O
performed O
after O
transfection O
of O
COS O
- O
7 O
or O
HeLa O
cells O
with O
these O
viral O
RNAs O
revealed O
that O
Y88S B
and O
Y88L B
RNAs I
replicated O
at O
only O
very O
low O
levels O
. O

Deletion O
analyses O
implicate O
the O
N O
- O
terminal O
110 O
amino O
acids O
of O
Grb14 B
and O
ankyrin B
repeats O
10 O
- O
19 O
of O
tankyrase B
2 I
in O
mediating O
this O
interaction O
. O

Deletion O
analyses O
implicate O
the O
N O
- O
terminal O
110 O
amino O
acids O
of O
Grb14 B
and O
ankyrin B
repeats O
10 O
- O
19 O
of O
tankyrase B
2 I
in O
mediating O
this O
interaction O
. O

Plasma O
CCK B
levels O
were O
determined O
at O
regular O
intervals O
. O

The O
algorithm O
also O
limited O
TG O
to O
20 O
and O
64 O
% O
, O
apoB B
to O
6 O
and O
20 O
% O
, O
and O
Lp B
( I
a I
) I
to O
15 O
and O
56 O
% O
, O
of O
low O
- O
and O
high O
- O
risk O
groups O
, O
respectively O
. O

These O
results O
are O
consistent O
with O
the O
roles O
that O
CCK B
and O
trypsin B
inhibitors O
are O
believed O
to O
play O
in O
the O
negative O
feedback O
control O
of O
pancreatic O
exocrine O
function O
. O

These O
results O
are O
consistent O
with O
the O
roles O
that O
CCK B
and O
trypsin B
inhibitors O
are O
believed O
to O
play O
in O
the O
negative O
feedback O
control O
of O
pancreatic O
exocrine O
function O
. O

Surprisingly O
, O
the O
COOH O
- O
terminal O
domain O
of O
RanGAP1 B
was O
also O
found O
to O
harbor O
a O
nuclear O
localization O
signal O
. O

Chloroplast B
mutator I
( O
chm B
) O
of O
Arabidopsis O
is O
a O
recessive O
nuclear O
mutation O
that O
causes O
green O
and O
white O
variegation O
in O
leaves O
and O
is O
inherited O
in O
a O
non O
- O
Mendelian O
fashion O
. O

It O
is O
largely O
predicted O
by O
lupus O
anticoagulant O
( O
estimated O
by O
activated O
partial O
thromboplastin B
time O
) O
and O
/ O
or O
antibody O
to O
cardiolipin O
. O

TNFalpha B
and O
IL B
- I
6 I
levels O
were O
determined O
in O
the O
culture O
supernatants O
. O

Among O
these O
, O
ACT1 B
was O
isolated O
four O
times O
, O
and O
NSR1 B
three O
times O
. O

Among O
these O
, O
ACT1 B
was O
isolated O
four O
times O
, O
and O
NSR1 B
three O
times O
. O

The O
phenotypes O
of O
the O
ICP0 B
nonsense O
mutants O
were O
intermediate O
between O
those O
of O
the O
wild O
- O
type O
virus O
and O
7134 O
in O
that O
the O
more O
ICP0 B
- I
coding I
sequence I
expressed O
by O
a O
given O
nonsense O
mutant O
, O
the O
more O
wild O
type O
- O
like O
was O
its O
phenotype O
. O

From O
sequence O
alignments O
with O
phylogenetically O
related O
viruses O
, O
including O
tymoviruses O
, O
we O
predicted O
that O
p223 B
contained O
a O
papain B
- I
like I
proteinase I
domain I
with O
a O
putative O
catalytic O
cysteine994 O
and O
histidine1075 O
. O

It O
is O
believed O
that O
these O
domains O
are O
important O
for O
directing O
specific O
protein O
- O
protein O
interactions O
necessary O
for O
the O
proper O
functioning O
of O
Src B
. O

By O
contrast O
, O
all O
proteins O
initiated O
with O
a O
methionine O
placed O
one O
residue O
upstream O
of O
the O
natural O
N O
terminus O
of O
PR B
failed O
to O
show O
specific O
proteolysis O
. O

Escherichia O
coli O
BL21 O
( O
DE3 O
) O
plysS O
, O
harbouring O
a O
recombinant O
plasmid O
containing O
the O
catalase B
- O
peroxidase B
gene O
, O
produced O
a O
large O
amount O
of O
proteins O
that O
co O
- O
migrated O
on O
SDS O
/ O
PAGE O
with O
the O
native O
enzyme O
. O

Escherichia O
coli O
BL21 O
( O
DE3 O
) O
plysS O
, O
harbouring O
a O
recombinant O
plasmid O
containing O
the O
catalase B
- O
peroxidase B
gene O
, O
produced O
a O
large O
amount O
of O
proteins O
that O
co O
- O
migrated O
on O
SDS O
/ O
PAGE O
with O
the O
native O
enzyme O
. O

Using O
adenoviral O
transfer O
of O
IkappaBalpha B
( O
IkappaBalpha B
overexpression O
) O
, O
the O
production O
of O
TNF B
- I
alpha I
induced O
by O
whole O
GBS O
was O
inhibited O
by O
only O
20 O
% O
. O

Using O
adenoviral O
transfer O
of O
IkappaBalpha B
( O
IkappaBalpha B
overexpression O
) O
, O
the O
production O
of O
TNF B
- I
alpha I
induced O
by O
whole O
GBS O
was O
inhibited O
by O
only O
20 O
% O
. O

We O
describe O
the O
identification O
and O
initial O
characterization O
of O
neurobeachin B
, O
a O
neuron O
- O
specific O
multidomain O
protein O
of O
327 O
kDa O
with O
a O
high O
- O
affinity O
binding O
site O
( O
K O
( O
d O
) O
, O
10 O
nm O
) O
for O
the O
type B
II I
regulatory I
subunit I
of I
protein I
kinase I
A I
( O
PKA B
RII I
) O
. O

Both O
groups O
were O
subjected O
to O
tests O
of O
delayed O
hypersensitivity O
with O
Candidin B
, O
Trycophytin B
and O
Tuberculin B
. O

Both O
groups O
were O
subjected O
to O
tests O
of O
delayed O
hypersensitivity O
with O
Candidin B
, O
Trycophytin B
and O
Tuberculin B
. O

Both O
groups O
were O
subjected O
to O
tests O
of O
delayed O
hypersensitivity O
with O
Candidin B
, O
Trycophytin B
and O
Tuberculin B
. O

Two O
putative O
Rev B
proteins I
with O
apparent O
molecular O
masses O
of O
18 O
and O
16 O
kDa O
were O
expressed O
by O
p2 B
/ I
2 I
and O
p176 B
, O
while O
p20 B
expressed O
only O
a O
16 O
- O
kDa O
species O
. O

Two O
putative O
Rev B
proteins I
with O
apparent O
molecular O
masses O
of O
18 O
and O
16 O
kDa O
were O
expressed O
by O
p2 B
/ I
2 I
and O
p176 B
, O
while O
p20 B
expressed O
only O
a O
16 O
- O
kDa O
species O
. O

TaqMan O
analysis O
of O
gene O
expression O
following O
chronic O
FA O
treatment O
showed O
neither O
a O
decrease O
in O
the O
amount O
of O
leptin B
receptor I
( O
Ob B
- I
R I
) O
mRNA O
, O
nor O
an O
increase O
in O
the O
negative O
regulators O
of O
STAT B
signalling O
, O
SOCS3 B
( O
suppressors B
of I
cytokine I
signalling I
) O
or O
cytokine B
inducible I
sequence I
( O
CIS B
) O
. O

TaqMan O
analysis O
of O
gene O
expression O
following O
chronic O
FA O
treatment O
showed O
neither O
a O
decrease O
in O
the O
amount O
of O
leptin B
receptor I
( O
Ob B
- I
R I
) O
mRNA O
, O
nor O
an O
increase O
in O
the O
negative O
regulators O
of O
STAT B
signalling O
, O
SOCS3 B
( O
suppressors B
of I
cytokine I
signalling I
) O
or O
cytokine B
inducible I
sequence I
( O
CIS B
) O
. O

TaqMan O
analysis O
of O
gene O
expression O
following O
chronic O
FA O
treatment O
showed O
neither O
a O
decrease O
in O
the O
amount O
of O
leptin B
receptor I
( O
Ob B
- I
R I
) O
mRNA O
, O
nor O
an O
increase O
in O
the O
negative O
regulators O
of O
STAT B
signalling O
, O
SOCS3 B
( O
suppressors B
of I
cytokine I
signalling I
) O
or O
cytokine B
inducible I
sequence I
( O
CIS B
) O
. O

That O
sequence O
strongly O
promoted O
the O
transcription O
of O
the O
promotorless O
chloramphenicol B
acetyltranferase I
( O
CAT B
) O
gene O
in O
cells O
of O
pancreatic O
origin O
( O
AR O
- O
42J O
) O
but O
not O
in O
cells O
of O
non O
- O
pancreatic O
origin O
( O
Rat O
2 O
and O
IEC O
6 O
) O
. O

Fructokinase B
activity O
is O
elevated O
up O
to O
twofold O
when O
Z O
. O
mobilis O
was O
grown O
on O
fructose O
instead O
of O
glucose O
, O
and O
there O
was O
a O
parallel O
increase O
in O
frk B
mRNA I
levels O
. O

We O
have O
determined O
the O
nucleotide O
( O
nt O
) O
sequence O
of O
the O
7 B
. I
5 I
- I
kb I
COR I
segment I
that O
encompasses O
a O
cluster O
of O
six O
genes O
( O
CYC1 B
, O
UTR1 B
, O
UTR3 B
, O
OSM1 B
, O
tRNA B
( I
Gly I
) I
and O
RAD7 B
) O
located O
on O
chromosome O
X O
of O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

We O
have O
determined O
the O
nucleotide O
( O
nt O
) O
sequence O
of O
the O
7 B
. I
5 I
- I
kb I
COR I
segment I
that O
encompasses O
a O
cluster O
of O
six O
genes O
( O
CYC1 B
, O
UTR1 B
, O
UTR3 B
, O
OSM1 B
, O
tRNA B
( I
Gly I
) I
and O
RAD7 B
) O
located O
on O
chromosome O
X O
of O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

We O
have O
determined O
the O
nucleotide O
( O
nt O
) O
sequence O
of O
the O
7 B
. I
5 I
- I
kb I
COR I
segment I
that O
encompasses O
a O
cluster O
of O
six O
genes O
( O
CYC1 B
, O
UTR1 B
, O
UTR3 B
, O
OSM1 B
, O
tRNA B
( I
Gly I
) I
and O
RAD7 B
) O
located O
on O
chromosome O
X O
of O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

We O
have O
determined O
the O
nucleotide O
( O
nt O
) O
sequence O
of O
the O
7 B
. I
5 I
- I
kb I
COR I
segment I
that O
encompasses O
a O
cluster O
of O
six O
genes O
( O
CYC1 B
, O
UTR1 B
, O
UTR3 B
, O
OSM1 B
, O
tRNA B
( I
Gly I
) I
and O
RAD7 B
) O
located O
on O
chromosome O
X O
of O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

We O
have O
determined O
the O
nucleotide O
( O
nt O
) O
sequence O
of O
the O
7 B
. I
5 I
- I
kb I
COR I
segment I
that O
encompasses O
a O
cluster O
of O
six O
genes O
( O
CYC1 B
, O
UTR1 B
, O
UTR3 B
, O
OSM1 B
, O
tRNA B
( I
Gly I
) I
and O
RAD7 B
) O
located O
on O
chromosome O
X O
of O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

Thus O
, O
the O
positive O
effect O
of O
NS1 B
on O
the O
steady O
- O
state O
levels O
of O
P4 B
transcripts I
depends O
on O
the O
amplification O
of O
gene O
copy O
number O
and O
the O
integrity O
of O
the O
terminal O
repeats O
. O

In O
light O
of O
the O
importance O
of O
GnRHR B
, O
the O
molecular O
mechanisms O
underlying O
the O
transcriptional O
regulation O
of O
the O
human B
GnRHR I
( O
hGnRHR B
) O
gene O
become O
a O
key O
issue O
in O
understanding O
human O
reproduction O
. O

In O
light O
of O
the O
importance O
of O
GnRHR B
, O
the O
molecular O
mechanisms O
underlying O
the O
transcriptional O
regulation O
of O
the O
human B
GnRHR I
( O
hGnRHR B
) O
gene O
become O
a O
key O
issue O
in O
understanding O
human O
reproduction O
. O

The O
EPO B
levels O
were O
distinctly O
increased O
before O
transfusion O
; O
they O
did O
not O
significantly O
change O
just O
after O
transfusion O
, O
but O
subsequently O
decreased O
. O

Overexpression O
of O
Trdpm1 B
in O
a O
dpm1 B
( I
+ I
) I
: O
: O
his7 B
/ I
dpm1 I
( I
+ I
) I
S O
. O
pombe O
diploid O
resulted O
in O
a O
4 O
- O
fold O
increase O
in O
specific O
DPM B
synthase I
activity O
. O

This O
dynamic O
response O
strongly O
suggests O
that O
the O
p53 B
and O
Rb B
tumor O
suppressor O
pathways O
are O
intact O
in O
HeLa O
cells O
and O
that O
repression O
of O
HPV B
E6 I
and O
E7 B
mobilizes O
these O
pathways O
in O
an O
orderly O
fashion O
to O
deliver O
growth O
inhibitory O
signals O
to O
the O
cells O
. O

This O
dynamic O
response O
strongly O
suggests O
that O
the O
p53 B
and O
Rb B
tumor O
suppressor O
pathways O
are O
intact O
in O
HeLa O
cells O
and O
that O
repression O
of O
HPV B
E6 I
and O
E7 B
mobilizes O
these O
pathways O
in O
an O
orderly O
fashion O
to O
deliver O
growth O
inhibitory O
signals O
to O
the O
cells O
. O

This O
dynamic O
response O
strongly O
suggests O
that O
the O
p53 B
and O
Rb B
tumor O
suppressor O
pathways O
are O
intact O
in O
HeLa O
cells O
and O
that O
repression O
of O
HPV B
E6 I
and O
E7 B
mobilizes O
these O
pathways O
in O
an O
orderly O
fashion O
to O
deliver O
growth O
inhibitory O
signals O
to O
the O
cells O
. O

The O
Y O
. O
lipolytica O
genomic O
POT1 B
gene O
was O
disrupted O
by O
replacing O
120 O
bp O
of O
its O
coding O
sequence O
with O
2 O
. O
7 O
kbp O
of O
DNA O
including O
the O
Y O
. O
lipolytica O
LEU2 B
gene I
. O

This O
enabled O
the O
formation O
of O
stem O
- O
loop O
templates O
with O
the O
fusion O
point O
of O
the O
chimeric O
transcript O
in O
the O
loop O
and O
the O
use O
of O
MLL B
primers O
in O
two O
- O
sided O
PCR O
. O

The O
specific O
interaction O
between O
a O
defined O
structural O
element O
of O
the O
human O
immunodeficiency O
virus O
mRNA O
( O
RRE B
, O
the O
Rev B
response I
element I
) O
and O
the O
virus B
- I
encoded I
protein I
Rev I
has O
been O
implicated O
in O
the O
regulation O
of O
the O
export O
of O
unspliced O
or O
singly O
spliced O
mRNA O
from O
the O
nucleus O
to O
the O
cytoplasm O
. O

Recent O
studies O
have O
demonstrated O
that O
the O
U1 B
snRNP I
is O
recruited O
to O
the O
5 O
' O
splice O
site O
by O
protein O
/ O
protein O
interactions O
involving O
the O
SR B
domains O
of O
the O
U1 B
- I
70K I
protein I
and O
SF2 B
/ O
ASF B
. O

Recent O
studies O
have O
demonstrated O
that O
the O
U1 B
snRNP I
is O
recruited O
to O
the O
5 O
' O
splice O
site O
by O
protein O
/ O
protein O
interactions O
involving O
the O
SR B
domains O
of O
the O
U1 B
- I
70K I
protein I
and O
SF2 B
/ O
ASF B
. O

Recent O
studies O
have O
demonstrated O
that O
the O
U1 B
snRNP I
is O
recruited O
to O
the O
5 O
' O
splice O
site O
by O
protein O
/ O
protein O
interactions O
involving O
the O
SR B
domains O
of O
the O
U1 B
- I
70K I
protein I
and O
SF2 B
/ O
ASF B
. O

Human O
T O
- O
cell O
leukemia O
virus O
type O
I O
Tax B
activation O
of O
NF B
- I
kappa I
B I
/ O
Rel B
involves O
phosphorylation O
and O
degradation O
of O
I B
kappa I
B I
alpha I
and O
RelA B
( I
p65 I
) I
- O
mediated O
induction O
of O
the O
c B
- I
rel I
gene I
. O

Human O
T O
- O
cell O
leukemia O
virus O
type O
I O
Tax B
activation O
of O
NF B
- I
kappa I
B I
/ O
Rel B
involves O
phosphorylation O
and O
degradation O
of O
I B
kappa I
B I
alpha I
and O
RelA B
( I
p65 I
) I
- O
mediated O
induction O
of O
the O
c B
- I
rel I
gene I
. O

The O
serum O
levels O
of O
beta B
- I
human I
chorionic I
gonadotropin I
( O
HCG B
) O
and O
placental B
alkaline I
phosphatase I
( O
PLAP B
) O
were O
not O
elevated O
. O

The O
serum O
levels O
of O
beta B
- I
human I
chorionic I
gonadotropin I
( O
HCG B
) O
and O
placental B
alkaline I
phosphatase I
( O
PLAP B
) O
were O
not O
elevated O
. O

Merosin B
positive O
congenital O
muscular O
dystrophy O
with O
mental O
deficiency O
, O
epilepsy O
and O
MRI O
changes O
in O
the O
cerebral O
white O
matter O
. O

Effects O
of O
long O
- O
term O
parenteral O
nutrition O
on O
gastrin B
release O
in O
dogs O
. O

The O
binding O
of O
transcription O
factor O
AP B
- I
1 I
and O
vitamin B
D I
receptor I
( O
VDR B
) O
to O
the O
composite O
AP B
- I
1 I
plus I
vitamin I
- I
D I
- I
responsive I
promoter I
region O
( O
AP B
- I
1 I
+ I
VDRE I
) O
of O
the O
human B
osteocalcin I
gene I
was O
characterized O
in O
osteocalcin B
- O
producing O
( O
MG O
- O
63 O
) O
and O
non O
- O
producing O
( O
U2 O
- O
Os O
, O
SaOs O
- O
2 O
) O
human O
osteosarcoma O
cell O
lines O
. O

The O
binding O
of O
transcription O
factor O
AP B
- I
1 I
and O
vitamin B
D I
receptor I
( O
VDR B
) O
to O
the O
composite O
AP B
- I
1 I
plus I
vitamin I
- I
D I
- I
responsive I
promoter I
region O
( O
AP B
- I
1 I
+ I
VDRE I
) O
of O
the O
human B
osteocalcin I
gene I
was O
characterized O
in O
osteocalcin B
- O
producing O
( O
MG O
- O
63 O
) O
and O
non O
- O
producing O
( O
U2 O
- O
Os O
, O
SaOs O
- O
2 O
) O
human O
osteosarcoma O
cell O
lines O
. O

To O
better O
understand O
the O
role O
of O
Ets B
proteins I
in O
Ras B
transformation O
, O
we O
have O
now O
analyzed O
the O
effects O
of O
stably O
expressing O
a O
variety O
of O
Ets2 B
constructs I
in O
Ras B
- O
transformed O
NIH3T3 O
( O
DT O
) O
cells O
. O

To O
better O
understand O
the O
role O
of O
Ets B
proteins I
in O
Ras B
transformation O
, O
we O
have O
now O
analyzed O
the O
effects O
of O
stably O
expressing O
a O
variety O
of O
Ets2 B
constructs I
in O
Ras B
- O
transformed O
NIH3T3 O
( O
DT O
) O
cells O
. O

Peroxisome B
proliferator I
- I
activated I
receptors I
( O
PPAR B
) O
modulate O
transcription O
by O
binding O
to O
specific O
peroxisome O
proliferator O
- O
response O
elements O
( O
PPRE O
) O
through O
heterodimerization O
with O
the O
9 B
- I
cis I
retinoic I
acid I
receptor I
( O
RXR B
) O
. O

Peroxisome B
proliferator I
- I
activated I
receptors I
( O
PPAR B
) O
modulate O
transcription O
by O
binding O
to O
specific O
peroxisome O
proliferator O
- O
response O
elements O
( O
PPRE O
) O
through O
heterodimerization O
with O
the O
9 B
- I
cis I
retinoic I
acid I
receptor I
( O
RXR B
) O
. O

Mutational O
analyses O
have O
demonstrated O
the O
importance O
of O
sequences O
within O
the O
327 O
bp O
segment O
that O
contain O
a O
putative O
cyclic B
AMP I
responsive I
element I
binding I
protein I
( O
CREB B
) O
binding O
site O
for O
TGF B
- I
beta I
1 I
and O
PMA O
responsiveness O
and O
putative O
PU B
- I
1 I
and O
Sp1 B
binding I
sites I
for O
basal O
promoter O
activity O
. O

Along O
with O
previously O
mapped O
genes O
including O
Ly B
- I
1 I
and O
CD20 B
, O
OSBP B
defines O
a O
new O
conserved O
syntenic O
group O
on O
the O
long O
arm O
of O
chromosome O
11 O
in O
the O
human O
and O
the O
proximal O
end O
of O
chromosome O
19 O
in O
the O
mouse O
. O

Along O
with O
previously O
mapped O
genes O
including O
Ly B
- I
1 I
and O
CD20 B
, O
OSBP B
defines O
a O
new O
conserved O
syntenic O
group O
on O
the O
long O
arm O
of O
chromosome O
11 O
in O
the O
human O
and O
the O
proximal O
end O
of O
chromosome O
19 O
in O
the O
mouse O
. O

In O
a O
gntR B
deletion I
mutant I
, O
the O
expression O
of O
a O
chromosomal O
gntT B
: O
: O
lacZ B
fusion O
is O
both O
high O
and O
constitutive O
, O
confirming O
that O
GntR B
is O
the O
negative O
regulator O
of O
gntT B
. O

In O
a O
gntR B
deletion I
mutant I
, O
the O
expression O
of O
a O
chromosomal O
gntT B
: O
: O
lacZ B
fusion O
is O
both O
high O
and O
constitutive O
, O
confirming O
that O
GntR B
is O
the O
negative O
regulator O
of O
gntT B
. O

In O
a O
gntR B
deletion I
mutant I
, O
the O
expression O
of O
a O
chromosomal O
gntT B
: O
: O
lacZ B
fusion O
is O
both O
high O
and O
constitutive O
, O
confirming O
that O
GntR B
is O
the O
negative O
regulator O
of O
gntT B
. O

In O
a O
gntR B
deletion I
mutant I
, O
the O
expression O
of O
a O
chromosomal O
gntT B
: O
: O
lacZ B
fusion O
is O
both O
high O
and O
constitutive O
, O
confirming O
that O
GntR B
is O
the O
negative O
regulator O
of O
gntT B
. O

The O
chloramphenicol B
- I
resistance I
transposon I
Tn4451 B
undergoes O
precise O
conjugative O
deletion O
from O
its O
parent O
plasmid O
plP401 O
in O
Clostridium O
perfringens O
and O
precise O
spontaneous O
excision O
from O
multicopy O
plasmids O
in O
Escherichia O
coli O
. O

Also O
like O
the O
thrombin B
receptor I
, O
PAR2 B
can O
be O
activated O
by O
the O
hexapeptide O
corresponding O
to O
its O
tethered O
ligand O
sequence O
independent O
of O
receptor O
cleavage O
. O

Expression O
of O
a O
hybrid O
protein O
containing O
the O
cytoplasmic O
C O
- O
terminal O
half O
of O
UhpB B
fused O
to O
glutathione B
S I
- I
transferase I
( O
GST B
) O
also O
interfered O
with O
Uhp B
signaling O
. O

Expression O
of O
a O
hybrid O
protein O
containing O
the O
cytoplasmic O
C O
- O
terminal O
half O
of O
UhpB B
fused O
to O
glutathione B
S I
- I
transferase I
( O
GST B
) O
also O
interfered O
with O
Uhp B
signaling O
. O

Expression O
of O
a O
hybrid O
protein O
containing O
the O
cytoplasmic O
C O
- O
terminal O
half O
of O
UhpB B
fused O
to O
glutathione B
S I
- I
transferase I
( O
GST B
) O
also O
interfered O
with O
Uhp B
signaling O
. O

Significantly O
, O
two O
proximal O
GATA B
- I
1 I
- I
binding I
sites I
( O
- O
118 O
/ O
- O
113 O
and O
- O
98 O
/ O
- O
93 O
) O
and O
a O
region O
located O
within O
- O
518 O
to O
- O
315bp O
of O
the O
mouse B
ALAS2 I
promoter I
were O
essential O
for O
transcriptional O
activation O
during O
chemically O
induced O
differentiation O
of O
MEL O
cells O
, O
implying O
their O
importance O
in O
conferring O
erythroid O
specificity O
to O
the O
ALAS2 B
transcriptional O
activation O
. O

In O
rlf2 B
mutants I
, O
telomeric O
chromatin O
is O
perturbed O
: O
Telomeric O
silencing O
is O
reduced O
and O
Rap1p B
localization O
is O
altered O
. O

The O
only O
abundant O
viral O
transcript O
expressed O
during O
latency O
is O
the O
latency B
- I
related I
( O
LR B
) O
RNA O
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
RP B
, O
like O
the O
20S B
proteasome I
, O
is O
functionally O
and O
structurally O
conserved O
among O
eukaryotes O
and O
indicate O
that O
the O
plant B
RPT I
subunits I
, O
like O
their O
yeast O
counterparts O
, O
have O
non O
- O
redundant O
functions O
. O

In O
contrast O
, O
exogenous B
PTHrP1 I
- I
34 I
and I
1 I
- I
86 I
peptides I
did O
not O
significantly O
affect O
IL B
- I
8 I
production O
; O
moreover O
, O
PTHrP B
- I
neutralizing I
antibodies I
did O
not O
inhibit O
the O
production O
of O
IL B
- I
8 I
by O
transfected O
PTHrP B
. O

Analysis O
with O
additional O
anti O
- O
peptide O
antibodies O
specific O
for O
alpha B
, I
beta I
, I
or I
gamma I
PKC I
indicated O
that O
all O
three O
types O
of O
PKC B
are O
expressed O
in O
JK O
cells O
; O
however O
, O
JKPE O
cells O
lost O
a O
major O
approximately O
82 O
kDa O
immunoreactive O
cytosolic O
protein O
detectable O
with O
anti B
- I
PKC I
alpha I
antibody I
. O

The O
urinary O
protein O
, O
serum O
albumin B
, O
BUN O
and O
SCr O
all O
had O
very O
significant O
improvement O
. O

MEKs B
and O
ERKs B
inhibited O
IL B
- I
6 I
activation O
of O
Stat3 B
harboring O
a O
mutation O
at O
serine O
- O
727 O
, O
the O
major O
site O
for O
serine O
phosphorylation O
, O
similar O
to O
inhibition O
of O
wild B
- I
type I
Stat3 I
, O
and O
inhibited O
Janus B
kinases I
Jak1 B
and O
Jak2 B
upstream O
of O
Stat3 B
in O
the O
Jak B
- O
STAT B
- O
signaling O
pathway O
. O

MEKs B
and O
ERKs B
inhibited O
IL B
- I
6 I
activation O
of O
Stat3 B
harboring O
a O
mutation O
at O
serine O
- O
727 O
, O
the O
major O
site O
for O
serine O
phosphorylation O
, O
similar O
to O
inhibition O
of O
wild B
- I
type I
Stat3 I
, O
and O
inhibited O
Janus B
kinases I
Jak1 B
and O
Jak2 B
upstream O
of O
Stat3 B
in O
the O
Jak B
- O
STAT B
- O
signaling O
pathway O
. O

MEKs B
and O
ERKs B
inhibited O
IL B
- I
6 I
activation O
of O
Stat3 B
harboring O
a O
mutation O
at O
serine O
- O
727 O
, O
the O
major O
site O
for O
serine O
phosphorylation O
, O
similar O
to O
inhibition O
of O
wild B
- I
type I
Stat3 I
, O
and O
inhibited O
Janus B
kinases I
Jak1 B
and O
Jak2 B
upstream O
of O
Stat3 B
in O
the O
Jak B
- O
STAT B
- O
signaling O
pathway O
. O

MEKs B
and O
ERKs B
inhibited O
IL B
- I
6 I
activation O
of O
Stat3 B
harboring O
a O
mutation O
at O
serine O
- O
727 O
, O
the O
major O
site O
for O
serine O
phosphorylation O
, O
similar O
to O
inhibition O
of O
wild B
- I
type I
Stat3 I
, O
and O
inhibited O
Janus B
kinases I
Jak1 B
and O
Jak2 B
upstream O
of O
Stat3 B
in O
the O
Jak B
- O
STAT B
- O
signaling O
pathway O
. O

MEKs B
and O
ERKs B
inhibited O
IL B
- I
6 I
activation O
of O
Stat3 B
harboring O
a O
mutation O
at O
serine O
- O
727 O
, O
the O
major O
site O
for O
serine O
phosphorylation O
, O
similar O
to O
inhibition O
of O
wild B
- I
type I
Stat3 I
, O
and O
inhibited O
Janus B
kinases I
Jak1 B
and O
Jak2 B
upstream O
of O
Stat3 B
in O
the O
Jak B
- O
STAT B
- O
signaling O
pathway O
. O

MEKs B
and O
ERKs B
inhibited O
IL B
- I
6 I
activation O
of O
Stat3 B
harboring O
a O
mutation O
at O
serine O
- O
727 O
, O
the O
major O
site O
for O
serine O
phosphorylation O
, O
similar O
to O
inhibition O
of O
wild B
- I
type I
Stat3 I
, O
and O
inhibited O
Janus B
kinases I
Jak1 B
and O
Jak2 B
upstream O
of O
Stat3 B
in O
the O
Jak B
- O
STAT B
- O
signaling O
pathway O
. O

MEKs B
and O
ERKs B
inhibited O
IL B
- I
6 I
activation O
of O
Stat3 B
harboring O
a O
mutation O
at O
serine O
- O
727 O
, O
the O
major O
site O
for O
serine O
phosphorylation O
, O
similar O
to O
inhibition O
of O
wild B
- I
type I
Stat3 I
, O
and O
inhibited O
Janus B
kinases I
Jak1 B
and O
Jak2 B
upstream O
of O
Stat3 B
in O
the O
Jak B
- O
STAT B
- O
signaling O
pathway O
. O

MEKs B
and O
ERKs B
inhibited O
IL B
- I
6 I
activation O
of O
Stat3 B
harboring O
a O
mutation O
at O
serine O
- O
727 O
, O
the O
major O
site O
for O
serine O
phosphorylation O
, O
similar O
to O
inhibition O
of O
wild B
- I
type I
Stat3 I
, O
and O
inhibited O
Janus B
kinases I
Jak1 B
and O
Jak2 B
upstream O
of O
Stat3 B
in O
the O
Jak B
- O
STAT B
- O
signaling O
pathway O
. O

Tryptic O
cleavage O
and O
peptide O
sequence O
analysis O
demonstrated O
that O
the O
98 O
- O
kD O
protein O
is O
identical O
to O
a O
recently O
cloned O
protein O
, O
special B
A I
- I
T I
- I
rich I
binding I
protein I
1 I
( O
SATB1 B
) O
, O
that O
binds O
selectively O
to O
nuclear O
matrix O
/ O
scaffold O
- O
associated O
regions O
of O
DNA O
( O
MARs O
/ O
SARs O
) O
. O

The O
predicted O
domain O
structures O
of O
FkbB B
and O
FkbC B
are O
analogous O
to O
that O
of O
FkbA B
and O
comprise O
30 O
fatty B
- I
acid I
- I
synthase I
( O
FAS B
) O
- O
like O
domains O
arranged O
in O
6 O
modules O
. O

The O
predicted O
domain O
structures O
of O
FkbB B
and O
FkbC B
are O
analogous O
to O
that O
of O
FkbA B
and O
comprise O
30 O
fatty B
- I
acid I
- I
synthase I
( O
FAS B
) O
- O
like O
domains O
arranged O
in O
6 O
modules O
. O

The O
predicted O
domain O
structures O
of O
FkbB B
and O
FkbC B
are O
analogous O
to O
that O
of O
FkbA B
and O
comprise O
30 O
fatty B
- I
acid I
- I
synthase I
( O
FAS B
) O
- O
like O
domains O
arranged O
in O
6 O
modules O
. O

The O
predicted O
domain O
structures O
of O
FkbB B
and O
FkbC B
are O
analogous O
to O
that O
of O
FkbA B
and O
comprise O
30 O
fatty B
- I
acid I
- I
synthase I
( O
FAS B
) O
- O
like O
domains O
arranged O
in O
6 O
modules O
. O

S2F B
, O
a O
leaf O
- O
specific O
trans O
- O
acting O
factor O
, O
binds O
to O
a O
novel O
cis O
- O
acting O
element O
and O
differentially O
activates O
the O
RPL21 B
gene I
. O

We O
further O
demonstrate O
that O
the O
Stress B
- I
Activated I
- I
Protein I
- I
Kinase I
( O
SAPK B
) O
target O
sites O
of O
ATF2 B
, O
Thr69 O
and O
Thr71 O
are O
not O
required O
for O
the O
formation O
of O
the O
p300 B
/ O
CBP B
- O
ATF2 B
multiprotein O
complex O
. O

We O
further O
demonstrate O
that O
the O
Stress B
- I
Activated I
- I
Protein I
- I
Kinase I
( O
SAPK B
) O
target O
sites O
of O
ATF2 B
, O
Thr69 O
and O
Thr71 O
are O
not O
required O
for O
the O
formation O
of O
the O
p300 B
/ O
CBP B
- O
ATF2 B
multiprotein O
complex O
. O

We O
further O
demonstrate O
that O
the O
Stress B
- I
Activated I
- I
Protein I
- I
Kinase I
( O
SAPK B
) O
target O
sites O
of O
ATF2 B
, O
Thr69 O
and O
Thr71 O
are O
not O
required O
for O
the O
formation O
of O
the O
p300 B
/ O
CBP B
- O
ATF2 B
multiprotein O
complex O
. O

We O
further O
demonstrate O
that O
the O
Stress B
- I
Activated I
- I
Protein I
- I
Kinase I
( O
SAPK B
) O
target O
sites O
of O
ATF2 B
, O
Thr69 O
and O
Thr71 O
are O
not O
required O
for O
the O
formation O
of O
the O
p300 B
/ O
CBP B
- O
ATF2 B
multiprotein O
complex O
. O

We O
further O
demonstrate O
that O
the O
Stress B
- I
Activated I
- I
Protein I
- I
Kinase I
( O
SAPK B
) O
target O
sites O
of O
ATF2 B
, O
Thr69 O
and O
Thr71 O
are O
not O
required O
for O
the O
formation O
of O
the O
p300 B
/ O
CBP B
- O
ATF2 B
multiprotein O
complex O
. O

In O
all O
sessions O
under O
IFN B
, O
the O
latency O
of O
the O
P100 O
component O
of O
the O
VEP O
was O
shortened O
as O
compared O
to O
baseline O
conditions O
. O

Analysis O
of O
disassociation O
rates O
indicates O
that O
the O
Grf10 B
- O
Swi5 B
- O
DNA O
complex O
has O
a O
longer O
half O
- O
life O
than O
protein O
- O
DNA O
complexes O
that O
contain O
only O
Swi5 B
or O
Grf10 B
. O

Analysis O
of O
disassociation O
rates O
indicates O
that O
the O
Grf10 B
- O
Swi5 B
- O
DNA O
complex O
has O
a O
longer O
half O
- O
life O
than O
protein O
- O
DNA O
complexes O
that O
contain O
only O
Swi5 B
or O
Grf10 B
. O

Analysis O
of O
disassociation O
rates O
indicates O
that O
the O
Grf10 B
- O
Swi5 B
- O
DNA O
complex O
has O
a O
longer O
half O
- O
life O
than O
protein O
- O
DNA O
complexes O
that O
contain O
only O
Swi5 B
or O
Grf10 B
. O

Analysis O
of O
disassociation O
rates O
indicates O
that O
the O
Grf10 B
- O
Swi5 B
- O
DNA O
complex O
has O
a O
longer O
half O
- O
life O
than O
protein O
- O
DNA O
complexes O
that O
contain O
only O
Swi5 B
or O
Grf10 B
. O

Several O
genes O
or O
transcriptional O
units O
were O
identified O
, O
including O
the O
3 O
' O
end O
of O
ribosomal B
s6 I
kinase I
( O
Rsk3 B
) O
; O
two O
apparently O
intronless O
and O
ORF O
- O
less O
genes O
; O
and O
Gpr31 B
, O
an O
intronless O
, O
putative O
G B
- I
protein I
coupled I
receptor I
. O

Several O
genes O
or O
transcriptional O
units O
were O
identified O
, O
including O
the O
3 O
' O
end O
of O
ribosomal B
s6 I
kinase I
( O
Rsk3 B
) O
; O
two O
apparently O
intronless O
and O
ORF O
- O
less O
genes O
; O
and O
Gpr31 B
, O
an O
intronless O
, O
putative O
G B
- I
protein I
coupled I
receptor I
. O

Its O
transcription O
product O
, O
a O
1 O
. O
3 O
kb O
mRNA O
, O
is O
polyadenylated O
at O
a O
site O
containing O
consensus O
eukaryotic O
polyadenylation O
signals O
and O
mapping O
87 O
bp O
downstream O
of O
the O
translation O
termination O
codon O
for O
CG30 B
. O

Mus81p B
also O
shares O
homology O
with O
motifs O
found O
in O
the O
XPF B
endonuclease I
superfamily I
. O

Plectin B
and O
desmoplakin B
have O
GSR O
- O
containing O
domains O
at O
their O
C O
- O
termini O
and O
we O
further O
demonstrate O
that O
the O
GSR O
- O
containing O
domain O
of O
plectin B
, O
but O
not O
desmoplakin B
, O
can O
bind O
to O
MTs O
in O
vivo O
. O

Plectin B
and O
desmoplakin B
have O
GSR O
- O
containing O
domains O
at O
their O
C O
- O
termini O
and O
we O
further O
demonstrate O
that O
the O
GSR O
- O
containing O
domain O
of O
plectin B
, O
but O
not O
desmoplakin B
, O
can O
bind O
to O
MTs O
in O
vivo O
. O

Plectin B
and O
desmoplakin B
have O
GSR O
- O
containing O
domains O
at O
their O
C O
- O
termini O
and O
we O
further O
demonstrate O
that O
the O
GSR O
- O
containing O
domain O
of O
plectin B
, O
but O
not O
desmoplakin B
, O
can O
bind O
to O
MTs O
in O
vivo O
. O

Plectin B
and O
desmoplakin B
have O
GSR O
- O
containing O
domains O
at O
their O
C O
- O
termini O
and O
we O
further O
demonstrate O
that O
the O
GSR O
- O
containing O
domain O
of O
plectin B
, O
but O
not O
desmoplakin B
, O
can O
bind O
to O
MTs O
in O
vivo O
. O

Interaction O
of O
HRI B
with O
Hsc70 B
was O
required O
for O
the O
transformation O
of O
HRI B
, O
as O
the O
Hsc70 B
antagonist O
clofibric O
acid O
inhibited O
the O
folding O
of O
HRI B
into O
a O
mature O
- O
competent O
conformation O
. O

Interaction O
of O
HRI B
with O
Hsc70 B
was O
required O
for O
the O
transformation O
of O
HRI B
, O
as O
the O
Hsc70 B
antagonist O
clofibric O
acid O
inhibited O
the O
folding O
of O
HRI B
into O
a O
mature O
- O
competent O
conformation O
. O

Interaction O
of O
HRI B
with O
Hsc70 B
was O
required O
for O
the O
transformation O
of O
HRI B
, O
as O
the O
Hsc70 B
antagonist O
clofibric O
acid O
inhibited O
the O
folding O
of O
HRI B
into O
a O
mature O
- O
competent O
conformation O
. O

Interaction O
of O
HRI B
with O
Hsc70 B
was O
required O
for O
the O
transformation O
of O
HRI B
, O
as O
the O
Hsc70 B
antagonist O
clofibric O
acid O
inhibited O
the O
folding O
of O
HRI B
into O
a O
mature O
- O
competent O
conformation O
. O

Interaction O
of O
HRI B
with O
Hsc70 B
was O
required O
for O
the O
transformation O
of O
HRI B
, O
as O
the O
Hsc70 B
antagonist O
clofibric O
acid O
inhibited O
the O
folding O
of O
HRI B
into O
a O
mature O
- O
competent O
conformation O
. O

The O
proteasome O
is O
a O
large O
complex O
consisting O
of O
two O
multisubunit O
structures O
, O
the O
20S B
and O
19S B
( O
PA700 B
) O
or O
P28 B
complexes I
, O
that O
combine O
to O
form O
the O
26S B
particles I
. O

The O
proteasome O
is O
a O
large O
complex O
consisting O
of O
two O
multisubunit O
structures O
, O
the O
20S B
and O
19S B
( O
PA700 B
) O
or O
P28 B
complexes I
, O
that O
combine O
to O
form O
the O
26S B
particles I
. O

The O
proteasome O
is O
a O
large O
complex O
consisting O
of O
two O
multisubunit O
structures O
, O
the O
20S B
and O
19S B
( O
PA700 B
) O
or O
P28 B
complexes I
, O
that O
combine O
to O
form O
the O
26S B
particles I
. O

The O
SSB B
- O
poly O
( O
dT O
) O
affinity O
is O
too O
high O
to O
measure O
in O
buffers O
containing O
even O
5 O
M O
NaCl O
; O
however O
, O
in O
1 O
. O
8 O
- O
2 O
. O
5 O
M O
NaBr O
, O
we O
measure O
alpha O
log O
Kobsd O
/ O
alpha O
log O
[ O
NaBr O
] O
= O
- O
5 O
. O
7 O
+ O
/ O
- O
0 O
. O
7 O
, O
with O
a O
lower O
value O
of O
omega O
T O
/ O
O O
= O
130 O
+ O
/ O
- O
70 O
. O

Agonist O
- O
induced O
receptor O
internalization O
, O
determined O
as O
the O
percent O
of O
total O
[ O
125I O
] O
Tyr0 B
- I
oCRF I
bound O
located O
in O
the O
acid O
- O
resistant O
fraction O
of O
transfected O
Cos O
7 O
cells O
, O
increased O
with O
time O
( O
0 O
- O
60 O
min O
at O
37 O
degrees O
C O
) O
for O
both O
wild O
- O
type O
and O
variant O
oCRF1 B
. O

Toward O
this O
end O
, O
we O
prepared O
synthetic O
proteins O
with O
either O
the O
catalytic O
domain O
of O
FAP B
- I
1 I
( I
C I
- I
terminal I
399 I
amino I
acids I
) I
or O
its O
inactive O
form O
( O
Cys2408 O
- O
- O
> O
Ser O
) O
fused O
to O
glutathione B
- I
S I
- I
transferase I
( O
GST B
) O
. O

Structure O
and O
expression O
of O
the O
alternative O
sigma B
factor I
, O
RpoN B
, O
in O
Rhodobacter O
capsulatus O
; O
physiological O
relevance O
of O
an O
autoactivated O
nifU2 B
- O
rpoN B
superoperon O
. O

Structure O
and O
expression O
of O
the O
alternative O
sigma B
factor I
, O
RpoN B
, O
in O
Rhodobacter O
capsulatus O
; O
physiological O
relevance O
of O
an O
autoactivated O
nifU2 B
- O
rpoN B
superoperon O
. O

Structure O
and O
expression O
of O
the O
alternative O
sigma B
factor I
, O
RpoN B
, O
in O
Rhodobacter O
capsulatus O
; O
physiological O
relevance O
of O
an O
autoactivated O
nifU2 B
- O
rpoN B
superoperon O
. O

Here O
we O
focused O
on O
the O
role O
of O
the O
5 O
' O
proximal O
regulatory O
cassette O
( O
- O
190 O
; O
+ O
53 O
bp O
) O
of O
the O
rat B
enkephalin I
( O
rENK B
) O
gene O
in O
the O
developmental O
regulation O
of O
the O
enkephalin B
phenotype O
. O

Here O
we O
focused O
on O
the O
role O
of O
the O
5 O
' O
proximal O
regulatory O
cassette O
( O
- O
190 O
; O
+ O
53 O
bp O
) O
of O
the O
rat B
enkephalin I
( O
rENK B
) O
gene O
in O
the O
developmental O
regulation O
of O
the O
enkephalin B
phenotype O
. O

The O
transcription O
factor O
Jun B
( O
c B
- I
Jun I
) O
functions O
as O
a O
recipient O
of O
extracellular O
growth O
signals O
and O
converts O
them O
into O
patterns O
of O
gene O
expression O
. O

Phd B
antibody O
- O
immunoreactive O
peptides O
are O
seen O
in O
light O
- O
adapted O
mouse O
retinal O
cytosolic O
and O
nuclear O
extracts O
. O

Our O
observations O
suggest O
that O
members O
of O
the O
HMG B
- I
I I
family I
play O
an O
important O
role O
in O
SRF B
- O
dependent O
transcription O
and O
that O
their O
effect O
is O
mediated O
primarily O
by O
a O
protein O
- O
protein O
interaction O
. O

Expression O
of O
the O
dibasic O
proprotein O
processing O
enzyme O
furin B
is O
directed O
by O
multiple O
promoters O
. O

A O
suspected O
hypothalamic O
dysfunction O
and O
a O
slightly O
impaired O
pituitary O
function O
manifested O
as O
GH B
deficiency O
were O
their O
common O
endocrinological O
features O
. O

The O
NarX B
and O
NarQ B
proteins I
with O
amino O
acid O
substitutions O
at O
the O
first O
conserved O
histidine O
position O
were O
also O
unable O
to O
dephosphorylate O
NarL B
- O
phosphate O
in O
vitro O
. O

The O
NarX B
and O
NarQ B
proteins I
with O
amino O
acid O
substitutions O
at O
the O
first O
conserved O
histidine O
position O
were O
also O
unable O
to O
dephosphorylate O
NarL B
- O
phosphate O
in O
vitro O
. O

Using O
immunogold O
electron O
microscopy O
, O
we O
found O
that O
p58 B
/ O
p45 B
and O
p54 B
are O
localized O
on O
both O
sides O
of O
the O
nuclear O
pore O
complex O
, O
like O
p62 B
. O

Using O
immunogold O
electron O
microscopy O
, O
we O
found O
that O
p58 B
/ O
p45 B
and O
p54 B
are O
localized O
on O
both O
sides O
of O
the O
nuclear O
pore O
complex O
, O
like O
p62 B
. O

Using O
immunogold O
electron O
microscopy O
, O
we O
found O
that O
p58 B
/ O
p45 B
and O
p54 B
are O
localized O
on O
both O
sides O
of O
the O
nuclear O
pore O
complex O
, O
like O
p62 B
. O

Using O
immunogold O
electron O
microscopy O
, O
we O
found O
that O
p58 B
/ O
p45 B
and O
p54 B
are O
localized O
on O
both O
sides O
of O
the O
nuclear O
pore O
complex O
, O
like O
p62 B
. O

Our O
results O
indicate O
that O
the O
minimal O
requirements O
for O
induction O
of O
PEPCK B
by O
PKA B
and O
inhibition O
by O
insulin B
include O
: O
1 O
) O
the O
CREB B
activation I
domain I
, O
2 O
) O
the O
PEPCK B
TATA I
sequence I
, O
and O
3 O
) O
insulin B
- O
responsive O
hepatoma O
cells O
. O

Our O
results O
indicate O
that O
the O
minimal O
requirements O
for O
induction O
of O
PEPCK B
by O
PKA B
and O
inhibition O
by O
insulin B
include O
: O
1 O
) O
the O
CREB B
activation I
domain I
, O
2 O
) O
the O
PEPCK B
TATA I
sequence I
, O
and O
3 O
) O
insulin B
- O
responsive O
hepatoma O
cells O
. O

Our O
results O
indicate O
that O
the O
minimal O
requirements O
for O
induction O
of O
PEPCK B
by O
PKA B
and O
inhibition O
by O
insulin B
include O
: O
1 O
) O
the O
CREB B
activation I
domain I
, O
2 O
) O
the O
PEPCK B
TATA I
sequence I
, O
and O
3 O
) O
insulin B
- O
responsive O
hepatoma O
cells O
. O

Our O
results O
indicate O
that O
the O
minimal O
requirements O
for O
induction O
of O
PEPCK B
by O
PKA B
and O
inhibition O
by O
insulin B
include O
: O
1 O
) O
the O
CREB B
activation I
domain I
, O
2 O
) O
the O
PEPCK B
TATA I
sequence I
, O
and O
3 O
) O
insulin B
- O
responsive O
hepatoma O
cells O
. O

Regulation O
of O
Gax B
homeobox B
gene I
transcription O
by O
a O
combination O
of O
positive O
factors O
including O
myocyte B
- I
specific I
enhancer I
factor I
2 I
. O

Although O
the O
Src B
tyrosine I
kinase I
induces O
constitutive O
Stat3 B
phosphorylation O
on O
tyrosine O
, O
activation O
of O
Stat3 B
- O
mediated O
gene O
regulation O
requires O
both O
tyrosine O
and O
serine O
phosphorylation O
of O
Stat3 B
. O

Although O
the O
Src B
tyrosine I
kinase I
induces O
constitutive O
Stat3 B
phosphorylation O
on O
tyrosine O
, O
activation O
of O
Stat3 B
- O
mediated O
gene O
regulation O
requires O
both O
tyrosine O
and O
serine O
phosphorylation O
of O
Stat3 B
. O

Although O
the O
Src B
tyrosine I
kinase I
induces O
constitutive O
Stat3 B
phosphorylation O
on O
tyrosine O
, O
activation O
of O
Stat3 B
- O
mediated O
gene O
regulation O
requires O
both O
tyrosine O
and O
serine O
phosphorylation O
of O
Stat3 B
. O

The O
recognition O
specificity O
of O
the O
p55 B
PDZ B
domain I
appears O
to O
be O
unique O
, O
since O
the O
three O
PDZ B
domains I
of O
hDlg B
( O
human O
lymphocyte O
homologue O
of O
the O
Drosophila B
discs I
large I
tumor I
suppressor I
) O
do O
not O
bind O
the O
cytoplasmic O
domain O
of O
glycophorin B
C I
. O

The O
recognition O
specificity O
of O
the O
p55 B
PDZ B
domain I
appears O
to O
be O
unique O
, O
since O
the O
three O
PDZ B
domains I
of O
hDlg B
( O
human O
lymphocyte O
homologue O
of O
the O
Drosophila B
discs I
large I
tumor I
suppressor I
) O
do O
not O
bind O
the O
cytoplasmic O
domain O
of O
glycophorin B
C I
. O

Cytosolic B
acetyl I
- I
CoA I
synthetase I
( O
AceCS1 B
) O
activates O
acetate O
to O
supply O
the O
cells O
with O
acetyl O
- O
CoA O
for O
lipid O
synthesis O
. O

The O
Cdk2 B
- O
cyclin B
- I
D1 I
complex O
did O
not O
phosphorylate O
any O
tested O
substrates O
, O
such O
as O
H1 B
histone I
, O
pRB B
, O
SV40 B
large I
T I
antigen I
, O
p53 B
, O
E2F B
- I
1 I
or O
a O
preparation O
of O
nuclear O
proteins O
from O
HeLa O
cells O
; O
in O
contrast O
, O
Cdk2 B
- O
cyclin B
- I
E I
and O
Cdk2 B
- O
cyclin B
- I
A I
phosphorylated O
these O
proteins O
. O

The O
Cdk2 B
- O
cyclin B
- I
D1 I
complex O
did O
not O
phosphorylate O
any O
tested O
substrates O
, O
such O
as O
H1 B
histone I
, O
pRB B
, O
SV40 B
large I
T I
antigen I
, O
p53 B
, O
E2F B
- I
1 I
or O
a O
preparation O
of O
nuclear O
proteins O
from O
HeLa O
cells O
; O
in O
contrast O
, O
Cdk2 B
- O
cyclin B
- I
E I
and O
Cdk2 B
- O
cyclin B
- I
A I
phosphorylated O
these O
proteins O
. O

The O
Cdk2 B
- O
cyclin B
- I
D1 I
complex O
did O
not O
phosphorylate O
any O
tested O
substrates O
, O
such O
as O
H1 B
histone I
, O
pRB B
, O
SV40 B
large I
T I
antigen I
, O
p53 B
, O
E2F B
- I
1 I
or O
a O
preparation O
of O
nuclear O
proteins O
from O
HeLa O
cells O
; O
in O
contrast O
, O
Cdk2 B
- O
cyclin B
- I
E I
and O
Cdk2 B
- O
cyclin B
- I
A I
phosphorylated O
these O
proteins O
. O

The O
Cdk2 B
- O
cyclin B
- I
D1 I
complex O
did O
not O
phosphorylate O
any O
tested O
substrates O
, O
such O
as O
H1 B
histone I
, O
pRB B
, O
SV40 B
large I
T I
antigen I
, O
p53 B
, O
E2F B
- I
1 I
or O
a O
preparation O
of O
nuclear O
proteins O
from O
HeLa O
cells O
; O
in O
contrast O
, O
Cdk2 B
- O
cyclin B
- I
E I
and O
Cdk2 B
- O
cyclin B
- I
A I
phosphorylated O
these O
proteins O
. O

The O
Cdk2 B
- O
cyclin B
- I
D1 I
complex O
did O
not O
phosphorylate O
any O
tested O
substrates O
, O
such O
as O
H1 B
histone I
, O
pRB B
, O
SV40 B
large I
T I
antigen I
, O
p53 B
, O
E2F B
- I
1 I
or O
a O
preparation O
of O
nuclear O
proteins O
from O
HeLa O
cells O
; O
in O
contrast O
, O
Cdk2 B
- O
cyclin B
- I
E I
and O
Cdk2 B
- O
cyclin B
- I
A I
phosphorylated O
these O
proteins O
. O

The O
relatively O
mild O
defects O
observed O
in O
Rpd3 B
mutants I
suggest O
that O
the O
recently O
identified O
Groucho B
and O
dCtBP B
corepressor I
proteins I
do O
not O
function O
solely O
through O
the O
recruitment O
of O
histone B
deacetylases I
. O

A O
mutant O
( O
residues O
1 O
- O
332 O
) O
showed O
complete O
Ca2 O
+ O
/ O
CaM B
- O
dependent O
activity O
. O

These O
data O
further O
define O
a O
role O
for O
TRADD B
and O
TRAF2 B
in O
JNK B
activation O
and O
confirm O
that O
LMP1 B
utilizes O
signalling O
mechanisms O
used O
by O
the O
TNF B
receptor I
/ O
CD40 B
family O
to O
elicit O
its O
pleiotropic O
activities O
. O

These O
data O
further O
define O
a O
role O
for O
TRADD B
and O
TRAF2 B
in O
JNK B
activation O
and O
confirm O
that O
LMP1 B
utilizes O
signalling O
mechanisms O
used O
by O
the O
TNF B
receptor I
/ O
CD40 B
family O
to O
elicit O
its O
pleiotropic O
activities O
. O

These O
data O
further O
define O
a O
role O
for O
TRADD B
and O
TRAF2 B
in O
JNK B
activation O
and O
confirm O
that O
LMP1 B
utilizes O
signalling O
mechanisms O
used O
by O
the O
TNF B
receptor I
/ O
CD40 B
family O
to O
elicit O
its O
pleiotropic O
activities O
. O

These O
data O
further O
define O
a O
role O
for O
TRADD B
and O
TRAF2 B
in O
JNK B
activation O
and O
confirm O
that O
LMP1 B
utilizes O
signalling O
mechanisms O
used O
by O
the O
TNF B
receptor I
/ O
CD40 B
family O
to O
elicit O
its O
pleiotropic O
activities O
. O

These O
data O
further O
define O
a O
role O
for O
TRADD B
and O
TRAF2 B
in O
JNK B
activation O
and O
confirm O
that O
LMP1 B
utilizes O
signalling O
mechanisms O
used O
by O
the O
TNF B
receptor I
/ O
CD40 B
family O
to O
elicit O
its O
pleiotropic O
activities O
. O

These O
results O
demonstrate O
the O
existence O
of O
different O
PI B
3 I
- I
kinase I
isoforms I
and O
define O
a O
family O
of O
genes O
encoding O
distinct O
PI B
3 I
- I
kinase I
catalytic I
subunits I
that O
can O
associate O
with O
p85 B
. O

The O
immune O
system O
is O
closely O
integrated O
with O
the O
neuroendocrine O
system O
, O
and O
infection O
- O
induced O
increases O
in O
cytokines O
such O
as O
IL B
- I
1 I
, O
IL B
- I
6 I
and O
TNF B
have O
numerous O
effects O
on O
the O
central O
nervous O
system O
. O

Thus O
, O
the O
tri O
- O
snRNP O
- O
specific O
27K O
protein O
could O
potentially O
be O
involved O
in O
SR B
protein O
- O
mediated O
protein O
/ O
protein O
interactions O
and O
, O
additionally O
, O
its O
phosphorylation O
state O
could O
modulate O
pre O
- O
mRNA O
splicing O
. O

Here O
we O
localize O
a O
transferable O
40 O
- O
amino O
acid O
region O
within O
the O
LBDs B
of O
RXR B
, O
RAR B
, O
TR B
, O
and O
chicken B
ovalbumin I
upstream I
promoter I
transcription I
factor I
that O
is O
critical O
for O
determining O
identity O
in O
the O
heterodimeric O
interaction O
and O
for O
high O
- O
affinity O
DNA O
binding O
. O

Here O
we O
localize O
a O
transferable O
40 O
- O
amino O
acid O
region O
within O
the O
LBDs B
of O
RXR B
, O
RAR B
, O
TR B
, O
and O
chicken B
ovalbumin I
upstream I
promoter I
transcription I
factor I
that O
is O
critical O
for O
determining O
identity O
in O
the O
heterodimeric O
interaction O
and O
for O
high O
- O
affinity O
DNA O
binding O
. O

Here O
we O
localize O
a O
transferable O
40 O
- O
amino O
acid O
region O
within O
the O
LBDs B
of O
RXR B
, O
RAR B
, O
TR B
, O
and O
chicken B
ovalbumin I
upstream I
promoter I
transcription I
factor I
that O
is O
critical O
for O
determining O
identity O
in O
the O
heterodimeric O
interaction O
and O
for O
high O
- O
affinity O
DNA O
binding O
. O

Here O
we O
localize O
a O
transferable O
40 O
- O
amino O
acid O
region O
within O
the O
LBDs B
of O
RXR B
, O
RAR B
, O
TR B
, O
and O
chicken B
ovalbumin I
upstream I
promoter I
transcription I
factor I
that O
is O
critical O
for O
determining O
identity O
in O
the O
heterodimeric O
interaction O
and O
for O
high O
- O
affinity O
DNA O
binding O
. O

Mutation O
of O
the O
octamer O
element O
also O
significantly O
reduced O
the O
ability O
of O
HDAC1 B
to O
confer O
repression O
of O
inducible O
HLA B
- I
DRA I
promoter I
activation O
. O

The O
AtERF B
genes I
were O
differentially O
regulated O
by O
ethylene O
and O
by O
abiotic O
stress O
conditions O
, O
such O
as O
wounding O
, O
cold O
, O
high O
salinity O
, O
or O
drought O
, O
via O
ETHYLENE B
- I
INSENSITIVE2 I
( O
EIN2 B
) O
- O
dependent O
or O
- O
independent O
pathways O
. O

Therefore O
, O
we O
conclude O
that O
DnaA B
may O
contact O
the O
beta O
subunit O
of O
RNA B
polymerase I
during O
activation O
of O
the O
pR B
promoter I
. O

The O
presence O
of O
truncated O
receptor O
isoforms O
in O
diverse O
species O
suggests O
that O
these O
proteins O
may O
have O
important O
functional O
roles O
in O
regulating O
EGFR B
activity O
. O

It O
is O
present O
in O
the O
nucleus O
of O
the O
cells O
in O
which O
it O
is O
expressed O
and O
can O
phosphorylate O
and O
activate O
the O
cyclic B
AMP I
response I
element I
binding I
proteins I
CREB B
and O
CREM B
tau I
in O
a O
manner O
analogous O
to O
protein B
kinase I
A I
. O

We O
postulate O
that O
CaM B
binding O
by O
HIV B
envelope I
proteins I
is O
likely O
to O
exert O
diverse O
modulatory O
effects O
, O
and O
the O
mechanism O
for O
HIV O
- O
induced O
cytotoxicity O
may O
involve O
, O
in O
part O
, O
inhibition O
of O
CaM B
- O
regulated O
cellular O
functions O
. O

We O
postulate O
that O
CaM B
binding O
by O
HIV B
envelope I
proteins I
is O
likely O
to O
exert O
diverse O
modulatory O
effects O
, O
and O
the O
mechanism O
for O
HIV O
- O
induced O
cytotoxicity O
may O
involve O
, O
in O
part O
, O
inhibition O
of O
CaM B
- O
regulated O
cellular O
functions O
. O

Further O
, O
Ser O
/ O
Thr O
phosphorylation O
of O
downstream O
molecules O
Akt B
and O
p70 B
S6 I
kinase I
was O
inhibited O
. O

In O
addition O
, O
expected O
decreases O
in O
ATIC B
enzymatic O
function O
in O
ATIC B
- O
ALK B
- O
containing O
lymphomas O
may O
render O
these O
tumors O
more O
sensitive O
to O
antifolate O
drugs O
such O
as O
methotrexate O
. O

In O
addition O
, O
expected O
decreases O
in O
ATIC B
enzymatic O
function O
in O
ATIC B
- O
ALK B
- O
containing O
lymphomas O
may O
render O
these O
tumors O
more O
sensitive O
to O
antifolate O
drugs O
such O
as O
methotrexate O
. O

In O
addition O
, O
expected O
decreases O
in O
ATIC B
enzymatic O
function O
in O
ATIC B
- O
ALK B
- O
containing O
lymphomas O
may O
render O
these O
tumors O
more O
sensitive O
to O
antifolate O
drugs O
such O
as O
methotrexate O
. O

The O
malate B
synthase I
gene I
, O
MLS1 B
, O
of O
the O
yeast O
Saccharomyces O
cerevisiae O
is O
transcriptionally O
regulated O
by O
the O
carbon O
source O
in O
the O
growth O
medium O
. O

At O
temperatures O
permissive O
for O
transformation O
, O
6m2 O
cells O
contain O
P58gag B
produced O
from O
the O
4 O
. O
0 O
- O
kilobase O
( O
kb O
) O
viral O
RNA O
genome O
and O
P85gag B
- O
mos B
translated O
from O
a O
3 O
. O
5 O
- O
kb O
spliced O
mRNA O
. O

At O
temperatures O
permissive O
for O
transformation O
, O
6m2 O
cells O
contain O
P58gag B
produced O
from O
the O
4 O
. O
0 O
- O
kilobase O
( O
kb O
) O
viral O
RNA O
genome O
and O
P85gag B
- O
mos B
translated O
from O
a O
3 O
. O
5 O
- O
kb O
spliced O
mRNA O
. O

At O
temperatures O
permissive O
for O
transformation O
, O
6m2 O
cells O
contain O
P58gag B
produced O
from O
the O
4 O
. O
0 O
- O
kilobase O
( O
kb O
) O
viral O
RNA O
genome O
and O
P85gag B
- O
mos B
translated O
from O
a O
3 O
. O
5 O
- O
kb O
spliced O
mRNA O
. O

ENV B
also O
was O
secreted O
from O
P O
. O
pastoris O
using O
the O
S B
. I
cerevisiae I
alpha I
- I
factor I
prepro I
secretion I
leader I
and O
the O
S B
. I
cerevisiae I
invertase I
signal I
sequence I
. O

Functional O
rearranged O
antibody O
genes O
were O
detected O
with O
JH B
and O
VH B
heavy I
chain I
probes O
and O
with O
Jk B
and O
Vk B
light I
chain I
probes O
. O

Functional O
rearranged O
antibody O
genes O
were O
detected O
with O
JH B
and O
VH B
heavy I
chain I
probes O
and O
with O
Jk B
and O
Vk B
light I
chain I
probes O
. O

Differential O
association O
of O
products O
of O
alternative O
transcripts O
of O
the O
candidate O
tumor B
suppressor I
ING1 I
with O
the O
mSin3 B
/ O
HDAC1 B
transcriptional O
corepressor O
complex O
. O

Differential O
association O
of O
products O
of O
alternative O
transcripts O
of O
the O
candidate O
tumor B
suppressor I
ING1 I
with O
the O
mSin3 B
/ O
HDAC1 B
transcriptional O
corepressor O
complex O
. O

During O
both O
encephalopathy O
episodes O
, O
CSF O
protein O
and O
immunoglobulin B
G I
( O
IgG B
) O
levels O
were O
elevated O
without O
an O
increased O
IgG B
index O
or O
IgG B
synthesis O
rate O
. O

During O
both O
encephalopathy O
episodes O
, O
CSF O
protein O
and O
immunoglobulin B
G I
( O
IgG B
) O
levels O
were O
elevated O
without O
an O
increased O
IgG B
index O
or O
IgG B
synthesis O
rate O
. O

During O
both O
encephalopathy O
episodes O
, O
CSF O
protein O
and O
immunoglobulin B
G I
( O
IgG B
) O
levels O
were O
elevated O
without O
an O
increased O
IgG B
index O
or O
IgG B
synthesis O
rate O
. O

Expression O
of O
h6 O
. O
1 O
in O
COS O
- O
1 O
cells O
led O
to O
the O
production O
of O
a O
typical O
type B
IV I
PDE I
activity O
in O
that O
cAMP O
, O
but O
not O
cGMP O
, O
served O
as O
substrate O
and O
its O
activity O
was O
insensitive O
to O
either O
Ca2 O
+ O
/ O
CaM B
or O
cGMP O
but O
was O
inhibited O
by O
low O
concentrations O
of O
rolipram O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

The O
amino O
acid O
sequences O
of O
the O
predicted O
RfbA B
and O
RfbB B
homologs I
showed O
identities O
of O
75 O
. O
7 O
% O
( O
87 O
. O
9 O
% O
total O
similarity O
) O
and O
78 O
. O
0 O
% O
( O
86 O
. O
5 O
% O
total O
similarity O
) O
, O
respectively O
. O

Striking O
sequence O
similarities O
( O
57 O
and O
53 O
% O
) O
were O
observed O
with O
yeast O
mitochondrial O
proteins O
, O
SMF1 B
and O
SMF2 B
, O
especially O
within O
putative O
functional O
domains O
: O
exon O
6 O
encoding O
the O
second O
transmembrane O
spanning O
domain O
, O
site O
of O
the O
murine B
susceptibility I
mutation O
; O
and O
exon O
11 O
encoding O
a O
conserved O
transport O
motif O
. O

Striking O
sequence O
similarities O
( O
57 O
and O
53 O
% O
) O
were O
observed O
with O
yeast O
mitochondrial O
proteins O
, O
SMF1 B
and O
SMF2 B
, O
especially O
within O
putative O
functional O
domains O
: O
exon O
6 O
encoding O
the O
second O
transmembrane O
spanning O
domain O
, O
site O
of O
the O
murine B
susceptibility I
mutation O
; O
and O
exon O
11 O
encoding O
a O
conserved O
transport O
motif O
. O

These O
data O
locate O
the O
aniridia B
gene I
( O
AN2 B
) O
and O
a O
recurrent O
T B
- I
cell I
leukemia I
breakpoint I
( O
TCL2 B
) O
in O
the O
marker O
sequence O
, O
on O
opposite O
sides O
of O
MIC1 B
. O

These O
data O
locate O
the O
aniridia B
gene I
( O
AN2 B
) O
and O
a O
recurrent O
T B
- I
cell I
leukemia I
breakpoint I
( O
TCL2 B
) O
in O
the O
marker O
sequence O
, O
on O
opposite O
sides O
of O
MIC1 B
. O

These O
data O
locate O
the O
aniridia B
gene I
( O
AN2 B
) O
and O
a O
recurrent O
T B
- I
cell I
leukemia I
breakpoint I
( O
TCL2 B
) O
in O
the O
marker O
sequence O
, O
on O
opposite O
sides O
of O
MIC1 B
. O

In O
vivo O
association O
between O
Shb B
- O
SH3 B
domain O
proteins O
v B
- I
Src I
and O
Eps8 B
was O
detected O
by O
coimmunoprecipitation O
. O

In O
vivo O
association O
between O
Shb B
- O
SH3 B
domain O
proteins O
v B
- I
Src I
and O
Eps8 B
was O
detected O
by O
coimmunoprecipitation O
. O

In O
vivo O
association O
between O
Shb B
- O
SH3 B
domain O
proteins O
v B
- I
Src I
and O
Eps8 B
was O
detected O
by O
coimmunoprecipitation O
. O

IE2 B
- O
IE2 B
interactions O
were O
mapped O
to O
a O
domain O
containing O
a O
putative O
helix O
- O
turn O
- O
helix O
motif O
located O
near O
the O
C O
terminus O
of O
IE2 B
, O
between O
amino O
acids O
456 O
and O
539 O
. O

IE2 B
- O
IE2 B
interactions O
were O
mapped O
to O
a O
domain O
containing O
a O
putative O
helix O
- O
turn O
- O
helix O
motif O
located O
near O
the O
C O
terminus O
of O
IE2 B
, O
between O
amino O
acids O
456 O
and O
539 O
. O

IE2 B
- O
IE2 B
interactions O
were O
mapped O
to O
a O
domain O
containing O
a O
putative O
helix O
- O
turn O
- O
helix O
motif O
located O
near O
the O
C O
terminus O
of O
IE2 B
, O
between O
amino O
acids O
456 O
and O
539 O
. O

In O
addition O
, O
another O
derivative O
of O
pCMVJS21 O
( O
pCMVJS21DeltaGP O
) O
in O
which O
the O
gag B
, O
pol B
( O
and O
orf B
- I
x I
) O
coding O
sequences O
were O
deleted O
also O
gave O
transformed O
foci O
. O

In O
addition O
, O
another O
derivative O
of O
pCMVJS21 O
( O
pCMVJS21DeltaGP O
) O
in O
which O
the O
gag B
, O
pol B
( O
and O
orf B
- I
x I
) O
coding O
sequences O
were O
deleted O
also O
gave O
transformed O
foci O
. O

Analysis O
of O
the O
protein O
sequences O
of O
these O
two O
replicases B
, O
together O
with O
previously O
characterized O
H B
. I
pylori I
plasmid I
replication I
proteins I
, O
supports O
the O
formation O
of O
a O
distinct O
class O
of O
H B
. I
pylori I
plasmid I
proteins I
. O

At O
Cabras O
( O
Oristano O
) O
, O
a O
town O
characterized O
by O
a O
high O
incidence O
of O
thalassaemia O
and O
G6PD B
deficiency O
less O
than O
half O
the O
people O
between O
18 O
and O
35 O
have O
a O
fair O
knowledge O
of O
genetic O
diseases O
and O
of O
their O
prevention O
. O

The O
coding O
sequences O
of O
the O
Crry B
gene I
encompass O
over O
25 O
kb O
of O
DNA O
, O
whereas O
the O
Crry B
- O
ps B
sequences O
are O
included O
within O
a O
single O
5 B
. I
6 I
- I
kb I
Eco I
- I
R1 I
fragment I
. O

The O
coding O
sequences O
of O
the O
Crry B
gene I
encompass O
over O
25 O
kb O
of O
DNA O
, O
whereas O
the O
Crry B
- O
ps B
sequences O
are O
included O
within O
a O
single O
5 B
. I
6 I
- I
kb I
Eco I
- I
R1 I
fragment I
. O

We O
found O
that O
PML B
was O
expressed O
at O
a O
lower O
level O
in O
S O
, O
G2 O
, O
and O
M O
phases O
and O
at O
a O
significantly O
higher O
level O
in O
G1 O
phase O
. O

The O
localization O
of O
ZAP B
- I
70 I
to O
the O
cell O
cortex O
is O
, O
therefore O
, O
regulated O
by O
the O
activity O
of O
SRC B
- I
family I
kinases I
, O
independently O
of O
their O
ability O
to O
phosphorylate O
immunoreceptor O
tyrosine O
- O
based O
activation O
motifs O
of O
the O
TCR B
. O

The O
227 O
- O
to O
- O
239 O
region O
blocked O
ADR1 B
activity O
independently O
of O
the O
TAD B
present O
on O
ADR1 B
, O
ADR1 B
DNA O
binding O
, O
and O
specific O
ADH2 B
promoter I
sequences I
. O

The O
227 O
- O
to O
- O
239 O
region O
blocked O
ADR1 B
activity O
independently O
of O
the O
TAD B
present O
on O
ADR1 B
, O
ADR1 B
DNA O
binding O
, O
and O
specific O
ADH2 B
promoter I
sequences I
. O

The O
227 O
- O
to O
- O
239 O
region O
blocked O
ADR1 B
activity O
independently O
of O
the O
TAD B
present O
on O
ADR1 B
, O
ADR1 B
DNA O
binding O
, O
and O
specific O
ADH2 B
promoter I
sequences I
. O

The O
227 O
- O
to O
- O
239 O
region O
blocked O
ADR1 B
activity O
independently O
of O
the O
TAD B
present O
on O
ADR1 B
, O
ADR1 B
DNA O
binding O
, O
and O
specific O
ADH2 B
promoter I
sequences I
. O

Our O
results O
show O
that O
CVN B
specifically O
recognizes O
with O
nanomolar O
affinity O
Man O
( O
9 O
) O
GlcNAc O
( O
2 O
) O
and O
the O
D1D3 O
isomer O
of O
Man O
( O
8 O
) O
GlcNAc O
( O
2 O
) O
. O

SL1 B
trans O
- O
splicing O
specified O
by O
AU O
- O
rich O
synthetic O
RNA O
inserted O
at O
the O
5 O
' O
end O
of O
Caenorhabditis O
elegans O
pre O
- O
mRNA O
. O

The O
seventh O
cysteine O
residue O
of O
CTSE B
is O
located O
within O
the O
activation O
peptide O
region O
of O
the O
proenzyme O
. O

The O
chick O
axon O
- O
associated O
surface O
glycoprotein O
neurofascin B
is O
implicated O
in O
axonal O
growth O
and O
fasciculation O
as O
revealed O
by O
antibody O
perturbation O
experiments O
. O

Cdk2 B
formed O
a O
complex O
with O
cyclin B
D1 I
in O
this O
system O
. O

Five O
cell O
strains O
of O
human O
dermal O
fibroblasts O
were O
each O
treated O
with O
three O
samples O
of O
burn O
blister O
fluid O
and O
the O
effect O
compared O
with O
the O
rate O
of O
contraction O
of O
free O
floating O
fibroblast O
populated O
collagen B
lattices O
( O
FPCL O
) O
. O

Recent O
studies O
using O
isolated O
rat O
adipocytes O
and O
chemically O
synthesized O
PIG O
compounds O
point O
to O
IRS1 B
/ I
3 I
tyrosine O
phosphorylation O
by O
p59Lyn B
kinase I
as O
the O
site O
of O
cross O
- O
talk O
, O
the O
negative O
regulation O
of O
which O
by O
interaction O
with O
caveolin B
is O
apparently O
abrogated O
by O
PIG O
. O

Genes O
for O
ocs B
element I
binding I
factors I
( O
OBFs B
) O
, O
belonging O
to O
a O
specific O
class O
of O
basic B
- I
region I
leucine I
zipper I
( I
bZIP I
) I
transcription I
factors I
, O
have O
been O
isolated O
in O
a O
number O
of O
plants O
. O

The O
remainder O
( O
18 O
. O
4 O
% O
) O
was O
with O
IgA B
nephropathy O
, O
which O
was O
histologically O
mild O
. O

We O
cloned O
the O
third O
human O
gene O
for O
the O
LD78 B
, O
termed O
LD78 B
gamma I
and O
the O
sequence O
analysis O
showed O
that O
it O
is O
a O
5 O
' O
- O
truncated O
pseudogene O
. O

Two O
mammalian O
enzymes O
, O
the O
haem B
- I
controlled I
repressor I
( O
HCR B
) O
and O
the O
double B
- I
stranded I
RNA I
- I
activated I
inhibitor I
( O
dsI B
) O
, O
phosphorylate O
Ser O
- O
51 O
of O
the O
alpha O
subunit O
, O
thereby O
inhibiting O
the O
exchange O
of O
bound O
nucleotides O
on O
, O
and O
thus O
the O
recycling O
of O
, O
eIF B
- I
2 I
. O

Two O
mammalian O
enzymes O
, O
the O
haem B
- I
controlled I
repressor I
( O
HCR B
) O
and O
the O
double B
- I
stranded I
RNA I
- I
activated I
inhibitor I
( O
dsI B
) O
, O
phosphorylate O
Ser O
- O
51 O
of O
the O
alpha O
subunit O
, O
thereby O
inhibiting O
the O
exchange O
of O
bound O
nucleotides O
on O
, O
and O
thus O
the O
recycling O
of O
, O
eIF B
- I
2 I
. O

Polypyrimidine O
and O
ssDNA O
binding O
by O
the O
isolated O
VH B
domain I
of O
immunization O
- O
induced O
anti O
- O
Z O
- O
DNA O
Ab O
resembles O
the O
activity O
of O
natural O
autoantibodies O
and O
suggests O
that O
VH B
- O
dependent O
binding O
to O
a O
ligand O
mimicked O
by O
polypyrimidines O
may O
play O
a O
role O
in O
B O
cell O
selection O
before O
immunization O
with O
Z O
- O
DNA O
. O

We O
have O
been O
studying O
the O
interaction O
of O
the O
oncogenic O
human O
polyomavirus O
BK O
( O
BKV O
) O
with O
the O
tumor B
- I
suppressor I
protein I
p53 I
to O
understand O
the O
biology O
of O
this O
virus O
as O
well O
as O
to O
understand O
the O
basic O
mechanisms O
of O
p53 B
transactivation O
. O

These O
results O
suggest O
that O
, O
for O
the O
HML B
ARS O
cluster O
( O
ARS303 B
, O
ARS320 B
, O
and O
ARS302 B
) O
, O
inactivity O
of O
origins O
is O
independent O
of O
local O
transcriptional O
silencing O
, O
even O
though O
origins O
and O
silencers O
share O
key O
cis O
- O
and O
trans O
- O
acting O
components O
. O

These O
results O
suggest O
that O
, O
for O
the O
HML B
ARS O
cluster O
( O
ARS303 B
, O
ARS320 B
, O
and O
ARS302 B
) O
, O
inactivity O
of O
origins O
is O
independent O
of O
local O
transcriptional O
silencing O
, O
even O
though O
origins O
and O
silencers O
share O
key O
cis O
- O
and O
trans O
- O
acting O
components O
. O

These O
results O
suggest O
that O
, O
for O
the O
HML B
ARS O
cluster O
( O
ARS303 B
, O
ARS320 B
, O
and O
ARS302 B
) O
, O
inactivity O
of O
origins O
is O
independent O
of O
local O
transcriptional O
silencing O
, O
even O
though O
origins O
and O
silencers O
share O
key O
cis O
- O
and O
trans O
- O
acting O
components O
. O

These O
results O
suggest O
that O
, O
for O
the O
HML B
ARS O
cluster O
( O
ARS303 B
, O
ARS320 B
, O
and O
ARS302 B
) O
, O
inactivity O
of O
origins O
is O
independent O
of O
local O
transcriptional O
silencing O
, O
even O
though O
origins O
and O
silencers O
share O
key O
cis O
- O
and O
trans O
- O
acting O
components O
. O

Northern O
blot O
analysis O
with O
one O
of O
the O
PARNAs B
revealed O
a O
highly O
abundant O
signal O
of O
approximately O
2 O
. O
0 O
kilobases O
( O
kb O
) O
present O
in O
all O
cell O
lines O
tested O
. O

In O
addition O
, O
we O
identified O
two O
mutations O
, O
Delta O
M1281 O
and O
IVS51 O
+ O
5G O
- O
- O
> O
A O
, O
in O
a O
German O
USH1 B
patient O
. O

Furthermore O
, O
deletion O
and O
mutation O
analyses O
of O
the O
VCAM B
- I
1 I
promoter I
performed O
with O
chloramphenicol B
acetyltransferase I
constructs I
revealed O
that O
Tax B
was O
trans O
activating O
the O
VCAM B
- I
1 I
promoter I
via O
two O
NF B
- I
kappaB I
sites I
present O
at O
bp O
- O
72 O
and O
- O
57 O
in O
the O
VCAM B
- I
1 I
gene I
promoter I
, O
with O
both O
of O
them O
being O
required O
for O
the O
Tax B
- O
induced O
expression O
of O
this O
adhesion O
molecule O
. O

Furthermore O
, O
deletion O
and O
mutation O
analyses O
of O
the O
VCAM B
- I
1 I
promoter I
performed O
with O
chloramphenicol B
acetyltransferase I
constructs I
revealed O
that O
Tax B
was O
trans O
activating O
the O
VCAM B
- I
1 I
promoter I
via O
two O
NF B
- I
kappaB I
sites I
present O
at O
bp O
- O
72 O
and O
- O
57 O
in O
the O
VCAM B
- I
1 I
gene I
promoter I
, O
with O
both O
of O
them O
being O
required O
for O
the O
Tax B
- O
induced O
expression O
of O
this O
adhesion O
molecule O
. O

In O
this O
study O
we O
provide O
evidence O
that O
B B
- I
Myb I
is O
a O
direct O
physiological O
target O
for O
cyclin B
A I
/ O
Cdk2 B
. O

During O
treatment O
, O
the O
phosphorylation O
state O
of O
Rb B
shifted O
to O
a O
hypophosphorylated O
form O
. O

mRNA O
for O
the O
HPV O
E6 B
/ O
E7 B
genes O
decreased O
; O
however O
, O
significant O
changes O
in O
the O
E7 B
protein I
were O
not O
observed O
, O
while O
increased O
levels O
of O
Rb B
immunoprecipitated O
with O
anti B
- I
E7 I
antibodies I
were O
observed O
. O

mRNA O
for O
the O
HPV O
E6 B
/ O
E7 B
genes O
decreased O
; O
however O
, O
significant O
changes O
in O
the O
E7 B
protein I
were O
not O
observed O
, O
while O
increased O
levels O
of O
Rb B
immunoprecipitated O
with O
anti B
- I
E7 I
antibodies I
were O
observed O
. O

mRNA O
for O
the O
HPV O
E6 B
/ O
E7 B
genes O
decreased O
; O
however O
, O
significant O
changes O
in O
the O
E7 B
protein I
were O
not O
observed O
, O
while O
increased O
levels O
of O
Rb B
immunoprecipitated O
with O
anti B
- I
E7 I
antibodies I
were O
observed O
. O

Southern O
blot O
hybridization O
experiments O
suggest O
the O
presence O
of O
one O
copy O
of O
Atcys1 B
, O
Athyp1 B
and O
AKin10 B
per O
haploid O
genome O
, O
and O
Northern O
blot O
analysis O
demonstrates O
that O
the O
three O
genes O
are O
differentially O
expressed O
in O
roots O
, O
shoots O
and O
leaves O
. O

Southern O
blot O
hybridization O
experiments O
suggest O
the O
presence O
of O
one O
copy O
of O
Atcys1 B
, O
Athyp1 B
and O
AKin10 B
per O
haploid O
genome O
, O
and O
Northern O
blot O
analysis O
demonstrates O
that O
the O
three O
genes O
are O
differentially O
expressed O
in O
roots O
, O
shoots O
and O
leaves O
. O

Southern O
blot O
hybridization O
experiments O
suggest O
the O
presence O
of O
one O
copy O
of O
Atcys1 B
, O
Athyp1 B
and O
AKin10 B
per O
haploid O
genome O
, O
and O
Northern O
blot O
analysis O
demonstrates O
that O
the O
three O
genes O
are O
differentially O
expressed O
in O
roots O
, O
shoots O
and O
leaves O
. O

The O
two O
- O
hybrid O
assay O
was O
then O
performed O
using O
full O
- O
length O
genes O
of O
CI B
, O
HC B
- I
Pro I
, O
P1 B
, O
P3 B
, O
and O
CP B
, O
but O
no O
heterologous O
interactions O
were O
detected O
. O

The O
two O
- O
hybrid O
assay O
was O
then O
performed O
using O
full O
- O
length O
genes O
of O
CI B
, O
HC B
- I
Pro I
, O
P1 B
, O
P3 B
, O
and O
CP B
, O
but O
no O
heterologous O
interactions O
were O
detected O
. O

The O
two O
- O
hybrid O
assay O
was O
then O
performed O
using O
full O
- O
length O
genes O
of O
CI B
, O
HC B
- I
Pro I
, O
P1 B
, O
P3 B
, O
and O
CP B
, O
but O
no O
heterologous O
interactions O
were O
detected O
. O

The O
two O
- O
hybrid O
assay O
was O
then O
performed O
using O
full O
- O
length O
genes O
of O
CI B
, O
HC B
- I
Pro I
, O
P1 B
, O
P3 B
, O
and O
CP B
, O
but O
no O
heterologous O
interactions O
were O
detected O
. O

CPDs O
at O
these O
three O
sites O
may O
partially O
displace O
TFIIIA B
, O
thereby O
enabling O
rapid O
repair O
. O

NF B
- I
kappaB I
is O
involved O
in O
the O
regulation O
of O
CD154 B
( O
CD40 B
ligand I
) O
expression O
in O
primary O
human O
T O
cells O
. O

Since O
the O
UfAP B
and O
UTMP B
share O
many O
biosynthetic O
and O
structural O
features O
that O
include O
site O
of O
biosynthesis O
in O
the O
endometrium O
, O
P4 O
- O
responsiveness O
, O
the O
presence O
of O
the O
mannose O
6 O
- O
phosphate O
lysosomal O
recognition O
marker O
, O
and O
considerable O
sequence O
similarity O
, O
the O
UfAP B
and O
the O
UTMP B
may O
have O
homologous O
function O
which O
for O
both O
still O
remains O
obscure O
. O

Since O
the O
UfAP B
and O
UTMP B
share O
many O
biosynthetic O
and O
structural O
features O
that O
include O
site O
of O
biosynthesis O
in O
the O
endometrium O
, O
P4 O
- O
responsiveness O
, O
the O
presence O
of O
the O
mannose O
6 O
- O
phosphate O
lysosomal O
recognition O
marker O
, O
and O
considerable O
sequence O
similarity O
, O
the O
UfAP B
and O
the O
UTMP B
may O
have O
homologous O
function O
which O
for O
both O
still O
remains O
obscure O
. O

Since O
the O
UfAP B
and O
UTMP B
share O
many O
biosynthetic O
and O
structural O
features O
that O
include O
site O
of O
biosynthesis O
in O
the O
endometrium O
, O
P4 O
- O
responsiveness O
, O
the O
presence O
of O
the O
mannose O
6 O
- O
phosphate O
lysosomal O
recognition O
marker O
, O
and O
considerable O
sequence O
similarity O
, O
the O
UfAP B
and O
the O
UTMP B
may O
have O
homologous O
function O
which O
for O
both O
still O
remains O
obscure O
. O

Since O
the O
UfAP B
and O
UTMP B
share O
many O
biosynthetic O
and O
structural O
features O
that O
include O
site O
of O
biosynthesis O
in O
the O
endometrium O
, O
P4 O
- O
responsiveness O
, O
the O
presence O
of O
the O
mannose O
6 O
- O
phosphate O
lysosomal O
recognition O
marker O
, O
and O
considerable O
sequence O
similarity O
, O
the O
UfAP B
and O
the O
UTMP B
may O
have O
homologous O
function O
which O
for O
both O
still O
remains O
obscure O
. O

The O
yeast O
gene O
that O
encodes O
eIF B
- I
5 I
, O
designated O
TIF5 B
, O
has O
been O
isolated O
and O
expressed O
in O
Escherichia O
coli O
to O
yield O
a O
catalytically O
active O
eIF B
- I
5 I
protein I
. O

In O
conclusion O
, O
IgM B
class O
CIC O
is O
the O
predominant O
CIC O
in O
acute O
hepatitis O
A O
and O
correlated O
with O
disease O
activity O
. O

As O
expected O
for O
a O
positive O
SpHE B
transcriptional I
regulator I
, O
the O
timing O
of O
SpEts4 B
gene I
expression O
precedes O
the O
transient O
expression O
of O
SpHE B
in O
the O
very O
early O
sea O
urchin O
blastula O
. O

A O
secondary O
phosphorylation O
of O
CREB341 B
at O
Ser129 O
is O
required O
for O
the O
cAMP O
- O
mediated O
control O
of O
gene O
expression O
. O

The O
activity O
of O
the O
coat B
protein I
promoter I
of O
chloris O
striate O
mosaic O
virus O
is O
enhanced O
by O
its O
own O
and O
C1 B
- O
C2 B
gene O
products O
. O

The O
activity O
of O
the O
coat B
protein I
promoter I
of O
chloris O
striate O
mosaic O
virus O
is O
enhanced O
by O
its O
own O
and O
C1 B
- O
C2 B
gene O
products O
. O

The O
sequence O
of O
the O
HIR1 B
gene I
predicts O
an O
88 O
- O
kDa O
protein O
with O
three O
repeats O
of O
a O
motif O
found O
in O
the O
G B
beta I
subunit I
of O
retinal B
transducin I
and O
in O
a O
yeast O
transcriptional O
repressor O
, O
Tup1 B
. O

U73 B
contains O
C O
, O
D O
and O
D O
' O
boxes O
and O
a O
12 O
- O
nucleotide O
antisense O
complementarity O
to O
the O
28S B
ribosomal I
RNA I
. O

CONCLUSIONS O
: O
XCoe2 B
may O
play O
a O
pivotal O
role O
in O
the O
transcriptional O
cascade O
that O
specifies O
primary O
neurons O
in O
Xenopus O
embryos O
: O
by O
maintaining O
Delta B
- O
Notch B
signalling O
, O
XCoe2 B
stabilises O
the O
higher O
neural O
potential O
of O
selected O
progenitor O
cells O
that O
express O
X B
- I
ngnr I
- I
1 I
, O
ensuring O
the O
transition O
between O
neural O
competence O
and O
irreversible O
commitment O
to O
a O
neural O
fate O
; O
and O
it O
promotes O
neuronal O
differentiation O
by O
activating O
XNeuroD B
expression O
, O
directly O
or O
indirectly O
. O

CONCLUSIONS O
: O
XCoe2 B
may O
play O
a O
pivotal O
role O
in O
the O
transcriptional O
cascade O
that O
specifies O
primary O
neurons O
in O
Xenopus O
embryos O
: O
by O
maintaining O
Delta B
- O
Notch B
signalling O
, O
XCoe2 B
stabilises O
the O
higher O
neural O
potential O
of O
selected O
progenitor O
cells O
that O
express O
X B
- I
ngnr I
- I
1 I
, O
ensuring O
the O
transition O
between O
neural O
competence O
and O
irreversible O
commitment O
to O
a O
neural O
fate O
; O
and O
it O
promotes O
neuronal O
differentiation O
by O
activating O
XNeuroD B
expression O
, O
directly O
or O
indirectly O
. O

CONCLUSIONS O
: O
XCoe2 B
may O
play O
a O
pivotal O
role O
in O
the O
transcriptional O
cascade O
that O
specifies O
primary O
neurons O
in O
Xenopus O
embryos O
: O
by O
maintaining O
Delta B
- O
Notch B
signalling O
, O
XCoe2 B
stabilises O
the O
higher O
neural O
potential O
of O
selected O
progenitor O
cells O
that O
express O
X B
- I
ngnr I
- I
1 I
, O
ensuring O
the O
transition O
between O
neural O
competence O
and O
irreversible O
commitment O
to O
a O
neural O
fate O
; O
and O
it O
promotes O
neuronal O
differentiation O
by O
activating O
XNeuroD B
expression O
, O
directly O
or O
indirectly O
. O

CONCLUSIONS O
: O
XCoe2 B
may O
play O
a O
pivotal O
role O
in O
the O
transcriptional O
cascade O
that O
specifies O
primary O
neurons O
in O
Xenopus O
embryos O
: O
by O
maintaining O
Delta B
- O
Notch B
signalling O
, O
XCoe2 B
stabilises O
the O
higher O
neural O
potential O
of O
selected O
progenitor O
cells O
that O
express O
X B
- I
ngnr I
- I
1 I
, O
ensuring O
the O
transition O
between O
neural O
competence O
and O
irreversible O
commitment O
to O
a O
neural O
fate O
; O
and O
it O
promotes O
neuronal O
differentiation O
by O
activating O
XNeuroD B
expression O
, O
directly O
or O
indirectly O
. O

CONCLUSIONS O
: O
XCoe2 B
may O
play O
a O
pivotal O
role O
in O
the O
transcriptional O
cascade O
that O
specifies O
primary O
neurons O
in O
Xenopus O
embryos O
: O
by O
maintaining O
Delta B
- O
Notch B
signalling O
, O
XCoe2 B
stabilises O
the O
higher O
neural O
potential O
of O
selected O
progenitor O
cells O
that O
express O
X B
- I
ngnr I
- I
1 I
, O
ensuring O
the O
transition O
between O
neural O
competence O
and O
irreversible O
commitment O
to O
a O
neural O
fate O
; O
and O
it O
promotes O
neuronal O
differentiation O
by O
activating O
XNeuroD B
expression O
, O
directly O
or O
indirectly O
. O

In O
contrast O
, O
an O
amino O
- O
terminal O
fragment O
containing O
the O
C O
/ O
H1 O
domain O
was O
sufficient O
for O
coactivation O
of O
Zta B
transcription O
and O
viral O
reactivation O
function O
. O

